From 397f9305309c41024ae3b6725784f751fc2fd643 Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Tue, 11 Jun 2024 08:40:45 -0700 Subject: [PATCH 01/45] creating script to build drug_descriptor table --- build/utils/build_drug_desc.py | 52 ++++++++++++++++++++++++++++++++++ 1 file changed, 52 insertions(+) create mode 100644 build/utils/build_drug_desc.py diff --git a/build/utils/build_drug_desc.py b/build/utils/build_drug_desc.py new file mode 100644 index 00000000..1efc9e76 --- /dev/null +++ b/build/utils/build_drug_desc.py @@ -0,0 +1,52 @@ +''' +build drug descriptor table from drug table + + +''' + + +import argparse +from rdkit import Chem +from rdkit.Chem import AllChem +import pandas as pd +import numpy as np +from mordred import Calculator, descriptors + +def smiles_to_fingerprint(smiles): + ''' + takes smiles nad create morgan fingerprint + ''' + fdict = [] + ##get morgan fingerprint + for s in smiles: + mol = Chem.MolFromSmiles(s) + fingerprint = AllChem.GetMorganFingerprintAsBitVect(mol, radius=2, nBits=1024) # update these parameters + fingerprint_array = np.array(fingerprint) + fdict.append({'smile':s,'descriptor_value':str(fingerprint_array),'structural_descriptor':'morgan fingerprint'}) + + return pd.DataFrame(fdict)#fingerprint_array + + +def smiles_to_mordred(smiles): + ''' + get descriptors - which ones? + ''' + + +def main: + parser = argparse.ArgumentParser('Build drug descriptor table') + parser.add_arg('--drugtable',dest='drugtable') + parser.add_arg('--desctable',dest='outtable') + + args = parser.parse_args() + + tab = pd.read_csv(args.drugtable,sep='\t') + + cansmiles = list(set(tab.canSMILES)) + # isosmiles = list(set(tab.isoSMILES)) + morgs = smiles_to_fingerprint(cansmiles) + + ids = pd.DataFrame(tab[['improve_drug_id','canSMILES']]).drop_duplicates() + ids = ids.rename({"canSMILES":'smile'},axis=1).merge(morgs)[['improve_drug_id','structural_descriptor','descriptor_value']] + + ids.to_csv(args.outtable,sep='\t',index=False) From 9b5a4856f91dd2a424d88674d557fb66772b4266 Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Tue, 11 Jun 2024 09:06:09 -0700 Subject: [PATCH 02/45] Updated Docker and build scripts --- build/beatAML/build_drugs.sh | 1 + build/beatAML/requirements.txt | 2 ++ build/broad_sanger/build_drugs.sh | 1 + build/broad_sanger/requirements.txt | 2 ++ build/docker/Dockerfile.beataml | 1 + build/mpnst/build_drugs.sh | 1 + build/mpnst/requirements.txt | 2 ++ build/utils/build_drug_desc.py | 14 ++++++++++---- 8 files changed, 20 insertions(+), 4 deletions(-) diff --git a/build/beatAML/build_drugs.sh b/build/beatAML/build_drugs.sh index 1627c172..e1d1e033 100644 --- a/build/beatAML/build_drugs.sh +++ b/build/beatAML/build_drugs.sh @@ -1 +1,2 @@ python GetBeatAML.py --token $SYNAPSE_AUTH_TOKEN --drugs --drugFile $1 +python build_drug_desc.py --drugtable /tmp/beataml_drugs.tsv --desctable /tmp/beataml_drug_desciptors.tsv diff --git a/build/beatAML/requirements.txt b/build/beatAML/requirements.txt index 4aec7b0e..2fcf5a32 100755 --- a/build/beatAML/requirements.txt +++ b/build/beatAML/requirements.txt @@ -7,3 +7,5 @@ numpy openpyxl matplotlib scikit-learn +mordred +rdkit diff --git a/build/broad_sanger/build_drugs.sh b/build/broad_sanger/build_drugs.sh index 32c3e9d9..429c7b57 100644 --- a/build/broad_sanger/build_drugs.sh +++ b/build/broad_sanger/build_drugs.sh @@ -1,2 +1,3 @@ /opt/venv/bin/python 03a-nci60Drugs.py Rscript 03-createDrugFile.R CTRPv2,GDSC,gCSI,PRISM,CCLE,FIMM +/opt/venv/bin/python build_drug_desc.py --drugtable /tmp/broad_sanger_drugs.tsv --desctable /tmp/broad_sanger_drug_desciptors.tsv diff --git a/build/broad_sanger/requirements.txt b/build/broad_sanger/requirements.txt index 8dcce8fe..b18f14ca 100755 --- a/build/broad_sanger/requirements.txt +++ b/build/broad_sanger/requirements.txt @@ -8,3 +8,5 @@ scipy requests openpyxl polars +mordred +rdkit diff --git a/build/docker/Dockerfile.beataml b/build/docker/Dockerfile.beataml index 033a21f3..c7e166c1 100644 --- a/build/docker/Dockerfile.beataml +++ b/build/docker/Dockerfile.beataml @@ -5,6 +5,7 @@ WORKDIR /usr/src/app COPY build/beatAML/GetBeatAML.py . COPY build/utils/fit_curve.py . +COPY build/utils/built_drug_desc.py . COPY build/beatAML/*sh ./ COPY build/beatAML/requirements.txt . diff --git a/build/mpnst/build_drugs.sh b/build/mpnst/build_drugs.sh index 3046a185..e107d5c3 100644 --- a/build/mpnst/build_drugs.sh +++ b/build/mpnst/build_drugs.sh @@ -1 +1,2 @@ Rscript 02_get_drug_data.R $SYNAPSE_AUTH_TOKEN $1 /tmp/mpnst_drugs.tsv +/opt/venv/bin/python build_drug_desc.py --drugtable /tmp/mpnst_drugs.tsv --desctable /tmp/mpnst_desciptors.tsv diff --git a/build/mpnst/requirements.txt b/build/mpnst/requirements.txt index a576cde6..6d3f9eeb 100755 --- a/build/mpnst/requirements.txt +++ b/build/mpnst/requirements.txt @@ -7,3 +7,5 @@ tqdm scikit-learn scipy requests +mordred +rdkit diff --git a/build/utils/build_drug_desc.py b/build/utils/build_drug_desc.py index 1efc9e76..b1ebef4f 100644 --- a/build/utils/build_drug_desc.py +++ b/build/utils/build_drug_desc.py @@ -18,11 +18,13 @@ def smiles_to_fingerprint(smiles): ''' fdict = [] ##get morgan fingerprint + print('Computing morgan fingerprints for '+str(len(smiles))+' SMILES') for s in smiles: mol = Chem.MolFromSmiles(s) fingerprint = AllChem.GetMorganFingerprintAsBitVect(mol, radius=2, nBits=1024) # update these parameters fingerprint_array = np.array(fingerprint) - fdict.append({'smile':s,'descriptor_value':str(fingerprint_array),'structural_descriptor':'morgan fingerprint'}) + fstr = ''.join([str(a) for a in fingerprint_array]) + fdict.append({'smile':s,'descriptor_value':fstr,'structural_descriptor':'morgan fingerprint'}) return pd.DataFrame(fdict)#fingerprint_array @@ -33,13 +35,14 @@ def smiles_to_mordred(smiles): ''' -def main: +def main(): parser = argparse.ArgumentParser('Build drug descriptor table') - parser.add_arg('--drugtable',dest='drugtable') - parser.add_arg('--desctable',dest='outtable') + parser.add_argument('--drugtable',dest='drugtable') + parser.add_argument('--desctable',dest='outtable') args = parser.parse_args() + print('Adding drug table for '+args.drugtable) tab = pd.read_csv(args.drugtable,sep='\t') cansmiles = list(set(tab.canSMILES)) @@ -50,3 +53,6 @@ def main: ids = ids.rename({"canSMILES":'smile'},axis=1).merge(morgs)[['improve_drug_id','structural_descriptor','descriptor_value']] ids.to_csv(args.outtable,sep='\t',index=False) + +if __name__=='__main__': + main() From f5221ea6b5dff09737879a61314a754c3b8b2820 Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Tue, 11 Jun 2024 15:20:05 -0700 Subject: [PATCH 03/45] updated READMEs with instructions, added mordred only the 2d descriptors for now --- beataml_samples.csv | 1190 +++++++++++++++++++ build/beatAML/README.md | 65 +- build/beatAML/requirements.txt | 2 +- build/broad_sanger/README.md | 84 +- build/broad_sanger/requirements.txt | 2 +- build/docker/Dockerfile.beataml | 2 +- build/mpnst/README.md | 33 +- build/mpnst/build_drugs.sh | 2 +- build/mpnst/requirements.txt | 2 +- build/utils/build_drug_desc.py | 19 +- mpnst_ignore_chems.txt | 1707 +++++++++++++++++++++++++++ mpnst_samples.csv | 51 + 12 files changed, 3080 insertions(+), 79 deletions(-) create mode 100644 beataml_samples.csv create mode 100755 mpnst_ignore_chems.txt create mode 100644 mpnst_samples.csv diff --git a/beataml_samples.csv b/beataml_samples.csv new file mode 100644 index 00000000..3f711905 --- /dev/null +++ b/beataml_samples.csv @@ -0,0 +1,1190 @@ +other_id,improve_sample_id,other_names,common_name,cancer_type,model_type,other_id_source,species +11-00261,2054,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +11-00503,2055,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +11-00475,2056,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00047,2057,"Mixed phenotype acute leukaemia, T/myeloid, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +12-00032,2058,Chronic myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +11-00376,2059,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +11-00378,2060,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +11-00382,2061,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +11-00388,2062,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +11-00416,2063,AML with minimal differentiation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +11-00465,2064,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +11-00466,2065,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +12-00069,2066,AML without maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00033,2067,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +12-00123,2068,AML with mutated NPM1,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +12-00127,2069,AML with mutated NPM1,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +12-00145,2070,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +12-00154,2071,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +12-00196,2072,"Acute myeloid leukaemia, NOS",Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +12-00250,2073,Acute monoblastic and monocytic leukaemia ,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00147,2074,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +12-00294,2075,AML with myelodysplasia-related changes,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +12-00383,2076,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00226,2077,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00016,2078,Acute undifferentiated leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00034,2079,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00160,2080,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00059,2081,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00075,2082,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00077,2083,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00092,2084,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00123,2085,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00149,2086,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +12-00268,2087,"Mixed phenotype acute leukaemia, T/myeloid, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00157,2088,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00186,2089,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00195,2090,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00245,2091,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00262,2092,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00331,2093,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00393,2094,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00450,2095,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00468,2096,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00495,2097,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00558,2098,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00581,2099,AML with t(6;9)(p23;q34); DEK-NUP214,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00584,2100,AML with maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00602,2101,AML with mutated CEBPA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00615,2102,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00045,2103,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00065,2104,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00126,2105,"Mixed phenotype acute leukaemia, T/myeloid, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00092,2106,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00127,2107,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00193,2108,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00482,2109,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00528,2110,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00240,2111,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00270,2112,"Myelodysplastic syndrome, unclassifiable",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00272,2113,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00423,2114,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00434,2115,AML with t(9;11)(p22;q23); MLLT3-MLL,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00477,2116,Acute monoblastic and monocytic leukaemia ,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00514,2117,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00608,2118,AML with maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00613,2119,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00711,2120,AML with maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00712,2121,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00641,2122,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00817,2123,Acute myelomonocytic leukaemia,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00043,2124,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00051,2125,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00888,2126,AML with minimal differentiation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00137,2127,AML with mutated CEBPA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00083,2128,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00880,2129,Therapy-related myeloid neoplasms,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00276,2130,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00302,2131,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00287,2132,AML with mutated CEBPA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00377,2133,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00563,2134,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00571,2135,AML with maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00578,2136,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00265,2137,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00653,2138,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00742,2139,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00764,2140,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00777,2141,AML with myelodysplasia-related changes,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00811,2142,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00813,2143,AML with maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00837,2144,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00855,2145,Myeloid leukaemia associated with Down syndrome,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00870,2146,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00872,2147,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00088,2148,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00976,2149,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00983,2150,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00001,2151,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00035,2152,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00031,2153,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00041,2154,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00056,2155,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00094,2156,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00109,2157,AML with mutated NPM1,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00120,2158,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00271,2159,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00289,2160,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00292,2161,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00310,2162,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00306,2163,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00351,2164,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00354,2165,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00459,2166,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00538,2167,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00611,2168,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00479,2169,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00481,2170,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00886,2171,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00494,2172,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00498,2173,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00504,2174,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00519,2175,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00667,2176,Primary myelofibrosis,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00627,2177,Chronic myelomonocytic leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00731,2178,AML with maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00751,2179,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00882,2180,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00811,2181,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00818,2182,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00817,2183,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00836,2184,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00844,2185,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00149,2186,Unknown,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01004,2187,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01061,2188,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00963,2189,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01049,2190,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01098,2191,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01100,2192,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01102,2193,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01109,2194,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00436,2195,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01151,2196,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01185,2197,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01191,2198,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01201,2199,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01220,2200,AML with mutated CEBPA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01225,2201,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01227,2202,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01237,2203,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01267,2204,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01270,2205,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00021,2206,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00025,2207,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00028,2208,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00066,2209,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00072,2210,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00115,2211,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00123,2212,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00249,2213,AML without maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00649,2214,Unknown,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00313,2215,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00322,2216,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00325,2217,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00328,2218,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00337,2219,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00361,2220,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00441,2221,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00444,2222,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00251,2223,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00500,2224,Acute monoblastic and monocytic leukaemia ,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00536,2225,Unknown,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00551,2226,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00613,2227,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00634,2228,AML with minimal differentiation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00678,2229,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00676,2230,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00687,2231,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00689,2232,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00741,2233,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00763,2234,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00770,2235,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00775,2236,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00834,2237,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00849,2238,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00878,2239,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00881,2240,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00896,2241,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00901,2242,Acute monoblastic and monocytic leukaemia ,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00908,2243,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00915,2244,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-01027,2245,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-01054,2246,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-01060,2247,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00007,2248,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00103,2249,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00101,2250,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00105,2251,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00190,2252,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00203,2253,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00218,2254,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00260,2255,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00278,2256,Unknown,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00290,2257,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00327,2258,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00408,2259,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00414,2260,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00084,2261,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00092,2262,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00154,2263,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +10-00669,2264,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00334,2265,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00395,2266,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00639,2267,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +10-00507,2268,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +11-00295,2269,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +10-00819,2270,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +11-00261,2054,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +09-00705,2271,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +10-00792,2272,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +10-00136,2273,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +10-00542,2274,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +11-00049,2275,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +10-00172,2276,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +11-00162,2277,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +10-00791,2278,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +11-00178,2279,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +11-00254,2280,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +10-00692,2281,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +10-00715,2282,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +11-00170,2283,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +11-00090,2284,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +11-00319,2285,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00106,2286,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00047,2057,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +12-00371,2287,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00111,2288,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +12-00069,2066,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +12-00362,2289,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00004,2290,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00033,2067,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +12-00127,2069,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00180,2291,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00059,2081,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00075,2082,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00077,2083,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00083,2292,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00090,2293,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00092,2084,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00137,2294,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00141,2295,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00201,2296,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00242,2297,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00218,2298,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00294,2299,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00236,2300,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00237,2301,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00247,2302,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00268,2303,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00286,2304,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00316,2305,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00346,2306,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00383,2307,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00053,2308,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00417,2309,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00424,2310,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00236,2311,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00476,2312,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00267,2313,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00497,2314,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00540,2315,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00554,2316,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00535,2317,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00600,2318,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00614,2319,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00622,2320,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00654,2321,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00004,2322,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00244,2323,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00052,2324,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00066,2325,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00067,2326,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00134,2327,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00150,2328,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00173,2329,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00171,2330,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00212,2331,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00245,2332,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00242,2333,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00253,2334,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00268,2335,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00270,2112,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00272,2113,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00298,2336,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00311,2337,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00329,2338,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00335,2339,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00369,2340,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00401,2341,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00404,2342,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00430,2343,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00449,2344,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00451,2345,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00477,2116,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00484,2346,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00487,2347,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00498,2348,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00499,2349,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00805,2350,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00502,2351,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00521,2352,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00527,2353,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00536,2354,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00543,2355,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00555,2356,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00573,2357,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00803,2358,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00603,2359,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00664,2360,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00715,2361,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00720,2362,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00738,2363,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00756,2364,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00758,2365,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00777,2366,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00793,2367,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00009,2368,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00143,2369,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00056,2370,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00129,2371,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00148,2372,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00150,2373,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00159,2374,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00167,2375,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00180,2376,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00294,2377,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00196,2378,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00200,2379,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00208,2380,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00281,2381,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00357,2382,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00358,2383,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00361,2384,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00396,2385,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00392,2386,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00407,2387,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00416,2388,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00492,2389,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00147,2390,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00514,2391,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00684,2392,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00571,2135,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00581,2393,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00655,2394,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00682,2395,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00704,2396,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00726,2397,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00731,2398,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00964,2399,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00895,2400,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00988,2401,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00898,2402,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00135,2403,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00947,2404,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00006,2405,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00015,2406,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00017,2407,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00026,2408,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00033,2409,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00035,2152,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00261,2410,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00782,2411,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00041,2154,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00046,2412,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00593,2413,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00062,2414,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00070,2415,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01059,2416,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00161,2417,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00359,2418,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00294,2419,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00232,2420,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00083,2421,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00366,2422,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00374,2423,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00783,2424,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00400,2425,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00486,2426,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00484,2427,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00524,2428,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00562,2429,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01018,2430,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00096,2431,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00595,2432,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00599,2433,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00618,2434,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00632,2435,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00709,2436,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00852,2437,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01009,2438,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00880,2439,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00950,2440,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00952,2441,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00968,2442,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00970,2443,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00981,2444,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01022,2445,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01024,2446,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01055,2447,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01078,2448,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01098,2191,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01123,2449,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01130,2450,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01139,2451,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01142,2452,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00334,2453,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01245,2454,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01256,2455,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01267,2204,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00057,2456,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00187,2457,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00277,2458,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00937,2459,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00938,2460,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00319,2461,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00340,2462,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00434,2463,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00439,2464,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00436,2465,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00534,2466,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00547,2467,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00618,2468,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00651,2469,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00664,2470,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00670,2471,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00745,2472,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00748,2473,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00850,2474,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00871,2475,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00876,2476,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00953,2477,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00095,2478,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00110,2479,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00205,2480,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00206,2481,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00232,2482,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00385,2483,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00418,2484,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00393,2485,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00428,2486,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00431,2487,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00433,2488,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00450,2489,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00465,2490,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00640,2491,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00007,2492,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +12-00426,2493,AML with t(6;9)(p23;q34); DEK-NUP214,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00061,2494,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +12-00023,2495,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +12-00372,2496,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +12-00066,2497,Chronic myelomonocytic leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +12-00051,2498,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00118,2499,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +12-00150,2500,unknown,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00537,2501,AML with maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +12-00211,2502,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +12-00258,2503,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00147,2074,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +12-00294,2075,AML with myelodysplasia-related changes,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +12-00301,2504,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00138,2505,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +12-00423,2506,AML with maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00226,2077,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00016,2078,Acute undifferentiated leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00028,2507,Acute myelomonocytic leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00034,2079,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00160,2080,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00098,2508,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00123,2085,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00126,2509,Acute erythroid leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00145,2510,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00146,2511,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00149,2086,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00150,2512,"Mixed phenotype acute leukaemia, T/myeloid, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00157,2088,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00163,2513,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00165,2514,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00166,2515,AML with maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00186,2089,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00195,2090,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00202,2516,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00204,2517,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00780,2518,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00232,2519,Acute myelomonocytic leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00255,2520,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00245,2091,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00250,2521,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00253,2522,Acute megakaryoblastic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00260,2523,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00262,2092,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00266,2524,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00270,2525,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00273,2526,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00281,2527,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00318,2528,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00331,2093,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00044,2529,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00338,2530,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00342,2531,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00353,2532,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00015,2533,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00354,2534,Acute monoblastic and monocytic leukaemia ,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00365,2535,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00384,2536,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00393,2094,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00396,2537,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00406,2538,Acute monoblastic and monocytic leukaemia ,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00409,2539,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00420,2540,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00425,2541,AML with t(9;11)(p22;q23); MLLT3-MLL,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00450,2095,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00454,2542,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00468,2096,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00557,2543,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00471,2544,AML with t(9;11)(p22;q23); MLLT3-MLL,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00487,2545,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00493,2546,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00495,2097,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00496,2547,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00500,2548,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00513,2549,AML with t(9;11)(p22;q23); MLLT3-MLL,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00515,2550,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00593,2551,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00522,2552,Secondary myelofibrosis,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00532,2553,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00544,2554,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00545,2555,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00546,2556,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00551,2557,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00552,2558,AML with maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00558,2098,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00563,2559,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00572,2560,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00573,2561,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00578,2562,AML with t(6;9)(p23;q34); DEK-NUP214,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00581,2099,AML with t(6;9)(p23;q34); DEK-NUP214,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00584,2100,AML with maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00601,2563,Refractory anaemia with excess blasts,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00602,2101,AML with mutated CEBPA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00619,2564,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00615,2102,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00625,2565,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00655,2566,AML with t(9;11)(p22;q23); MLLT3-MLL,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00658,2567,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00659,2568,Acute myelomonocytic leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00660,2569,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00001,2570,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00012,2571,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00021,2572,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00023,2573,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00026,2574,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00034,2575,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00041,2576,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00045,2103,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00053,2577,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00060,2578,"Myelodysplastic syndrome, unclassifiable",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00063,2579,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00064,2580,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00078,2581,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00126,2105,"Mixed phenotype acute leukaemia, T/myeloid, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00081,2582,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00092,2106,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00096,2583,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00113,2584,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00125,2585,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00127,2107,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00135,2586,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00141,2587,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00152,2588,Acute myelomonocytic leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00757,2589,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00175,2590,Acute monoblastic and monocytic leukaemia ,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00184,2591,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00193,2108,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00228,2592,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00482,2109,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00231,2593,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00528,2110,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00240,2111,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00259,2594,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00273,2595,AML with mutated CEBPA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00279,2596,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00289,2597,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00676,2598,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00466,2599,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00331,2600,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00355,2601,Acute monoblastic and monocytic leukaemia ,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00359,2602,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00597,2603,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00376,2604,Refractory anaemia with excess blasts,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00380,2605,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-01098,2606,Myeloid sarcoma,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00423,2114,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00425,2607,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00434,2115,AML with t(9;11)(p22;q23); MLLT3-MLL,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00447,2608,AML with t(9;11)(p22;q23); MLLT3-MLL,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00448,2609,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00458,2610,Refractory anaemia with excess blasts,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00464,2611,AML with t(9;11)(p22;q23); MLLT3-MLL,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00454,2612,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00473,2613,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00476,2614,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00488,2615,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00496,2616,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00504,2617,AML with t(9;11)(p22;q23); MLLT3-MLL,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00514,2117,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00537,2618,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00542,2619,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00546,2620,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00564,2621,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00559,2622,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00140,2623,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00567,2624,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00231,2625,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00578,2626,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00581,2627,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00588,2628,Acute erythroid leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00599,2629,AML with minimal differentiation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00974,2630,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00602,2631,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00608,2118,AML with maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00613,2119,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00618,2632,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00081,2633,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00632,2634,Acute myelomonocytic leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00643,2635,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00644,2636,Acute monoblastic and monocytic leukaemia ,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00658,2637,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00667,2638,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00672,2639,Essential thrombocythaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00670,2640,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00681,2641,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00690,2642,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00712,2121,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00714,2643,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00641,2122,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00725,2644,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00815,2645,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00730,2646,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00735,2647,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00739,2648,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00742,2649,"Myelodysplastic syndrome, unclassifiable",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00761,2650,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00774,2651,AML with minimal differentiation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00781,2652,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00787,2653,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00798,2654,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00800,2655,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00801,2656,Myeloid sarcoma,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00817,2123,Acute myelomonocytic leukaemia,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00831,2657,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00832,2658,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00901,2659,AML with minimal differentiation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00014,2660,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00018,2661,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00024,2662,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00029,2663,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00043,2124,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00045,2664,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00051,2125,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00057,2665,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00084,2666,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00071,2667,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00073,2668,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00075,2669,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00312,2670,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00123,2671,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00194,2672,AML with minimal differentiation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00874,2673,AML with minimal differentiation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00315,2674,AML with minimal differentiation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00147,2675,AML with mutated CEBPA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +14-00083,2128,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00275,2676,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00175,2677,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00169,2678,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00829,2679,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00171,2680,AML with minimal differentiation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00201,2681,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00229,2682,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00237,2683,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00246,2684,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00248,2685,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00261,2686,Acute myelomonocytic leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00269,2687,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00276,2130,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00350,2688,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00300,2689,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00302,2131,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00303,2690,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00287,2132,AML with mutated CEBPA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00309,2691,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00296,2692,AML with t(9;11)(p22;q23); MLLT3-MLL,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00320,2693,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00279,2694,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00331,2695,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00338,2696,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00351,2697,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00353,2698,Acute megakaryoblastic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00371,2699,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00377,2133,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01097,2700,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00395,2701,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00548,2702,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00733,2703,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00383,2704,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00406,2705,Refractory cytopenia with multilineage dysplasia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00417,2706,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00471,2707,AML with mutated CEBPA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00470,2708,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00464,2709,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00479,2710,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00491,2711,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00525,2712,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00534,2713,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00539,2714,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00556,2715,AML without maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00563,2134,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00559,2716,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00572,2717,AML with maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00578,2136,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00593,2718,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00264,2719,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00595,2720,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00608,2721,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00610,2722,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00614,2723,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00615,2724,"Acute myeloid leukaemia, NOS",Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00616,2725,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00626,2726,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00633,2727,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00650,2728,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00653,2138,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01094,2729,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00304,2730,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00670,2731,AML without maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00674,2732,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00680,2733,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00683,2734,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00688,2735,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00692,2736,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00693,2737,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00701,2738,AML with minimal differentiation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00702,2739,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00724,2740,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00734,2741,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00717,2742,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00742,2139,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00755,2743,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00756,2744,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00763,2745,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00764,2140,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00766,2746,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00767,2747,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00777,2141,AML with myelodysplasia-related changes,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00939,2748,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00778,2749,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01138,2750,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00782,2751,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00786,2752,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00807,2753,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00811,2142,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00864,2754,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00936,2755,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00813,2143,AML with maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00819,2756,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00821,2757,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00839,2758,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00837,2144,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00850,2759,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00855,2145,Myeloid leukaemia associated with Down syndrome,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00858,2760,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00870,2146,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00872,2147,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00883,2761,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00967,2762,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00900,2763,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00892,2764,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00903,2765,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00909,2766,AML with minimal differentiation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00912,2767,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00921,2768,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00929,2769,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00942,2770,AML with t(9;11)(p22;q23); MLLT3-MLL,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00010,2771,AML with t(9;11)(p22;q23); MLLT3-MLL,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00088,2148,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00073,2772,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00118,2773,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00961,2774,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00965,2775,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00975,2776,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00976,2149,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00981,2777,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00979,2778,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +15-00990,2779,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00001,2151,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00003,2780,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00004,2781,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00007,2782,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00027,2783,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00031,2153,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00124,2784,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00496,2785,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00048,2786,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00050,2787,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00056,2155,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00087,2788,Therapy-related myeloid neoplasms,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00067,2789,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00075,2790,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00078,2791,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00077,2792,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00094,2156,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00226,2793,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00102,2794,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00109,2157,AML with mutated NPM1,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00120,2158,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00129,2795,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00113,2796,Myeloid sarcoma,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00115,2797,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00132,2798,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00139,2799,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00358,2800,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00143,2801,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00145,2802,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00157,2803,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01127,2804,AML with mutated NPM1,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00442,2805,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00150,2806,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00151,2807,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00217,2808,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00220,2809,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00249,2810,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00269,2811,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00271,2159,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00273,2812,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00278,2813,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00289,2160,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00292,2161,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00303,2814,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01118,2815,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00307,2816,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00483,2817,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00316,2818,unknown,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00332,2819,"Myelodysplastic syndrome, unclassifiable",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00458,2820,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00339,2821,"Atypical chronic myeloid leukaemia, BCR-ABL1 negative",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00344,2822,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00351,2164,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00354,2165,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00356,2823,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00373,2824,Myeloid sarcoma,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00392,2825,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00406,2826,AML with maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00410,2827,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00466,2828,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00533,2829,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00459,2166,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00460,2830,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00465,2831,Acute myelomonocytic leukaemia,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00474,2832,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00538,2167,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00710,2833,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00059,2834,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00477,2835,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00611,2168,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00883,2836,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00479,2169,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00481,2170,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00491,2837,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00765,2838,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00886,2171,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00494,2172,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00498,2173,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00504,2174,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00510,2839,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00519,2175,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00525,2840,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00541,2841,Plasma cell myeloma,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00540,2842,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00547,2843,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +13-00650,2844,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00564,2845,Chronic myelomonocytic leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00566,2846,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00701,2847,Chronic myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00822,2848,Chronic myelomonocytic leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00627,2177,Chronic myelomonocytic leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00699,2849,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00702,2850,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00705,2851,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00708,2852,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00724,2853,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00731,2178,AML with maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00755,2854,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00766,2855,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00882,2180,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00770,2856,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00771,2857,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00810,2858,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00818,2182,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00815,2859,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00820,2860,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00834,2861,"Mixed phenotype acute leukaemia, T/myeloid, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00831,2862,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00836,2184,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00867,2863,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00846,2864,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01017,2865,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00875,2866,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00118,2867,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00048,2868,Unknown,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00149,2186,Unknown,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00951,2869,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-00980,2870,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01004,2187,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01005,2871,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01010,2872,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01061,2188,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01103,2873,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01192,2874,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00963,2189,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01047,2875,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01049,2190,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01080,2876,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01082,2877,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01093,2878,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01100,2192,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01102,2193,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01109,2194,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01121,2879,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00215,2880,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00436,2195,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01151,2196,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01185,2197,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01191,2198,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01201,2199,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01210,2881,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01216,2882,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01219,2883,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01223,2884,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01225,2201,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01227,2202,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01237,2203,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01254,2885,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01262,2886,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01272,2887,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +16-01270,2205,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00077,2888,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00011,2889,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00021,2206,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00281,2890,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00025,2207,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00029,2891,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00033,2892,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00064,2893,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00066,2209,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00072,2210,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00093,2894,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00094,2895,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00105,2896,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00111,2897,Myeloid sarcoma,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00113,2898,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00123,2212,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00126,2899,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00177,2900,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00179,2901,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00189,2902,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00195,2903,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00210,2904,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00230,2905,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00248,2906,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00368,2907,AML without maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00252,2908,AML with minimal differentiation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00256,2909,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00262,2910,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00264,2911,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00276,2912,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00287,2913,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00300,2914,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00313,2215,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00321,2915,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00322,2216,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00325,2217,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00326,2916,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00328,2218,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00337,2219,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00346,2917,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00360,2918,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00423,2919,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00438,2920,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00441,2221,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00444,2222,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00443,2921,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00251,2223,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00446,2922,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00452,2923,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00457,2924,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00463,2925,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00464,2926,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00466,2927,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00467,2928,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00478,2929,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00482,2930,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00485,2931,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00491,2932,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00499,2933,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00831,2934,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00043,2935,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00511,2936,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00514,2937,AML with t(9;11)(p22;q23); MLLT3-MLL,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00518,2938,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00536,2225,Unknown,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00539,2939,Acute erythroid leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00551,2226,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00556,2940,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00613,2227,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00634,2228,AML with minimal differentiation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00637,2941,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00656,2942,unknown,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00678,2229,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00679,2943,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00676,2230,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00685,2944,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00687,2231,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00690,2945,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00694,2946,"Mixed phenotype acute leukaemia, B/myeloid, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00741,2233,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00755,2947,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00761,2948,Acute myelomonocytic leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00768,2949,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00770,2235,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00772,2950,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00776,2951,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00779,2952,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00781,2953,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00834,2237,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00838,2954,Myeloid sarcoma,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00843,2955,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00848,2956,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00849,2238,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00851,2957,AML with minimal differentiation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00857,2958,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00862,2959,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00867,2960,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00878,2239,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00881,2240,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00883,2961,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00887,2962,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00893,2963,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00896,2241,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00901,2242,Acute monoblastic and monocytic leukaemia ,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00908,2243,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00915,2244,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00926,2964,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00933,2965,Unknown,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-01020,2966,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-01021,2967,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-01023,2968,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-01024,2969,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-01038,2970,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-01047,2971,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-01036,2972,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-01054,2246,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-01060,2247,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-01081,2973,AML with maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-01083,2974,Acute myelomonocytic leukaemia,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-01106,2975,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-01110,2976,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-01117,2977,AML with maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00007,2248,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00012,2978,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00014,2979,Unknown,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00016,2980,Unknown,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00029,2981,AML with mutated NPM1,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00039,2982,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00053,2983,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00055,2984,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00361,2985,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00073,2986,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00077,2987,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00082,2988,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00103,2249,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00101,2250,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00105,2251,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00127,2989,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00129,2990,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00131,2991,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00135,2992,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00173,2993,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00179,2994,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00184,2995,Unknown,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00190,2252,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00192,2996,AML with mutated NPM1,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00204,2997,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00206,2998,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00208,2999,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00218,2254,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00219,3000,Refractory cytopenia with multilineage dysplasia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00223,3001,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00226,3002,AML with minimal differentiation,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00230,3003,AML with mutated NPM1,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00238,3004,Unknown,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00253,3005,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00260,2255,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00334,3006,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00267,3007,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00269,3008,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00270,3009,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00278,2256,Unknown,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00279,3010,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00280,3011,Unknown,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00283,3012,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00290,2257,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00298,3013,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00305,3014,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00332,3015,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00320,3016,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00327,2258,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00341,3017,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00390,3018,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00408,2259,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00027,3019,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00035,3020,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +18-00414,2260,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00019,3021,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00025,3022,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00029,3023,AML with mutated NPM1,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00062,3024,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00051,3025,AML with maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00084,2261,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00092,2262,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00107,3026,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00137,3027,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00154,2263,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00156,3028,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00165,3029,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00179,3030,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00200,3031,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00261,3032,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00290,3033,"Mixed phenotype acute leukaemia, T/myeloid, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00313,3034,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00315,3035,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00327,3036,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00369,3037,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +19-00400,3038,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +00-00002,3039,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +00-00003,3040,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +00-00004,3041,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +00-00005,3042,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +00-00006,3043,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +00-00007,3044,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +00-00008,3045,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +00-00009,3046,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +00-00010,3047,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +00-00011,3048,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +00-00012,3049,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +00-00013,3050,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +00-00015,3051,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +00-00016,3052,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +00-00017,3053,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +00-00018,3054,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00035,3055,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00036,3056,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00037,3057,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00038,3058,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00039,3059,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00040,3060,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00041,3061,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00042,3062,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00043,3063,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00044,3064,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00045,3065,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00046,3066,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00047,3067,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00048,3068,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00049,3069,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00050,3070,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00051,3071,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00052,3072,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00053,3073,Control,Healthy Individual CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00055,3074,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens +17-00056,3075,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens diff --git a/build/beatAML/README.md b/build/beatAML/README.md index fe1f47af..7cb09358 100644 --- a/build/beatAML/README.md +++ b/build/beatAML/README.md @@ -1,24 +1,51 @@ ## BeatAML Data generation -This directory builds the data for the BeatAML samples - -### Sample generation - -To generate samples, you need to pass in the path of the previous -sample file. - -``` -python GetBeatAML.py --token $SYNAPSE_AUTH_TOKEN --prevSamples=[path to previous samples] -``` - -### Drug generation - -How are the drugs generated??? - -### Omics and Experiment Data - +This directory builds the data for the BeatAML samples. To build and +test this module, run the following commands from the root directory. + +### Build with test data +Build commands should be similar to every other coderdata build module. + +1. Build the Docker image: + ``` + docker build -f build/docker/Dockerfile.beataml -t beataml . --build-arg HTTPS_PROXY=$HTTPS_PROXY + ``` + +2. Generate new identifiers for these samples to create a + `beataml_samples.csv` file. This pulls from the latest synapse + project metadata table. + ``` + docker run -e SYNAPSE_AUTH_TOKEN=$SYNAPSE_AUTH_TOKEN -v $PWD:/tmp beataml sh build_samples.sh /tmp/build/build_test/test_samples.csv + ``` + +3. Pull the data and map it to the samples. This uses the metadata + table pulled above. + ``` + docker run -v $PWD:/tmp -e SYNAPSE_AUTH_TOKEN=$SYNAPSE_AUTH_TOKEN beataml sh build_omics.sh /tmp/build/build_test/test_genes.csv /tmp/beataml_samples.csv + ``` + +4. Process drug data + ``` + docker run -e SYNAPSE_AUTH_TOKEN=$SYNAPSE_AUTH_TOKEN -v $PWD:/tmp beataml sh build_drugs.sh /tmp/build/build_test/test_drugs.tsv + ``` + +5. Process experiment data. This uses the metadata from above as well as the file metadata on synapse: + ``` + docker run -e SYNAPSE_AUTH_TOKEN=$SYNAPSE_AUTH_TOKEN -v $PWD:/tmp beataml sh build_exp.sh /tmp/beataml_samples.csv /tmp/beataml_drugs.tsv.gz + ``` + +Please ensure that each step is followed in order for correct dataset +compilation. + + +### BeatAML Dataset structure +The build commands above create the following files ``` -python GetBeatAML.py --token $SYNAPSE_AUTH_TOKEN --curSamples=[path togenerated sample file] - +├── beataml_samples.csv +├── beataml_transcriptomics.csv +├── beataml_mutations.csv +├── beataml_drugs.tsv.gz +├── beataml_drug_descriptors.tsv.gz +├── beataml_experiments.tsv.gz ``` diff --git a/build/beatAML/requirements.txt b/build/beatAML/requirements.txt index 2fcf5a32..4faf477e 100755 --- a/build/beatAML/requirements.txt +++ b/build/beatAML/requirements.txt @@ -7,5 +7,5 @@ numpy openpyxl matplotlib scikit-learn -mordred +mordredcommunity rdkit diff --git a/build/broad_sanger/README.md b/build/broad_sanger/README.md index 0a0f1cce..d7f7728a 100644 --- a/build/broad_sanger/README.md +++ b/build/broad_sanger/README.md @@ -1,56 +1,67 @@ ## Building Broad and Sanger cell line data The Broad and Sanger data is the first to be built, and requires the following commands. All scripts write files in to the `/tmp/` -directory, so mounting to that directly will help output the files +directory, so mounting to that directly will help output the files. We +broke the Docker image into two to reduce overall size and complexity +of each image. -### Docker image and gene file -First step is to build the docker file and the genes.csv file. This is -required for all future data files. -``` -docker build -f ../../build/docker/Dockerfile.broad_sanger -t broad_sanger ../../ -docker run -v $PWD:/tmp/ broad_sanger Rscript 00-buildGeneFile.R +### Build gene, sample, and omics data +Below are the steps required to build and test the gene/sample/omics +builds. Commands are designed to be run from the root of the repo. +1. Build omics docker ``` - -### DepMap reference samples and identifiers -Next we retrieve all the standard cell line identifiers we can, from diverse -sources, and map them to IMPROVE sample identifiers for future reference. + docker build -f build/docker/Dockerfile.broad_sanger_omics -t broad_sanger_omics . --build-arg HTTPS_PROXY=$HTTPS_PROXY ``` -docker run -v $PWD:/tmp/ broad_sanger Rscript 01-broadSangerSamples.R - +2. Build gene file +``` + docker run -v $PWD:/tmp broad_sanger_omics sh build_genes.sh ``` -### Omics data for Broad/Sanger cell lines -Third we collect the omics data for these cell lines, again from -diverse sources. Currently we have a single script for each -source. Each script takes our list of gene and sample identifiers +3. Build sample file +``` + docker run -v $PWD:/tmp broad_sanger_omics sh build_samples.sh +``` +4. Build omics files +``` + docker run -v $PWD:/tmp broad_sanger_omics sh build_omics.sh ``` -docker run -v $PWD:/tmp/ broad_sanger Rscript 02-broadSangerOmics.R /tmp/genes.csv /tmp/broad_sanger_samples.csv +This should leave you with the following files for al the cell lines +``` +├── broad_sanger_samples.csv.gz +├── broad_sanger_transcriptomics.csv.gz +├── broad_sanger_mutations.csv.gz +├── broad_sanger_copy_number.csv.gz +├── genes.csv ``` -### Drug data for all experiments +### Build out drug files and experiments +Both of these steps can be lengthy - the experiment fitting can be +parallelized but the drug information requires querying PubChem which +can take a while. -Fourth we collect drugs and map them to pubchem, then structure. This -is a slow step as we collect from diverse studies including: -1. CTRPv2 -2. GDSCv1 -3. GDSCv2 -4. gCSI -5. PRISM2020 -6. CCLE -7. FIMM -8. NCI60 +1. Build experiment docker fille ``` -docker run -v $PWD:/tmp broad_sanger Rscript 03-createDrugFile.R CTRPv2,GDSC,gCSI,PRISM,CCLE,FIMM,NCI60 + docker build -f build/docker/Dockerfile.broad_sanger_exp -t broad_sanger_exp . --build-arg HTTPS_PROXY=$HTTPS_PROXY + ``` -### Dose response and curve fitting -This last command will generate the drug file, drugs.tsv.gz, which we -can pass into the next commands. Then we will collect the dose -response data and fit the curves for the following experiments: +2. Build drug files + ``` + docker run -v $PWD:/tmp broad_sanger_exp sh build_drugs.sh /tmp/build/build_test/test_drugs.tsv + ``` +3. Build experiment files + ``` + docker run -v $PWD:/tmp broad_sanger_exp sh build_exp.sh /tmp/broad_sanger_samples.csv /tmp/broad_sanger_drugs.tsv.gz + ``` + +### Datasets collected + +Fourth we collect drugs and map them to pubchem, then structure. This +is a slow step as we collect from diverse studies including: 1. CTRPv2 2. GDSCv1 3. GDSCv2 @@ -60,9 +71,4 @@ response data and fit the curves for the following experiments: 7. FIMM 8. NCI60 -``` -docker run -v $PWD:/tmp/ broad_sanger /opt/venv/bin/python 04-drug_dosage_and_curves.py --drugfile=/tmp/broad_sanger_drugs.tsv --curSampleFile=/tmp/broad_sanger_samples.csv - -``` - diff --git a/build/broad_sanger/requirements.txt b/build/broad_sanger/requirements.txt index b18f14ca..f4df6ef1 100755 --- a/build/broad_sanger/requirements.txt +++ b/build/broad_sanger/requirements.txt @@ -8,5 +8,5 @@ scipy requests openpyxl polars -mordred +mordredcommunity rdkit diff --git a/build/docker/Dockerfile.beataml b/build/docker/Dockerfile.beataml index c7e166c1..e8a99bb1 100644 --- a/build/docker/Dockerfile.beataml +++ b/build/docker/Dockerfile.beataml @@ -5,7 +5,7 @@ WORKDIR /usr/src/app COPY build/beatAML/GetBeatAML.py . COPY build/utils/fit_curve.py . -COPY build/utils/built_drug_desc.py . +COPY build/utils/build_drug_desc.py . COPY build/beatAML/*sh ./ COPY build/beatAML/requirements.txt . diff --git a/build/mpnst/README.md b/build/mpnst/README.md index 7c90b73e..13c08454 100755 --- a/build/mpnst/README.md +++ b/build/mpnst/README.md @@ -1,29 +1,34 @@ ## Build Instructions for MPNST Dataset -To build the MPNST dataset, follow these steps: +To build the MPNST dataset, follow these steps from the coderdata root +directory. Currently using the test files as input. 1. Build the Docker image: ``` - docker build -f dockerfile.mpnst -t mpnst . --build-arg HTTPS_PROXY=$HTTPS_PROXY + docker build -f build/docker/Dockerfile.mpnst -t mpnst . --build-arg HTTPS_PROXY=$HTTPS_PROXY ``` 2. Generate new identifiers for these samples to create a - `MPNST_samples.csv` file. This pulls from the latest synapse + `mpnst_samples.csv` file. This pulls from the latest synapse project metadata table. ``` - docker run -v $PWD:/tmp mpnst Rscript 00_sample_gen.R /tmp/beatAML/beataml_samples.csv $SYNAPSE_AUTH_TOKEN + docker run -v $PWD:/tmp -e -e SYNAPSE_AUTH_TOKEN=$SYNAPSE_AUTH_TOKEN mpnst sh build_samples.sh /tmp/build/build_test/test_samples.csv ``` 3. Pull the data and map it to the samples. This uses the metadata table pulled above. ``` - docker run -v $PWD:/tmp mpnst Rscript 01_mpnst_get_omics.R $SYNAPSE_AUTH_TOKEN /tmp/MPNST_samples.csv /tmp/cell_line/genes.csv + docker run -v $PWD:/tmp -e SYNAPSE_AUTH_TOKEN=$SYNAPSE_AUTH_TOKEN mpnst sh build_omics.sh /tmp/build/build_test/test_genes.csv /tmp/mpnst_samples.csv ``` -4. Process drug and experiment data. This uses the metadata from above - as well as the file directory on synapse: +4. Process drug data ``` - docker run -v $PWD:/tmp mpnst Rscript 02_get_drug_data.R $SYNAPSE_AUTH_TOKEN /tmp/MPNST_samples.csv /tmp/cell_line/drugs.tsv.gz + docker run -v $PWD:/tmp -e SYNAPSE_AUTH_TOKEN=$SYNAPSE_AUTH_TOKEN mpnst sh build_drugs.sh /tmp/build/build_test/test_drugs.tsv + ``` + +5. Process experiment data. This uses the metadata from above as well as the file directory on synapse: + ``` + docker run -v $PWD:/tmp -e SYNAPSE_AUTH_TOKEN=$SYNAPSE_AUTH_TOKEN mpnst sh build_exp.sh /tmp/mpnst_samples.csv /tmp/mpnst_drugs.tsv.gz ``` Please ensure that each step is followed in order for correct dataset compilation. @@ -31,10 +36,12 @@ Please ensure that each step is followed in order for correct dataset compilatio ## MPNST Dataset Structure The MPNST dataset includes the following output files: ``` -├── MPNST_transcriptomics.csv -├── MPNST_mutations.csv -├── MPNST_copy_number.csv -├── MPNST_drugs.tsv.gz -├── MPNST_experiments.tsv.gz +├── mpnst_samples.csv +├── mpnst_transcriptomics.csv +├── mpnst_mutations.csv +├── mpnst_copy_number.csv +├── mpnst_drugs.tsv +├── mpnst_drug_descriptors.tsv.gz +├── mpnst_experiments.tsv.gz ``` diff --git a/build/mpnst/build_drugs.sh b/build/mpnst/build_drugs.sh index e107d5c3..8e6ac887 100644 --- a/build/mpnst/build_drugs.sh +++ b/build/mpnst/build_drugs.sh @@ -1,2 +1,2 @@ Rscript 02_get_drug_data.R $SYNAPSE_AUTH_TOKEN $1 /tmp/mpnst_drugs.tsv -/opt/venv/bin/python build_drug_desc.py --drugtable /tmp/mpnst_drugs.tsv --desctable /tmp/mpnst_desciptors.tsv +/opt/venv/bin/python build_drug_desc.py --drugtable /tmp/mpnst_drugs.tsv --desctable /tmp/mpnst_drug_descriptors.tsv.gz diff --git a/build/mpnst/requirements.txt b/build/mpnst/requirements.txt index 6d3f9eeb..fe381e8c 100755 --- a/build/mpnst/requirements.txt +++ b/build/mpnst/requirements.txt @@ -7,5 +7,5 @@ tqdm scikit-learn scipy requests -mordred +mordredcommunity rdkit diff --git a/build/utils/build_drug_desc.py b/build/utils/build_drug_desc.py index b1ebef4f..ddc21865 100644 --- a/build/utils/build_drug_desc.py +++ b/build/utils/build_drug_desc.py @@ -33,7 +33,15 @@ def smiles_to_mordred(smiles): ''' get descriptors - which ones? ''' - + mols = [Chem.MolFromSmiles(s) for s in smiles] + calc = Calculator(descriptors, ignore_3D=True) + dd = calc.pandas( mols, nmols=None, quiet=False, ipynb=False ) + values = dd.columns + dd['smile'] = smiles + ##reformat here + longtab = pd.melt(dd,id_vars='smile',value_vars=values) + longtab = longtab.rename({'variable':'structural_descriptor','value':'descriptor_value'},axis=1) + return longtab def main(): parser = argparse.ArgumentParser('Build drug descriptor table') @@ -50,9 +58,14 @@ def main(): morgs = smiles_to_fingerprint(cansmiles) ids = pd.DataFrame(tab[['improve_drug_id','canSMILES']]).drop_duplicates() - ids = ids.rename({"canSMILES":'smile'},axis=1).merge(morgs)[['improve_drug_id','structural_descriptor','descriptor_value']] + id_morg = ids.rename({"canSMILES":'smile'},axis=1).merge(morgs)[['improve_drug_id','structural_descriptor','descriptor_value']] - ids.to_csv(args.outtable,sep='\t',index=False) + mords = smiles_to_mordred(cansmiles) + + id_mord = ids.rename({'canSMILES':'smile'},axis=1).merge(mords)[['improve_drug_id','structural_descriptor','descriptor_value']] + + full = pd.concat([id_morg,id_mord],axis=0) + full.to_csv(args.outtable,sep='\t',index=False,compression='gzip') if __name__=='__main__': main() diff --git a/mpnst_ignore_chems.txt b/mpnst_ignore_chems.txt new file mode 100755 index 00000000..b85487c6 --- /dev/null +++ b/mpnst_ignore_chems.txt @@ -0,0 +1,1707 @@ +nsc241240 +platinum, diammine[1,1-cyclobutanedi(carboxylato-ko)(2-)]-, (sp-4-2)- +platinum,1-cyclobutanedicarboxylato(2-)-o,o']-, (sp-4-2)- +stl451040 +cbdca +tox21_112586_1 +cis-diammine(1,1-cyclobutanedicarboxylato)platinum(ii) +epitope id:194801 +carboplatin +7,7-diamino-6,8-dioxa-7-platinaspiro[3.5]nonane-5,9-dione +diamino[cyclobutane-1,1-dicarboxylato(2-)-kappa~2~o~1~,o~1~]platinum +nsc758182 +paraplatin +hms3269h03 +ncgc00167800-01 +pharmakon1600-01502106 +en300-123065 +azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) +cis-diammine(1,1-cyclobutanedicarboxylato)platinum +platinum(ii),1-cyclobutanedicarboxylato)diammine-, cis- +dtxsid3046742 +sy075575 +1,1-cyclobutanedicarboxylate diammine platinum(ii) +chebi:31355 +cis-(1,1-cyclobutanedicarboxylato)diammineplatinum(ii) +platinum,1-cyclobutanedicarboxylato(2-)-o,o')-, (sp-4-2)- +platinum, diammine[1,1-cyclobutanedicarboxylato(2-)-.kappa.o,.kappa.o'']-, (sp-4-2)- +ab01273939-01 +mfcd00070464 +ns00076275 +carboplatinum +nsc201345 +nsc-241240 +lopac0_000230 +1,1-cyclobutanedicarboxylatodiammineplatinum(ii) +dtxcid201476080 +cas-41575-94-4 +41575-94-4 +schembl4964 +bp-25385 +nsc-758182 +ncgc00263858-02 +paraplatin (bristol meyers) +(-)-n-(((r)-2,3-dihydroxypropyl)oxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide +n-((r)-2,3-dihydroxy[propoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide +4bm +nsc800840 +bdbm104963 +schembl172904 +cs-0062 +n-[(2r)-2,3-dihydroxypropoxy]-3,4-d ifluoro-2-[(2-fluoro-4-iodophenyl)amino]-benzamide +benzamide, n-((2r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)- +mirdametinib [usan] +db07101 +nsc-755770 +n-((2r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)-benzamide +mirdametinib [inn] +ex-8602 +gtpl7935 +(r)-n-(2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)benzamide +pd 901 +pd0325901 (pd325901) +benzamide, n-[(2r)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]- +n-[(2r)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide +hms3648a14 +(r)-n-(2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide +n-((r)-2,3-dihydroxy-propoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide +us8575391, q +j-502503 +pd-325901 +c16h14f3in2o4 +ccg-221316 +who 11299 +chembl507361 +mirdametinib +391209-97-5 +ns00069616 +mirdametinib [who-dd] +cas-391210-10-9 +pd 0325901 +n-[((r)-2,3-dihydroxypropyl)oxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide +(s)-n-(2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide +q27088255 +dtxcid8024024 +dtxsid0044024 +d11675 +n-[(r)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide +n-[(2r)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide +n-(((r)-2,3-dihydroxypropyl)oxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide n-((2r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide +pd325901 , pd0325901 +mfcd08435926 +nsc-800840 +hb2240 +chebi:88249 +86k0j5ak6m +pd 0325901, >=98% (hplc) +bcp9001057 +n-{[(2r)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide +pd-0325901 +unii-86k0j5ak6m +nsc755770 +tox21_113364 +pd0325901 +n-[(2r)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-benzamide +sr-01000946344 +amy36437 +n-(((r)-2,3-dihydroxypropyl)oxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide +s1036 +sw218101-2 +sr-01000946344-1 +ncgc00189075-01 +391210-10-9 +pd-0325901,pd325901 +pd0325901(mirdametinib) +ncgc00381744-09 +brd-k49865102-001-01-9 +ex-a102 +pd 325901 +mirdametinib (usan) +hy-10254 +akos015855518 +bcpp000126 +pd 03525901 +n-[(2r)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]- benzamide +digoxin pediatric +lanorale +nsc 95100 +20830-75-5 (free) +digomal +20830-75-5 +mapluxin +digoxin [who-ip] +digoxina (inn-spanish) +hy-b1049 +3-[(3s,5r,8r,9s,10s,12r,13s,14s,17r)-3-[(2r,4s,5s,6r)-5-[(2s,4s,5s,6r)-5-[(2s,4s,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2h-furan-5-one +prestwick2_000437 +lifusin +sr-01000721866 +digoxin, certified reference material, tracecert(r) +digoxine navtivelle +db00390 +tox21_201678 +smr000653537 +vanoxin +d00298 +prestwick0_000437 +ncgc00090797-07 +saroxin +digoxin (jp17/usp) +lanoxicaps (tn) +toloxin +ncgc00090797-04 +human serum - digoxin, low level +ncgc00259227-01 +digoxin +lanocardin +sk-digoxin +digoxin, analytical standard +ncgc00257022-01 +hms1569g16 +0b9662a7-264e-4acd-94b2-9e1138c0ca5a +digoxin, european pharmacopoeia (ep) reference standard +digoxina [inn-spanish] +stillacor- +digitek +12a-hydroxydigitoxin +davoxin +lanoxin pediatric +digoxin [ep monograph] +lanoxin (tn) +bpbio1_000500 +12beta-hydroxydigitoxin +c01aa05 +novodigal (inj.) +q422222 +digoxin for peak identification, european pharmacopoeia (ep) reference standard +digoxin [mart.] +digoxin [iarc] +digoxin (ep monograph) +digoxigenin-tridigitoxosid [german] +acygoxin +3.beta.-((o-2,6-dideoxy-.beta.-d-ribo-hexopyranosyl-(1->4)-o-2,6-dideoxy-.beta.-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-.beta.-d-ribo-hexopyranosyl)oxy)-12.beta.,14-dihydroxy-5.beta.-card-20(22)-enolide +digoxin (usp:inn:ban:jan) +digitalis glycoside +cas-20830-75-5 +digos +bdbm46355 +4-[(1r,3as,3br,5ar,7s,9as,9bs,11r,11as)-7-{[(2r,4s,5s,6r)-5-{[(2s,4s,5s,6r)-5-{[(2s,4s,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-3a,11-dihydroxy-9a,11a-dimethyl-hexadecahydro-1h-cyclopenta[a]phenanthren-1-yl]-2,5-dihydrofuran-2-one +prestwick3_000437 +hsdb 214 +ncgc00090797-12 +digoxin (mart.) +4-((3s,5r,8r,9s,10s,12r,13s,14s,17r)-3-(((2r,4s,5s,6r)-5-(((2s,4s,5s,6r)-5-(((2s,4s,5s,6r)-4,5-dihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-4-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-4-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-12,14-dihydroxy-10,13-dimethylhexadecahydro-1h-cyclopenta[a]phenanthren-17-yl)furan-2(5h)-one +digossina +digoxin [hsdb] +dtxsid5022934 +digoxin [who-dd] +12 beta -hydroxydigitoxin +gtpl4726 +s4290 +digoxina +spbio_002393 +3-[(3s,5r,8r,9s,10s,12r,13s,14s,17r)-10,13-dimethyl-3-[(2r,4s,5s,6r)-6-methyl-5-[(2s,4s,5s,6r)-6-methyl-5-[(2s,4s,5s,6r)-6-methyl-4,5-bis(oxidanyl)oxan-2-yl]oxy-4-oxidanyl-oxan-2-yl]oxy-4-oxidanyl-oxan-2-yl]oxy-12,14-bis(oxidanyl)-1,2,3,4,5,6,7,8,9,11,12, +3-[(3s,5r,8r,9s,10s,12r,13s,14s,17r)-3-[[(2r,4s,5s,6r)-5-[[(2s,4s,5s,6r)-5-[[(2s,4s,5s,6r)-4,5-dihydroxy-6-methyl-2-oxanyl]oxy]-4-hydroxy-6-methyl-2-oxanyl]oxy]-4-hydroxy-6-methyl-2-oxanyl]oxy]-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16, +card-20(22)-enolide, 3-((o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(hexopyranosyl-(1-4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, +digoxin, pharmaceutical secondary standard; certified reference material +3b0w +brd-k23478508-001-03-7 +digitoxin, 12beta-hydroxy- +hb1138 +ncgc00090797-01 +3beta-(2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-d-ribo-hexopyranosyloxy)-12beta,14-dihydroxy-5beta,14beta-card-20(22)-enolide +ncgc00090797-15 +digoxin (usp monograph) +cardiogoxin +digoxine +d1828 +ncgc00090797-02 +dixina +digoxin [orange book] +digoxin [usp-rs] +lenoxin +mfcd00003674 +[3h]-digoxin +digoxina-sandoz +schembl20506 +digoxin for peak identification +ncgc00090797-03 +sr-01000721866-4 +sr-01000721866-3 +cardigox +bidd:pxr0148 +ncgc00090797-09 +coragoxine +digon +akos024283494 +dynamos +digoxin [usp monograph] +hemigoxine nativelle +digoxin, 1mg/ml in methanol +digoxin [usp:inn:ban:jan] +digoxinum +(3beta,5beta,12beta)-3-((o-2,6-dideoxy-beta-d-ribo-hexapyranosyl-(1-4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl)oxy)-12,14-dihydroxycard-20(22)-enolide +chembl1751 +lanoxicaps +lanikor +tox21_303050 +ccg-220437 +card-20(22)-enolide, 3-((o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1->4)-o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-,(3beta,5beta,12beta)- +digoxin [jan] +card-20(22)-enolide, 3-((o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1.fwdarw.4)-o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1.fwdarw.4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)- +prestwick_170 +cordioxil +digacin +homolle's digitalin +hms3713g16 +lanoxin pg +c06956 +natigoxin +dimecip +nsc95100 +digoxinum [who-ip latin] +dokim +3beta-((o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1-4)-o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl)oxy)-12beta,14-dihydroxy-5beta-card-20(22)-enolide +73k4184t59 +card-20(22)-enolide, 3-((o-2,6-dideoxy-.beta.-d-ribo-hexopyranosyl-(1->4)-o-2,6-dideoxy-.beta.-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-.beta.-d-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-,(3.beta.,5.beta.,12.beta.)- +[3h]digoxin +card-20(22)-enolide, 3-((o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1-4)-o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)- +epitope id:122964 +lanacordin +4-((1s,2s,5s,11s,15s,7r,10r,14r,16r)-5-{5-[5-((2s,4s,5s,6r)-4,5-dihydroxy-6-me thyl(2h-3,4,5,6-tetrahydropyran-2-yloxy))(4s,5s,2r,6r)-4-hydroxy-6-methyl(2h-3 ,4,5,6-tetrahydropyran-2-yloxy)](4s,5s,2r,6r)-4-hydroxy-6-methyl(2h-3,4,5,6-te trahydropyran-2-yl +digox +card-20(22)-enolide, 3-((o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1->4)-o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)- +unii-73k4184t59 +lanacrist +purgoxin +bspbio_000454 +digoxin [inn] +rougoxin +digossina [dcit] +4-[(1s,2s,5s,7r,10r,11s,14r,15s,16r)-5-{[(2r,4s,5s,6r)-5-{[(2s,4s,5s,6r)-5-{[(2s,4s,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-11,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]-2,5-dihydrofuran-2-one +digoxinum (latin) +ncgc00090797-05 +akos015895113 +digoxin-sandoz +digoxin (usp-rs) +chebi:4551 +hms2096g16 +digoxin 1.0 mg/ml in methanol +ncgc00090797-06 +novodigal [inj.] +smr000059217 +a814956 +human serum - digoxin, high level +mls000069819 +(3beta,5beta,12beta)-3-{[2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide +neo-lanicor +brn 0077011 +as-13281 +mls001055371 +card-20(22)-enolide, 3-[[o-2,6-dideoxy-.beta.-d-ribo-hexopyranosyl-(1-->4)-o-2,6-dideoxy-.beta.-d-ribo-hexopyranosyl-(1-->4)-2,6-dideoxy-.beta.-d-ribo-hexopyranosyl]oxy]-12,14-dihydroxy-, (3.beta.,5.beta.,12.beta.)- +digoxinum [inn-latin] +cs-4571 +digoxin [vandf] +mls001076495 +5-18-04-00381 (beilstein handbook reference) +digoxinum (inn-latin) +opera_id_1134 +digoxin, united states pharmacopeia (usp) reference standard +digosin +nsc-95100 +3beta-((o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1->4)-o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl)oxy)-12beta,14-dihydroxy-5beta-card-20(22)-enolide +grexin +c41h64o14 +chloroformic digitalin +prestwick1_000437 +digoxin nativelle +eudigox +cardioxin +gtpl4725 +3beta,12beta,14-trihydroxy-5beta,14beta-card-20(22)-enolid-3-tridigitoxosid +digoxin-zori +hms2232g20 +4-[(3s,5r,8r,9s,10s,12r,13s,14s)-3-[(2s,4s,5r,6r)-5-[(2s,4s,5r,6r)-5-[(2s,4s,5r,6r)-4,5-dihydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5h-furan-2-one +tox21_111025 +z2108699066 +fargoxin +ns00008620 +3-[(3s,5r,8r,9s,10s,12r,13s,14s,17r)-3-[(2r,4s,5s,6r)-5-[(2s,4s,5s,6r)-5-[(2s,4s,5s,6r)-4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2h-furan-5-one +digonix +neodioxanin +digoxin [mi] +en300-6492954 +j-013666 +3-[(3s,5r,10s,12r,13s,14s,17r)-3-[(2r,4s,5s,6r)-5-[(2s,4s,5s,6r)-5-[(2s,4s,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2h-furan-5-one +(3beta,5beta,12beta)-3-((2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl)oxy)-12,14-dihydroxycard-20(22)-enolide +cid_2724385 +lanoxin +regid_for_cid_2724385 +digoksyna [polish] +lenoxicaps +digoksyna +dilanacin +dtxcid502934 +einecs 244-068-1 +digoxin (iarc) +digoxigenin-tridigitoxosid +6gy +db12267 +ncgc00483924-01 +d10866 +brigatinib +(2-((5-chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethyl-,delta5-phosphanone +(2-((5-chloro-2-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)anilino)pyrimidin-4-yl)amino)phenyl)dimethyl-lambda5-phosphanone +brigatinib; ap26113 +alunbrig (tn) +compound 11q (pmid: 27144831) +5-chloro-n4-[2-(dimethylphosphoryl)phenyl]-n2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine +schembl11916361 +cs-4278 +ap-26113 +brigatinib (ap-26113) +compound 11q [pmid: 27144831] +brigatinib [who-dd] +nsc-787457 +nsc-784728 +brigatinib [jan] +db-118419 +(2-((5-chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethyl-,.delta.5-phosphanone +chembl3545311 +unii-hyw8db273j +brigatinib [orange book] +nsc787457 +5-chloro-n4-(2-(dimethylphosphoryl)phenyl)-n2-(2-methoxy-4(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine +2,4-pyrimidinediamine, 5-chloro-n4-[2-(dimethylphosphinyl)phenyl]-n2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]- +en300-6477855 +brigatinib (jan/usan) +brigatinib [mi] +brigatinibum +5-chloro-n4-(2-(dimethylphosphoryl)phenyl)-n2-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine +alunbrig +ap 26113 +brigatinib [usan] +q27456393 +(2-((5-chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethylphosphine oxide +gtpl7741 +bdbm50185140 +5-chloro-n4-(2-(dimethylphosphoryl)phenyl)-n2-(2-methoxy-4-(4-(4-methylpiperazin-1- yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine +mfcd29472221 +akos030257612 +as-75176 +amy10294 +2,4-pyrimidinediamine, 5-chloro-n4-(2-(dimethylphosphinyl)phenyl)-n2-(2-methoxy-4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)- +dtxsid501027929 +hy-12857 +ex-a775 +5-chloro-4-n-(2-dimethylphosphorylphenyl)-2-n-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine +ns00073439 +l01xe43 +brigatinib [inn] +hyw8db273j +brigatinib [usan:inn] +brigatinib (ap26113) +5-chloro-n~4~-[2-(dimethylphosphoryl)phenyl]-n~2~-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine +z2512157852 +bcp17214 +sb40412 +s8229 +1197953-54-0 +ac-29958 +nsc784728 +ripretinibum +1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea +schembl14999718 +akos040759418 +ripretinib [who-dd] +hy-112306 +unii-9xw757o13d +qinlock (tn) +ripretinib [inn] +ms-29471 +gtpl9175 +ripretinib [orange book] +9xw757o13d +1442472-39-0 +qinlock +3-{4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl]-2-fluorophenyl}-1-phenylurea +at18473 +n-{4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3- yl]-2-fluorophenyl}-n'-phenylurea +ripretinib; urea, n-[4-bromo-5-[1-ethyl-1,2-dihydro-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl]-2-fluorophenyl]-n'-phenyl-; n-[4-bromo-5-[1-ethyl-1,2-dihydro-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl]-2-fluorophenyl]-n'-phenylurea; 1-[4-bromo-5-[1-ethyl-7-(methyla +quinlock +ripretinib [mi] +cs-0044835 +db14840 +en300-22895298 +dcc2618 +dtxsid201027956 +1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl]-2-fluorophenyl]-3-phenylurea +ex-a4883 +bdbm50609506 +1-n'-(2,5-difluoro-4-(2-(1-methylpyrazol-4-yl)pyridin-4-yl)oxyphenyl)-1-n'-phenylcyclopropane-1,1-dicarboxamide +s8757 +ripretinib +1442472-39-0 (free base) +ac-36722 +kit/pdgfr inhibitor dcc-2618 +3-{4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl]-2-fluorophenyl}-1-phenylurea +dcc 2618;dcc2618;kit/pdgfr inhibitor;ripretinib +bcp29218 +dcc-2618 +ripretinib (dcc-2618) +d11353 +chembl4216467 +ripretinib free base +urea, n-(4-bromo-5-(1-ethyl-1,2-dihydro-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl)-2-fluorophenyl)-n'-phenyl- +glxc-15506 +urea, n-[4-bromo-5-[1-ethyl-1,2-dihydro-7-(methylamino)-2-oxo-1,6- naphthyridin-3-yl]-2-fluorophenyl]-n'-phenyl-39-0 +ripretinib (usan) +n-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-n'-phenylurea +ripretinib [usan] +c24h21brfn5o2 +fimepinostat +bcp06870 +hy-13522 +pi3k/hdac inhibitor centn +ncgc00346692-01 +cudc-907 (pi3k/hdac inhibitori) +pi3k/hdac inhibitor +gtpl8952 +jowxjlifiioyms-uhfffaoysa-n +mls006010994 +pi3k/hdac inhibitor cudc-907 +smr004702794 +db11891 +mfcd22420823 +sb16569 +n-hydroxy-2-[[2-(6-methoxypyridin-3-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl-methylamino]pyrimidine-5-carboxamide +unii-3s9rx35s5x +fimepinostat (usan/inn) +cudc 907 +nsc771751 +j-690133 +n-hydroxy-2-({[2-(6-methoxypyridin-3-yl)-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl}(methyl)amino)pyrimidine-5-carboxamide +bdbm50188961 +hms3673e03 +chembl3622533 +5-pyrimidinecarboxamide, n-hydroxy-2-[[[2-(6-methoxy-3-pyridinyl)-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl]methylamino]- +d11319 +cudc-907 +n-hydroxy-2-(((2-(6-methoxypyridin-3-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)(methyl)amino)pyrimidine-5-carboxamide +fimepinostat [inn] +schembl1284705 +sw219871-1 +q27076926 +ncgc00346692-11 +ns00072982 +cs-1610 +ncgc00346692-04 +dtxsid90712307 +cudc907 +5-pyrimidinecarboxamide, n-hydroxy-2-(((2-(6-methoxy-3-pyridinyl)-4-(4-morpholinyl)thieno(3,2-d)pyrimidin-6-yl)methyl)methylamino)- +fimepinostat (cudc-907) +akos026750340 +fimepinostat [usan] +ac-30227 +1339928-25-4 +da-34958 +cudc-907 (pi3k/hdac inhibitori)? +db-057451 +as-57131 +3s9rx35s5x +n-hydroxy-2-[{[2-(6-methoxypyridin-3-yl)-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl}(methyl)amino]pyrimidine-5-carboxamide +nsc-771751 +fimepinostat [who-dd] +hms3656h04 +ccg-269763 +ex-a742 +s2759 +2-benzoxazolamine, 5-(4-amino-1-(1-methylethyl)-1h-pyrazolo(3,4-d)pyrimidin-3-yl)- +ncgc00346654-10 +d11183 +ccg-265002 +schembl7902875 +us10172858, table 1.22 +jgh0df1u03 +3-(2-amino-5-benzoxazolyl)-1-(1-methylethyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine +sapanisertib [inn] +ns00072976 +ink-128/ink128 +cb-228 +nsc764658 +5-(4-amino-1-isopropyl-1h-pyrazolo[3,4-d]pyrimidin-3-yl)benzo[d]oxazol-2-amine +nsc780880 +smr004702810 +3-(2-aminobenzo[d]oxazol-5-yl)-1-isopropyl-1h-pyrazolo[3,4-d]pyrimidin-4-amine +ncgc00346654-01 +cs-0557 +ink-128,cas:1224844-38-5 +j-004811 +q27078072 +5-(4-amino-1-isopropyl-1h-pyrazolo[3,4-d]-pyrimidin-3-yl)benzo[d]oxazol-2-amine +ac-26848 +chembl3545097 +unii-jgh0df1u03 +mln-0128 +s2811 +1224844-38-5 +ink-128;sapanisertib;mln0128 +chebi:91450 +1h-pyrazolo[3,4-d]pyrimidin-4-amine, 3-(2-amino-5-benzoxazolyl)-1-(1-methylethyl)- +hms3656h12 +3-(2-amino-1,3-benzoxazol-5-yl)-1-isopropyl-1h-pyrazolo(3,4-d)pyrimidin-4-amine +nsc768435 +ink-128 +mls006011012 +ink-0128 +sapanisertibum +fe5 +as-16294 +tak-228 +sapanisertib (usan/inn) +db11836 +bcp0726000086 +akos025149512 +nsc-764658 +sapanisertib [usan:inn] +bcp9000789 +bdbm315477 +3-(2-amino-1,3-benzoxazol-5-yl)-1-(propan-2-yl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine +bs170924 +ink 128 +sapanisertib +5-(4-azanyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine +ink128 +ink 128 (mln0128) +sb16566 +sw220210-1 +sapanisertib [who-dd] +1h-pyrazolo(3,4-d)pyrimidin-4-amine, 3-(2-amino-5-benzoxazolyl)-1-(1-methylethyl)- +db-293450 +5-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine +us10172858, table 1.1 +sapanisertib; ink128 +mln0128 +nsc-780880 +ink 128; mln 0128; sapanisertib +5-(4-amino-1-isopropyl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine +mfcd22124893 +dtxsid401022538 +hms3672c21 +sapanisertib [usan] +3-(2-amino-1,3-benzoxazol-5-yl)-1-(propan-2-yl)-1h-pyrazolo(3,4-d)pyrimidin-4-amine +sapanisertib (mln0128) +nsc-768435 +ex-a951 +gtpl7933 +hy-13328 +chembl3545110 +7-cyclopentyl-n,n-dimethyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}-7h-pyrrolo[2,3-d]pyrimidine-6-carboxamide +1211441-98-3 +q27088552 +da-35904 +akos025404915 +nsc-794613 +7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide +as-10159 +en300-7409093 +ribociclibum +7-cyclopentyl-n,n-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7h-pyrrolo(2,3-d)pyrimidine-6-carboxamide +7-cyclopentyl-n,n-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxamide +ribociclib (lee011) +sw220101-1 +nsc778909 +lee-011; lee 011;lee011 +a858033 +rhxhgraepcafml-uhfffaoysa-n +ribociclib (usan/inn) +ribociclib [who-dd] +sb18480 +ns00072964 +lee011 +ribociclib [mi] +ribociclib +hms3748m05 +7h-pyrrolo[2,3-d]pyrimidine-6-carboxamide, 7-cyclopentyl-n,n-dimethyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-; 7-cyclopentyl-n,n-dimethyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-7h-pyrrolo[2,3-d]pyrimidine-6-carboxamide; kisqali; lee 011; lee 011a; ribociclib +s7440 +ex-a304 +example 74 [us8962630] +gtpl7383 +us8962630, 74 +7h-pyrrolo(2,3-d)pyrimidine-6-carboxamide, 7-cyclopentyl-n,n-dimethyl-2-((5-(1-piperazinyl)-2-pyridinyl)amino)- +lee-011a +7-cyclopentyl-n,n-dimethyl-2-(5-(piperazin-1-yl)pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxamide +bcp08804 +lee-011 +7-cyclopentyl-n,n-dimethyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-7h-pyrrolo[2,3-d]pyrimidine-6-carboxamide +hy-15777 +6zz +lee011a +tk8ere8p56 +bdbm148264 +nvp-lee011 +nsc800867 +ribociclib, lee011 +chebi:230905 +hms3673i19 +nsc-800867 +ribociclib [usan:inn] +example 74 (us8962630) +6-(1h-indazol-6-yl)-n-[4-(4-morpholinyl)phenyl]-imidazo[1,2-a]pyrazin-8-amine +hms3653n03 +cs-1750 +akos032949987 +kisqali +ac-30029 +j-690066 +schembl302310 +ncgc00386317-11 +l01xe42 +dtxsid201021027 +ribociclib (lee011)? +7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo [2,3-d]pyrimidine-6-carboxylic acid dimethylamide +ribociclib [inn] +d10883 +ncgc00386317-10 +lee 011 +unii-tk8ere8p56 +db11730 +ribociclib [usan] +ccg-269070 +mfcd27976795 +amy16792 +nsc-778909 +nsc794613 +7-cyclopentyl-n,n-dimethyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrrolo[2,3-d]pyrimidine-6-carboxamide +n,n-bis(beta-chloroethyl)-amino-n',o-propylene-phosphoric acid ester diamide +q418560 +isophosphamide,(s) +asta z-4942 +tox21_302775 +ifosfamide (ep impurity) +tronoxal +bi166243 +n,n-bis(beta-chloroethyl)-amino-n'-o-propylene-phosphoric acid ester diamide +2h-1,3,2-oxazaphosphorin-2-amine, n,3-bis(2-chloroethyl)tetrahydro-, 2-oxide +hms1570h07 +ifosfamide; (rs)-n,3-bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide +z-4942 +ifosfamide [vandf] +akos005711213 +ifosfamide [inn] +ifosfamide, analytical reference material +3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2h-1,2-oxazaphosphorine 2-oxide +isophosphamide [iarc] +ifosfamide, >=98% +sw197177-4 +nsc759154 +ab00513932_09 +nsc-759154 +2,3-(n,n(sup 1)-bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd +ifosfamide (usp monograph) +ifosphamide +ifoxan +nci60_000233 +ncgc00179435-07 +{3-(2-chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2h-1,3,} 2-oxazaphosphorine oxide +holoxan +i0713 +ab00513932-08 +3-(2-chloroethyl)-2-[(2-chloroethyl)amino]-1,3,2$l^{5}-oxazaphosphinan-2-one +ncgc00256413-01 +tox21_110539_1 +asta z 4942 +hms2090m12 +2,3-(n,n(,)-bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxy +s1302 +ifosfamid a +naxamide +nci-co1638 +a823873 +tox21_110539 +bbl028071 +gtpl7201 +1,3,2-oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide +n-(2-chloraethyl)-n'-(2 chloroethyl)-n'-o-propylen-phosphorsaeureester-diamid +ifosfamida +3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2h-1,3,2-oxazaphosphorine-2 -oxide +ifosfamide [ep impurity] +3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2h-1,3,2-oxazaphosphorine 2-oxide +iphosphamide +n,3-bis(2-chloroethyl)-2-oxo-1,3,2$l;{5}-oxazaphosphinan-2-amine +n-(2-chloroethyl)-n-(3-(2-chloroethyl)-2-oxido-1,3,2-oxazaphosphinan-2-yl)amine +hsdb 7023 +3-(2-chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2h-1,2-oxazaphosphorineoxide +l01aa06 +tox21_201815 +ncgc00179435-02 +bcp06596 +unii-um20qqm95y +n,3-bis(2-chloroethyl)-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine +3-(2-chloroethyl)-2-((2-chloroethyl)amino)perhydro-2h-1,3,2-oxazaphosphorine oxide +wln: t6npotj am2g bo b2g +ncgc00179435-01 +ifosfamida (inn-spanish) +ccg-213464 +n,3-bis(2-chloroethyl)tetrahydro-2h-1,3,2-oxazaphosphorin-2-amine 2-oxide +cas-3778-73-2 +um20qqm95y +z4942 +ifosfamide (ep monograph) +2-oxo-n,3-bis-(2-chloroethyl) tetrahydro-2h-1,3,2-oxazaphosphorin-2-amine +bdbm189358 +ifosfamide [mart.] +ifosfamide, european pharmacopoeia (ep) reference standard +ifosfamida [inn-spanish] +3-(2-chloroethyl)-2-[(2-chloroethyl)amino]-1,3,2lambda5-oxazaphosphinan-2-one +ab00513932_10 +ifosfamide - bio-x +{3-(2-chloroethyl)-2-[(2- +hms2097h07 +pharmakon1600-01505480 +ifosfamide [orange book] +66849-34-1 +mjf 9325 +ifosfamide [ep monograph] +n,3-bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide +ifosfamide (jan/usp/inn) +seromida +einecs 223-237-3 +prestwick2_000833 +n-(2-chloroethyl)-n'-(2-chloroethyl)-n',o-propylenephosphoric acid diamide +sy066721 +ab00513932-07 +hms2232o10 +3-(2-chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2h-1,2-oxazaphosphorine oxide +ccris 352 +hms3714h07 +dtxsid7020760 +3-(2-chloroethyl)-2-((2-chloroethyl)amino)perhydro-2h-1,3,2-oxazaphosphorineoxide +ifosfamide [who-dd] +3-(2-chloroethyl)-2-(2-chloroethylamino)tetrahydro-2h-1,3,2-oxaazaphosphorin 2-oxide +bspbio_000785 +ab02316 +2,n(sup 1)-bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd +(2-chloro-ethyl)-[(r)-3-(2-chloro-ethyl)-2-oxo-2lambda5-[1,3,2]oxazaphosphinan-2-yl]-amine +hy-17419 +sr-05000002022-5 +ifosfamide in bulk +spbio_002706 +isocyclophosphamide +ifosfamide [usp-rs] +ifosfamide [usp monograph] +mls002154021 +3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2h-1,3,2-oxazaphosphorin-2-oxide +brn 0611835 +bpbio1_000865 +isophosphamide (iarc) +cyfos +db01181 +1,2-oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide +3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2h-1,3,2-oxazaphosphorine 2-oxide +sr-05000002022-1 +iso-endoxan +ncgc00016639-01 +a 4942 +ifosfamidum (inn-latin) +prestwick1_000833 +ns00000356 +n,3-bis(2-chloroethyl)tetrahydro-2h-1,3,2-oxazaphosphinan-2-amine 2-oxide # +ifosfamide (usp-rs) +d00343 +ac-2113 +ifosfamide, british pharmacopoeia (bp) reference standard +iso endoxan +ifosfamide [mi] +holoxan 1000 +nsc-109724 +stl058690 +n-(2-chloraethyl)-n'-(2-chloraethyl)-n',o-propylen-phosphorsaureester-diamid +isofosfamide +ifosfamide +holoxane +schembl4885 +isophosphamide +(s)-3-(2-chloroethyl)-2-((2-chloroethyl)amino)-1,3,2-oxazaphosphinane 2-oxide +3-(2-chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2h-1,3,2-oxazaphosphorineoxide +(r)-3-(2-chloroethyl)-2-((2-chloroethyl)amino)-1,3,2-oxazaphosphinane 2-oxide +sr-05000002022-3 +hms3654b15 +ifosfamide [usan] +nsc109724 +ifosfamidum +prestwick0_000833 +ifosfamide [jan] +ncgc00259364-01 +z 4942 +hms2093n07 +hms3374b08 +ifo-cell +iphosphamid +n-(2-chloroethyl)-n'-(2-chloroethyl)-n',o-propylenephosphoric acid ester diamide +smr001233348 +3778-73-2 +ncgc00179435-06 +ifosfamid +ifomida +mitoxana +ifosfamide (mart.) +prestwick3_000833 +db-049196 +ab00513932 +ifomide +n,3-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine +en300-7476797 +chebi:5864 +3-(2-chloroethyl)-2-((2-chloroethyl)amino)-1,3,2-oxazaphosphinane 2-oxide +starbld0001221 +isosfamide +n-(2-chloraethyl)-n'-(2-chloraethyl)-n',o-propylen-phosphorsaureester-diamid [german] +ifex +ifosfamidum [inn-latin] +ifolem +n,3-bis(2-chloroethyl)tetrahydro-2h-1,3,2-oxazaphosphorin-2-amine-2-oxide +cs-1424 +sr-05000002022 +ncgc00179435-03 +brd-a67097164-001-11-2 +n-(2-chloroethyl)-n'-(2-chloroethyl)-n',o-propylene phosphoric acid ester diamide +sbi-0206804.p001 +2,n(sup 1)-bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxy- +ifosfamide [usan:usp:inn:ban:jan] +mjf-9325 +ifex (tn) (bristol meyers) +c07047 +dtxcid90760 +2h-1,2-oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide +chembl1024 +ifosfamide (usan:usp:inn:ban:jan) +q-101874 +ifsofamide +nsc 109724 +2h-1,2-oxazaphosphorin-2-amine, n,3-bis(2-chloroethyl)tetrahydro-, 2-oxide +mfcd00057374 +nci-c01638 +ifex (tn) +ab00513932-06 +ifosfamide, united states pharmacopeia (usp) reference standard +i-phosphamide +as-10978 +ifosfamide sterile +ifosfamide [hsdb] +isoendoxan +2h-1,3,2-oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide +epirubicina (inn-spanish) +4' epi dxr +epirubicine [inn-french] +3z8479zz5x +q425122 +10-((3-amino-2,3,6-trideoxy-beta-l-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-(8s-cis)-5,12-naphthacenedione +l01db03 +4' epiadriamycin +nsc256942 +ab00698552_16 +pidorubicine [inn-french] +brd-k04548931-003-16-5 +hsdb 6962 +pidorubicine +5,12-naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-l-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, (8s,10s)- +epirubicin (inn) +(8s,10s)-10-(((2r,4s,5r,6s)-4-amino-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione +(7s,9r)-7-[(2s,4s,5r,6s)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione +ellence +pidorubicinum [inn-latin] +(1s,3s)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-l-arabino-hexopyranoside +5,12-naphthacenedione,10-[(3-amino-2,3,6-trideoxy-a-l-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8s,10s)- +epirubicinum [inn-latin] +pidorubicina [inn-spanish] +56420-45-2 +4'-epiadriamycin +db00445 +farmorubicin +schembl8582 +epirubicinum (inn-latin) +epirubicine (inn-french) +epirubicina [spanish] +dm2 +epirubicinum +epirubicin [mi] +ab00698552-11 +epi-dx +(7s,9s)-7-[(2r,4s,5r,6s)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-4-methoxy-6,9,11-tris(oxidanyl)-9-(2-oxidanylethanoyl)-8,10-dihydro-7h-tetracene-5,12-dione +(7s,9s)-7-[(2r,4s,5r,6s)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione +epirubicine +pidorubicine (inn-french) +dtxcid202987 +nsc-256942 +4'-epidoxorubicin +4'-epi-doxorubicin +bdbm43839 +epirubicin free base +4'-epi-dxr +pidorubicinum (latin) +5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-beta-l-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8s-cis)- +brn 1445813 +pidorubicina (inn-spanish) +(1s,3s)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-l-arabino-hexopyranoside +ridorubicin +4-epidoxorubicin +epi dx +5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-.alpha.-l-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8s-cis)- +nsc 256942 +imi 28 +ab00698552-14 +epirubicin [who-dd] +(8s-cis)-10-((3-amino-2,3,6-trideoxy-beta-l-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione +4' epi doxorubicin +dm6 +4'-epi dx +4' epi adriamycin +epirubicinum (latin) +(7s,9s)-7-[(2r,4s,5r,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione +epidoxorubicin +acid, 8 +unii-3z8479zz5x +d07901 +epirubicin [inn] +(1s,3s)-3-glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-.alpha.-l-arabino-hexopyranoside +ab00698552_15 +pidorubicin +(1s,3s)-3-glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-alpha-l-arabino-hexopyranoside +5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-beta-l-arabino-hexopyranosyl)oxy-7,8,9,10-tetrahydro -6,8,(8s-cis)- +dtxsid0022987 +4' epidoxorubicin +hy-13624 +sbi-0206890.p001 +pidorubicina +epirubicin [hsdb] +56420-45-2 (free base) +epirubicina [inn-spanish] +pidorubicinum +epirubicin [vandf] +ncgc00263918-08 +ncgc00263918-04 +pidorubicinum (inn-latin) +3-glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl-3-amino-2,3,6-trideoxy-alpha-l-arabino-hexopyranoside +epiadriamycin +a831042 +wp 697 +chembl417 +ns00069619 +epirubicin [inn:ban] +epirubicin +ab00698552-13 +farmorubicin (tn) +5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-l-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8s-cis)- +(8s,10s)-10-{[(2r,4s,5r,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione +epirubicine [french] +ccris 2261 +epirubicinum [latin] +chebi:47898 +epirubicina +epi-doxorubicin +(7s,9s)-7-[[(2r,4s,5r,6s)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione +en300-7410311 +hy-100388 +6-(4-amino-4-methylpiperidin-1-yl)-3-(2,3-dichlorophenyl)pyrazin-2-amine +akos030526670 +sb18819 +shp099 2hcl +ac-35665 +6-(4-azanyl-4-methyl-piperidin-1-yl)-3-[2,3-bis(chloranyl)phenyl]pyrazin-2-amine +sy251378 +db-107836 +a901187 +shp099 +6-(4-amino-4-methylpiperidin-1-yl)-3-(2,3-dichlorophenyl)pyrazin-2-amin +chembl4060033 +6-(4-amino-4-methyl-1-piperidinyl)-3-(2,3-dichlorophenyl)-2-pyrazinamine +bxc74742 +cs-5684 +bs-16291 +us10093646, compound 1 +nsc804254 +nsc-804254 +shp099 free base? +q27455906 +mfcd29059453 +shp099 free base +s6388 +schembl16914284 +shp-099 2hcl +bcp18366 +ex-a1067 +2-pyrazinamine, 6-(4-amino-4-methyl-1-piperidinyl)-3-(2,3-dichlorophenyl)- +1801747-42-1 +shp-099 +en300-21637536 +5od +bdbm38019 +epipodophyllotoxin, 4'-demethyl-, 9-(4,6-o-ethylidene-beta-d-glucopyranoside) +9-((4,6-o-ethylidine-beta-d-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-d)-1,3-dioxol-6(5ah)-one +hsdb 6517 +cpd000112002 +mls001424283 +hy-13629 +brd-k37798499-001-02-5 +etoposide (usp impurity) +bdbm50127140 +etoposide [usan:usp:inn:ban:jan] +etoposide impurity c (ep impurity) +brd-k37798499-001-27-2 +etoposide (ep monograph) +nsc141540 +etoposido [inn-spanish] +etoposide [ep impurity] +einecs 251-509-1 +furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5ah)-one-, 9-((4,6-o-ethylidene-.beta.-d-glucopyranosyl)oxy)5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl), (5r-(5.alpha.,5a.beta.,8a.alpha.,9.beta.(r*)))- +4''-demethylepipodophyllotoxin 9-(4,6-o-(r)-ethylidene-beta-d-glucopyranoside) +evp +cs-1774 +zuyeyidal +etoposide (ep impurity) +vp-16 +9-((4,6-o-ethylidene-beta-d-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5ah)-one, (5r-(5alpha,5abeta,8aalpha,9beta(r*)))- +4-demethylepipodophyllotoxin beta-d-ethylideneglucoside +etoposide [mart.] +sbi-0051910.p002 +(5s,5ar,8ar,9r)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-o-[(1r)-ethylidene]-beta-d-glucopyranoside +(5s,5ar,8ar,9r)-5-[[(2r,4ar,6r,7r,8r,8as)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxy-phenyl)-5a,6,8a,9-tetrahydro-5h-isobenzofuro[5,6-f][1,3]benzodioxol-8-one +trans-etoposide +c01576 +sr-01000763196-3 +4'-demethylepipodophyllotoxin 9-(4,6-o-(r)-ethylidene-beta-d-glucopyranoside) +9-((4,6-o-ethylidine-beta-d-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3'',4'''':6,7)naptho-(2,3-d)-1,3-dioxol-6(5ah)-one +ncgc00255126-01 +(-)-etoposide +4'-demethylepipodophyllotoxin ethylidene-.beta.-d-glucoside +tox21_110630 +4'-demethyl-epipodophyllotoxin 9-[4,6-o-(r)-ethylidene-beta-d-glucopyranoside +bcp9000669 +4'-o-demethyl-1-o-(4,6-o-ethylidene-beta-d-glucopyranosyl)epipodophyllotoxin +(5r,5ar,8ar,9s)-9-((4,6-o-((1r)-ethane-1,1-diyl)-.alpha.-d-glucopyranosyl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydro(2)benzofuro(5,6-f)(1,3)benzodioxol-6(5ah)-one +ccg-101165 +ccris 2392 +etoposide [inn] +prestwick3_000396 +etoposide, united states pharmacopeia (usp) reference standard +(10r,11r,15r,16s)-16-{[(2r,4ar,6r,7r,8r,8as)-7,8-dihydroxy-2-methyl-hexahydro-2h-pyrano[3,2-d][1,3]dioxin-6-yl]oxy}-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0^{3,7}.0^{11,15}]hexadeca-1(9),2,7-trien-12-one +bpbio1_000673 +gtpl6815 +etoposide [usp monograph] +vepesid (tn) +etoposide [jan] +etoposide, british pharmacopoeia (bp) reference standard +epipodophyllotoxin vp-16213 +ncgc00016821-01 +hms3713o13 +4'-demethylepipodophyllotoxin ethylidene-beta-d-glucoside +mls001074951 +etoposide (mart.) +nc00415 +etosid +vp 16 +etoposide [usan] +mfcd00869325 +mls002222184 +(5r,5ar,8ar,9s)-9-(((4ar,6r,7r,8r,8as)-7,8-dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8h)-one +etoposide - cas 33419-42-0 +etoposide [vandf] +ab00438905_19 +etoposide; vp-16 +hms2096o13 +etoposidum [inn-latin] +etoposide [mi] +ex-a1207 +sr-01000763196 +etoposido +bspbio_000611 +tox21_302201 +sintopozid +ncgc00179504-02 +akos007930275 +etoposide (vp-16) +q418817 +etoposide (jp17/usp/inn) +4'-demethylepipodophyllotoxin 9-(4,6-o-ethylidene-beta-d-glucopyranoside) +etoposide [usp impurity] +etoposide [iarc] +(5s,5ar,8ar,9r)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol -5-yl 4,6-o-[(1r)-ethylidene]-beta-d-glucopyranoside +(5r,5ar,8ar,9s)-9-[[4,6-o-(1r)-ethylidene-beta-d-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5ah)-one +vepesid +(5r,5ar,8ar,9s)-9-(((2r,4ar,6r,7r,8r,8as)-7,8-dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8h)-one +toposar +etopophos (phosphate salt) +etoposide (iarc) +etopol +cas-33419-42-0 +mls002153463 +epe +as-35312 +etoposide [ep monograph] +etoposide [orange book] +unii-6plq3cp4p3 +epeg +etoposide [who-ip] +furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5ah)-one, 9-((4,6-o-(1r)-ethylidene-beta-d-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, (5r,5ar,8ar,9s)- +epipodophyllotoxin-beta-d-ethyliden-glucoside, 4'-demethyl- +etoposide, european pharmacopoeia (ep) reference standard +hms2232l03 +121471-01-0 +z1304065033 +etoposido (inn-spanish) +ab00438905-17 +d00125 +etoposide +(5r,5ar,8ar,9s)-9-(((2r,4ar,6r,7r,8r,8as)-7,8-dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahy +-5-yl 4,6-o-[(1r)-ethylidene]-beta-d-glucopyranoside +nk 171 +dtxsid5023035 +epipodophyllotoxin, 4'-demethyl-, 4,6-o-ethylidene-beta-d-glucopyranoside +33419-42-0 +etoposide [usp-rs] +s1225 +brd-k37798499-001-14-0 +db00773 +furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5ah)-one, 9-[[4,6-o-(1r)-ethylidene-.beta.-d-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, (5r,5ar,8ar,9s)- +furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5ah)-one-, 9-((4,6-o-ethylidene-beta-d-glucopyranosyl)oxy)5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl), (5r-(5alpha,5abeta,8aalpha,9beta(r*)))- +smr000112002 +etoposide,(s) +dtxcid601473876 +9-((4,6-o-ethylidine-beta-d-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4- hydroxy-3,4-dimethyloxyphenyl)furo (3',4'':6,7) naptho-(2,3-d)-1,3-dioxol-6 (5ah)-one +ab00438905-18 +eposide +etoposide (usp-rs) +etoposide [hsdb] +brd-k37798499-001-10-8 +vp 16 (pharmaceutical) +brd-k37798499-001-05-8 +etoposide (vp16) +schembl4259 +l01cb01 +hms2052n05 +etoposide [who-dd] +etoposidum [who-ip latin] +etoposide (usan:usp:inn:ban:jan) +en300-97099 +(5s,5ar,8ar,9r)-5-[[(2r,4ar,6r,7r,8r,8as)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5h-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one +be164434 +nsc 141540 +etoposide, synthetic, >=98%, powder +demethyl epipodophyllotoxin ethylidine glucoside +lastet +vp 16213 +mls002207239 +prestwick 211 +ns00009585 +4'-demethylepipodophyllotoxin 9-(4,6-o-(r)-ethylidene-.beta.-d-glucopyranoside) +etoposide for system suitability, european pharmacopoeia (ep) reference standard +demethylepipodophyllotoxin-beta-d-ethylideneglucoside +etoposide (usp monograph) +6plq3cp4p3 +ab00438905 +sdccgsbi-0050405.p002 +etoposidum (inn-latin) +hms2089f14 +nsc-141540 +chembl44657 +mls000049957 +vp-16-213 +(5s,5ar,8ar,9r)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3'',4'':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-o-[(1r)-ethylidene]-beta-d-glucopyranoside +etoposidum +chebi:4911 +vepesid j +vp 16-213 +campto +nsc-728073 +cs-1138 +(19s)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-7-yl 4-(piperidin-1-yl)piperidine-1-carboxylate +dtxsid1041051 +irinotecan [inn:ban] +(diethyl-hydroxy-dioxo-[?]yl) 4-(1-piperidyl)piperidine-1-carboxylate +irinotecan [mi] +s1198 +(+)-7-ethyl-10-hydroxycamptothecine 10-(1,4'-bipiperidine)-1'-carboxylate +(s)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate +hy-16562 +ns00004943 +ncgc00178697-02 +ab00698464_12 +a845740 +dtxcid9021051 +(4s)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1h-pyrano[3'',4'':6,7]indolizino[1,2-b]quinolin-9-yl 1,4''-bipiperidine-1''-carboxylate +ab00698464_14 +brd-k08547377-003-02-4 +2-methoxy-5-[2-(3-sulfophenyl)-5-(4-sulfophenyl)pyrylium-4-yl]benzenesulfonic acid +(4s)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate +as-14323 +(+)-(4s)-4,11-diethyl-4-hydroxy-9-((4-piperidino-piperidino)carbonyloxy)-1h-pyrano(3',4':6,7)indolizino(1,2-b)quinol-3,14,(4h,12h)-dione +irinotecanum +(1,4'-bipiperidine)-1'-carboxylic acid (s)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1h-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl ester +schembl4034 +cpt-11 hydrochloride;camptothecin 11 hydrochloride +ab00698464-10 +(1,4'-bipiperidine)-1'-carboxylic acid, 4,11-diethyl-3,4,12-14-tetrahydro-4-hydroxy-3,14-dioxo-1h-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl ester, (s)- +(19s)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-7-yl [1,4'-bipiperidine]-1'-carboxylate +(+)-irinotecan +bspbio_002346 +mfcd00866307 +camptosar +bcp9000793 +nci60_005051 +irinotecan lactone +irinotecan [vandf] +(s)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl[1,4'-bipiperidine]-1'-carboxylate +1,4'-bipiperidine-1'-carboxylic acid (s)-4,11-diethyl-3,4,12,14- tetrahydro-4-hydroxy-3,14-dioxo-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester +(4s)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1h-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl (1,4'-bipiperidine)-1'-carboxylate +(4s)-4,11-diethyl-4-hydroxy-3,14-dioxo-4,12-dihydro-1h-pyrano[3,4-f]quinolino[2,3-a]indolizin-9-yl 4-piperidylpiperidinecarboxylate +[1,4'']bipiperidinyl-1''-carboxylic acid (s)-4,11-diethyl-4-hydroxy-3,13-dioxo-3,4,12,13-tetrahydro-1h-2-oxa-6,12a-diaza-dibenzo[b,h]fluoren-9-yl ester +irinotecanum (inn-latin) +nsc728073 +ab00698464_13 +irinotecan mylan +unii-7673326042 +97682-44-5 (free base) +irinotecan [who-dd] +chembl481 +irinotecan; cpt-11 +irinotecan +biotecan (tn) +bcp02860 +ab00698464-07 +cpt-11 +ac-7469 +1u65 +irrinotecan +irinotecan [hsdb] +ab00698464-11 +irinotecan (inn) +d08086 +irinotecan [inn] +ncgc00178697-05 +l01xx19 +[(19s)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate +97682-44-5 +1,4'-bipiperidine-1'-carboxylic acid (s)-4,11-diethyl-3,4,12,14- tetrahydro-4-hydroxy-3,14-dioxo-1h-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl ester +(4s)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate +akos015894969 +amy4227 +biotecan +irinotecanum [inn-latin] +(1,4'-bipiperidine)-1'-carboxylic acid, (4s)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1h-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl ester +en300-708800 +nsc 728073 +irinophore c +bdbm50128267 +gtpl6823 +irinotecan? +chebi:80630 +q412197 +[1,4'']bipiperidinyl-1''-carboxylic acid 4,11-diethyl-4-hydroxy-3,13-dioxo-3,4,12,13-tetrahydro-1h-2-oxa-6,12a-diaza-dibenzo[b,h]fluoren-9-yl ester +ab07527 +hsdb 7607 +db00762 +ab00698464-09 +irinotecan free base +eribulinum +(1s,3s,6s,9s,12s,14r,16r,18s,20r,21r,22s,26r,29s,31r,32s,35r,36s)-20-((2s)-3-amino-2-hydroxypropyl)-21-methoxy-14-methyl-8,15-bis(methylene)-2,19,30,34,37,39,40,41-octaoxanonacyclo(24.9.2.1(3,32).1(3,33).1(6,9).1(12,16).0(18,22).0(29,36).0(31,35))hentetracontan-24-one +nsc-707389 +dtxsid101009321 +(2r,3r,3as,7r,8as,9s,10ar,11s,12r,13ar,13bs,15s,18s,21s,24s,26r,28r,29as)-2-[(2s)-3-amino-2-hydroxypropyl]hexacosahydro-3-methoxy-26-methyl-20,27-bis(methylene)-11,15:18,21:24,28-triepoxy-7,9-ethano-12,15-methano-9h,15h-furo[3,2-i]furo[2',3':5,6]pyrano[4,3-b][1,4]dioxacyclopentacosin-5(4h)-one +hy-13442 +gtpl6813 +eribulin (mart.) +eribulin free +253128-41-5 +eribulin [vandf] +(1s,3s,6s,9s,12s,14r,16r,18s,20r,21r,22s,26r,29s,31r,32s,33r,35r,36s)-20-[(2s)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-dimethylidene-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-24-one +dtxcid701436148 +glxc-10730 +eribulin [mart.] +(1s,3s,6s,9s,12s,14r,16r,18s,20r,21r,22s,26r,29s,31r,32s,35r,36s)-20-[(2s)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-bis(methylene)-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.1(3,32).1(3,33).1(6,9).1(12,16).0(18,22).0(29,36).0(31,35)]hentetracontan-24-one +chembl1683590 +eribulin +eribulin [mi] +2-(3-amino-2-hydroxypropyl)hexacosahydro-3-methoxy-26-methyl-20,27-bis(methylene)11,15-18,21-24,28-triepoxy-7,9-ethano-12,15-methano-9h,15h-furo(3,2-i)furo(2',3'-5,6)pyrano(4,3-b)(1,4)dioxacyclopentacosin-5-(4h)-one +chebi:63587 +ex-a4873d +eribuline +ufnvpogxiszxjd-jbqzkeiosa-n +l01xx41 +db08871 +11,15:18,21:24,28-triepoxy-7,9-ethano-12,15-methano-9h,15h-furo[3,2-i]furo[2',3':5,6]pyrano[4,3-b][1,4]dioxacyclopentacosin-5(4h)-one, 2-[(2s)-3-amino-2-hydroxypropyl]hexacosahydro-3-methoxy-26-methyl-20,27-bis(methylene)-, (2r,3r,3as,7r,8as,9s,10ar,11s,12r,13ar,13bs,15s,18s,21s,24s,26r,28r,29as)- +er-086526 +schembl15783821 +lr24g6354g +b 1939 +unii-lr24g6354g +ms-31267 +q408717 +eribulin [who-dd] +(1s,3s,6s,9s,12s,14r,16r,18s,20r,21r,22s,26r,29s,31r,32s,33r,35r,36s)-20-[(2s)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-dimethylidene-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-24-o +2-[4-[[(2r)-2-aminobutyl]amino]-2-quinazolinyl]-4-chloro-phenol +akos040740784 +at36513 +ncgc00510497-02 +bp-29357 +e-7389 free base +er 086526 +eribulina +(1s,3s,6s,9s,12s,14r,16r,18s,20r,21r,22s,26r,29s,31r,32s,33r,35r,36s)-20-[(2s)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-dimethylidene-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.1~3,32~.1~3,33~.1~6,9~.1~12,16~.0~18,22~.0~29,36~.0~31,35~]hentetracontan-24-one (non-preferred name) +e7389-lf +eribulin [inn] +verteporfin +nsc-825827 +nsc800071 +5-pyrimidinecarboxamide, 4-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)-1-piperazinyl)phenyl)amino)- +c71670 +prt-2070 +yxb30079 +ac-30243 +prt062070 +cerdulatinib (prt062070) +prt 062070 +schembl736734 +4-(cyclopropylamino)-2-(4-(4-(ethylsulfonyl)piperazin-1-yl)phenylamino)pyrimidine-5-carboxamide +cerdulatinib [inn] +unii-d1lxq45s1o +bcp10681 +d1lxq45s1o +bdbm50468574 +akos026750510 +cerdulatinib; prt062070; prt2070 +4-(cyclopropylamino)-2-({4-[4-(ethanesulfonyl)piperazin-1-yl]phenyl}amino)pyrimidine-5-carboxamide +cerdulatinib +db15499 +dtxsid001115521 +s3566 +4-(cyclopropylamino)-2-[4-(4-ethylsulfonylpiperazin-1-yl)anilino]pyrimidine-5-carboxamide +as-56368 +prt-062070 +rvt-502 +nsc825827 +s5i +da-34986 +cs-3329 +4-(cyclopropylamino)-2-((4-(4-(ethanesulfonyl)piperazin-1-yl)phenyl)amino)pyrimidine-5-carboxamide +1198300-79-6 +4-(cyclopropylamino)-2-[[4-[4-(ethylsulfonyl)-1-piperazinyl]phenyl]amino]-5-pyrimidinecarboxamide, +4-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)piperazin-1-yl)phenyl)amino)pyrimidine-5-carboxamide +hy-15999 +nsc-800071 +gtpl8957 +ex-a2143 +chembl4116008 +sb16931 +q27075860 +cerdulatinib (prt2070) +ncgc00386415-04 +prt2070; prt-2070; prt 2070; prt-062070; prt 062070; prt062070 +cerdulatinib [who-dd] +ncgc00164574-03 +erlotinib [vandf] +ac-399 +mfcd02089651 +j4t82ndh7e +hms3713c22 +erlotinibum +sr-05000001460-2 +183321-74-6 (free base) +cp-35877401 +gtpl4920 +ab01273955-02 +tox21_112202 +sr-05000001460-6 +kinome_3317 +db00530 +hy-50896 +tox21_112202_1 +rg-1415 +4-quinazolinamine, n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)- +183321-74-6 +chembl553 +(6,7-bis(2-methoxy-ethoxy)quinazoline-4-yl)-(3-ethynylphenyl)amine +unii-j4t82ndh7e +sr-05000001460 +[6,7-bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine +ncgc00164574-01 +nsc-800097 +hms3745m05 +n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine +en300-708808 +hms3295a19 +as-35132 +nsc800097 +cp-358774 +erotinib +bcb03_000783 +sy028059 +be164419 +am20090621 +erlotinib, free base +erlotinib free base +ncgc00164574-25 +nchembio866-comp3 +ab01273955-01 +ns00006169 +chebi:114785 +1429636-49-6 +aakjlrggtjkamg-uhfffaoysa-n +bdbm5446 +(6,7-bis-(2-methoxy-ethoxy)-quinazolin-4-yl)-(3-ethynyl-phenyl)-amine +sr-05000001460-3 +z2588038919 +osi 744 +hms2089f05 +osi-774 +ro-508231 +dtxcid6026454 +k00241 +erlotinib [ema epar] +dtxsid8046454 +stk623143 +n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine monohydrochloride +4-[(3-ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline +hms3244m20 +hms3244n19 +cas-183321-74-6 +n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine +erlotinib [who-dd] +l01xe03 +q418369 +ncgc00164574-14 +cid_176870 +ncgc00164574-06 +erlotinib [inn:ban] +hms3244m19 +cp-358,774 +r-1415 +tarceva +brd-k70401845-003-04-7 +nsc 718781 +hsdb 8082 +ncgc00164574-05 +schembl8413 +cs-0620 +[6,7-bis(2-methoxy-ethoxy)quinazoline-4-yl]-(3-ethynylphenyl)amine +sr-05000001460-1 +erlotinib free base? +cp358774 +ccg-220420 +r 1415 +erlotinib(tarceva) +akos000282911 +ab01273955-03 +sb16916 +s7786 +erlotinib +erlotinib [mi] +(6r,6ar,7r,13s,14s,16r,20r)-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-19-oxo-3',4',6,7,12,13,14,16-octahydro-2'h,6ah-spiro(7,13-epimino-6,16-(epithiopropanooxymethano)(1,3)dioxolo(7,8)isoquinolino(3,2-b)(3)benzazocine-20,1'-isoquinolin)-5-yl acetate +ncgc00181159-01 +trabectedin [ema epar] +(1'r,6r,6ar,7r,13s,14s,16r)-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-19-oxo-3',4',6,7,12,13,14,16-octahydrospiro(6,16-(epithiopropanooxymethano)-7,13-imino-6ah-1,3-dioxolo(7,8)isoquino(3,2-b)(3)benzazocine-20,1'(2'h)-isoquinolin)-5-yl acetate +id0yzq2tcp +trabectedin [usan] +ccris 8133 +cs-1608 +cas-114899-77-3 +trabectedina +ecteinascidin-743 +(1'r,6r,6ar,7r,13s,14s,16r)-5-(acetyloxy)-3',4',6,6a,7,13,14,16-octahydro-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethylspiro[6,16-(epithiopropanoxymethano)-7,13-imino-12h-1,3-dioxolo[7,8]isoquino[3,2-b][3]benzazocine-20,1'(2'h)-isoquinolin]-19-one; ecteinascidin 743; et 743; nsc 648766; yondelis; +(1r,2r,3r,11s,12s,14r,26r)-5,6',12-trihydroxy-6,7'-dimethoxy-7,21,30-trimethyl-27-oxo-3',4'-dihydro-2'h-17,19,28-trioxa-24-thia-13,30-diazaspiro[heptacyclo[12.9.6.1^{3,11}.0^{2,13}.0^{4,9}.0^{15,23}.0^{16,20}]triacontane-26,1'-isoquinoline]-4(9),5,7,15(23),16(20),21-hexaen-22-yl acetate +et743 +et-743 +ac-27767 +ms-31361 +tox21_112762 +dtxsid2046880 +gtpl2774 +ecteinascidine 743 +spiro(6,16-(epithiopropanoxymethano)-7,13-imino-12h-1,3-dioxolo(7,8)isoquino(3,2,-b)(3)benzazocine-20,1'(2'h)-isoquinolin)-19-one, 3',4',6,6a,7,13,14,16-octahydro-5-(acetyloxy)-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-, (6r-(6-alpha,6a-beta,7-beta,13-beta,14-beta,16-alpha,20r*))- +ecteinascidin +hy-50936 +nsc648766 +[(1r,2r,3r,11s,12s,14r,26r)-5,6',12-trihydroxy-6,7'-dimethoxy-7,21,30-trimethyl-27-oxospiro[17,19,28-trioxa-24-thia-13,30-diazaheptacyclo[12.9.6.13,11.02,13.04,9.015,23.016,20]triaconta-4(9),5,7,15,20,22-hexaene-26,1'-3,4-dihydro-2h-isoquinoline]-22-yl] acetate +nsc-684766 +q2637746 +trabectedinum +114899-77-3 +pkvrcirhqmsyjx-aifwhqitsa-n +trabectedin +ecteinascidins trabectedin +(6r,6ar,7r,13s,14s,16r,20r)-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-19-oxo-3',4',6,7,12,13,14,16-octahydro-2'h,6ah-spiro[7,13-epimino-6,16-(epithiopropanooxymethano)[1,3]dioxolo[7,8]isoquinolino[3,2-b][3]benzazocine-20,1'-isoquinolin]-5-yl acetate +chebi:84050 +nsc813783 +trabectedin [inn] +en300-19768451 +f81329 +trabectedine +nsc 684766 +trabectedin [jan] +et 743 +trabectedin [usan:inn:ban] +nsc-813783 +schembl12119916 +trabectedin (mart.) +nsc-648766 +ect 743 +unii-id0yzq2tcp +ex-a4317 +ncgc00181159-02 +dtxcid0026880 +trabectedin [who-dd] +chembl450449 +ecteinascidins trabectedin [mi] +yondelis +(1'r,6r,6ar,7r,13s,14s,16r)-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-19-oxo-3',4',6a,7,12,13,14,16-octahydro-2'h,6h-spiro(6,16-(epithiopropanooxymethano)-7,13-epiminobenzo(4,5)azocino(1,2-b)(1,3)dioxolo(4,5-h)isoquinolin-20,1'-isoquinolin)-5-yl acetate +akos025401985 +tox21_113236 +trabectedin [mart.] +trabectedin [orange book] +db05109 +spiro(6,16-(epithiopropanoxymethano)-7,13-imino-12h-1,3-dioxolo(7,8)isoquino(3,2,-b)(3)benzazocine-20,1'(2'h)-isoquinolin)-19-one, 5-(acetyloxy)-3',4',6,6a,7,13,14,16-octahydro-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-, (1'r,6r,6ar,7r,13s,14s,16r)- +ecteinascidin 743;et-743 +ecteinascidin 743 +nsc 648766 +l01cx01 +(1s,3s)-3-glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl-(3-amino-2,3,6-tridesoxy-alpha-l-lyxo-hexopyranosid) +doxorubicin (usan/inn) +bpbio1_000502 +bspbio_001031 +doxorubicinum +doxorubicina (inn-spanish) +dtxcid301480 +(8s-cis)-10-[(3-amino-2,3,6-trideoxy-.alpha.-l-lyxo-hexopyranosyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione +ncgc00024415-38 +doxorubicin (mart.) +c01661 +chembl53463 +doxorubicin [who-dd] +unii-80168379ag +nsc-123127 +doxorubicine (inn-french) +conjugate of doxorubicin with humanized monoclonal antibody ll1 against cd74 +d03899 +adr +en300-120698 +bp-23114 +(8s,10s)-10-((2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yloxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione +23214-92-8 +1,2,3,4,6,11-hexahydro-4beta,5,12-trihydroxy-4-(hydroxyacetyl)-10-methoxy-6,11-dioxonaphthacen-1beta-yl-3-amino-2,3,6-trideoxy-alpha-l-lyxohexopyranoside +chebi:28748 +(7s,9s)-7-[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione +dtxsid8021480 +adriablastin +(8s-cis)-10- +hydroxyl daunorubicin +smp1_000106 +doxorubicin-hll1 conjugate +adriamycin +(8s,10s)-10-((3-amino-2,3,6-trideoxy-.alpha.-l-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione +prestwick3_000438 +spbio_002395 +mls000028393 +10-((3-amino-2,3,6-trideoxy-d-lyxohexopyranosyl)oxy)-8-glycolcyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione +5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8s-cis)- +(8s,10s)-10 +doxorubicin [usan:inn:ban] +hydroxydaunomycin +h11954 +(7s,9r)-7-[(2s,4s,5s,6s)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione +14-hydroxydaunorubicine +5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-.alpha.-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8s-cis)- +akos015951330 +nsc-759155 +hsdb 3070 +nci-c01514 +caelyx (liposomal doxorubicin) +valrubicin impurity, doxorubicin (usp impurity) +(8s,10s)-10- +1392315-46-6 +80168379ag +doxorubicin [mi] +prestwick0_000438 +lmpk13050001 +nsc 123127 +doxil +adm +doxorubicin-hll1 +doxorubicin [inn] +5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro- 6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione +doxorubicin [hsdb] +(7s,9s)-7-[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione +hydroxydaunorubicin +bspbio_000456 +(1s,3s)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranoside +(7s,9s)-7-[(4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione +hydroxyldaunorubicin +brd-k92093830-003-25-8 +cid_443939 +einecs 245-495-6 +5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8s,10s)- +ncgc00024415-42 +doxorubicina +(1s,3s)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranoside +doxorubicin [mart.] +schembl3243 +epirubicin hydrochloride impurity, doxorubicin- [usp impurity] +(7s,9s)-7-[(2r,4s,5s,6s)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-4-methoxy-6,9,11-tris(oxidanyl)-9-(2-oxidanylethanoyl)-8,10-dihydro-7h-tetracene-5,12-dione;hydrochloride +1,2,3,4,6,11-hexahydro-4beta,5,12-trihydroxy-4-(hydroxyacetyl)-10-methoxy-6, 11-dioxonaphthacen-1beta-yl-3-amino-2,3,6-trideoxy-alpha-l-lyxohexopyranoside +(8s-cis)-10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione +(7s,9s)-7-[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-9-glycoloyl-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7h-tetracene-5,12-quinone;hydrochloride +5,12-naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, (8s,10s)- +doxorubicina [inn-spanish] +doxorubicinum [inn-latin] +hms2089h06 +bdbm22984 +doxorubicine +gtpl7069 +db00997 +ncgc00024415-61 +ns00002473 +doxorubicin +probes1_000151 +valrubicin impurity, doxorubicin [usp impurity] +probes2_000129 +doxorubicin [vandf] +ncgc00024415-40 +a816625 +nsc123127 +adriamycin semiquinone +(8s,10s)-10-{[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione +(8s-cis)-10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroacetyl)-1-methoxy-5,12-naphthacenedione +l01db01 +bdbm32022 +prestwick2_000438 +ncgc00024415-37 +(7s,9s)-7-[[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione;hydrochloride +epirubicin hydrochloride impurity c [ep impurity] +ndc 38242-874 +doxorubicin [usan] +(7s,9s)-7-[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione;hydrochloride +ccris 739 +brd-k92093830-003-04-3 +14-hydroxydaunomycin +doxorubicin-p4/d10 conjugate +valrubicin impurity, doxorubicin +q18936 +ncgc00024415-35 +hy-15142a +fi 106 +(8s,10s)-10-(((2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione;(7s,9s)-7-[(4s,5s,6s)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione +thermodox +(8s,10s)-10-(((2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione +gr-319 +doxorubicine [inn-french] +(8s,10s)-10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione +adriblastina +prestwick1_000438 +conjugate of doxorubicin with monoclonal antibody p4/d10 against gp120 +ncgc00024415-41 +doxorubicinum (inn-latin) +epirubicin hydrochloride impurity, doxorubicin- +daunorubicin hydrochloride impurity d [ep impurity] +doxorrubicina +doxorubicin-p4/d10 +(1s,3s)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranoside +adriblastina (tn) diff --git a/mpnst_samples.csv b/mpnst_samples.csv new file mode 100644 index 00000000..7670cc11 --- /dev/null +++ b/mpnst_samples.csv @@ -0,0 +1,51 @@ +other_id,common_name,other_id_source,other_names,cancer_type,species,model_type,improve_sample_id +JH-2-002 patient derived xenograft,JH-2-002,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2054 +JH-2-009 patient derived xenograft,JH-2-009,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2055 +JH-2-023 patient derived xenograft,JH-2-023,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2056 +JH-2-031 patient derived xenograft,JH-2-031,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2057 +JH-2-055 patient derived xenograft,JH-2-055,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2058 +JH-2-079c patient derived xenograft,JH-2-079c,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2059 +JH-2-103 patient derived xenograft,JH-2-103,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2060 +MN-1 patient derived xenograft,MN-1,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2061 +MN-2 patient derived xenograft,MN-2,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2062 +MN-3 patient derived xenograft,MN-3,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2063 +WU-225 patient derived xenograft,WU-225,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2064 +WU-356 patient derived xenograft,WU-356,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2065 +WU-368 patient derived xenograft,WU-368,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2066 +WU-386 patient derived xenograft,WU-386,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2067 +WU-436 patient derived xenograft,WU-436,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2068 +WU-487 patient derived xenograft,WU-487,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2069 +WU-505 patient derived xenograft,WU-505,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2070 +WU-536 patient derived xenograft,WU-536,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2071 +WU-545 patient derived xenograft,WU-545,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2072 +WU-561 patient derived xenograft,WU-561,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2073 +JH-2-002 patient derived xenograft,JH-2-002,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,organoid,2074 +JH-2-031 patient derived xenograft,JH-2-031,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,organoid,2075 +JH-2-079c patient derived xenograft,JH-2-079c,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,organoid,2076 +JH-2-103 patient derived xenograft,JH-2-103,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,organoid,2077 +MN-1 patient derived xenograft,MN-1,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,organoid,2078 +MN-2 patient derived xenograft,MN-2,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,organoid,2079 +MN-3 patient derived xenograft,MN-3,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,organoid,2080 +WU-225 patient derived xenograft,WU-225,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,organoid,2081 +WU-356 patient derived xenograft,WU-356,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,organoid,2082 +WU-368 patient derived xenograft,WU-368,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,organoid,2083 +JH-2-002 tumor,JH-2-002,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2084 +JH-2-009 tumor,JH-2-009,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2085 +JH-2-023 tumor,JH-2-023,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2086 +JH-2-031 tumor,JH-2-031,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2087 +JH-2-055 tumor,JH-2-055,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2088 +JH-2-079c tumor,JH-2-079c,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2089 +JH-2-103 tumor,JH-2-103,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2090 +MN-1 tumor,MN-1,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2091 +MN-2 tumor,MN-2,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2092 +MN-3 tumor,MN-3,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2093 +WU-225 tumor,WU-225,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2094 +WU-356 tumor,WU-356,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2095 +WU-368 tumor,WU-368,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2096 +WU-386 tumor,WU-386,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2097 +WU-436 tumor,WU-436,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2098 +WU-487 tumor,WU-487,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2099 +WU-505 tumor,WU-505,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2100 +WU-536 tumor,WU-536,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2101 +WU-545 tumor,WU-545,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2102 +WU-561 tumor,WU-561,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2103 From c6ecf7d0bdd0393b980fa00da29c6271ebf9445d Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Tue, 11 Jun 2024 15:50:15 -0700 Subject: [PATCH 04/45] fixed bug when there are nans in smiles string --- build/utils/build_drug_desc.py | 6 +++++- 1 file changed, 5 insertions(+), 1 deletion(-) diff --git a/build/utils/build_drug_desc.py b/build/utils/build_drug_desc.py index ddc21865..205e8236 100644 --- a/build/utils/build_drug_desc.py +++ b/build/utils/build_drug_desc.py @@ -20,6 +20,7 @@ def smiles_to_fingerprint(smiles): ##get morgan fingerprint print('Computing morgan fingerprints for '+str(len(smiles))+' SMILES') for s in smiles: + print(s) mol = Chem.MolFromSmiles(s) fingerprint = AllChem.GetMorganFingerprintAsBitVect(mol, radius=2, nBits=1024) # update these parameters fingerprint_array = np.array(fingerprint) @@ -33,7 +34,10 @@ def smiles_to_mordred(smiles): ''' get descriptors - which ones? ''' + print('Computing mordred descriptors for '+str(len(smiles))+' SMILES') + mols = [Chem.MolFromSmiles(s) for s in smiles] + calc = Calculator(descriptors, ignore_3D=True) dd = calc.pandas( mols, nmols=None, quiet=False, ipynb=False ) values = dd.columns @@ -53,7 +57,7 @@ def main(): print('Adding drug table for '+args.drugtable) tab = pd.read_csv(args.drugtable,sep='\t') - cansmiles = list(set(tab.canSMILES)) + cansmiles = [a for a in set(tab.canSMILES) if str(a)!='nan'] # isosmiles = list(set(tab.isoSMILES)) morgs = smiles_to_fingerprint(cansmiles) From 8091d7de8eb810df8263dfb969b98c7bf1331f34 Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Tue, 11 Jun 2024 15:56:37 -0700 Subject: [PATCH 05/45] updated write file for samples this closes #160 --- build/broad_sanger/01-broadSangerSamples.R | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/build/broad_sanger/01-broadSangerSamples.R b/build/broad_sanger/01-broadSangerSamples.R index 13e307d5..b3c0965e 100755 --- a/build/broad_sanger/01-broadSangerSamples.R +++ b/build/broad_sanger/01-broadSangerSamples.R @@ -127,5 +127,5 @@ long.df<-full.df%>% subset(other_id!="") -write.table(long.df,'/tmp/broad_sanger_samples.csv',sep=',',row.names=F,col.names=T) +readr::write_csv(long.df,'/tmp/broad_sanger_samples.csv',quote='needed') From 69eb784200670510fb7333fe19394c21491984c2 Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Fri, 14 Jun 2024 09:39:06 -0700 Subject: [PATCH 06/45] updates to readmes and docker images --- build/broad_sanger/README.md | 24 ++++++++++++++-------- build/docker/Dockerfile.broad_sanger_omics | 1 - build/docker/Dockerfile.genes | 6 ++---- build/genes/README.md | 18 ++++++++++++++++ 4 files changed, 36 insertions(+), 13 deletions(-) create mode 100644 build/genes/README.md diff --git a/build/broad_sanger/README.md b/build/broad_sanger/README.md index d7f7728a..50c2eb8e 100644 --- a/build/broad_sanger/README.md +++ b/build/broad_sanger/README.md @@ -6,24 +6,32 @@ broke the Docker image into two to reduce overall size and complexity of each image. -### Build gene, sample, and omics data -Below are the steps required to build and test the gene/sample/omics -builds. Commands are designed to be run from the root of the repo. +### Build gene table +First we need to build the gene table -1. Build omics docker +1. Build genes docker ``` - docker build -f build/docker/Dockerfile.broad_sanger_omics -t broad_sanger_omics . --build-arg HTTPS_PROXY=$HTTPS_PROXY + docker build -f build/docker/Dockerfile.genes -t genes . --build-arg HTTPS_PROXY=$HTTPS_PROXY ``` + 2. Build gene file ``` - docker run -v $PWD:/tmp broad_sanger_omics sh build_genes.sh + docker run -v $PWD:/tmp genes sh build_genes.sh ``` -3. Build sample file +### Build sample, and omics data +Below are the steps required to build and test the gene/sample/omics +builds. Commands are designed to be run from the root of the repo. + +1. Build omics docker +``` + docker build -f build/docker/Dockerfile.broad_sanger_omics -t broad_sanger_omics . --build-arg HTTPS_PROXY=$HTTPS_PROXY +``` +2. Build sample file ``` docker run -v $PWD:/tmp broad_sanger_omics sh build_samples.sh ``` -4. Build omics files +3. Build omics files ``` docker run -v $PWD:/tmp broad_sanger_omics sh build_omics.sh ``` diff --git a/build/docker/Dockerfile.broad_sanger_omics b/build/docker/Dockerfile.broad_sanger_omics index 9ec2324f..a736c52a 100755 --- a/build/docker/Dockerfile.broad_sanger_omics +++ b/build/docker/Dockerfile.broad_sanger_omics @@ -1,7 +1,6 @@ FROM r-base:4.2.1 ENV DEBIAN_FRONTEND=noninteractive RUN apt-get update --fix-missing -#RUN apt-get install -y --fix-missing --allow-unauthenticated build-essential libpq-dev python3.10 python3-pip python3-setuptools python3-dev python3-venv libcurl4-openssl-dev libxml2-dev libglpk-dev RUN apt-get install -y --fix-missing --allow-unauthenticated build-essential python3-pip python3-setuptools python3-dev python3-venv libcurl4-openssl-dev libglpk-dev libxml2-dev libpq-dev diff --git a/build/docker/Dockerfile.genes b/build/docker/Dockerfile.genes index 289578e7..dff88d8a 100755 --- a/build/docker/Dockerfile.genes +++ b/build/docker/Dockerfile.genes @@ -1,10 +1,8 @@ -#FROM bioconductor/bioconductor_docker FROM r-base:4.2.1 ENV DEBIAN_FRONTEND=noninteractive RUN apt-get update --fix-missing -RUN apt-get install -y --fix-missing --allow-unauthenticated build-essential libpq-dev libcurl4-openssl-dev -RUN apt-get install -y --fix-missing libxml2-dev -#libxml2 libglpk-dev +RUN apt-get install -y --fix-missing --allow-unauthenticated build-essential python3-pip python3-setuptools python3-dev python3-venv libcurl4-openssl-dev libglpk-dev libxml2-dev libpq-dev + WORKDIR /app diff --git a/build/genes/README.md b/build/genes/README.md new file mode 100644 index 00000000..7264a684 --- /dev/null +++ b/build/genes/README.md @@ -0,0 +1,18 @@ + +# Gene table docker container +This directory contains the data and scripts needed to build a gene +table from Bioconductor + + +### Build gene table +First we need to build the gene table + +1. Build genes docker +``` + docker build -f build/docker/Dockerfile.genes -t genes . --build-arg HTTPS_PROXY=$HTTPS_PROXY +``` + +2. Build gene file +``` + docker run -v $PWD:/tmp genes sh build_genes.sh +``` From 655c6df282aec87f4a4fd41dda91e5b0b5f5ed9a Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Mon, 17 Jun 2024 17:42:29 -0700 Subject: [PATCH 07/45] added TPM conversion step for BeatAML data --- build/beatAML/GetBeatAML.py | 20 ++++++++----- build/beatAML/README.md | 20 +++++++++++-- build/docker/Dockerfile.beataml | 1 + build/utils/tpmFromCounts.py | 52 +++++++++++++++++++++++++++++++++ 4 files changed, 83 insertions(+), 10 deletions(-) create mode 100644 build/utils/tpmFromCounts.py diff --git a/build/beatAML/GetBeatAML.py b/build/beatAML/GetBeatAML.py index 1d873e71..91c38088 100755 --- a/build/beatAML/GetBeatAML.py +++ b/build/beatAML/GetBeatAML.py @@ -409,7 +409,7 @@ def map_and_combine(df, data_type, entrez_map_file, improve_map_file, map_file=N # Process each dataframe based on its data_type if data_type == "transcriptomics": df['Gene'] = df['Gene'].str.replace(r'\.\d+$', '', regex=True) - mapped_df = df.merge(genes, left_on='Gene', right_on='gene_symbol', how='left').reindex( + mapped_df = df.merge(genes, left_on='Gene', right_on='other_id', how='left').reindex( columns=['transcriptomics', 'entrez_id', "sample_id","Gene"]) mapped_df = mapped_df.merge(mapped_ids[['dbgap_rnaseq_sample', 'labId']], left_on='sample_id', @@ -631,8 +631,8 @@ def generate_drug_list(drug_map_path,drug_path): exit() else: improve_map_file = args.curSamples - transcriptomics_file = "beataml_waves1to4_norm_exp_dbgap.txt" - transcriptomics_url = "https://github.com/biodev/beataml2.0_data/raw/main/beataml_waves1to4_norm_exp_dbgap.txt" + transcriptomics_file = "beataml_waves1to4_counts_dbgap.txt" #"beataml_waves1to4_norm_exp_dbgap.txt" ##this is the wrong file, these are the normalize values + transcriptomics_url = "https://github.com/biodev/beataml2.0_data/raw/main/beataml_waves1to4_counts_dbgap.txt" #"https://github.com/biodev/beataml2.0_data/raw/main/beataml_waves1to4_norm_exp_dbgap.txt" download_from_github(transcriptomics_url, transcriptomics_file) mutations_file = "beataml_wes_wv1to4_mutations_dbgap.txt" @@ -644,15 +644,19 @@ def generate_drug_list(drug_map_path,drug_path): download_from_github(mutation_map_url, mutation_map_file) # New Transcriptomics Data print("Starting Transcriptomics Data") - t_df = pd.read_csv(transcriptomics_file, sep = '\t') - t_df.index = t_df.display_label - t_df = t_df.iloc[:, 4:] - t_df = t_df.reset_index().rename(columns={'display_label': 'Gene'}) + ##first run conversion tool + os.system("python tpmFromCounts.py --counts "+transcriptomics_file) + + + t_df = pd.read_csv('tpm_'+transcriptomics_file, sep = '\t') + # t_df.index = t_df.stable_id#display_label +# t_df = t_df.iloc[:, 4:] + t_df = t_df.reset_index().rename(columns={'stable_id': 'Gene'}) t_df = pd.melt(t_df, id_vars=['Gene'], var_name='sample_id', value_name='transcriptomics') print(improve_map_file) t_df = map_and_combine(t_df, "transcriptomics", args.genes, improve_map_file, sample_mapping_file) t_df = t_df[t_df.entrez_id.notna()] - t_df = t_df[["improve_sample_id","transcriptomics","entrez_id","source","study"]] + t_df = t_df[["improve_sample_id","transcriptomics","entrez_id","source","study"]].drop_duplicates() t_df.to_csv("/tmp/beataml_transcriptomics.csv.gz",index=False,compression='gzip') # New Proteomics Data diff --git a/build/beatAML/README.md b/build/beatAML/README.md index 7cb09358..e04b1205 100644 --- a/build/beatAML/README.md +++ b/build/beatAML/README.md @@ -3,9 +3,25 @@ This directory builds the data for the BeatAML samples. To build and test this module, run the following commands from the root directory. -### Build with test data -Build commands should be similar to every other coderdata build module. +## Build with test data +Build commands should be similar to every other coderdata build +module. + +### Build gene table +First we need to build the gene table + +1. Build genes docker +``` + docker build -f build/docker/Dockerfile.genes -t genes . --build-arg HTTPS_PROXY=$HTTPS_PROXY +``` + +2. Build gene file +``` + docker run -v $PWD:/tmp genes sh build_genes.sh +``` + +### Build AML data 1. Build the Docker image: ``` docker build -f build/docker/Dockerfile.beataml -t beataml . --build-arg HTTPS_PROXY=$HTTPS_PROXY diff --git a/build/docker/Dockerfile.beataml b/build/docker/Dockerfile.beataml index e8a99bb1..936a2008 100644 --- a/build/docker/Dockerfile.beataml +++ b/build/docker/Dockerfile.beataml @@ -6,6 +6,7 @@ WORKDIR /usr/src/app COPY build/beatAML/GetBeatAML.py . COPY build/utils/fit_curve.py . COPY build/utils/build_drug_desc.py . +COPY build/utils/tpmFromCounts.py . COPY build/beatAML/*sh ./ COPY build/beatAML/requirements.txt . diff --git a/build/utils/tpmFromCounts.py b/build/utils/tpmFromCounts.py new file mode 100644 index 00000000..bafbbc5f --- /dev/null +++ b/build/utils/tpmFromCounts.py @@ -0,0 +1,52 @@ +''' +python script to read in counts matrix and gene lengths to calculate tpm + +''' + +import argparse +import pandas as pd + +def main(): + parser = argparse.ArgumentParser("Quick script to get TPM from counts matrix") + parser.add_argument('--counts') + + + args = parser.parse_args() + print('Creating TPM from '+args.counts) + counts = pd.read_csv(args.counts,sep='\t') + counts.index=counts.stable_id + + ##get list of patients + pats = set(counts.columns)-set(['stable_id','display_label','description','biotype']) + + ##transcript info from grc37 + gtf = pd.read_csv("https://ftp.ensembl.org/pub/grch37/current/gtf/homo_sapiens/Homo_sapiens.GRCh37.87.gtf.gz",sep='\t',comment='#') + gtf.index = [a.split(';')[0].split(' ')[1].strip('"') for a in gtf[gtf.columns[8]]] + ##first select only exons + gtf = gtf[gtf.gene=='exon'] + ##compute length and convert to kilobases + length = abs(gtf[gtf.columns[4]]-gtf[gtf.columns[3]])/1000 ##get difference between start and end, then divide by kb + + #gtf = gtf[gtf.gene=='exon'].groupby(level=0).sum() ##sum over all the exons for a particular gene. yes this doesn't really tell you about which exon + length = length.groupby(level=0).sum() ##sum over all exon lengths for each gene + + + ##set counts matrix + X = counts[list(pats)] + tg = [g for g in X. index if g in length.index] + + X = X.loc[tg].transpose() + length = pd.Series(length)[X.columns] + # length =length.loc[tg] + + ## df = pd.DataFrame(lengths=lengths,Genes=gnames) + C = X.values + L = length.values + N = X.sum(axis=1).values.reshape(-1,1) + rpk = C/L + per_million_scaling_factor = (rpk.sum(axis=1)/1e6).reshape(-1,1) + tpm = pd.DataFrame( rpk/per_million_scaling_factor, index=X.index, columns=X.columns).transpose() + tpm.to_csv('tpm_'+args.counts,sep='\t') + +if __name__=='__main__': + main() From f055be20d24eca9b9984047c87cd7c9f64894bf4 Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Mon, 17 Jun 2024 18:38:19 -0700 Subject: [PATCH 08/45] updated readme --- build/beatAML/README.md | 9 +++++---- 1 file changed, 5 insertions(+), 4 deletions(-) diff --git a/build/beatAML/README.md b/build/beatAML/README.md index e04b1205..a6f6c978 100644 --- a/build/beatAML/README.md +++ b/build/beatAML/README.md @@ -55,12 +55,13 @@ compilation. ### BeatAML Dataset structure -The build commands above create the following files +The build commands above create the following files in the local directory ``` -├── beataml_samples.csv -├── beataml_transcriptomics.csv -├── beataml_mutations.csv +├── beataml_samples.csv.gz +├── beataml_transcriptomics.csv.gz +├── beataml_mutations.csv.gz +├── beataml_proteomics.csv.gg ├── beataml_drugs.tsv.gz ├── beataml_drug_descriptors.tsv.gz ├── beataml_experiments.tsv.gz From 242e7a70980d375f9e58ded6f5335eea79672a9e Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Mon, 17 Jun 2024 18:54:52 -0700 Subject: [PATCH 09/45] removing files --- beataml_samples.csv | 1190 ---------------------------- mpnst_ignore_chems.txt | 1707 ---------------------------------------- mpnst_samples.csv | 51 -- requirements.txt | 13 - 4 files changed, 2961 deletions(-) delete mode 100644 beataml_samples.csv delete mode 100755 mpnst_ignore_chems.txt delete mode 100644 mpnst_samples.csv delete mode 100755 requirements.txt diff --git a/beataml_samples.csv b/beataml_samples.csv deleted file mode 100644 index 3f711905..00000000 --- a/beataml_samples.csv +++ /dev/null @@ -1,1190 +0,0 @@ -other_id,improve_sample_id,other_names,common_name,cancer_type,model_type,other_id_source,species -11-00261,2054,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -11-00503,2055,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -11-00475,2056,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00047,2057,"Mixed phenotype acute leukaemia, T/myeloid, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -12-00032,2058,Chronic myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -11-00376,2059,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -11-00378,2060,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -11-00382,2061,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -11-00388,2062,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -11-00416,2063,AML with minimal differentiation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -11-00465,2064,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -11-00466,2065,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -12-00069,2066,AML without maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00033,2067,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -12-00123,2068,AML with mutated NPM1,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -12-00127,2069,AML with mutated NPM1,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -12-00145,2070,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -12-00154,2071,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -12-00196,2072,"Acute myeloid leukaemia, NOS",Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -12-00250,2073,Acute monoblastic and monocytic leukaemia ,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00147,2074,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -12-00294,2075,AML with myelodysplasia-related changes,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -12-00383,2076,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00226,2077,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00016,2078,Acute undifferentiated leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00034,2079,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00160,2080,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00059,2081,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00075,2082,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00077,2083,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00092,2084,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00123,2085,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00149,2086,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -12-00268,2087,"Mixed phenotype acute leukaemia, T/myeloid, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00157,2088,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00186,2089,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00195,2090,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00245,2091,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00262,2092,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00331,2093,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00393,2094,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00450,2095,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00468,2096,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00495,2097,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00558,2098,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00581,2099,AML with t(6;9)(p23;q34); DEK-NUP214,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00584,2100,AML with maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00602,2101,AML with mutated CEBPA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00615,2102,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00045,2103,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00065,2104,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00126,2105,"Mixed phenotype acute leukaemia, T/myeloid, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00092,2106,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00127,2107,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00193,2108,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00482,2109,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00528,2110,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00240,2111,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00270,2112,"Myelodysplastic syndrome, unclassifiable",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00272,2113,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00423,2114,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00434,2115,AML with t(9;11)(p22;q23); MLLT3-MLL,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00477,2116,Acute monoblastic and monocytic leukaemia ,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00514,2117,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00608,2118,AML with maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00613,2119,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00711,2120,AML with maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00712,2121,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00641,2122,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00817,2123,Acute myelomonocytic leukaemia,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00043,2124,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00051,2125,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00888,2126,AML with minimal differentiation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00137,2127,AML with mutated CEBPA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00083,2128,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00880,2129,Therapy-related myeloid neoplasms,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00276,2130,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00302,2131,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00287,2132,AML with mutated CEBPA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00377,2133,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00563,2134,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00571,2135,AML with maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00578,2136,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00265,2137,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00653,2138,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00742,2139,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00764,2140,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00777,2141,AML with myelodysplasia-related changes,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00811,2142,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00813,2143,AML with maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00837,2144,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00855,2145,Myeloid leukaemia associated with Down syndrome,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00870,2146,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00872,2147,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00088,2148,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00976,2149,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00983,2150,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00001,2151,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00035,2152,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00031,2153,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00041,2154,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00056,2155,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00094,2156,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00109,2157,AML with mutated NPM1,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00120,2158,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00271,2159,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00289,2160,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00292,2161,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00310,2162,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00306,2163,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00351,2164,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00354,2165,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00459,2166,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00538,2167,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00611,2168,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00479,2169,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00481,2170,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00886,2171,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00494,2172,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00498,2173,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00504,2174,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00519,2175,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00667,2176,Primary myelofibrosis,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00627,2177,Chronic myelomonocytic leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00731,2178,AML with maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00751,2179,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00882,2180,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00811,2181,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00818,2182,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00817,2183,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00836,2184,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00844,2185,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00149,2186,Unknown,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01004,2187,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01061,2188,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00963,2189,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01049,2190,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01098,2191,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01100,2192,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01102,2193,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01109,2194,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00436,2195,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01151,2196,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01185,2197,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01191,2198,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01201,2199,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01220,2200,AML with mutated CEBPA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01225,2201,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01227,2202,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01237,2203,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01267,2204,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01270,2205,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00021,2206,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00025,2207,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00028,2208,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00066,2209,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00072,2210,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00115,2211,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00123,2212,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00249,2213,AML without maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00649,2214,Unknown,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00313,2215,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00322,2216,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00325,2217,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00328,2218,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00337,2219,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00361,2220,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00441,2221,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00444,2222,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00251,2223,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00500,2224,Acute monoblastic and monocytic leukaemia ,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00536,2225,Unknown,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00551,2226,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00613,2227,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00634,2228,AML with minimal differentiation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00678,2229,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00676,2230,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00687,2231,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00689,2232,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00741,2233,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00763,2234,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00770,2235,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00775,2236,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00834,2237,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00849,2238,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00878,2239,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00881,2240,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00896,2241,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00901,2242,Acute monoblastic and monocytic leukaemia ,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00908,2243,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00915,2244,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-01027,2245,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-01054,2246,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-01060,2247,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00007,2248,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00103,2249,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00101,2250,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00105,2251,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00190,2252,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00203,2253,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00218,2254,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00260,2255,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00278,2256,Unknown,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00290,2257,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00327,2258,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00408,2259,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00414,2260,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00084,2261,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00092,2262,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00154,2263,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -10-00669,2264,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00334,2265,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00395,2266,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00639,2267,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -10-00507,2268,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -11-00295,2269,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -10-00819,2270,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -11-00261,2054,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -09-00705,2271,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -10-00792,2272,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -10-00136,2273,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -10-00542,2274,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -11-00049,2275,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -10-00172,2276,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -11-00162,2277,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -10-00791,2278,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -11-00178,2279,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -11-00254,2280,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -10-00692,2281,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -10-00715,2282,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -11-00170,2283,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -11-00090,2284,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -11-00319,2285,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00106,2286,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00047,2057,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -12-00371,2287,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00111,2288,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -12-00069,2066,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -12-00362,2289,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00004,2290,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00033,2067,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -12-00127,2069,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00180,2291,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00059,2081,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00075,2082,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00077,2083,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00083,2292,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00090,2293,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00092,2084,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00137,2294,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00141,2295,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00201,2296,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00242,2297,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00218,2298,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00294,2299,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00236,2300,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00237,2301,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00247,2302,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00268,2303,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00286,2304,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00316,2305,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00346,2306,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00383,2307,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00053,2308,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00417,2309,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00424,2310,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00236,2311,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00476,2312,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00267,2313,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00497,2314,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00540,2315,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00554,2316,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00535,2317,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00600,2318,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00614,2319,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00622,2320,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00654,2321,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00004,2322,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00244,2323,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00052,2324,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00066,2325,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00067,2326,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00134,2327,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00150,2328,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00173,2329,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00171,2330,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00212,2331,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00245,2332,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00242,2333,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00253,2334,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00268,2335,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00270,2112,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00272,2113,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00298,2336,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00311,2337,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00329,2338,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00335,2339,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00369,2340,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00401,2341,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00404,2342,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00430,2343,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00449,2344,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00451,2345,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00477,2116,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00484,2346,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00487,2347,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00498,2348,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00499,2349,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00805,2350,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00502,2351,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00521,2352,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00527,2353,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00536,2354,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00543,2355,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00555,2356,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00573,2357,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00803,2358,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00603,2359,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00664,2360,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00715,2361,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00720,2362,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00738,2363,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00756,2364,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00758,2365,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00777,2366,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00793,2367,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00009,2368,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00143,2369,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00056,2370,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00129,2371,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00148,2372,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00150,2373,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00159,2374,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00167,2375,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00180,2376,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00294,2377,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00196,2378,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00200,2379,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00208,2380,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00281,2381,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00357,2382,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00358,2383,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00361,2384,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00396,2385,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00392,2386,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00407,2387,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00416,2388,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00492,2389,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00147,2390,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00514,2391,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00684,2392,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00571,2135,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00581,2393,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00655,2394,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00682,2395,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00704,2396,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00726,2397,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00731,2398,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00964,2399,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00895,2400,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00988,2401,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00898,2402,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00135,2403,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00947,2404,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00006,2405,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00015,2406,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00017,2407,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00026,2408,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00033,2409,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00035,2152,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00261,2410,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00782,2411,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00041,2154,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00046,2412,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00593,2413,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00062,2414,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00070,2415,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01059,2416,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00161,2417,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00359,2418,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00294,2419,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00232,2420,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00083,2421,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00366,2422,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00374,2423,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00783,2424,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00400,2425,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00486,2426,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00484,2427,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00524,2428,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00562,2429,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01018,2430,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00096,2431,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00595,2432,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00599,2433,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00618,2434,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00632,2435,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00709,2436,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00852,2437,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01009,2438,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00880,2439,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00950,2440,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00952,2441,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00968,2442,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00970,2443,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00981,2444,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01022,2445,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01024,2446,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01055,2447,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01078,2448,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01098,2191,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01123,2449,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01130,2450,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01139,2451,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01142,2452,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00334,2453,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01245,2454,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01256,2455,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01267,2204,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00057,2456,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00187,2457,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00277,2458,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00937,2459,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00938,2460,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00319,2461,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00340,2462,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00434,2463,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00439,2464,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00436,2465,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00534,2466,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00547,2467,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00618,2468,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00651,2469,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00664,2470,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00670,2471,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00745,2472,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00748,2473,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00850,2474,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00871,2475,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00876,2476,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00953,2477,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00095,2478,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00110,2479,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00205,2480,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00206,2481,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00232,2482,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00385,2483,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00418,2484,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00393,2485,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00428,2486,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00431,2487,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00433,2488,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00450,2489,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00465,2490,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00640,2491,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00007,2492,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -12-00426,2493,AML with t(6;9)(p23;q34); DEK-NUP214,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00061,2494,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -12-00023,2495,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -12-00372,2496,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -12-00066,2497,Chronic myelomonocytic leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -12-00051,2498,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00118,2499,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -12-00150,2500,unknown,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00537,2501,AML with maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -12-00211,2502,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -12-00258,2503,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00147,2074,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -12-00294,2075,AML with myelodysplasia-related changes,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -12-00301,2504,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00138,2505,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -12-00423,2506,AML with maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00226,2077,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00016,2078,Acute undifferentiated leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00028,2507,Acute myelomonocytic leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00034,2079,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00160,2080,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00098,2508,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00123,2085,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00126,2509,Acute erythroid leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00145,2510,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00146,2511,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00149,2086,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00150,2512,"Mixed phenotype acute leukaemia, T/myeloid, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00157,2088,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00163,2513,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00165,2514,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00166,2515,AML with maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00186,2089,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00195,2090,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00202,2516,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00204,2517,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00780,2518,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00232,2519,Acute myelomonocytic leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00255,2520,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00245,2091,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00250,2521,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00253,2522,Acute megakaryoblastic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00260,2523,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00262,2092,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00266,2524,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00270,2525,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00273,2526,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00281,2527,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00318,2528,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00331,2093,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00044,2529,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00338,2530,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00342,2531,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00353,2532,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00015,2533,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00354,2534,Acute monoblastic and monocytic leukaemia ,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00365,2535,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00384,2536,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00393,2094,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00396,2537,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00406,2538,Acute monoblastic and monocytic leukaemia ,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00409,2539,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00420,2540,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00425,2541,AML with t(9;11)(p22;q23); MLLT3-MLL,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00450,2095,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00454,2542,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00468,2096,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00557,2543,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00471,2544,AML with t(9;11)(p22;q23); MLLT3-MLL,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00487,2545,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00493,2546,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00495,2097,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00496,2547,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00500,2548,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00513,2549,AML with t(9;11)(p22;q23); MLLT3-MLL,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00515,2550,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00593,2551,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00522,2552,Secondary myelofibrosis,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00532,2553,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00544,2554,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00545,2555,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00546,2556,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00551,2557,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00552,2558,AML with maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00558,2098,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00563,2559,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00572,2560,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00573,2561,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00578,2562,AML with t(6;9)(p23;q34); DEK-NUP214,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00581,2099,AML with t(6;9)(p23;q34); DEK-NUP214,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00584,2100,AML with maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00601,2563,Refractory anaemia with excess blasts,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00602,2101,AML with mutated CEBPA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00619,2564,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00615,2102,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00625,2565,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00655,2566,AML with t(9;11)(p22;q23); MLLT3-MLL,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00658,2567,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00659,2568,Acute myelomonocytic leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00660,2569,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00001,2570,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00012,2571,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00021,2572,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00023,2573,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00026,2574,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00034,2575,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00041,2576,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00045,2103,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00053,2577,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00060,2578,"Myelodysplastic syndrome, unclassifiable",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00063,2579,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00064,2580,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00078,2581,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00126,2105,"Mixed phenotype acute leukaemia, T/myeloid, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00081,2582,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00092,2106,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00096,2583,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00113,2584,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00125,2585,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00127,2107,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00135,2586,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00141,2587,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00152,2588,Acute myelomonocytic leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00757,2589,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00175,2590,Acute monoblastic and monocytic leukaemia ,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00184,2591,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00193,2108,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00228,2592,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00482,2109,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00231,2593,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00528,2110,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00240,2111,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00259,2594,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00273,2595,AML with mutated CEBPA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00279,2596,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00289,2597,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00676,2598,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00466,2599,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00331,2600,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00355,2601,Acute monoblastic and monocytic leukaemia ,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00359,2602,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00597,2603,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00376,2604,Refractory anaemia with excess blasts,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00380,2605,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-01098,2606,Myeloid sarcoma,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00423,2114,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00425,2607,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00434,2115,AML with t(9;11)(p22;q23); MLLT3-MLL,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00447,2608,AML with t(9;11)(p22;q23); MLLT3-MLL,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00448,2609,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00458,2610,Refractory anaemia with excess blasts,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00464,2611,AML with t(9;11)(p22;q23); MLLT3-MLL,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00454,2612,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00473,2613,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00476,2614,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00488,2615,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00496,2616,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00504,2617,AML with t(9;11)(p22;q23); MLLT3-MLL,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00514,2117,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00537,2618,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00542,2619,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00546,2620,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00564,2621,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00559,2622,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00140,2623,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00567,2624,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00231,2625,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00578,2626,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00581,2627,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00588,2628,Acute erythroid leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00599,2629,AML with minimal differentiation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00974,2630,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00602,2631,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00608,2118,AML with maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00613,2119,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00618,2632,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00081,2633,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00632,2634,Acute myelomonocytic leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00643,2635,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00644,2636,Acute monoblastic and monocytic leukaemia ,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00658,2637,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00667,2638,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00672,2639,Essential thrombocythaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00670,2640,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00681,2641,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00690,2642,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00712,2121,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00714,2643,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00641,2122,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00725,2644,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00815,2645,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00730,2646,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00735,2647,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00739,2648,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00742,2649,"Myelodysplastic syndrome, unclassifiable",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00761,2650,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00774,2651,AML with minimal differentiation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00781,2652,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00787,2653,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00798,2654,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00800,2655,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00801,2656,Myeloid sarcoma,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00817,2123,Acute myelomonocytic leukaemia,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00831,2657,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00832,2658,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00901,2659,AML with minimal differentiation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00014,2660,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00018,2661,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00024,2662,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00029,2663,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00043,2124,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00045,2664,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00051,2125,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00057,2665,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00084,2666,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00071,2667,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00073,2668,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00075,2669,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00312,2670,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00123,2671,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00194,2672,AML with minimal differentiation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00874,2673,AML with minimal differentiation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00315,2674,AML with minimal differentiation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00147,2675,AML with mutated CEBPA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -14-00083,2128,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00275,2676,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00175,2677,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00169,2678,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00829,2679,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00171,2680,AML with minimal differentiation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00201,2681,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00229,2682,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00237,2683,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00246,2684,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00248,2685,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00261,2686,Acute myelomonocytic leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00269,2687,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00276,2130,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00350,2688,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00300,2689,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00302,2131,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00303,2690,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00287,2132,AML with mutated CEBPA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00309,2691,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00296,2692,AML with t(9;11)(p22;q23); MLLT3-MLL,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00320,2693,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00279,2694,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00331,2695,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00338,2696,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00351,2697,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00353,2698,Acute megakaryoblastic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00371,2699,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00377,2133,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01097,2700,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00395,2701,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00548,2702,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00733,2703,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00383,2704,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00406,2705,Refractory cytopenia with multilineage dysplasia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00417,2706,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00471,2707,AML with mutated CEBPA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00470,2708,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00464,2709,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00479,2710,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00491,2711,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00525,2712,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00534,2713,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00539,2714,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00556,2715,AML without maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00563,2134,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00559,2716,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00572,2717,AML with maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00578,2136,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00593,2718,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00264,2719,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00595,2720,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00608,2721,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00610,2722,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00614,2723,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00615,2724,"Acute myeloid leukaemia, NOS",Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00616,2725,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00626,2726,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00633,2727,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00650,2728,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00653,2138,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01094,2729,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00304,2730,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00670,2731,AML without maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00674,2732,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00680,2733,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00683,2734,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00688,2735,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00692,2736,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00693,2737,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00701,2738,AML with minimal differentiation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00702,2739,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00724,2740,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00734,2741,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00717,2742,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00742,2139,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00755,2743,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00756,2744,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00763,2745,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00764,2140,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00766,2746,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00767,2747,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00777,2141,AML with myelodysplasia-related changes,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00939,2748,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00778,2749,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01138,2750,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00782,2751,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00786,2752,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00807,2753,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00811,2142,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00864,2754,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00936,2755,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00813,2143,AML with maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00819,2756,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00821,2757,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00839,2758,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00837,2144,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00850,2759,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00855,2145,Myeloid leukaemia associated with Down syndrome,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00858,2760,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00870,2146,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00872,2147,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00883,2761,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00967,2762,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00900,2763,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00892,2764,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00903,2765,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00909,2766,AML with minimal differentiation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00912,2767,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00921,2768,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00929,2769,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00942,2770,AML with t(9;11)(p22;q23); MLLT3-MLL,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00010,2771,AML with t(9;11)(p22;q23); MLLT3-MLL,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00088,2148,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00073,2772,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00118,2773,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00961,2774,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00965,2775,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00975,2776,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00976,2149,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00981,2777,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00979,2778,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -15-00990,2779,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00001,2151,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00003,2780,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00004,2781,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00007,2782,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00027,2783,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00031,2153,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00124,2784,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00496,2785,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00048,2786,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00050,2787,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00056,2155,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00087,2788,Therapy-related myeloid neoplasms,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00067,2789,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00075,2790,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00078,2791,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00077,2792,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00094,2156,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00226,2793,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00102,2794,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00109,2157,AML with mutated NPM1,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00120,2158,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00129,2795,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00113,2796,Myeloid sarcoma,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00115,2797,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00132,2798,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00139,2799,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00358,2800,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00143,2801,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00145,2802,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00157,2803,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01127,2804,AML with mutated NPM1,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00442,2805,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00150,2806,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00151,2807,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00217,2808,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00220,2809,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00249,2810,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00269,2811,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00271,2159,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00273,2812,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00278,2813,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00289,2160,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00292,2161,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00303,2814,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01118,2815,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00307,2816,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00483,2817,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00316,2818,unknown,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00332,2819,"Myelodysplastic syndrome, unclassifiable",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00458,2820,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00339,2821,"Atypical chronic myeloid leukaemia, BCR-ABL1 negative",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00344,2822,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00351,2164,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00354,2165,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00356,2823,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00373,2824,Myeloid sarcoma,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00392,2825,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00406,2826,AML with maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00410,2827,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00466,2828,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00533,2829,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00459,2166,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00460,2830,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00465,2831,Acute myelomonocytic leukaemia,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00474,2832,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00538,2167,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00710,2833,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00059,2834,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00477,2835,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00611,2168,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00883,2836,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00479,2169,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00481,2170,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00491,2837,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00765,2838,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00886,2171,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00494,2172,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00498,2173,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00504,2174,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00510,2839,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00519,2175,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00525,2840,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00541,2841,Plasma cell myeloma,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00540,2842,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00547,2843,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -13-00650,2844,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00564,2845,Chronic myelomonocytic leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00566,2846,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00701,2847,Chronic myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00822,2848,Chronic myelomonocytic leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00627,2177,Chronic myelomonocytic leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00699,2849,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00702,2850,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00705,2851,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00708,2852,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00724,2853,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00731,2178,AML with maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00755,2854,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00766,2855,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00882,2180,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00770,2856,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00771,2857,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00810,2858,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00818,2182,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00815,2859,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00820,2860,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00834,2861,"Mixed phenotype acute leukaemia, T/myeloid, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00831,2862,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00836,2184,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00867,2863,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00846,2864,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01017,2865,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00875,2866,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00118,2867,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00048,2868,Unknown,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00149,2186,Unknown,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00951,2869,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-00980,2870,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01004,2187,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01005,2871,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01010,2872,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01061,2188,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01103,2873,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01192,2874,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00963,2189,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01047,2875,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01049,2190,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01080,2876,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01082,2877,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01093,2878,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01100,2192,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01102,2193,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01109,2194,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01121,2879,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00215,2880,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00436,2195,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01151,2196,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01185,2197,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01191,2198,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01201,2199,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01210,2881,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01216,2882,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01219,2883,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01223,2884,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01225,2201,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01227,2202,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01237,2203,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01254,2885,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01262,2886,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01272,2887,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -16-01270,2205,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00077,2888,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00011,2889,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00021,2206,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00281,2890,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00025,2207,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00029,2891,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00033,2892,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00064,2893,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00066,2209,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00072,2210,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00093,2894,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00094,2895,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00105,2896,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00111,2897,Myeloid sarcoma,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00113,2898,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00123,2212,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00126,2899,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00177,2900,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00179,2901,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00189,2902,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00195,2903,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00210,2904,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00230,2905,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00248,2906,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00368,2907,AML without maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00252,2908,AML with minimal differentiation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00256,2909,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00262,2910,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00264,2911,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00276,2912,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00287,2913,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00300,2914,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00313,2215,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00321,2915,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00322,2216,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00325,2217,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00326,2916,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00328,2218,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00337,2219,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00346,2917,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00360,2918,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00423,2919,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00438,2920,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00441,2221,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00444,2222,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00443,2921,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00251,2223,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00446,2922,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00452,2923,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00457,2924,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00463,2925,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00464,2926,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00466,2927,AML with t(8;21)(q22;q22); RUNX1-RUNX1T1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00467,2928,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00478,2929,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00482,2930,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00485,2931,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00491,2932,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00499,2933,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00831,2934,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00043,2935,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00511,2936,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00514,2937,AML with t(9;11)(p22;q23); MLLT3-MLL,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00518,2938,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00536,2225,Unknown,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00539,2939,Acute erythroid leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00551,2226,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00556,2940,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00613,2227,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00634,2228,AML with minimal differentiation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00637,2941,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00656,2942,unknown,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00678,2229,Acute myelomonocytic leukaemia,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00679,2943,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00676,2230,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00685,2944,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00687,2231,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00690,2945,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00694,2946,"Mixed phenotype acute leukaemia, B/myeloid, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00741,2233,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00755,2947,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00761,2948,Acute myelomonocytic leukaemia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00768,2949,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00770,2235,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00772,2950,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00776,2951,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00779,2952,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00781,2953,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00834,2237,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00838,2954,Myeloid sarcoma,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00843,2955,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00848,2956,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00849,2238,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00851,2957,AML with minimal differentiation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00857,2958,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00862,2959,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00867,2960,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00878,2239,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00881,2240,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00883,2961,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00887,2962,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00893,2963,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00896,2241,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00901,2242,Acute monoblastic and monocytic leukaemia ,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00908,2243,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00915,2244,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00926,2964,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00933,2965,Unknown,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-01020,2966,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-01021,2967,AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-01023,2968,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-01024,2969,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-01038,2970,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-01047,2971,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-01036,2972,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-01054,2246,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-01060,2247,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-01081,2973,AML with maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-01083,2974,Acute myelomonocytic leukaemia,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-01106,2975,"Acute myeloid leukaemia, NOS",Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-01110,2976,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-01117,2977,AML with maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00007,2248,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00012,2978,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00014,2979,Unknown,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00016,2980,Unknown,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00029,2981,AML with mutated NPM1,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00039,2982,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00053,2983,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00055,2984,Therapy-related myeloid neoplasms,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00361,2985,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00073,2986,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00077,2987,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00082,2988,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00103,2249,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00101,2250,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00105,2251,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00127,2989,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00129,2990,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00131,2991,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00135,2992,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00173,2993,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00179,2994,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00184,2995,Unknown,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00190,2252,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00192,2996,AML with mutated NPM1,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00204,2997,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00206,2998,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00208,2999,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00218,2254,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00219,3000,Refractory cytopenia with multilineage dysplasia,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00223,3001,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00226,3002,AML with minimal differentiation,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00230,3003,AML with mutated NPM1,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00238,3004,Unknown,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00253,3005,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00260,2255,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00334,3006,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00267,3007,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00269,3008,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00270,3009,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00278,2256,Unknown,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00279,3010,Acute monoblastic and monocytic leukaemia ,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00280,3011,Unknown,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00283,3012,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00290,2257,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00298,3013,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00305,3014,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00332,3015,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00320,3016,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00327,2258,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00341,3017,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00390,3018,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00408,2259,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00027,3019,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00035,3020,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -18-00414,2260,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00019,3021,AML with mutated CEBPA,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00025,3022,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00029,3023,AML with mutated NPM1,Leukapheresis,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00062,3024,Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00051,3025,AML with maturation,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00084,2261,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00092,2262,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00107,3026,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00137,3027,AML with myelodysplasia-related changes,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00154,2263,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00156,3028,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00165,3029,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00179,3030,AML with myelodysplasia-related changes,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00200,3031,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00261,3032,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00290,3033,"Mixed phenotype acute leukaemia, T/myeloid, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00313,3034,AML with mutated NPM1,Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00315,3035,"Acute myeloid leukaemia, NOS",Peripheral Blood,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00327,3036,AML with mutated NPM1,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00369,3037,AML without maturation,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -19-00400,3038,Therapy-related myeloid neoplasms,Bone Marrow Aspirate,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -00-00002,3039,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -00-00003,3040,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -00-00004,3041,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -00-00005,3042,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -00-00006,3043,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -00-00007,3044,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -00-00008,3045,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -00-00009,3046,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -00-00010,3047,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -00-00011,3048,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -00-00012,3049,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -00-00013,3050,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -00-00015,3051,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -00-00016,3052,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -00-00017,3053,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -00-00018,3054,Control,Healthy pooled CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00035,3055,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00036,3056,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00037,3057,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00038,3058,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00039,3059,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00040,3060,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00041,3061,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00042,3062,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00043,3063,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00044,3064,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00045,3065,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00046,3066,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00047,3067,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00048,3068,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00049,3069,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00050,3070,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00051,3071,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00052,3072,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00053,3073,Control,Healthy Individual CD34+,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00055,3074,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens -17-00056,3075,Control,Healthy Individual BM MNC,Acute Myeloid Leukaemia,ex vivo,beatAML,Homo sapiens diff --git a/mpnst_ignore_chems.txt b/mpnst_ignore_chems.txt deleted file mode 100755 index b85487c6..00000000 --- a/mpnst_ignore_chems.txt +++ /dev/null @@ -1,1707 +0,0 @@ -nsc241240 -platinum, diammine[1,1-cyclobutanedi(carboxylato-ko)(2-)]-, (sp-4-2)- -platinum,1-cyclobutanedicarboxylato(2-)-o,o']-, (sp-4-2)- -stl451040 -cbdca -tox21_112586_1 -cis-diammine(1,1-cyclobutanedicarboxylato)platinum(ii) -epitope id:194801 -carboplatin -7,7-diamino-6,8-dioxa-7-platinaspiro[3.5]nonane-5,9-dione -diamino[cyclobutane-1,1-dicarboxylato(2-)-kappa~2~o~1~,o~1~]platinum -nsc758182 -paraplatin -hms3269h03 -ncgc00167800-01 -pharmakon1600-01502106 -en300-123065 -azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) -cis-diammine(1,1-cyclobutanedicarboxylato)platinum -platinum(ii),1-cyclobutanedicarboxylato)diammine-, cis- -dtxsid3046742 -sy075575 -1,1-cyclobutanedicarboxylate diammine platinum(ii) -chebi:31355 -cis-(1,1-cyclobutanedicarboxylato)diammineplatinum(ii) -platinum,1-cyclobutanedicarboxylato(2-)-o,o')-, (sp-4-2)- -platinum, diammine[1,1-cyclobutanedicarboxylato(2-)-.kappa.o,.kappa.o'']-, (sp-4-2)- -ab01273939-01 -mfcd00070464 -ns00076275 -carboplatinum -nsc201345 -nsc-241240 -lopac0_000230 -1,1-cyclobutanedicarboxylatodiammineplatinum(ii) -dtxcid201476080 -cas-41575-94-4 -41575-94-4 -schembl4964 -bp-25385 -nsc-758182 -ncgc00263858-02 -paraplatin (bristol meyers) -(-)-n-(((r)-2,3-dihydroxypropyl)oxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide -n-((r)-2,3-dihydroxy[propoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide -4bm -nsc800840 -bdbm104963 -schembl172904 -cs-0062 -n-[(2r)-2,3-dihydroxypropoxy]-3,4-d ifluoro-2-[(2-fluoro-4-iodophenyl)amino]-benzamide -benzamide, n-((2r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)- -mirdametinib [usan] -db07101 -nsc-755770 -n-((2r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)-benzamide -mirdametinib [inn] -ex-8602 -gtpl7935 -(r)-n-(2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)benzamide -pd 901 -pd0325901 (pd325901) -benzamide, n-[(2r)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]- -n-[(2r)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide -hms3648a14 -(r)-n-(2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide -n-((r)-2,3-dihydroxy-propoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide -us8575391, q -j-502503 -pd-325901 -c16h14f3in2o4 -ccg-221316 -who 11299 -chembl507361 -mirdametinib -391209-97-5 -ns00069616 -mirdametinib [who-dd] -cas-391210-10-9 -pd 0325901 -n-[((r)-2,3-dihydroxypropyl)oxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide -(s)-n-(2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide -q27088255 -dtxcid8024024 -dtxsid0044024 -d11675 -n-[(r)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide -n-[(2r)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide -n-(((r)-2,3-dihydroxypropyl)oxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide n-((2r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide -pd325901 , pd0325901 -mfcd08435926 -nsc-800840 -hb2240 -chebi:88249 -86k0j5ak6m -pd 0325901, >=98% (hplc) -bcp9001057 -n-{[(2r)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide -pd-0325901 -unii-86k0j5ak6m -nsc755770 -tox21_113364 -pd0325901 -n-[(2r)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-benzamide -sr-01000946344 -amy36437 -n-(((r)-2,3-dihydroxypropyl)oxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide -s1036 -sw218101-2 -sr-01000946344-1 -ncgc00189075-01 -391210-10-9 -pd-0325901,pd325901 -pd0325901(mirdametinib) -ncgc00381744-09 -brd-k49865102-001-01-9 -ex-a102 -pd 325901 -mirdametinib (usan) -hy-10254 -akos015855518 -bcpp000126 -pd 03525901 -n-[(2r)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]- benzamide -digoxin pediatric -lanorale -nsc 95100 -20830-75-5 (free) -digomal -20830-75-5 -mapluxin -digoxin [who-ip] -digoxina (inn-spanish) -hy-b1049 -3-[(3s,5r,8r,9s,10s,12r,13s,14s,17r)-3-[(2r,4s,5s,6r)-5-[(2s,4s,5s,6r)-5-[(2s,4s,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2h-furan-5-one -prestwick2_000437 -lifusin -sr-01000721866 -digoxin, certified reference material, tracecert(r) -digoxine navtivelle -db00390 -tox21_201678 -smr000653537 -vanoxin -d00298 -prestwick0_000437 -ncgc00090797-07 -saroxin -digoxin (jp17/usp) -lanoxicaps (tn) -toloxin -ncgc00090797-04 -human serum - digoxin, low level -ncgc00259227-01 -digoxin -lanocardin -sk-digoxin -digoxin, analytical standard -ncgc00257022-01 -hms1569g16 -0b9662a7-264e-4acd-94b2-9e1138c0ca5a -digoxin, european pharmacopoeia (ep) reference standard -digoxina [inn-spanish] -stillacor- -digitek -12a-hydroxydigitoxin -davoxin -lanoxin pediatric -digoxin [ep monograph] -lanoxin (tn) -bpbio1_000500 -12beta-hydroxydigitoxin -c01aa05 -novodigal (inj.) -q422222 -digoxin for peak identification, european pharmacopoeia (ep) reference standard -digoxin [mart.] -digoxin [iarc] -digoxin (ep monograph) -digoxigenin-tridigitoxosid [german] -acygoxin -3.beta.-((o-2,6-dideoxy-.beta.-d-ribo-hexopyranosyl-(1->4)-o-2,6-dideoxy-.beta.-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-.beta.-d-ribo-hexopyranosyl)oxy)-12.beta.,14-dihydroxy-5.beta.-card-20(22)-enolide -digoxin (usp:inn:ban:jan) -digitalis glycoside -cas-20830-75-5 -digos -bdbm46355 -4-[(1r,3as,3br,5ar,7s,9as,9bs,11r,11as)-7-{[(2r,4s,5s,6r)-5-{[(2s,4s,5s,6r)-5-{[(2s,4s,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-3a,11-dihydroxy-9a,11a-dimethyl-hexadecahydro-1h-cyclopenta[a]phenanthren-1-yl]-2,5-dihydrofuran-2-one -prestwick3_000437 -hsdb 214 -ncgc00090797-12 -digoxin (mart.) -4-((3s,5r,8r,9s,10s,12r,13s,14s,17r)-3-(((2r,4s,5s,6r)-5-(((2s,4s,5s,6r)-5-(((2s,4s,5s,6r)-4,5-dihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-4-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-4-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-12,14-dihydroxy-10,13-dimethylhexadecahydro-1h-cyclopenta[a]phenanthren-17-yl)furan-2(5h)-one -digossina -digoxin [hsdb] -dtxsid5022934 -digoxin [who-dd] -12 beta -hydroxydigitoxin -gtpl4726 -s4290 -digoxina -spbio_002393 -3-[(3s,5r,8r,9s,10s,12r,13s,14s,17r)-10,13-dimethyl-3-[(2r,4s,5s,6r)-6-methyl-5-[(2s,4s,5s,6r)-6-methyl-5-[(2s,4s,5s,6r)-6-methyl-4,5-bis(oxidanyl)oxan-2-yl]oxy-4-oxidanyl-oxan-2-yl]oxy-4-oxidanyl-oxan-2-yl]oxy-12,14-bis(oxidanyl)-1,2,3,4,5,6,7,8,9,11,12, -3-[(3s,5r,8r,9s,10s,12r,13s,14s,17r)-3-[[(2r,4s,5s,6r)-5-[[(2s,4s,5s,6r)-5-[[(2s,4s,5s,6r)-4,5-dihydroxy-6-methyl-2-oxanyl]oxy]-4-hydroxy-6-methyl-2-oxanyl]oxy]-4-hydroxy-6-methyl-2-oxanyl]oxy]-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16, -card-20(22)-enolide, 3-((o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(hexopyranosyl-(1-4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, -digoxin, pharmaceutical secondary standard; certified reference material -3b0w -brd-k23478508-001-03-7 -digitoxin, 12beta-hydroxy- -hb1138 -ncgc00090797-01 -3beta-(2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-d-ribo-hexopyranosyloxy)-12beta,14-dihydroxy-5beta,14beta-card-20(22)-enolide -ncgc00090797-15 -digoxin (usp monograph) -cardiogoxin -digoxine -d1828 -ncgc00090797-02 -dixina -digoxin [orange book] -digoxin [usp-rs] -lenoxin -mfcd00003674 -[3h]-digoxin -digoxina-sandoz -schembl20506 -digoxin for peak identification -ncgc00090797-03 -sr-01000721866-4 -sr-01000721866-3 -cardigox -bidd:pxr0148 -ncgc00090797-09 -coragoxine -digon -akos024283494 -dynamos -digoxin [usp monograph] -hemigoxine nativelle -digoxin, 1mg/ml in methanol -digoxin [usp:inn:ban:jan] -digoxinum -(3beta,5beta,12beta)-3-((o-2,6-dideoxy-beta-d-ribo-hexapyranosyl-(1-4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl)oxy)-12,14-dihydroxycard-20(22)-enolide -chembl1751 -lanoxicaps -lanikor -tox21_303050 -ccg-220437 -card-20(22)-enolide, 3-((o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1->4)-o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-,(3beta,5beta,12beta)- -digoxin [jan] -card-20(22)-enolide, 3-((o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1.fwdarw.4)-o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1.fwdarw.4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)- -prestwick_170 -cordioxil -digacin -homolle's digitalin -hms3713g16 -lanoxin pg -c06956 -natigoxin -dimecip -nsc95100 -digoxinum [who-ip latin] -dokim -3beta-((o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1-4)-o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl)oxy)-12beta,14-dihydroxy-5beta-card-20(22)-enolide -73k4184t59 -card-20(22)-enolide, 3-((o-2,6-dideoxy-.beta.-d-ribo-hexopyranosyl-(1->4)-o-2,6-dideoxy-.beta.-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-.beta.-d-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-,(3.beta.,5.beta.,12.beta.)- -[3h]digoxin -card-20(22)-enolide, 3-((o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1-4)-o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)- -epitope id:122964 -lanacordin -4-((1s,2s,5s,11s,15s,7r,10r,14r,16r)-5-{5-[5-((2s,4s,5s,6r)-4,5-dihydroxy-6-me thyl(2h-3,4,5,6-tetrahydropyran-2-yloxy))(4s,5s,2r,6r)-4-hydroxy-6-methyl(2h-3 ,4,5,6-tetrahydropyran-2-yloxy)](4s,5s,2r,6r)-4-hydroxy-6-methyl(2h-3,4,5,6-te trahydropyran-2-yl -digox -card-20(22)-enolide, 3-((o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1->4)-o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)- -unii-73k4184t59 -lanacrist -purgoxin -bspbio_000454 -digoxin [inn] -rougoxin -digossina [dcit] -4-[(1s,2s,5s,7r,10r,11s,14r,15s,16r)-5-{[(2r,4s,5s,6r)-5-{[(2s,4s,5s,6r)-5-{[(2s,4s,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-11,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]-2,5-dihydrofuran-2-one -digoxinum (latin) -ncgc00090797-05 -akos015895113 -digoxin-sandoz -digoxin (usp-rs) -chebi:4551 -hms2096g16 -digoxin 1.0 mg/ml in methanol -ncgc00090797-06 -novodigal [inj.] -smr000059217 -a814956 -human serum - digoxin, high level -mls000069819 -(3beta,5beta,12beta)-3-{[2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide -neo-lanicor -brn 0077011 -as-13281 -mls001055371 -card-20(22)-enolide, 3-[[o-2,6-dideoxy-.beta.-d-ribo-hexopyranosyl-(1-->4)-o-2,6-dideoxy-.beta.-d-ribo-hexopyranosyl-(1-->4)-2,6-dideoxy-.beta.-d-ribo-hexopyranosyl]oxy]-12,14-dihydroxy-, (3.beta.,5.beta.,12.beta.)- -digoxinum [inn-latin] -cs-4571 -digoxin [vandf] -mls001076495 -5-18-04-00381 (beilstein handbook reference) -digoxinum (inn-latin) -opera_id_1134 -digoxin, united states pharmacopeia (usp) reference standard -digosin -nsc-95100 -3beta-((o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1->4)-o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl)oxy)-12beta,14-dihydroxy-5beta-card-20(22)-enolide -grexin -c41h64o14 -chloroformic digitalin -prestwick1_000437 -digoxin nativelle -eudigox -cardioxin -gtpl4725 -3beta,12beta,14-trihydroxy-5beta,14beta-card-20(22)-enolid-3-tridigitoxosid -digoxin-zori -hms2232g20 -4-[(3s,5r,8r,9s,10s,12r,13s,14s)-3-[(2s,4s,5r,6r)-5-[(2s,4s,5r,6r)-5-[(2s,4s,5r,6r)-4,5-dihydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5h-furan-2-one -tox21_111025 -z2108699066 -fargoxin -ns00008620 -3-[(3s,5r,8r,9s,10s,12r,13s,14s,17r)-3-[(2r,4s,5s,6r)-5-[(2s,4s,5s,6r)-5-[(2s,4s,5s,6r)-4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2h-furan-5-one -digonix -neodioxanin -digoxin [mi] -en300-6492954 -j-013666 -3-[(3s,5r,10s,12r,13s,14s,17r)-3-[(2r,4s,5s,6r)-5-[(2s,4s,5s,6r)-5-[(2s,4s,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2h-furan-5-one -(3beta,5beta,12beta)-3-((2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl)oxy)-12,14-dihydroxycard-20(22)-enolide -cid_2724385 -lanoxin -regid_for_cid_2724385 -digoksyna [polish] -lenoxicaps -digoksyna -dilanacin -dtxcid502934 -einecs 244-068-1 -digoxin (iarc) -digoxigenin-tridigitoxosid -6gy -db12267 -ncgc00483924-01 -d10866 -brigatinib -(2-((5-chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethyl-,delta5-phosphanone -(2-((5-chloro-2-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)anilino)pyrimidin-4-yl)amino)phenyl)dimethyl-lambda5-phosphanone -brigatinib; ap26113 -alunbrig (tn) -compound 11q (pmid: 27144831) -5-chloro-n4-[2-(dimethylphosphoryl)phenyl]-n2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine -schembl11916361 -cs-4278 -ap-26113 -brigatinib (ap-26113) -compound 11q [pmid: 27144831] -brigatinib [who-dd] -nsc-787457 -nsc-784728 -brigatinib [jan] -db-118419 -(2-((5-chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethyl-,.delta.5-phosphanone -chembl3545311 -unii-hyw8db273j -brigatinib [orange book] -nsc787457 -5-chloro-n4-(2-(dimethylphosphoryl)phenyl)-n2-(2-methoxy-4(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine -2,4-pyrimidinediamine, 5-chloro-n4-[2-(dimethylphosphinyl)phenyl]-n2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]- -en300-6477855 -brigatinib (jan/usan) -brigatinib [mi] -brigatinibum -5-chloro-n4-(2-(dimethylphosphoryl)phenyl)-n2-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine -alunbrig -ap 26113 -brigatinib [usan] -q27456393 -(2-((5-chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethylphosphine oxide -gtpl7741 -bdbm50185140 -5-chloro-n4-(2-(dimethylphosphoryl)phenyl)-n2-(2-methoxy-4-(4-(4-methylpiperazin-1- yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine -mfcd29472221 -akos030257612 -as-75176 -amy10294 -2,4-pyrimidinediamine, 5-chloro-n4-(2-(dimethylphosphinyl)phenyl)-n2-(2-methoxy-4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)- -dtxsid501027929 -hy-12857 -ex-a775 -5-chloro-4-n-(2-dimethylphosphorylphenyl)-2-n-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine -ns00073439 -l01xe43 -brigatinib [inn] -hyw8db273j -brigatinib [usan:inn] -brigatinib (ap26113) -5-chloro-n~4~-[2-(dimethylphosphoryl)phenyl]-n~2~-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine -z2512157852 -bcp17214 -sb40412 -s8229 -1197953-54-0 -ac-29958 -nsc784728 -ripretinibum -1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea -schembl14999718 -akos040759418 -ripretinib [who-dd] -hy-112306 -unii-9xw757o13d -qinlock (tn) -ripretinib [inn] -ms-29471 -gtpl9175 -ripretinib [orange book] -9xw757o13d -1442472-39-0 -qinlock -3-{4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl]-2-fluorophenyl}-1-phenylurea -at18473 -n-{4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3- yl]-2-fluorophenyl}-n'-phenylurea -ripretinib; urea, n-[4-bromo-5-[1-ethyl-1,2-dihydro-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl]-2-fluorophenyl]-n'-phenyl-; n-[4-bromo-5-[1-ethyl-1,2-dihydro-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl]-2-fluorophenyl]-n'-phenylurea; 1-[4-bromo-5-[1-ethyl-7-(methyla -quinlock -ripretinib [mi] -cs-0044835 -db14840 -en300-22895298 -dcc2618 -dtxsid201027956 -1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl]-2-fluorophenyl]-3-phenylurea -ex-a4883 -bdbm50609506 -1-n'-(2,5-difluoro-4-(2-(1-methylpyrazol-4-yl)pyridin-4-yl)oxyphenyl)-1-n'-phenylcyclopropane-1,1-dicarboxamide -s8757 -ripretinib -1442472-39-0 (free base) -ac-36722 -kit/pdgfr inhibitor dcc-2618 -3-{4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl]-2-fluorophenyl}-1-phenylurea -dcc 2618;dcc2618;kit/pdgfr inhibitor;ripretinib -bcp29218 -dcc-2618 -ripretinib (dcc-2618) -d11353 -chembl4216467 -ripretinib free base -urea, n-(4-bromo-5-(1-ethyl-1,2-dihydro-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl)-2-fluorophenyl)-n'-phenyl- -glxc-15506 -urea, n-[4-bromo-5-[1-ethyl-1,2-dihydro-7-(methylamino)-2-oxo-1,6- naphthyridin-3-yl]-2-fluorophenyl]-n'-phenyl-39-0 -ripretinib (usan) -n-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-n'-phenylurea -ripretinib [usan] -c24h21brfn5o2 -fimepinostat -bcp06870 -hy-13522 -pi3k/hdac inhibitor centn -ncgc00346692-01 -cudc-907 (pi3k/hdac inhibitori) -pi3k/hdac inhibitor -gtpl8952 -jowxjlifiioyms-uhfffaoysa-n -mls006010994 -pi3k/hdac inhibitor cudc-907 -smr004702794 -db11891 -mfcd22420823 -sb16569 -n-hydroxy-2-[[2-(6-methoxypyridin-3-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl-methylamino]pyrimidine-5-carboxamide -unii-3s9rx35s5x -fimepinostat (usan/inn) -cudc 907 -nsc771751 -j-690133 -n-hydroxy-2-({[2-(6-methoxypyridin-3-yl)-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl}(methyl)amino)pyrimidine-5-carboxamide -bdbm50188961 -hms3673e03 -chembl3622533 -5-pyrimidinecarboxamide, n-hydroxy-2-[[[2-(6-methoxy-3-pyridinyl)-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl]methylamino]- -d11319 -cudc-907 -n-hydroxy-2-(((2-(6-methoxypyridin-3-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)(methyl)amino)pyrimidine-5-carboxamide -fimepinostat [inn] -schembl1284705 -sw219871-1 -q27076926 -ncgc00346692-11 -ns00072982 -cs-1610 -ncgc00346692-04 -dtxsid90712307 -cudc907 -5-pyrimidinecarboxamide, n-hydroxy-2-(((2-(6-methoxy-3-pyridinyl)-4-(4-morpholinyl)thieno(3,2-d)pyrimidin-6-yl)methyl)methylamino)- -fimepinostat (cudc-907) -akos026750340 -fimepinostat [usan] -ac-30227 -1339928-25-4 -da-34958 -cudc-907 (pi3k/hdac inhibitori)? -db-057451 -as-57131 -3s9rx35s5x -n-hydroxy-2-[{[2-(6-methoxypyridin-3-yl)-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl}(methyl)amino]pyrimidine-5-carboxamide -nsc-771751 -fimepinostat [who-dd] -hms3656h04 -ccg-269763 -ex-a742 -s2759 -2-benzoxazolamine, 5-(4-amino-1-(1-methylethyl)-1h-pyrazolo(3,4-d)pyrimidin-3-yl)- -ncgc00346654-10 -d11183 -ccg-265002 -schembl7902875 -us10172858, table 1.22 -jgh0df1u03 -3-(2-amino-5-benzoxazolyl)-1-(1-methylethyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine -sapanisertib [inn] -ns00072976 -ink-128/ink128 -cb-228 -nsc764658 -5-(4-amino-1-isopropyl-1h-pyrazolo[3,4-d]pyrimidin-3-yl)benzo[d]oxazol-2-amine -nsc780880 -smr004702810 -3-(2-aminobenzo[d]oxazol-5-yl)-1-isopropyl-1h-pyrazolo[3,4-d]pyrimidin-4-amine -ncgc00346654-01 -cs-0557 -ink-128,cas:1224844-38-5 -j-004811 -q27078072 -5-(4-amino-1-isopropyl-1h-pyrazolo[3,4-d]-pyrimidin-3-yl)benzo[d]oxazol-2-amine -ac-26848 -chembl3545097 -unii-jgh0df1u03 -mln-0128 -s2811 -1224844-38-5 -ink-128;sapanisertib;mln0128 -chebi:91450 -1h-pyrazolo[3,4-d]pyrimidin-4-amine, 3-(2-amino-5-benzoxazolyl)-1-(1-methylethyl)- -hms3656h12 -3-(2-amino-1,3-benzoxazol-5-yl)-1-isopropyl-1h-pyrazolo(3,4-d)pyrimidin-4-amine -nsc768435 -ink-128 -mls006011012 -ink-0128 -sapanisertibum -fe5 -as-16294 -tak-228 -sapanisertib (usan/inn) -db11836 -bcp0726000086 -akos025149512 -nsc-764658 -sapanisertib [usan:inn] -bcp9000789 -bdbm315477 -3-(2-amino-1,3-benzoxazol-5-yl)-1-(propan-2-yl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine -bs170924 -ink 128 -sapanisertib -5-(4-azanyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine -ink128 -ink 128 (mln0128) -sb16566 -sw220210-1 -sapanisertib [who-dd] -1h-pyrazolo(3,4-d)pyrimidin-4-amine, 3-(2-amino-5-benzoxazolyl)-1-(1-methylethyl)- -db-293450 -5-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine -us10172858, table 1.1 -sapanisertib; ink128 -mln0128 -nsc-780880 -ink 128; mln 0128; sapanisertib -5-(4-amino-1-isopropyl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine -mfcd22124893 -dtxsid401022538 -hms3672c21 -sapanisertib [usan] -3-(2-amino-1,3-benzoxazol-5-yl)-1-(propan-2-yl)-1h-pyrazolo(3,4-d)pyrimidin-4-amine -sapanisertib (mln0128) -nsc-768435 -ex-a951 -gtpl7933 -hy-13328 -chembl3545110 -7-cyclopentyl-n,n-dimethyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}-7h-pyrrolo[2,3-d]pyrimidine-6-carboxamide -1211441-98-3 -q27088552 -da-35904 -akos025404915 -nsc-794613 -7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide -as-10159 -en300-7409093 -ribociclibum -7-cyclopentyl-n,n-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7h-pyrrolo(2,3-d)pyrimidine-6-carboxamide -7-cyclopentyl-n,n-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxamide -ribociclib (lee011) -sw220101-1 -nsc778909 -lee-011; lee 011;lee011 -a858033 -rhxhgraepcafml-uhfffaoysa-n -ribociclib (usan/inn) -ribociclib [who-dd] -sb18480 -ns00072964 -lee011 -ribociclib [mi] -ribociclib -hms3748m05 -7h-pyrrolo[2,3-d]pyrimidine-6-carboxamide, 7-cyclopentyl-n,n-dimethyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-; 7-cyclopentyl-n,n-dimethyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-7h-pyrrolo[2,3-d]pyrimidine-6-carboxamide; kisqali; lee 011; lee 011a; ribociclib -s7440 -ex-a304 -example 74 [us8962630] -gtpl7383 -us8962630, 74 -7h-pyrrolo(2,3-d)pyrimidine-6-carboxamide, 7-cyclopentyl-n,n-dimethyl-2-((5-(1-piperazinyl)-2-pyridinyl)amino)- -lee-011a -7-cyclopentyl-n,n-dimethyl-2-(5-(piperazin-1-yl)pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxamide -bcp08804 -lee-011 -7-cyclopentyl-n,n-dimethyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-7h-pyrrolo[2,3-d]pyrimidine-6-carboxamide -hy-15777 -6zz -lee011a -tk8ere8p56 -bdbm148264 -nvp-lee011 -nsc800867 -ribociclib, lee011 -chebi:230905 -hms3673i19 -nsc-800867 -ribociclib [usan:inn] -example 74 (us8962630) -6-(1h-indazol-6-yl)-n-[4-(4-morpholinyl)phenyl]-imidazo[1,2-a]pyrazin-8-amine -hms3653n03 -cs-1750 -akos032949987 -kisqali -ac-30029 -j-690066 -schembl302310 -ncgc00386317-11 -l01xe42 -dtxsid201021027 -ribociclib (lee011)? -7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo [2,3-d]pyrimidine-6-carboxylic acid dimethylamide -ribociclib [inn] -d10883 -ncgc00386317-10 -lee 011 -unii-tk8ere8p56 -db11730 -ribociclib [usan] -ccg-269070 -mfcd27976795 -amy16792 -nsc-778909 -nsc794613 -7-cyclopentyl-n,n-dimethyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrrolo[2,3-d]pyrimidine-6-carboxamide -n,n-bis(beta-chloroethyl)-amino-n',o-propylene-phosphoric acid ester diamide -q418560 -isophosphamide,(s) -asta z-4942 -tox21_302775 -ifosfamide (ep impurity) -tronoxal -bi166243 -n,n-bis(beta-chloroethyl)-amino-n'-o-propylene-phosphoric acid ester diamide -2h-1,3,2-oxazaphosphorin-2-amine, n,3-bis(2-chloroethyl)tetrahydro-, 2-oxide -hms1570h07 -ifosfamide; (rs)-n,3-bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide -z-4942 -ifosfamide [vandf] -akos005711213 -ifosfamide [inn] -ifosfamide, analytical reference material -3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2h-1,2-oxazaphosphorine 2-oxide -isophosphamide [iarc] -ifosfamide, >=98% -sw197177-4 -nsc759154 -ab00513932_09 -nsc-759154 -2,3-(n,n(sup 1)-bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd -ifosfamide (usp monograph) -ifosphamide -ifoxan -nci60_000233 -ncgc00179435-07 -{3-(2-chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2h-1,3,} 2-oxazaphosphorine oxide -holoxan -i0713 -ab00513932-08 -3-(2-chloroethyl)-2-[(2-chloroethyl)amino]-1,3,2$l^{5}-oxazaphosphinan-2-one -ncgc00256413-01 -tox21_110539_1 -asta z 4942 -hms2090m12 -2,3-(n,n(,)-bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxy -s1302 -ifosfamid a -naxamide -nci-co1638 -a823873 -tox21_110539 -bbl028071 -gtpl7201 -1,3,2-oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide -n-(2-chloraethyl)-n'-(2 chloroethyl)-n'-o-propylen-phosphorsaeureester-diamid -ifosfamida -3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2h-1,3,2-oxazaphosphorine-2 -oxide -ifosfamide [ep impurity] -3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2h-1,3,2-oxazaphosphorine 2-oxide -iphosphamide -n,3-bis(2-chloroethyl)-2-oxo-1,3,2$l;{5}-oxazaphosphinan-2-amine -n-(2-chloroethyl)-n-(3-(2-chloroethyl)-2-oxido-1,3,2-oxazaphosphinan-2-yl)amine -hsdb 7023 -3-(2-chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2h-1,2-oxazaphosphorineoxide -l01aa06 -tox21_201815 -ncgc00179435-02 -bcp06596 -unii-um20qqm95y -n,3-bis(2-chloroethyl)-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine -3-(2-chloroethyl)-2-((2-chloroethyl)amino)perhydro-2h-1,3,2-oxazaphosphorine oxide -wln: t6npotj am2g bo b2g -ncgc00179435-01 -ifosfamida (inn-spanish) -ccg-213464 -n,3-bis(2-chloroethyl)tetrahydro-2h-1,3,2-oxazaphosphorin-2-amine 2-oxide -cas-3778-73-2 -um20qqm95y -z4942 -ifosfamide (ep monograph) -2-oxo-n,3-bis-(2-chloroethyl) tetrahydro-2h-1,3,2-oxazaphosphorin-2-amine -bdbm189358 -ifosfamide [mart.] -ifosfamide, european pharmacopoeia (ep) reference standard -ifosfamida [inn-spanish] -3-(2-chloroethyl)-2-[(2-chloroethyl)amino]-1,3,2lambda5-oxazaphosphinan-2-one -ab00513932_10 -ifosfamide - bio-x -{3-(2-chloroethyl)-2-[(2- -hms2097h07 -pharmakon1600-01505480 -ifosfamide [orange book] -66849-34-1 -mjf 9325 -ifosfamide [ep monograph] -n,3-bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide -ifosfamide (jan/usp/inn) -seromida -einecs 223-237-3 -prestwick2_000833 -n-(2-chloroethyl)-n'-(2-chloroethyl)-n',o-propylenephosphoric acid diamide -sy066721 -ab00513932-07 -hms2232o10 -3-(2-chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2h-1,2-oxazaphosphorine oxide -ccris 352 -hms3714h07 -dtxsid7020760 -3-(2-chloroethyl)-2-((2-chloroethyl)amino)perhydro-2h-1,3,2-oxazaphosphorineoxide -ifosfamide [who-dd] -3-(2-chloroethyl)-2-(2-chloroethylamino)tetrahydro-2h-1,3,2-oxaazaphosphorin 2-oxide -bspbio_000785 -ab02316 -2,n(sup 1)-bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd -(2-chloro-ethyl)-[(r)-3-(2-chloro-ethyl)-2-oxo-2lambda5-[1,3,2]oxazaphosphinan-2-yl]-amine -hy-17419 -sr-05000002022-5 -ifosfamide in bulk -spbio_002706 -isocyclophosphamide -ifosfamide [usp-rs] -ifosfamide [usp monograph] -mls002154021 -3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2h-1,3,2-oxazaphosphorin-2-oxide -brn 0611835 -bpbio1_000865 -isophosphamide (iarc) -cyfos -db01181 -1,2-oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide -3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2h-1,3,2-oxazaphosphorine 2-oxide -sr-05000002022-1 -iso-endoxan -ncgc00016639-01 -a 4942 -ifosfamidum (inn-latin) -prestwick1_000833 -ns00000356 -n,3-bis(2-chloroethyl)tetrahydro-2h-1,3,2-oxazaphosphinan-2-amine 2-oxide # -ifosfamide (usp-rs) -d00343 -ac-2113 -ifosfamide, british pharmacopoeia (bp) reference standard -iso endoxan -ifosfamide [mi] -holoxan 1000 -nsc-109724 -stl058690 -n-(2-chloraethyl)-n'-(2-chloraethyl)-n',o-propylen-phosphorsaureester-diamid -isofosfamide -ifosfamide -holoxane -schembl4885 -isophosphamide -(s)-3-(2-chloroethyl)-2-((2-chloroethyl)amino)-1,3,2-oxazaphosphinane 2-oxide -3-(2-chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2h-1,3,2-oxazaphosphorineoxide -(r)-3-(2-chloroethyl)-2-((2-chloroethyl)amino)-1,3,2-oxazaphosphinane 2-oxide -sr-05000002022-3 -hms3654b15 -ifosfamide [usan] -nsc109724 -ifosfamidum -prestwick0_000833 -ifosfamide [jan] -ncgc00259364-01 -z 4942 -hms2093n07 -hms3374b08 -ifo-cell -iphosphamid -n-(2-chloroethyl)-n'-(2-chloroethyl)-n',o-propylenephosphoric acid ester diamide -smr001233348 -3778-73-2 -ncgc00179435-06 -ifosfamid -ifomida -mitoxana -ifosfamide (mart.) -prestwick3_000833 -db-049196 -ab00513932 -ifomide -n,3-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine -en300-7476797 -chebi:5864 -3-(2-chloroethyl)-2-((2-chloroethyl)amino)-1,3,2-oxazaphosphinane 2-oxide -starbld0001221 -isosfamide -n-(2-chloraethyl)-n'-(2-chloraethyl)-n',o-propylen-phosphorsaureester-diamid [german] -ifex -ifosfamidum [inn-latin] -ifolem -n,3-bis(2-chloroethyl)tetrahydro-2h-1,3,2-oxazaphosphorin-2-amine-2-oxide -cs-1424 -sr-05000002022 -ncgc00179435-03 -brd-a67097164-001-11-2 -n-(2-chloroethyl)-n'-(2-chloroethyl)-n',o-propylene phosphoric acid ester diamide -sbi-0206804.p001 -2,n(sup 1)-bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxy- -ifosfamide [usan:usp:inn:ban:jan] -mjf-9325 -ifex (tn) (bristol meyers) -c07047 -dtxcid90760 -2h-1,2-oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide -chembl1024 -ifosfamide (usan:usp:inn:ban:jan) -q-101874 -ifsofamide -nsc 109724 -2h-1,2-oxazaphosphorin-2-amine, n,3-bis(2-chloroethyl)tetrahydro-, 2-oxide -mfcd00057374 -nci-c01638 -ifex (tn) -ab00513932-06 -ifosfamide, united states pharmacopeia (usp) reference standard -i-phosphamide -as-10978 -ifosfamide sterile -ifosfamide [hsdb] -isoendoxan -2h-1,3,2-oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide -epirubicina (inn-spanish) -4' epi dxr -epirubicine [inn-french] -3z8479zz5x -q425122 -10-((3-amino-2,3,6-trideoxy-beta-l-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-(8s-cis)-5,12-naphthacenedione -l01db03 -4' epiadriamycin -nsc256942 -ab00698552_16 -pidorubicine [inn-french] -brd-k04548931-003-16-5 -hsdb 6962 -pidorubicine -5,12-naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-l-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, (8s,10s)- -epirubicin (inn) -(8s,10s)-10-(((2r,4s,5r,6s)-4-amino-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione -(7s,9r)-7-[(2s,4s,5r,6s)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione -ellence -pidorubicinum [inn-latin] -(1s,3s)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-l-arabino-hexopyranoside -5,12-naphthacenedione,10-[(3-amino-2,3,6-trideoxy-a-l-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8s,10s)- -epirubicinum [inn-latin] -pidorubicina [inn-spanish] -56420-45-2 -4'-epiadriamycin -db00445 -farmorubicin -schembl8582 -epirubicinum (inn-latin) -epirubicine (inn-french) -epirubicina [spanish] -dm2 -epirubicinum -epirubicin [mi] -ab00698552-11 -epi-dx -(7s,9s)-7-[(2r,4s,5r,6s)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-4-methoxy-6,9,11-tris(oxidanyl)-9-(2-oxidanylethanoyl)-8,10-dihydro-7h-tetracene-5,12-dione -(7s,9s)-7-[(2r,4s,5r,6s)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione -epirubicine -pidorubicine (inn-french) -dtxcid202987 -nsc-256942 -4'-epidoxorubicin -4'-epi-doxorubicin -bdbm43839 -epirubicin free base -4'-epi-dxr -pidorubicinum (latin) -5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-beta-l-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8s-cis)- -brn 1445813 -pidorubicina (inn-spanish) -(1s,3s)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-l-arabino-hexopyranoside -ridorubicin -4-epidoxorubicin -epi dx -5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-.alpha.-l-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8s-cis)- -nsc 256942 -imi 28 -ab00698552-14 -epirubicin [who-dd] -(8s-cis)-10-((3-amino-2,3,6-trideoxy-beta-l-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione -4' epi doxorubicin -dm6 -4'-epi dx -4' epi adriamycin -epirubicinum (latin) -(7s,9s)-7-[(2r,4s,5r,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione -epidoxorubicin -acid, 8 -unii-3z8479zz5x -d07901 -epirubicin [inn] -(1s,3s)-3-glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-.alpha.-l-arabino-hexopyranoside -ab00698552_15 -pidorubicin -(1s,3s)-3-glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-alpha-l-arabino-hexopyranoside -5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-beta-l-arabino-hexopyranosyl)oxy-7,8,9,10-tetrahydro -6,8,(8s-cis)- -dtxsid0022987 -4' epidoxorubicin -hy-13624 -sbi-0206890.p001 -pidorubicina -epirubicin [hsdb] -56420-45-2 (free base) -epirubicina [inn-spanish] -pidorubicinum -epirubicin [vandf] -ncgc00263918-08 -ncgc00263918-04 -pidorubicinum (inn-latin) -3-glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl-3-amino-2,3,6-trideoxy-alpha-l-arabino-hexopyranoside -epiadriamycin -a831042 -wp 697 -chembl417 -ns00069619 -epirubicin [inn:ban] -epirubicin -ab00698552-13 -farmorubicin (tn) -5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-l-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8s-cis)- -(8s,10s)-10-{[(2r,4s,5r,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione -epirubicine [french] -ccris 2261 -epirubicinum [latin] -chebi:47898 -epirubicina -epi-doxorubicin -(7s,9s)-7-[[(2r,4s,5r,6s)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione -en300-7410311 -hy-100388 -6-(4-amino-4-methylpiperidin-1-yl)-3-(2,3-dichlorophenyl)pyrazin-2-amine -akos030526670 -sb18819 -shp099 2hcl -ac-35665 -6-(4-azanyl-4-methyl-piperidin-1-yl)-3-[2,3-bis(chloranyl)phenyl]pyrazin-2-amine -sy251378 -db-107836 -a901187 -shp099 -6-(4-amino-4-methylpiperidin-1-yl)-3-(2,3-dichlorophenyl)pyrazin-2-amin -chembl4060033 -6-(4-amino-4-methyl-1-piperidinyl)-3-(2,3-dichlorophenyl)-2-pyrazinamine -bxc74742 -cs-5684 -bs-16291 -us10093646, compound 1 -nsc804254 -nsc-804254 -shp099 free base? -q27455906 -mfcd29059453 -shp099 free base -s6388 -schembl16914284 -shp-099 2hcl -bcp18366 -ex-a1067 -2-pyrazinamine, 6-(4-amino-4-methyl-1-piperidinyl)-3-(2,3-dichlorophenyl)- -1801747-42-1 -shp-099 -en300-21637536 -5od -bdbm38019 -epipodophyllotoxin, 4'-demethyl-, 9-(4,6-o-ethylidene-beta-d-glucopyranoside) -9-((4,6-o-ethylidine-beta-d-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-d)-1,3-dioxol-6(5ah)-one -hsdb 6517 -cpd000112002 -mls001424283 -hy-13629 -brd-k37798499-001-02-5 -etoposide (usp impurity) -bdbm50127140 -etoposide [usan:usp:inn:ban:jan] -etoposide impurity c (ep impurity) -brd-k37798499-001-27-2 -etoposide (ep monograph) -nsc141540 -etoposido [inn-spanish] -etoposide [ep impurity] -einecs 251-509-1 -furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5ah)-one-, 9-((4,6-o-ethylidene-.beta.-d-glucopyranosyl)oxy)5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl), (5r-(5.alpha.,5a.beta.,8a.alpha.,9.beta.(r*)))- -4''-demethylepipodophyllotoxin 9-(4,6-o-(r)-ethylidene-beta-d-glucopyranoside) -evp -cs-1774 -zuyeyidal -etoposide (ep impurity) -vp-16 -9-((4,6-o-ethylidene-beta-d-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5ah)-one, (5r-(5alpha,5abeta,8aalpha,9beta(r*)))- -4-demethylepipodophyllotoxin beta-d-ethylideneglucoside -etoposide [mart.] -sbi-0051910.p002 -(5s,5ar,8ar,9r)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-o-[(1r)-ethylidene]-beta-d-glucopyranoside -(5s,5ar,8ar,9r)-5-[[(2r,4ar,6r,7r,8r,8as)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxy-phenyl)-5a,6,8a,9-tetrahydro-5h-isobenzofuro[5,6-f][1,3]benzodioxol-8-one -trans-etoposide -c01576 -sr-01000763196-3 -4'-demethylepipodophyllotoxin 9-(4,6-o-(r)-ethylidene-beta-d-glucopyranoside) -9-((4,6-o-ethylidine-beta-d-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3'',4'''':6,7)naptho-(2,3-d)-1,3-dioxol-6(5ah)-one -ncgc00255126-01 -(-)-etoposide -4'-demethylepipodophyllotoxin ethylidene-.beta.-d-glucoside -tox21_110630 -4'-demethyl-epipodophyllotoxin 9-[4,6-o-(r)-ethylidene-beta-d-glucopyranoside -bcp9000669 -4'-o-demethyl-1-o-(4,6-o-ethylidene-beta-d-glucopyranosyl)epipodophyllotoxin -(5r,5ar,8ar,9s)-9-((4,6-o-((1r)-ethane-1,1-diyl)-.alpha.-d-glucopyranosyl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydro(2)benzofuro(5,6-f)(1,3)benzodioxol-6(5ah)-one -ccg-101165 -ccris 2392 -etoposide [inn] -prestwick3_000396 -etoposide, united states pharmacopeia (usp) reference standard -(10r,11r,15r,16s)-16-{[(2r,4ar,6r,7r,8r,8as)-7,8-dihydroxy-2-methyl-hexahydro-2h-pyrano[3,2-d][1,3]dioxin-6-yl]oxy}-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0^{3,7}.0^{11,15}]hexadeca-1(9),2,7-trien-12-one -bpbio1_000673 -gtpl6815 -etoposide [usp monograph] -vepesid (tn) -etoposide [jan] -etoposide, british pharmacopoeia (bp) reference standard -epipodophyllotoxin vp-16213 -ncgc00016821-01 -hms3713o13 -4'-demethylepipodophyllotoxin ethylidene-beta-d-glucoside -mls001074951 -etoposide (mart.) -nc00415 -etosid -vp 16 -etoposide [usan] -mfcd00869325 -mls002222184 -(5r,5ar,8ar,9s)-9-(((4ar,6r,7r,8r,8as)-7,8-dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8h)-one -etoposide - cas 33419-42-0 -etoposide [vandf] -ab00438905_19 -etoposide; vp-16 -hms2096o13 -etoposidum [inn-latin] -etoposide [mi] -ex-a1207 -sr-01000763196 -etoposido -bspbio_000611 -tox21_302201 -sintopozid -ncgc00179504-02 -akos007930275 -etoposide (vp-16) -q418817 -etoposide (jp17/usp/inn) -4'-demethylepipodophyllotoxin 9-(4,6-o-ethylidene-beta-d-glucopyranoside) -etoposide [usp impurity] -etoposide [iarc] -(5s,5ar,8ar,9r)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol -5-yl 4,6-o-[(1r)-ethylidene]-beta-d-glucopyranoside -(5r,5ar,8ar,9s)-9-[[4,6-o-(1r)-ethylidene-beta-d-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5ah)-one -vepesid -(5r,5ar,8ar,9s)-9-(((2r,4ar,6r,7r,8r,8as)-7,8-dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8h)-one -toposar -etopophos (phosphate salt) -etoposide (iarc) -etopol -cas-33419-42-0 -mls002153463 -epe -as-35312 -etoposide [ep monograph] -etoposide [orange book] -unii-6plq3cp4p3 -epeg -etoposide [who-ip] -furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5ah)-one, 9-((4,6-o-(1r)-ethylidene-beta-d-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, (5r,5ar,8ar,9s)- -epipodophyllotoxin-beta-d-ethyliden-glucoside, 4'-demethyl- -etoposide, european pharmacopoeia (ep) reference standard -hms2232l03 -121471-01-0 -z1304065033 -etoposido (inn-spanish) -ab00438905-17 -d00125 -etoposide -(5r,5ar,8ar,9s)-9-(((2r,4ar,6r,7r,8r,8as)-7,8-dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahy --5-yl 4,6-o-[(1r)-ethylidene]-beta-d-glucopyranoside -nk 171 -dtxsid5023035 -epipodophyllotoxin, 4'-demethyl-, 4,6-o-ethylidene-beta-d-glucopyranoside -33419-42-0 -etoposide [usp-rs] -s1225 -brd-k37798499-001-14-0 -db00773 -furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5ah)-one, 9-[[4,6-o-(1r)-ethylidene-.beta.-d-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, (5r,5ar,8ar,9s)- -furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5ah)-one-, 9-((4,6-o-ethylidene-beta-d-glucopyranosyl)oxy)5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl), (5r-(5alpha,5abeta,8aalpha,9beta(r*)))- -smr000112002 -etoposide,(s) -dtxcid601473876 -9-((4,6-o-ethylidine-beta-d-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4- hydroxy-3,4-dimethyloxyphenyl)furo (3',4'':6,7) naptho-(2,3-d)-1,3-dioxol-6 (5ah)-one -ab00438905-18 -eposide -etoposide (usp-rs) -etoposide [hsdb] -brd-k37798499-001-10-8 -vp 16 (pharmaceutical) -brd-k37798499-001-05-8 -etoposide (vp16) -schembl4259 -l01cb01 -hms2052n05 -etoposide [who-dd] -etoposidum [who-ip latin] -etoposide (usan:usp:inn:ban:jan) -en300-97099 -(5s,5ar,8ar,9r)-5-[[(2r,4ar,6r,7r,8r,8as)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5h-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one -be164434 -nsc 141540 -etoposide, synthetic, >=98%, powder -demethyl epipodophyllotoxin ethylidine glucoside -lastet -vp 16213 -mls002207239 -prestwick 211 -ns00009585 -4'-demethylepipodophyllotoxin 9-(4,6-o-(r)-ethylidene-.beta.-d-glucopyranoside) -etoposide for system suitability, european pharmacopoeia (ep) reference standard -demethylepipodophyllotoxin-beta-d-ethylideneglucoside -etoposide (usp monograph) -6plq3cp4p3 -ab00438905 -sdccgsbi-0050405.p002 -etoposidum (inn-latin) -hms2089f14 -nsc-141540 -chembl44657 -mls000049957 -vp-16-213 -(5s,5ar,8ar,9r)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3'',4'':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-o-[(1r)-ethylidene]-beta-d-glucopyranoside -etoposidum -chebi:4911 -vepesid j -vp 16-213 -campto -nsc-728073 -cs-1138 -(19s)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-7-yl 4-(piperidin-1-yl)piperidine-1-carboxylate -dtxsid1041051 -irinotecan [inn:ban] -(diethyl-hydroxy-dioxo-[?]yl) 4-(1-piperidyl)piperidine-1-carboxylate -irinotecan [mi] -s1198 -(+)-7-ethyl-10-hydroxycamptothecine 10-(1,4'-bipiperidine)-1'-carboxylate -(s)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate -hy-16562 -ns00004943 -ncgc00178697-02 -ab00698464_12 -a845740 -dtxcid9021051 -(4s)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1h-pyrano[3'',4'':6,7]indolizino[1,2-b]quinolin-9-yl 1,4''-bipiperidine-1''-carboxylate -ab00698464_14 -brd-k08547377-003-02-4 -2-methoxy-5-[2-(3-sulfophenyl)-5-(4-sulfophenyl)pyrylium-4-yl]benzenesulfonic acid -(4s)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate -as-14323 -(+)-(4s)-4,11-diethyl-4-hydroxy-9-((4-piperidino-piperidino)carbonyloxy)-1h-pyrano(3',4':6,7)indolizino(1,2-b)quinol-3,14,(4h,12h)-dione -irinotecanum -(1,4'-bipiperidine)-1'-carboxylic acid (s)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1h-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl ester -schembl4034 -cpt-11 hydrochloride;camptothecin 11 hydrochloride -ab00698464-10 -(1,4'-bipiperidine)-1'-carboxylic acid, 4,11-diethyl-3,4,12-14-tetrahydro-4-hydroxy-3,14-dioxo-1h-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl ester, (s)- -(19s)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-7-yl [1,4'-bipiperidine]-1'-carboxylate -(+)-irinotecan -bspbio_002346 -mfcd00866307 -camptosar -bcp9000793 -nci60_005051 -irinotecan lactone -irinotecan [vandf] -(s)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl[1,4'-bipiperidine]-1'-carboxylate -1,4'-bipiperidine-1'-carboxylic acid (s)-4,11-diethyl-3,4,12,14- tetrahydro-4-hydroxy-3,14-dioxo-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester -(4s)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1h-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl (1,4'-bipiperidine)-1'-carboxylate -(4s)-4,11-diethyl-4-hydroxy-3,14-dioxo-4,12-dihydro-1h-pyrano[3,4-f]quinolino[2,3-a]indolizin-9-yl 4-piperidylpiperidinecarboxylate -[1,4'']bipiperidinyl-1''-carboxylic acid (s)-4,11-diethyl-4-hydroxy-3,13-dioxo-3,4,12,13-tetrahydro-1h-2-oxa-6,12a-diaza-dibenzo[b,h]fluoren-9-yl ester -irinotecanum (inn-latin) -nsc728073 -ab00698464_13 -irinotecan mylan -unii-7673326042 -97682-44-5 (free base) -irinotecan [who-dd] -chembl481 -irinotecan; cpt-11 -irinotecan -biotecan (tn) -bcp02860 -ab00698464-07 -cpt-11 -ac-7469 -1u65 -irrinotecan -irinotecan [hsdb] -ab00698464-11 -irinotecan (inn) -d08086 -irinotecan [inn] -ncgc00178697-05 -l01xx19 -[(19s)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate -97682-44-5 -1,4'-bipiperidine-1'-carboxylic acid (s)-4,11-diethyl-3,4,12,14- tetrahydro-4-hydroxy-3,14-dioxo-1h-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl ester -(4s)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate -akos015894969 -amy4227 -biotecan -irinotecanum [inn-latin] -(1,4'-bipiperidine)-1'-carboxylic acid, (4s)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1h-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl ester -en300-708800 -nsc 728073 -irinophore c -bdbm50128267 -gtpl6823 -irinotecan? -chebi:80630 -q412197 -[1,4'']bipiperidinyl-1''-carboxylic acid 4,11-diethyl-4-hydroxy-3,13-dioxo-3,4,12,13-tetrahydro-1h-2-oxa-6,12a-diaza-dibenzo[b,h]fluoren-9-yl ester -ab07527 -hsdb 7607 -db00762 -ab00698464-09 -irinotecan free base -eribulinum -(1s,3s,6s,9s,12s,14r,16r,18s,20r,21r,22s,26r,29s,31r,32s,35r,36s)-20-((2s)-3-amino-2-hydroxypropyl)-21-methoxy-14-methyl-8,15-bis(methylene)-2,19,30,34,37,39,40,41-octaoxanonacyclo(24.9.2.1(3,32).1(3,33).1(6,9).1(12,16).0(18,22).0(29,36).0(31,35))hentetracontan-24-one -nsc-707389 -dtxsid101009321 -(2r,3r,3as,7r,8as,9s,10ar,11s,12r,13ar,13bs,15s,18s,21s,24s,26r,28r,29as)-2-[(2s)-3-amino-2-hydroxypropyl]hexacosahydro-3-methoxy-26-methyl-20,27-bis(methylene)-11,15:18,21:24,28-triepoxy-7,9-ethano-12,15-methano-9h,15h-furo[3,2-i]furo[2',3':5,6]pyrano[4,3-b][1,4]dioxacyclopentacosin-5(4h)-one -hy-13442 -gtpl6813 -eribulin (mart.) -eribulin free -253128-41-5 -eribulin [vandf] -(1s,3s,6s,9s,12s,14r,16r,18s,20r,21r,22s,26r,29s,31r,32s,33r,35r,36s)-20-[(2s)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-dimethylidene-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-24-one -dtxcid701436148 -glxc-10730 -eribulin [mart.] -(1s,3s,6s,9s,12s,14r,16r,18s,20r,21r,22s,26r,29s,31r,32s,35r,36s)-20-[(2s)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-bis(methylene)-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.1(3,32).1(3,33).1(6,9).1(12,16).0(18,22).0(29,36).0(31,35)]hentetracontan-24-one -chembl1683590 -eribulin -eribulin [mi] -2-(3-amino-2-hydroxypropyl)hexacosahydro-3-methoxy-26-methyl-20,27-bis(methylene)11,15-18,21-24,28-triepoxy-7,9-ethano-12,15-methano-9h,15h-furo(3,2-i)furo(2',3'-5,6)pyrano(4,3-b)(1,4)dioxacyclopentacosin-5-(4h)-one -chebi:63587 -ex-a4873d -eribuline -ufnvpogxiszxjd-jbqzkeiosa-n -l01xx41 -db08871 -11,15:18,21:24,28-triepoxy-7,9-ethano-12,15-methano-9h,15h-furo[3,2-i]furo[2',3':5,6]pyrano[4,3-b][1,4]dioxacyclopentacosin-5(4h)-one, 2-[(2s)-3-amino-2-hydroxypropyl]hexacosahydro-3-methoxy-26-methyl-20,27-bis(methylene)-, (2r,3r,3as,7r,8as,9s,10ar,11s,12r,13ar,13bs,15s,18s,21s,24s,26r,28r,29as)- -er-086526 -schembl15783821 -lr24g6354g -b 1939 -unii-lr24g6354g -ms-31267 -q408717 -eribulin [who-dd] -(1s,3s,6s,9s,12s,14r,16r,18s,20r,21r,22s,26r,29s,31r,32s,33r,35r,36s)-20-[(2s)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-dimethylidene-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-24-o -2-[4-[[(2r)-2-aminobutyl]amino]-2-quinazolinyl]-4-chloro-phenol -akos040740784 -at36513 -ncgc00510497-02 -bp-29357 -e-7389 free base -er 086526 -eribulina -(1s,3s,6s,9s,12s,14r,16r,18s,20r,21r,22s,26r,29s,31r,32s,33r,35r,36s)-20-[(2s)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-dimethylidene-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.1~3,32~.1~3,33~.1~6,9~.1~12,16~.0~18,22~.0~29,36~.0~31,35~]hentetracontan-24-one (non-preferred name) -e7389-lf -eribulin [inn] -verteporfin -nsc-825827 -nsc800071 -5-pyrimidinecarboxamide, 4-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)-1-piperazinyl)phenyl)amino)- -c71670 -prt-2070 -yxb30079 -ac-30243 -prt062070 -cerdulatinib (prt062070) -prt 062070 -schembl736734 -4-(cyclopropylamino)-2-(4-(4-(ethylsulfonyl)piperazin-1-yl)phenylamino)pyrimidine-5-carboxamide -cerdulatinib [inn] -unii-d1lxq45s1o -bcp10681 -d1lxq45s1o -bdbm50468574 -akos026750510 -cerdulatinib; prt062070; prt2070 -4-(cyclopropylamino)-2-({4-[4-(ethanesulfonyl)piperazin-1-yl]phenyl}amino)pyrimidine-5-carboxamide -cerdulatinib -db15499 -dtxsid001115521 -s3566 -4-(cyclopropylamino)-2-[4-(4-ethylsulfonylpiperazin-1-yl)anilino]pyrimidine-5-carboxamide -as-56368 -prt-062070 -rvt-502 -nsc825827 -s5i -da-34986 -cs-3329 -4-(cyclopropylamino)-2-((4-(4-(ethanesulfonyl)piperazin-1-yl)phenyl)amino)pyrimidine-5-carboxamide -1198300-79-6 -4-(cyclopropylamino)-2-[[4-[4-(ethylsulfonyl)-1-piperazinyl]phenyl]amino]-5-pyrimidinecarboxamide, -4-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)piperazin-1-yl)phenyl)amino)pyrimidine-5-carboxamide -hy-15999 -nsc-800071 -gtpl8957 -ex-a2143 -chembl4116008 -sb16931 -q27075860 -cerdulatinib (prt2070) -ncgc00386415-04 -prt2070; prt-2070; prt 2070; prt-062070; prt 062070; prt062070 -cerdulatinib [who-dd] -ncgc00164574-03 -erlotinib [vandf] -ac-399 -mfcd02089651 -j4t82ndh7e -hms3713c22 -erlotinibum -sr-05000001460-2 -183321-74-6 (free base) -cp-35877401 -gtpl4920 -ab01273955-02 -tox21_112202 -sr-05000001460-6 -kinome_3317 -db00530 -hy-50896 -tox21_112202_1 -rg-1415 -4-quinazolinamine, n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)- -183321-74-6 -chembl553 -(6,7-bis(2-methoxy-ethoxy)quinazoline-4-yl)-(3-ethynylphenyl)amine -unii-j4t82ndh7e -sr-05000001460 -[6,7-bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine -ncgc00164574-01 -nsc-800097 -hms3745m05 -n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine -en300-708808 -hms3295a19 -as-35132 -nsc800097 -cp-358774 -erotinib -bcb03_000783 -sy028059 -be164419 -am20090621 -erlotinib, free base -erlotinib free base -ncgc00164574-25 -nchembio866-comp3 -ab01273955-01 -ns00006169 -chebi:114785 -1429636-49-6 -aakjlrggtjkamg-uhfffaoysa-n -bdbm5446 -(6,7-bis-(2-methoxy-ethoxy)-quinazolin-4-yl)-(3-ethynyl-phenyl)-amine -sr-05000001460-3 -z2588038919 -osi 744 -hms2089f05 -osi-774 -ro-508231 -dtxcid6026454 -k00241 -erlotinib [ema epar] -dtxsid8046454 -stk623143 -n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine monohydrochloride -4-[(3-ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline -hms3244m20 -hms3244n19 -cas-183321-74-6 -n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine -erlotinib [who-dd] -l01xe03 -q418369 -ncgc00164574-14 -cid_176870 -ncgc00164574-06 -erlotinib [inn:ban] -hms3244m19 -cp-358,774 -r-1415 -tarceva -brd-k70401845-003-04-7 -nsc 718781 -hsdb 8082 -ncgc00164574-05 -schembl8413 -cs-0620 -[6,7-bis(2-methoxy-ethoxy)quinazoline-4-yl]-(3-ethynylphenyl)amine -sr-05000001460-1 -erlotinib free base? -cp358774 -ccg-220420 -r 1415 -erlotinib(tarceva) -akos000282911 -ab01273955-03 -sb16916 -s7786 -erlotinib -erlotinib [mi] -(6r,6ar,7r,13s,14s,16r,20r)-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-19-oxo-3',4',6,7,12,13,14,16-octahydro-2'h,6ah-spiro(7,13-epimino-6,16-(epithiopropanooxymethano)(1,3)dioxolo(7,8)isoquinolino(3,2-b)(3)benzazocine-20,1'-isoquinolin)-5-yl acetate -ncgc00181159-01 -trabectedin [ema epar] -(1'r,6r,6ar,7r,13s,14s,16r)-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-19-oxo-3',4',6,7,12,13,14,16-octahydrospiro(6,16-(epithiopropanooxymethano)-7,13-imino-6ah-1,3-dioxolo(7,8)isoquino(3,2-b)(3)benzazocine-20,1'(2'h)-isoquinolin)-5-yl acetate -id0yzq2tcp -trabectedin [usan] -ccris 8133 -cs-1608 -cas-114899-77-3 -trabectedina -ecteinascidin-743 -(1'r,6r,6ar,7r,13s,14s,16r)-5-(acetyloxy)-3',4',6,6a,7,13,14,16-octahydro-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethylspiro[6,16-(epithiopropanoxymethano)-7,13-imino-12h-1,3-dioxolo[7,8]isoquino[3,2-b][3]benzazocine-20,1'(2'h)-isoquinolin]-19-one; ecteinascidin 743; et 743; nsc 648766; yondelis; -(1r,2r,3r,11s,12s,14r,26r)-5,6',12-trihydroxy-6,7'-dimethoxy-7,21,30-trimethyl-27-oxo-3',4'-dihydro-2'h-17,19,28-trioxa-24-thia-13,30-diazaspiro[heptacyclo[12.9.6.1^{3,11}.0^{2,13}.0^{4,9}.0^{15,23}.0^{16,20}]triacontane-26,1'-isoquinoline]-4(9),5,7,15(23),16(20),21-hexaen-22-yl acetate -et743 -et-743 -ac-27767 -ms-31361 -tox21_112762 -dtxsid2046880 -gtpl2774 -ecteinascidine 743 -spiro(6,16-(epithiopropanoxymethano)-7,13-imino-12h-1,3-dioxolo(7,8)isoquino(3,2,-b)(3)benzazocine-20,1'(2'h)-isoquinolin)-19-one, 3',4',6,6a,7,13,14,16-octahydro-5-(acetyloxy)-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-, (6r-(6-alpha,6a-beta,7-beta,13-beta,14-beta,16-alpha,20r*))- -ecteinascidin -hy-50936 -nsc648766 -[(1r,2r,3r,11s,12s,14r,26r)-5,6',12-trihydroxy-6,7'-dimethoxy-7,21,30-trimethyl-27-oxospiro[17,19,28-trioxa-24-thia-13,30-diazaheptacyclo[12.9.6.13,11.02,13.04,9.015,23.016,20]triaconta-4(9),5,7,15,20,22-hexaene-26,1'-3,4-dihydro-2h-isoquinoline]-22-yl] acetate -nsc-684766 -q2637746 -trabectedinum -114899-77-3 -pkvrcirhqmsyjx-aifwhqitsa-n -trabectedin -ecteinascidins trabectedin -(6r,6ar,7r,13s,14s,16r,20r)-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-19-oxo-3',4',6,7,12,13,14,16-octahydro-2'h,6ah-spiro[7,13-epimino-6,16-(epithiopropanooxymethano)[1,3]dioxolo[7,8]isoquinolino[3,2-b][3]benzazocine-20,1'-isoquinolin]-5-yl acetate -chebi:84050 -nsc813783 -trabectedin [inn] -en300-19768451 -f81329 -trabectedine -nsc 684766 -trabectedin [jan] -et 743 -trabectedin [usan:inn:ban] -nsc-813783 -schembl12119916 -trabectedin (mart.) -nsc-648766 -ect 743 -unii-id0yzq2tcp -ex-a4317 -ncgc00181159-02 -dtxcid0026880 -trabectedin [who-dd] -chembl450449 -ecteinascidins trabectedin [mi] -yondelis -(1'r,6r,6ar,7r,13s,14s,16r)-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-19-oxo-3',4',6a,7,12,13,14,16-octahydro-2'h,6h-spiro(6,16-(epithiopropanooxymethano)-7,13-epiminobenzo(4,5)azocino(1,2-b)(1,3)dioxolo(4,5-h)isoquinolin-20,1'-isoquinolin)-5-yl acetate -akos025401985 -tox21_113236 -trabectedin [mart.] -trabectedin [orange book] -db05109 -spiro(6,16-(epithiopropanoxymethano)-7,13-imino-12h-1,3-dioxolo(7,8)isoquino(3,2,-b)(3)benzazocine-20,1'(2'h)-isoquinolin)-19-one, 5-(acetyloxy)-3',4',6,6a,7,13,14,16-octahydro-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-, (1'r,6r,6ar,7r,13s,14s,16r)- -ecteinascidin 743;et-743 -ecteinascidin 743 -nsc 648766 -l01cx01 -(1s,3s)-3-glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl-(3-amino-2,3,6-tridesoxy-alpha-l-lyxo-hexopyranosid) -doxorubicin (usan/inn) -bpbio1_000502 -bspbio_001031 -doxorubicinum -doxorubicina (inn-spanish) -dtxcid301480 -(8s-cis)-10-[(3-amino-2,3,6-trideoxy-.alpha.-l-lyxo-hexopyranosyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione -ncgc00024415-38 -doxorubicin (mart.) -c01661 -chembl53463 -doxorubicin [who-dd] -unii-80168379ag -nsc-123127 -doxorubicine (inn-french) -conjugate of doxorubicin with humanized monoclonal antibody ll1 against cd74 -d03899 -adr -en300-120698 -bp-23114 -(8s,10s)-10-((2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yloxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione -23214-92-8 -1,2,3,4,6,11-hexahydro-4beta,5,12-trihydroxy-4-(hydroxyacetyl)-10-methoxy-6,11-dioxonaphthacen-1beta-yl-3-amino-2,3,6-trideoxy-alpha-l-lyxohexopyranoside -chebi:28748 -(7s,9s)-7-[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione -dtxsid8021480 -adriablastin -(8s-cis)-10- -hydroxyl daunorubicin -smp1_000106 -doxorubicin-hll1 conjugate -adriamycin -(8s,10s)-10-((3-amino-2,3,6-trideoxy-.alpha.-l-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione -prestwick3_000438 -spbio_002395 -mls000028393 -10-((3-amino-2,3,6-trideoxy-d-lyxohexopyranosyl)oxy)-8-glycolcyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione -5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8s-cis)- -(8s,10s)-10 -doxorubicin [usan:inn:ban] -hydroxydaunomycin -h11954 -(7s,9r)-7-[(2s,4s,5s,6s)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione -14-hydroxydaunorubicine -5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-.alpha.-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8s-cis)- -akos015951330 -nsc-759155 -hsdb 3070 -nci-c01514 -caelyx (liposomal doxorubicin) -valrubicin impurity, doxorubicin (usp impurity) -(8s,10s)-10- -1392315-46-6 -80168379ag -doxorubicin [mi] -prestwick0_000438 -lmpk13050001 -nsc 123127 -doxil -adm -doxorubicin-hll1 -doxorubicin [inn] -5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro- 6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione -doxorubicin [hsdb] -(7s,9s)-7-[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione -hydroxydaunorubicin -bspbio_000456 -(1s,3s)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranoside -(7s,9s)-7-[(4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione -hydroxyldaunorubicin -brd-k92093830-003-25-8 -cid_443939 -einecs 245-495-6 -5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8s,10s)- -ncgc00024415-42 -doxorubicina -(1s,3s)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranoside -doxorubicin [mart.] -schembl3243 -epirubicin hydrochloride impurity, doxorubicin- [usp impurity] -(7s,9s)-7-[(2r,4s,5s,6s)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-4-methoxy-6,9,11-tris(oxidanyl)-9-(2-oxidanylethanoyl)-8,10-dihydro-7h-tetracene-5,12-dione;hydrochloride -1,2,3,4,6,11-hexahydro-4beta,5,12-trihydroxy-4-(hydroxyacetyl)-10-methoxy-6, 11-dioxonaphthacen-1beta-yl-3-amino-2,3,6-trideoxy-alpha-l-lyxohexopyranoside -(8s-cis)-10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione -(7s,9s)-7-[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-9-glycoloyl-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7h-tetracene-5,12-quinone;hydrochloride -5,12-naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, (8s,10s)- -doxorubicina [inn-spanish] -doxorubicinum [inn-latin] -hms2089h06 -bdbm22984 -doxorubicine -gtpl7069 -db00997 -ncgc00024415-61 -ns00002473 -doxorubicin -probes1_000151 -valrubicin impurity, doxorubicin [usp impurity] -probes2_000129 -doxorubicin [vandf] -ncgc00024415-40 -a816625 -nsc123127 -adriamycin semiquinone -(8s,10s)-10-{[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione -(8s-cis)-10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroacetyl)-1-methoxy-5,12-naphthacenedione -l01db01 -bdbm32022 -prestwick2_000438 -ncgc00024415-37 -(7s,9s)-7-[[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione;hydrochloride -epirubicin hydrochloride impurity c [ep impurity] -ndc 38242-874 -doxorubicin [usan] -(7s,9s)-7-[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione;hydrochloride -ccris 739 -brd-k92093830-003-04-3 -14-hydroxydaunomycin -doxorubicin-p4/d10 conjugate -valrubicin impurity, doxorubicin -q18936 -ncgc00024415-35 -hy-15142a -fi 106 -(8s,10s)-10-(((2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione;(7s,9s)-7-[(4s,5s,6s)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione -thermodox -(8s,10s)-10-(((2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione -gr-319 -doxorubicine [inn-french] -(8s,10s)-10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione -adriblastina -prestwick1_000438 -conjugate of doxorubicin with monoclonal antibody p4/d10 against gp120 -ncgc00024415-41 -doxorubicinum (inn-latin) -epirubicin hydrochloride impurity, doxorubicin- -daunorubicin hydrochloride impurity d [ep impurity] -doxorrubicina -doxorubicin-p4/d10 -(1s,3s)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranoside -adriblastina (tn) diff --git a/mpnst_samples.csv b/mpnst_samples.csv deleted file mode 100644 index 7670cc11..00000000 --- a/mpnst_samples.csv +++ /dev/null @@ -1,51 +0,0 @@ -other_id,common_name,other_id_source,other_names,cancer_type,species,model_type,improve_sample_id -JH-2-002 patient derived xenograft,JH-2-002,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2054 -JH-2-009 patient derived xenograft,JH-2-009,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2055 -JH-2-023 patient derived xenograft,JH-2-023,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2056 -JH-2-031 patient derived xenograft,JH-2-031,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2057 -JH-2-055 patient derived xenograft,JH-2-055,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2058 -JH-2-079c patient derived xenograft,JH-2-079c,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2059 -JH-2-103 patient derived xenograft,JH-2-103,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2060 -MN-1 patient derived xenograft,MN-1,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2061 -MN-2 patient derived xenograft,MN-2,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2062 -MN-3 patient derived xenograft,MN-3,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2063 -WU-225 patient derived xenograft,WU-225,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2064 -WU-356 patient derived xenograft,WU-356,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2065 -WU-368 patient derived xenograft,WU-368,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2066 -WU-386 patient derived xenograft,WU-386,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2067 -WU-436 patient derived xenograft,WU-436,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2068 -WU-487 patient derived xenograft,WU-487,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2069 -WU-505 patient derived xenograft,WU-505,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2070 -WU-536 patient derived xenograft,WU-536,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2071 -WU-545 patient derived xenograft,WU-545,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2072 -WU-561 patient derived xenograft,WU-561,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,patient derived xenograft,2073 -JH-2-002 patient derived xenograft,JH-2-002,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,organoid,2074 -JH-2-031 patient derived xenograft,JH-2-031,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,organoid,2075 -JH-2-079c patient derived xenograft,JH-2-079c,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,organoid,2076 -JH-2-103 patient derived xenograft,JH-2-103,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,organoid,2077 -MN-1 patient derived xenograft,MN-1,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,organoid,2078 -MN-2 patient derived xenograft,MN-2,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,organoid,2079 -MN-3 patient derived xenograft,MN-3,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,organoid,2080 -WU-225 patient derived xenograft,WU-225,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,organoid,2081 -WU-356 patient derived xenograft,WU-356,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,organoid,2082 -WU-368 patient derived xenograft,WU-368,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,organoid,2083 -JH-2-002 tumor,JH-2-002,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2084 -JH-2-009 tumor,JH-2-009,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2085 -JH-2-023 tumor,JH-2-023,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2086 -JH-2-031 tumor,JH-2-031,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2087 -JH-2-055 tumor,JH-2-055,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2088 -JH-2-079c tumor,JH-2-079c,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2089 -JH-2-103 tumor,JH-2-103,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2090 -MN-1 tumor,MN-1,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2091 -MN-2 tumor,MN-2,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2092 -MN-3 tumor,MN-3,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2093 -WU-225 tumor,WU-225,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2094 -WU-356 tumor,WU-356,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2095 -WU-368 tumor,WU-368,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2096 -WU-386 tumor,WU-386,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2097 -WU-436 tumor,WU-436,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2098 -WU-487 tumor,WU-487,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2099 -WU-505 tumor,WU-505,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2100 -WU-536 tumor,WU-536,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2101 -WU-545 tumor,WU-545,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2102 -WU-561 tumor,WU-561,NF Data Portal,"",Malignant peripheral nerve sheath tumor,Human,tumor,2103 diff --git a/requirements.txt b/requirements.txt deleted file mode 100755 index 97c7a444..00000000 --- a/requirements.txt +++ /dev/null @@ -1,13 +0,0 @@ -pandas==1.5.3 -wget==3.2 -requests -synapseclient -openpyxl -matplotlib -tqdm -scikit-learn -scipy -#polars -pyarrow -polars-lts-cpu -pyyaml From 227610abfc4fd10c8457813203640eeeec3d331b Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Wed, 19 Jun 2024 07:59:47 -0700 Subject: [PATCH 10/45] updated to new docker base image --- build/docker/Dockerfile.broad_sanger_exp | 2 +- build/docker/Dockerfile.broad_sanger_omics | 2 +- build/docker/Dockerfile.mpnst | 2 +- 3 files changed, 3 insertions(+), 3 deletions(-) diff --git a/build/docker/Dockerfile.broad_sanger_exp b/build/docker/Dockerfile.broad_sanger_exp index 7a8207f9..baf1fdf6 100755 --- a/build/docker/Dockerfile.broad_sanger_exp +++ b/build/docker/Dockerfile.broad_sanger_exp @@ -1,4 +1,4 @@ -FROM r-base:4.2.1 +FROM r-base:4.4.1 ENV DEBIAN_FRONTEND=noninteractive RUN apt-get update --fix-missing #RUN apt-get install -y --fix-missing --allow-unauthenticated build-essential libpq-dev python3.10 python3-pip python3-setuptools python3-dev python3-venv libcurl4-openssl-dev libxml2-dev libglpk-dev diff --git a/build/docker/Dockerfile.broad_sanger_omics b/build/docker/Dockerfile.broad_sanger_omics index a736c52a..1a47bb8a 100755 --- a/build/docker/Dockerfile.broad_sanger_omics +++ b/build/docker/Dockerfile.broad_sanger_omics @@ -1,4 +1,4 @@ -FROM r-base:4.2.1 +FROM r-base:4.4.1 ENV DEBIAN_FRONTEND=noninteractive RUN apt-get update --fix-missing diff --git a/build/docker/Dockerfile.mpnst b/build/docker/Dockerfile.mpnst index 8862b2b0..ba8c51b8 100755 --- a/build/docker/Dockerfile.mpnst +++ b/build/docker/Dockerfile.mpnst @@ -1,4 +1,4 @@ -FROM r-base:4.2.1 +FROM r-base:4.4.1 ENV DEBIAN_FRONTEND=noninteractive RUN apt-get update --allow-insecure-repositories #RUN apt-get install -y --allow-unauthenticated build-essential --fix-missing libpq-dev python3-pip python3-setuptools python3-dev python3-venv libcurl4-openssl-dev libxml2-dev From 57a9c7324a3fbcee5c7ad34ccbf690d41298b75c Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Wed, 19 Jun 2024 08:04:49 -0700 Subject: [PATCH 11/45] updated docker --- build/docker/Dockerfile.hcmi | 1 + 1 file changed, 1 insertion(+) diff --git a/build/docker/Dockerfile.hcmi b/build/docker/Dockerfile.hcmi index 61de5a97..cb431548 100644 --- a/build/docker/Dockerfile.hcmi +++ b/build/docker/Dockerfile.hcmi @@ -5,6 +5,7 @@ WORKDIR /usr/src/app COPY build/hcmi/01-createHCMISamplesFile.py . COPY build/hcmi/02-getHCMIData.py . COPY build/hcmi/full_manifest.txt . +COPY build/hcmi/requirements.txt COPY build/hcmi/*sh ./ COPY build/hcmi/hcmi_cancer_types.csv ./ From 672bd1e6d2d110322b565152639726617adcb8fe Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Wed, 19 Jun 2024 08:05:30 -0700 Subject: [PATCH 12/45] Update Dockerfile.hcmi --- build/docker/Dockerfile.hcmi | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/build/docker/Dockerfile.hcmi b/build/docker/Dockerfile.hcmi index cb431548..e061e4e0 100644 --- a/build/docker/Dockerfile.hcmi +++ b/build/docker/Dockerfile.hcmi @@ -5,7 +5,7 @@ WORKDIR /usr/src/app COPY build/hcmi/01-createHCMISamplesFile.py . COPY build/hcmi/02-getHCMIData.py . COPY build/hcmi/full_manifest.txt . -COPY build/hcmi/requirements.txt +COPY build/hcmi/requirements.txt . COPY build/hcmi/*sh ./ COPY build/hcmi/hcmi_cancer_types.csv ./ From 050bc0d376c5a9b0a8ad4306251de6b49a0168dc Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Wed, 19 Jun 2024 08:06:56 -0700 Subject: [PATCH 13/45] Update Dockerfile.hcmi --- build/docker/Dockerfile.hcmi | 2 -- 1 file changed, 2 deletions(-) diff --git a/build/docker/Dockerfile.hcmi b/build/docker/Dockerfile.hcmi index e061e4e0..2ab4139c 100644 --- a/build/docker/Dockerfile.hcmi +++ b/build/docker/Dockerfile.hcmi @@ -9,8 +9,6 @@ COPY build/hcmi/requirements.txt . COPY build/hcmi/*sh ./ COPY build/hcmi/hcmi_cancer_types.csv ./ - -COPY requirements.txt . RUN pip install --no-cache-dir -r requirements.txt # CMD python 01-createHCMISamplesFile.py && \ From 12f5173fe21f05bf7141e1d5b78374c250fb8b73 Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Wed, 19 Jun 2024 08:09:51 -0700 Subject: [PATCH 14/45] Update Dockerfile.genes --- build/docker/Dockerfile.genes | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/build/docker/Dockerfile.genes b/build/docker/Dockerfile.genes index dff88d8a..61e8fbdd 100755 --- a/build/docker/Dockerfile.genes +++ b/build/docker/Dockerfile.genes @@ -1,4 +1,4 @@ -FROM r-base:4.2.1 +FROM r-base:4.4.1 ENV DEBIAN_FRONTEND=noninteractive RUN apt-get update --fix-missing RUN apt-get install -y --fix-missing --allow-unauthenticated build-essential python3-pip python3-setuptools python3-dev python3-venv libcurl4-openssl-dev libglpk-dev libxml2-dev libpq-dev From ff19182c4851d1b9077c4186fe7afdbee7779a8d Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Wed, 19 Jun 2024 09:26:54 -0700 Subject: [PATCH 15/45] updated hcmi build --- build/docker/Dockerfile.hcmi | 4 ---- build/hcmi/requirements.txt | 2 +- 2 files changed, 1 insertion(+), 5 deletions(-) diff --git a/build/docker/Dockerfile.hcmi b/build/docker/Dockerfile.hcmi index 2ab4139c..e7b9256f 100644 --- a/build/docker/Dockerfile.hcmi +++ b/build/docker/Dockerfile.hcmi @@ -11,7 +11,3 @@ COPY build/hcmi/hcmi_cancer_types.csv ./ RUN pip install --no-cache-dir -r requirements.txt -# CMD python 01-createHCMISamplesFile.py && \ -# python 02-getHCMIData.py -m full_manifest.txt -t transcriptomics -o hcmi_transcriptomics.csv && \ -# python 02-getHCMIData.py -m full_manifest.txt -M full_manifest_files -t copy_number -o hcmi_copy_number.csv && \ -# python 02-getHCMIData.py -m full_manifest.txt -M full_manifest_files -t mutations -o hcmi_mutations.csv \ No newline at end of file diff --git a/build/hcmi/requirements.txt b/build/hcmi/requirements.txt index 0fbab8b6..0997f9d6 100644 --- a/build/hcmi/requirements.txt +++ b/build/hcmi/requirements.txt @@ -1,4 +1,4 @@ -pandas==1.5.3 +pandas==2.2 wget==3.2 requests synapseclient From 779f33010f771dfda76d1d011fd561e8e1e65775 Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Wed, 19 Jun 2024 09:32:39 -0700 Subject: [PATCH 16/45] does this fix --- build/mpnst/00_sample_gen.R | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/build/mpnst/00_sample_gen.R b/build/mpnst/00_sample_gen.R index 2dd0dc6b..7268b57e 100755 --- a/build/mpnst/00_sample_gen.R +++ b/build/mpnst/00_sample_gen.R @@ -36,7 +36,7 @@ tumorTable<-manifest|> ##then create samples for the PDX sampTable<-manifest|> - dplyr::select(c(common_name='Sample',MicroTissueDrugFolder))|> + dplyr::select(common_name='Sample',MicroTissueDrugFolder)|> dplyr::mutate(other_id_source='NF Data Portal',other_names='',cancer_type="Malignant peripheral nerve sheath tumor",species='Human',model_type='patient derived xenograft')|> tidyr::unite(col='other_id',c('common_name','model_type'),sep=' ',remove=FALSE) From 1fd58b401effaaacf108434becee4675dad5a9b3 Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Wed, 19 Jun 2024 09:43:05 -0700 Subject: [PATCH 17/45] tried an older image --- build/docker/Dockerfile.mpnst | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/build/docker/Dockerfile.mpnst b/build/docker/Dockerfile.mpnst index ba8c51b8..89f128e5 100755 --- a/build/docker/Dockerfile.mpnst +++ b/build/docker/Dockerfile.mpnst @@ -1,4 +1,4 @@ -FROM r-base:4.4.1 +FROM r-base:4.3.1 ENV DEBIAN_FRONTEND=noninteractive RUN apt-get update --allow-insecure-repositories #RUN apt-get install -y --allow-unauthenticated build-essential --fix-missing libpq-dev python3-pip python3-setuptools python3-dev python3-venv libcurl4-openssl-dev libxml2-dev From a0533a5ef82efd3e03567e43b1d41db59d782392 Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Wed, 19 Jun 2024 11:07:02 -0700 Subject: [PATCH 18/45] synapser update caused data frame function to fail --- build/mpnst/00_sample_gen.R | 3 ++- build/mpnst/01_mpnst_get_omics.R | 1 + build/mpnst/02_get_drug_data.R | 1 + build/mpnst/03_get_drug_response_data.R | 2 ++ 4 files changed, 6 insertions(+), 1 deletion(-) diff --git a/build/mpnst/00_sample_gen.R b/build/mpnst/00_sample_gen.R index 7268b57e..ec68b873 100755 --- a/build/mpnst/00_sample_gen.R +++ b/build/mpnst/00_sample_gen.R @@ -15,7 +15,8 @@ if(length(args)!=2){ orig_samples<-fread(args[1]) synapser::synLogin(authToken=args[2]) -manifest<-synapser::synTableQuery("select * from syn53503360")$asDataFrame() +manifest<-synapser::synTableQuery("select * from syn53503360")$asDataFrame()|> + as.data.frame() ###sample file has a strict schema diff --git a/build/mpnst/01_mpnst_get_omics.R b/build/mpnst/01_mpnst_get_omics.R index b9950977..ae5f1730 100755 --- a/build/mpnst/01_mpnst_get_omics.R +++ b/build/mpnst/01_mpnst_get_omics.R @@ -37,6 +37,7 @@ tumor_samps<-subset(samples_df,model_type=='tumor') ##now get the manifest from synapse manifest<-synapser::synTableQuery("select * from syn53503360")$asDataFrame()|> + as.data.frame() dplyr::rename(common_name='Sample') diff --git a/build/mpnst/02_get_drug_data.R b/build/mpnst/02_get_drug_data.R index 5403e8fc..27b238c6 100644 --- a/build/mpnst/02_get_drug_data.R +++ b/build/mpnst/02_get_drug_data.R @@ -27,6 +27,7 @@ synLogin(authToken = PAT) ##now get the manifest from synapse manifest<-synapser::synTableQuery("select * from syn53503360")$asDataFrame()|> + as.data.frame()|> dplyr::rename(common_name='Sample') diff --git a/build/mpnst/03_get_drug_response_data.R b/build/mpnst/03_get_drug_response_data.R index 49d8b896..4b44720e 100644 --- a/build/mpnst/03_get_drug_response_data.R +++ b/build/mpnst/03_get_drug_response_data.R @@ -31,6 +31,7 @@ org_samps<-subset(samples_df,model_type=='organoid') ##now get the manifest from synapse manifest<-synapser::synTableQuery("select * from syn53503360")$asDataFrame()|> + as.data.frame()|> dplyr::rename(common_name='Sample') @@ -68,6 +69,7 @@ extract_date_hour <- function(experiment_id) { ##first function to get children from parentId getDrugDataByParent<-function(parid,sampleId){ qtab<-synTableQuery(paste('select id,name,experimentalCondition,parentId from syn21993642 where parentId=\'',parid,'\''))$asDataFrame()|> + as.data.frame()|> subset(!is.na(experimentalCondition))|>dplyr::select(id,name,experimentalCondition) ##now we need to parse the metadatda table get the info From c6c50f1574e026145610cfdf368ad3b92ac9b7fe Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Wed, 19 Jun 2024 12:57:47 -0700 Subject: [PATCH 19/45] made updates to contributing guide --- build/beatAML/requirements.txt | 2 +- build/build_all.py | 6 +++--- docs/pages/coderDataBuild.jpg | Bin 0 -> 60444 bytes docs/pages/contribution.md | 20 ++++++++++++++++++-- 4 files changed, 22 insertions(+), 6 deletions(-) create mode 100644 docs/pages/coderDataBuild.jpg diff --git a/build/beatAML/requirements.txt b/build/beatAML/requirements.txt index 4faf477e..9851b4ad 100755 --- a/build/beatAML/requirements.txt +++ b/build/beatAML/requirements.txt @@ -3,7 +3,7 @@ wget==3.2 requests synapseclient argparse -numpy +numpy==1.26.0 openpyxl matplotlib scikit-learn diff --git a/build/build_all.py b/build/build_all.py index b1d45ca0..eedbb0cd 100644 --- a/build/build_all.py +++ b/build/build_all.py @@ -239,9 +239,9 @@ def compress_file(file_path): gene_thread = executor.submit(process_genes,executor) # Wait for both processes to complete before proceeding to omics and experiments - if args.drugs or args.all: + if args.drugs or args.all or args.exp: drug_thread.result() - if args.samples or args.all: + if args.samples or args.all or args.omics or args.exp:##need to wait for samples for all of these sample_thread.result() if args.samples or args.omics or args.exp or args.all: gene_thread.result() @@ -338,4 +338,4 @@ def compress_file(file_path): if __name__ == '__main__': - main() \ No newline at end of file + main() diff --git a/docs/pages/coderDataBuild.jpg b/docs/pages/coderDataBuild.jpg new file mode 100644 index 0000000000000000000000000000000000000000..dd6615ff5b6d3ab6d0af6e1217d437cfa7a924d5 GIT binary patch literal 60444 zcmd421zcOtwm%x&wYV244#lNNX$ur6P&7CNiWj$_X=!mQP@u)NK#>%8g1c)8Zp9%% zga6atx#ymH?*H0*|M%YKEi&P|Cu^^nHGB5Vnl)?gf8DPDNL7_olmKXG0KiMsAK-o! z@Kh0GZvz0Rs{?od001rkEzBN(i9#qA039j;0O;B1f6u`n&&K#WM(h3a z&0lM4Dyh6u{7W?YV}%#b6wyfm04HZpcWvcoECz-~EI4B*=>&iW01?0w3o8#-h1aiN z{gL48;%xor|3B0D%wIJCO!EJc_0PZkw^#U9uI`>Ft{YSmerxSvg;M7+3Oo9Ex}x&Y z(ovYg((y0+^AC2{)qal3??Pc>+rQzdKiKkbc;gRtM=62gIsLTz%c`ZS6c+gdabC%%bqt#nPHZ$JfKt+R1}O#o5Zm-POh2!qfUKiuZ5z z`*Rn7>~D;JT8v9bN=lOZuiXC!zy3Ujzll51`m24>sD}QL_m6_CyxhJ2Gy2_GF-G?3~~%KRscE~ z8U`8KeHVZk)znyMf6?Eog@%rSiG_`Wi-%8uVyGbnprc`6pkrcSVPT>=ELtGycK{|C z7WqRV1?&e}7C5YK6v7|kb8y+7RkTxTkHgtTEZu|g@TsV2Xz4f}adL6D3zNJ>dR zf1#+P{8B|#M^{fDh^nI1TWcFzJ9`HYPcLsDkgwmzPa&aU;SrGuiC>bEQ@(yn&CSa% z_+D64{G+m}x~8_SzM-+Bv#YzOx37O-VsdJFX7<+{Y;|pYWApdc_RcQi_~i8L`~rD- z^+zu>0LI_cLVf>Dvwx=-8A>m7OiT<+oIiS@q5Gf`1{o&SLm_N(1uYy4w+F1kA8;w2 z#phJC z0}x`Mp*j-=89*Lzdy^Z<1^7Qo&2?+Nkgo3r}2WWHe-6_SftPeHZ z1BFbf;@6jP9f2x^298u!OFx;LRM7a`5~#12LmfX}tH#xOvLA3bowi*2{2GPzrhVDx zDtC~lL2BDJ$MPG^rD^IrMyo;_^&~kO)^Xy>)E(C#L`yp!d)}!T&5eN-ynJg4n>he- z0#6*wAj>*~MooK2i|0bQ*TQmc^F^B+Cln#Pn_#wRV9L?b^NT1drHk`Pz))hSex=Lq)53!+JN3x1Gg$il&*Dij)kM-7XJCpOm`w5Qqq&=_#`(fB-;$n@?YWf(4-Y z4(Y{p`zsBIlb3tL?Sgx;Ok^$GH`+zej*+wu^H4bT;y zhrgnWu5xvpM}2O?pddBUTx*hZ=3R}N?>i^x%m6!@)jhyp-e+Fc5#zsVm%P2H^i|xZ z6SJ9P61(ygkFlb14-Xn<&6>UjZH;(%}o+xsrhKC}9ZZp}haS|_aK3oQ0qvGD?I z-h;20^-EmLve4*YugpxAQNhsa5CnD=mti(5!BsBaxyJnAOs#A3^wt69_>G2@#Vy5Z zOu#Mu8fdK%%bKC+=dL-v;FjS3I5#&Fm7TlO^AzJ`kP$Ur1~o+OgGQ8T6{ix_mZ)~Qib zsp#($2NGZiexGcW_;X`bS!^E`lxI<5*jr?ug6HM*ctC|7TmPV)a`fYnJ+SfPw0P=X zUTs&$kL2zF-jl4JEON1zcY>hnXEOoda!?TeBYLU{C(n5g_XIWmpFThZ!gQDRcIy#M zxy(yAbe%a8Vy*%=kE`|x>oSMOfSng#8N4ulcYxnBc5un~g*Q_PuV>sW@%w@Mm$*Xi z@;$l~cS_y239bOf;Q;x98&BkiwR=Fg9L;nyb*>uNwjAWJc5%&k#1=}k8GDd>^7dQe zb;*a2-KRamj*zT1syKvpZ>QhES@cf+ZIn?%>%`m72aaW;U9BeVxQ2Qv?=X(jgMl(c zKatM9hE4qD3u(86yVIL7vngx){;$B)GB^T7q8n3qAz1^|OUAb!3P)t(z2dm~51Qts z)>^nol@tS*SMCA0H)_ZTc*p44d&I9v=Ng$org#}G5|VDa%CC2$?DWJ+-93j52bm5> z-OOa5sMW$xGCI~Pi%M%VjB@Je#s;fj2Y%kx`WUX)`MST*pm5T5ee%Z5c#uTZEwRvZ zHqftNbNLSMi^GVps^9V*!*y)rrSm=DJc)@as@pB#DSW7r;~o&YR+}ox))>2CQm}sM zM)DX-*QpD83#?M+fHPaFEr zkg@gD)$@0|zmE1e0Ot_Ftv0-bbAhsB;Q@(5Pm1Kv6&V_%JKx`^p^8NMi# z>~rg5{BaNHya!MqM~$Zfv~rN2=5C>ik9)~Jm?-{MWtU0tp&Wp`@tc|Q_@R^fNoTsI zPPYL{S)o;)Rw?^z88}gXddj^sqNpG4mxC-2}93eMdFC`FG{#+DDTF^zz z9;ruITF5id$r3Cb%=<)d)>9o{a&rc<@>4|x*EY$DQ2Dh4S?anif=`YFY2moWy?zo> z5K^IwL!U8DhV75u_4b_dWVvewnO2MxVD#y(ZS=6ez?O)y)H#pRd>owrVA2~s(-Sp}*LK8b&t}mW zpG&g*qz~^macdg}QPe~5q}_|@VdAZ6oU@Zq=R)Zog_6u`#el(lZ7wpzPYT&MaLt}oJR3mPEm$l(QG|keAbuqUT$4x3Kla| zYZN%WL7EovCSt=N<>=)=ehAYB!u;tE#oi33hVeiFlhRKJ?2t!AFm}I~rd{3yr>-A1 zG_+E$Hrz%vl8ytzdLYc^3#if3-cfWiytSQGBldrAf63-C)^cM^Bg=Qhm3b1%~Yz5&4QP&F{g(gY6WS^P688L_KI6+}P`2c9+5z=txZIm*F--y_!CEquGorN1&!()f zw}u=rKC)$>xY$2!kbwQZFPQ#w6kQSkqRSHd z>k2q^tVq%Hst8iO@fPFbE|02fpTo1d>JUX2zrmEtrdDguEKQ`Vfp>xD_32^2H+bC| zN${yAIWl;H@%;R1_!MmMa`nkG@_{^u+wl`(Uf_CGT)-3AYz=R&`rjeLf1{VrRm=>GhElCxDjYNo@M7_EdH6cUVCeqJ0gLVuUOL3Ni zL^6X4#V$DX?UI+c%_b;MaQP@Kd}<{zudikd!$|bX7YejY3w-(mGiC)_3R9<2zuNM< zAn~kxvGc55ii{G*7J3qLSc-X89{0(_k~}vvN0fI0rvh+1h!g3DD-H7NV`Yv&q?>KM zIqfn`II1HkdvY={4zoS(>Mraa5LF)60o&>de6DjXA1Nb2m112Hm!6_E;1m1Np^6EN zzYmEnjQ9>8R`=jFPf!EvxinAc=$JI_ZH#7}l|64;;slfIK=DrtYiHjyL|k;^d>QM> z@*e@Ox3{w=j-8CkflD-3pA5=VE*Kc|G)%K5FNCYUs}WfF0T;Jr+g!PJ>)qz*rK5WL zv|z;GLv)s3psztJd6IF1u1f3Jq$4ly_VvZ2Bh4UA;POhqw^il`pa-3>qgd7{7J}R* z{`88c{BwDaKPwS}+WM0~7B@vmV+2mSA7?~>f<5uIf1u5k{Lg&Xj2t{`t(u_i%P`8b z49YoWmNE_91s>%EcgKZ0o5NQAnz8!Tjnu07!8^R;+5(?dP2!u^2%_a~`Uh^5$6cP6 zHlIdu!v$!tIz7hT664B>41;SyL_ti*33CEN2l=@ak>?EqKOWjM09e+au*riSkKi&Q zuWAh}GQ2hE`dXvWn9HQ}w4Slx=VdeCgLh9Myy}K0fm!}bt%p~z+uAX?(z98p##Z~% zgEY;!?j_pV@l+DhQVF4q5=$q6hk&?@MWN=xrNJk$Qjp33^L2jeb~;a^@AYp<)pk-B457yQUJQcNkR;3?*<{b2;lJZmT|4yJAVMD0MO(N|TSPmjva$LH*w z%jzzYlsrS52t9oB>=K2RgJtcT}^YM z%|_sNdeFjZA5E;0;$ALJ(hmggSJkhlUXSF)F5!O5b#;M+ia>Gi3ec2^VbhUN-PgESk5Ch`GxU~($SX4&PlLXYwfO|kkZoQfh98(LKz$mO1S1l2m zXE*Zg;%2Bk8@O4!JTi2253u#}zr6>v%OhWTnrct>%$8unns)XrCw1BN$9KxjXvXsi z&66K~{SZHfe>ri-1zlaKrKZP8yUk=+nG`(#`JLVL?zq%;WsjqQtyrVyE z)HCs>iJgm-sttpk*p=5kQoZ8WhK$>4$ubo($O(T?$4T%26OY~CQ`34oVTg(uy{rOG ztn={9O%5P5q&@dGE=WKCjC zwCyutAKL^_)@n@m?eDlBAT>QF;uFQXYj*X`2w-2&*yEQQ=)O{;dxm#ZNZ=X?;ew+? z@mjxaYYE8NZrg?l^F?0o!p(tcBrBuli@A;j|yo z%g5W>cu7 zr6z~PW84OPorZpv57CHTmRU+LT)Eq*JcH?D5pu$?y2-TlmAXq48tAq1SCML0DaiwK z&B|1oY?ec)}W0w+Hs;GtTyeE1K5&nZF}>X_OQjeumIEiMUea9u2gR8vkaOpPnv>BF`K;^opT%Pl=Z6tocR(fj zml;F+iPMUVc41!SC6?C*5KEO@OZ-jt*8{G;v^Y5>HA1V+ba9-#wQ*}H>Wv4RKU+%( zjF!J0j})(1!SmW1Z&HHT5_UUv>ylx-npH{9-FPx$J|BI2uORu_|C}-&zTQTs92+1{ z*&M_*#ndrBD3R*A5YJaCL8+}VAx!d6b5>?{);WUpApSY`zLFxVGK1AS2MRy5$n|@G zUeUEd&5dZ;;E~_aa9vWV@-&;*{MCt6nTJAC1H5yaiLOPOFM`3XUDUB@z@V?=!)I4r zrxAA%&4w|EU^542=#dzX|F_cN>J$st%>gH2C!AuLb@>?2Y9N%4o!+Tzy3V`q`?Bmv z=8J%J!L~&Y?b!KOvjN&Jo`c#=!2KVOV9i+MR5lE*!Wy!?HLXaeAB)KI*`6_E$f}wU zgWG&yx;Ts0N$+p!?VF7x&eXG1-jTx2UoQ`+8^IKfPGwi#zxpk*8=16LAYsyVpKg?k z9WR0&2EKGiAAMk4YP`TuLPfk##7>Ad(_$9MJJ!CkGZt2rUs|`=a%Jyf3^9gi`vc=}j8#H}2}yQUo3EW1KPaQ(W^!l_cd#!}I=mv1Y*3Xy!X zH!xHsU!s~N>YRU2FmEJYn&8tC?J&Jjo0erVZiXe_WBM9ogL)=mPuaA_Z4JEW?QQTj zcsKaouk+D{KE_tA-#FNXl6wt{=);Gb?20^(NYh>zCrVzvt?${y#SVJvzb=+K3NJHN zIo-Z$@;)rRmZfQ}!1$%cv+jl=SKT5dcCytYt9?Fmp)Oq*);gDOWcm!g7?s0(G+&{J zRo@##Qsy68k#DdEGaZR5&PkX#z<-$&nLtwCPC2g3e88hufK|%hGJO=Z=Oh6X5EFoz z5>a}B>)URL?Wb43*rH9c4@?oY@rA`|j%pjRk5w!weLf`kO+!cnp3R=c0D*95@Qt)r zz39rA*}#b}Z!(tYgU{|#3=A6##9PUkUd$yuHF`Gl`oQGknu4S&b4yCEf&5Wdef`as zlBb2hQRXUW%54-R+w?2EP({<1;G3nVV@h?fV#(lrV(_5R5vzjV`WXW(N zQ2q!#1V>!hS(!LY@Zb?QMQuv_!n-%Z7(b|XK_kjzCkA!Pj55Yn94Eu8b~B6uTl;nL zJ5M49=7X~z`bz2aVFn8G#v_!76m)-kH<=SQ@;2?vnIlrXCaZzNDf09IT2|k8 zMa+;E&#Tt~{Vrv{%ckL%mn6L2L*B+u4W1*4XDCbfGF5k4XF8e?AAifUiJJW*m! zvNfykl?jpD$xKp<_!$F3&G%@@sq?0yvzl7B4$Kp_(5l?ewC_2mCQG(RVwWh#70U{v zCLY~Q_&3=R99e#sPm5{jb{iIauMIp8dJ-dLW!h03Dk2yQ0 zLPM9fMq&w(!5SB>v3IKTPQ_+3BPNT)J&~8A%E&F>+cGQLwLsyenOSYu_(3Nh#!e-J z_cC42y4-z7CS)bc;uvmBq41+f%@9#jX}m+$n70YWO(;5$n5to!4Sb>h;eeeCh^ z@x4X|d$XNuZ2I{5;x^+64%^(cNvP6g_c~=f5Z)+XQY*I{#kl7-XMLntf{OE@HcX@$ zosuv_L6QyGh=}D)LzL$)lgg1SBjZdb<~1583x^wzEb~KOED-~&ABG{#%nriW_8?MHCq^O>Dn0 zJtAE`-En|2+ixTaQ2yxUH3@c4$lC#djJs$qVO)XB$qvmv*pV73m5w_e%#mFC$oj>2*c^A$jc|{Csr^-*8(wvy~4VL;oDM~4@#I$&468VBVT5P+i zVQ~@FaSwLoVcOdlD(ElSUiKp1zJKr4wwDU46?<0ARS)$$_cMO6SO?YURxQZSTR4~I z9g?v|Xm-d^r8-d^X+7Rm5{ctslSmkX@=EUX;y8Q6F3iZcgDD)%xF*i*&oY#+b@uCG zC`5eKsJ1(TarN|i{8pl)XPDi1=2IAxM!*{BUH$bWDps=deW}WFCt7^ zDBV|!wmI4Q(y&)U@`*>f_wPo8!GP|=QGFFb3Ck@pO7Bt4+*UBs3BlyCYU+cs2&dK0 zzNh(aa`b()*&Z4Dq!fv}@KPo^`ot7~Jb+JC6Wr$B16tW1Z1jKHq6MeKb&73`kHQlQ z=@L@ogd5fKFX}wF)>tN-ex2jbuR2=$<0;81? z7pqO!{Jx?fNwn-B<)Sv3K;N<>@&H4)W=LV^tWJ}6CTK>BL941VFS^+IYu^@5mP3!! z5>fZCUQF^;jz7rgrZ<1wlp)Zxj%(jpIvmv60g#%d*LPeo#FxxZbk74hbxzYD_YfNy|Z5zJe$p4 z_W)MSaQS^kpL;;AQ9Ts<<_$b7eDmj6_g;p!LA*)=YZQCC(n=vszf|w5^YY1F^J8}8 z$Gi4f@D)c%2~KQ5c$h5hqvog(MGjCEyfTujJa=?qIShKtf^@uVPeyU^Ldu`79^Hh? zp-j=A)>(HEs(afQo9fIxsf8b8eAhIIRU09ZX`be`(N8qCbJQBx(gWdgdIuxC;~U87 zY;cF@9eds65hvB8FZF9465+XUN#TtZZZ^P$jMrK{J+Dg?j3mY@i$-D9;J3Q5gQ&cH z#7|N{fq~rN!lwV}>0|}cW9?S0lS!m`#wv2w5TT;1ru#-)o+GM=50CcUdU3C|ujI`& zPIyndY6d0$*4vd+qx!j)!~L?Y4d1Cvtw(u5EpqFvP-KBs;qKL=B=HpAI@4>3M7N3; z56fS69FB5$oS;oKWJR{}t3T11tlkT+@#k_nWKBHKf5Xw-ef46*09{sj$3!Ei@Wy zl>@Y9OHkIB9*-Cj60_5rFfKQD+be+0JD%MGgbTDa1i|$e{I(iS=4uU-+PjXA>YwF0 zde8Crmw1b9nBx)`xRfB9l%P}PUZRtN)!wX;F&@?ipy@&FM+ zzh?Izoel!)yzI8LmX|!ZTfqzW0C@?x6Qnx>r^~NA$72=LoZ)xyC_Swn?B4LC_Q0F} z{ZdBBM2}@ILX@ZH!5-M#SahN_Gy7_*`m-0 zCICVJ>a`lf#P8i{RxhF2qZqRmAH`Tofc}(E`8z-gGu}uZ`&5tt=^kh{+fAo!qyXkM zjYzhe7p?$gznuFil$a?L4a8<@eFVC4|51>a;Fxq=zH~ljy!{mM9~gi zXp5V*ueHS+y%&|NNy$n(*gt=9cHTJJ~eGz0-aW z?a`~P%*Hk~8;ewHH%f`UBVINz6z1PI>PpeVmQYLcq(;M2OM}VH3Tb=?Agh`qb^%2o_k{G=QFjgx4S)lVAR_a zg6cd$s*+s;@*?vOi_q7FzYzqz6UtOVOf|jilgygcSPdyh;PB_ zU&_&d_Ke`-Rjao;nsFM9(kbT|}Pvr=?LPk=g`~~#0)3#fNMsVHoN7^L9ATFe)Nj8jSm4_x6x$r&TjU8 zLIjY?*`U16Oe%3EZjUX|5qQ^xZyDh$Y|{EZnT-|C(G_WV;@u$LmT58nK(MMB!4vyu zbE=g%BE89%;h5|13$yp4T^)CiZ*&*w%;w}!TMv6%^S`}y(l$-zt5Oi=-Hw99dt04U zbb7z5irFny*lN`0DMOX~5?mEltm22=GDQ#;2uR1?5tSXa#1(t0de21Uo!S%hAA08u zNu65|EdwZ70R38qZTH1h^b&=-L;s9uO(uO(?Kkx7k$rLF-=oVq(XLO6Q`(owSCA@R ztA>2tXNNf+#~l}Vt+4sc02dqlUiVX?p8ac*YnS}IMuLT%WsR2-L4E7# zyAtd(si)F$*f$nc&_HU%Y0<$wks_tf^Gh1grurmZ^yf@XY4w~5B4&H$VxTBRWJVDT zB)GrC5IvYpQ3UPZ|?Pe0yU2oRsXazP6Lvq8*Mb@xnR zGtL4MjknA<4+=@R9rEQOxgelz`TL3gdKC>xdk7coG3D&0%ZlnU^h-b`y^Zu5SSF`+W=m()!keebD}0uEjic#Qn2QiWh>fF?Gys8_sU&Ap7T zh$N9V`cRPpBRW$9hX&v_D&_^hSZDg-DdZ0>U=LzUpssz@A8IF5Gf$QP(u)5q8xkm` z=sLC9ER&m?o|IJWV(J13G`4Xec+ero3KCocM;G`L7%vLTK9b7I!~%<16VcqUlJ#o) z(d`|S1@V#)n<{$w7Sz^S>tOsC+`z40px?ytF|lyFm1T|Gjn%@^_R`(-b%C7KobGGq zmM_koY=zuBK=^cC9UK<9oF>Ns8&r+}CkCJK7JvFW#^UvgIUKbulLbhu5t-{C1Hty^ zvd%g(KNmlKEwEJK4Pl8+M7|+)OT9?t#f9HeVqtOH9cGC%wj8+_@2Yn8%rwcEuL6T* z>{ps%RAdxece3&y&UD7A+HyGH33Kt^ZT zBF_oQUuM30)$Q}S;-%d2XK6b4JpgHR52$pxrM$iepgw~405+f)Ph~r#WIWi-^fv^V zH{JPG@=`%Hl*v76E*}Q|aEcSt%7hwo5d3!~c8&VQ7VcyZLvIZ;vGf4@4;9SQIK$d^ zl^k&Ih>#!TXcmz2*BV0pvcH;O1$QHl0moG_^X?M1jBdSt+drP{ncxbPEH6=pQ%A~peK&wP$~_L#hfi1K%)QI*yE9m2Y{Mj# z+)QJ1%XHk9HSfHlYK`wL+ku;xvVVD?RO!T7E-X3fSMl9m+APX}&ok;}X<0k}X2%C= z&f>PiKt~$a=Aa60m8CRe(`E0)E75sBa65+uwb)W`bifNZ>S@xbUU|j*{zer;F+S`Z z_q(*MM{?oW<6X_?z?xAs5VV(xsDA9mKF~&tqTcYpx*B*q^&_b>6ko&V@rqme$wbTd z$kVNOtuKY#wU^VWPOxRTV4)Q-EXt|1aDWcn9!DGaW6t?NloyokCCI~Gen_$LIp2!& z4#O1qKX~wt+eW;pGD4xci(>xbnYZOF(g{C5*Tjh-4OdWGeyxm&YE$J2YxZ0A1Kn9X z{B1-<#tD+6F1tQ5PpG5Ur^UPxqURI8WU_zp0m2L_7v!F9(fen5j0l-}QSPq7Nel2@ zzr(cV%|{zb?eh~%Niv(A;3vICvk@+5#)=a)Y6PDn2qkuh;5sy zfD9H}w?_T8-pg@1)V5N^@*eQpz|Z^f^%S83%uIu^ep4hL<~@x17kYs^48; z-7PvcF^YtZ$d>G;UfQ0c`euUM@;Pbkou(;Lrjde!TcOV1`KYoYpPOqpZXosaDEJ<5 ztl#|b9$=wneoMnU^gmg!lO%|uLN*+YsJjAvdVsBjQw23sfLLLtuWDqkOFqBk4V@n$ zDU_>2G2w#J^x<)FVu};Y>T)cgjq0Cl@7_P#{I$>W=BFeE2B(Y_<(VnvF?_XbTD1(~ zyPsU8E&=}5_p@ag+;xeekDv~(XqPQCLOPp0gp20BvZ)rGJH3uX^bngK;mYXWIS>nAzuBLnPM9rpa z5jD(&CVQ{nUo)P5`NkXBeQPRKdWCC zJpm4AuaGOh^QJsi_jQRC8zt-XA*%aywn*2VODMoL#WBxf6=F7E+ryz>EKV1b;x`FU_yJUM0! zS5StrIMGY0K9;L2oyG8R8pUJGgS|Ex{06wo@VL_(_(<7G({{PwTPrtzv0}0}=!Wn3c&hdR!|sr^KNHnkibkU^DYd0jy2sfU0c}*nLA{)n_1(0Rz~iOZ%{7m zDn-*P1DvbTznVRm0aBU0`y7}n5jPZ3+n3f(AK&zNL}B0FQqoC7+c|GD0A?6ic6LVb zv(Ci~wfS;v9)6?885!WT0v74?p<}6T{XnqL^}6DO?G_f0$Mbb`eaxo{K@PhOVsS7k zJlCjtI}opkb^e7WqE&I^CYovR_~%YA9>i>{m2}%rsm2Aev`Y=^Ud()jee5D+#aRy^ z4k~1tg8<8=W#rAOInTZsX{hXH4lME`$rwcQvqW}%N!pF&Nez&SYY42YUyFxtK_6fI z96uAMG+mQuSJEJ8@9sqwDfpK(%Dw!e#_wB@(YC7gZ>U%!M`hh} z2hRp$A9(_<+{iN`&HvtK@lPS$<@DWm^a!~Yjw&R$E5S|$*Mc>lK=7-^V|T-sz3ZmK zl(B3ibU$4)4mMyndf$X29flB^NT4|xDts+x^d9iu@gC6Ym^~#&1@h>6{Yzz?^r|Pv z8okX~t@+VYJZEijfV(EN#m|(olQ4xaQA4KxG|}DMGfm0i6S(ZvBAfE0D5D&|pmLp> zv4Ik~CBX*?k`m=!Q7?lNYt6;e^pCwl0a5l)cGgUbPa$2T$aQ4L}lB?9(cbx}qp6{u% zlGF;_c5%v7^ld88pZrIO$=Ma}#B-LW6wrWm4uMA_OLjvdVB6gBsN@!;m3 zmM1IFn_?PzVJwOQ`a9jRg9e{xJo5!Kd2ZI3hdw?lwt9M+*yiD(s7jX}`QzMCh z?lpt2xOtBuRQG@dZg32EM_4W{6dEI_InDIMJkPx1=q9nn_^zW8ydCa%k_=UXS}k94 z`qkZryhVv3o!z>l0r$b=S5r3pO%(3-Z?(>nD74Hc3fuo}m;4L6FG-`~9XY$0&xxB* zxAL2+|NES$%pqU26ahiMZ)8!NIGyI_gjFa`Zqq<_W)kp*0(|!NBi}vXR269cAI2>H zDTZ0@Zj$-<)%+cl6=odF{;6tQKggC-2=wDgNkRrb;)#;Dvivs8Y=30^evU zQULxXq1{jYhi@Fl?|VS(l}pz>fEqRO1mVLkLY>ZJAKe2qz9>GPqMKM#i+4`hPm&o~7*5lWzlTZ32_P65uyMw+5C^RCl zs|uHq%9)9^hn73fg*# zS}=xwhlkerE)t|?dR`ieJFDuH}PeY zEK>c-emo*|T4+qEB-y90v1eR&UN>vIQ`g6a=P$v$!<>NfvW>NuA6|$vTfSUN6x!F*Hmv2zO2c3{lSw`2%v`mi?|9sL>tE<( zHEWe&@qMWb)m=r7*Sn##U^{+cMjaCb2`b?5J1A6>^p{bm3t%oU4KIZ!S8>(ah6X0p zg9=?!$i30LEj*G@28$iG6dNLwIHtOPC$dXG$YJ>cI)gF%Lu6RYqS_Je#*|la;A^P> z@@W~%0Dtf*uT)KyYn_u2QBC=S!+~+<D8#2=c_0kD;1p-$`5)mS6@=-N`##*xvFRQN+l~1gLRq|d_z7HJ1 zwc#wrs0mCG9XIZ={ua!2=%A>lRr3_!P1&*Mqba+mn3cf%g(T>As}5t7*X}@BSx{7A z{GuvDg_cBGmpHyFMqNF|RjSJkySMy8;xY5Oi5_L2A$;o~{#qP)avqFWidu8QGTk|^ zZS+p%+c3Vgj(pCNsv?{#S%Brbo}e)5a7l2-xQ=ML3vML2!!kjQgknLceIC7l)DV@1 zfr}v9CS~dtRNWH#mA8hB<27P z;<1LKefX8>58Mv>x3!uN?Ns_A^|0dj^0$xq<1QI})`gLI-gn+mc>J$>l!?&?j$!@> zbkhYYY%oIpReK71|pufDRz}6=ADC`ZZf-1)yl(>TE1ebSSMdgK45ux4oWF(j`~Y5cXZG;L0W$6+~Jy zhu;HEuD^qqcc92&X83?S$~51)cy$kePJ$7sw?w(`#cp`P#1X48%t}rA_WOJX2OHeM z1#2-{k%=FpVTq>=;WfLvw?d*I+sZawXPqyR!>!l<%pZ zvGL~HsE}3Jd&-yxifm)Rif?@n)=~NAqAdc@HSiO@xGhjyp1K6LXJN_ctu9m9 z)14hGCeH6%Xlb(c98>c|~6o$-agEYv&^x6+um-Hhc4_cG|uqE)l0CVGh)bItC&XD`}cg!HFJO- zS@F(ya~9L?-xx7Xv)+M1sZB5_qvsLfP7pUZQrsI%d=^KJ{9#V!5WjQP67Ly2d~vrg zldDKj(Q1jGNn}P%_`~dQ=B_D@Hqx`q+8<@Xe!GH;l`-u0Do~Gs?Qxrrs(hoid<}bU zzb)3u*wU0q-z-)qu5Ep66}R&?3d+C<4?wAx27(Yxk0#MoyIap~vDC8enAJL=pJt@sa@)*PB(Y`cm?gL|`={EVLPzTOP5tjNieLz-4{1k|3o- zZmXJt=pnmI zoD)hlJ~n(S4VE*z#vaw?9mBntXWh>dY&Dog3bY;4&6}sM4wlY;?KzH!F(dB*_4j~4 zXojDxZ%^Jmfcb*?sP5#4EIMl8^PetD{{3o*IR?rQB!1&jeVcPO8n#4)aGDNjPW?jV z?TW1zDV|}aM+S-$V?ih5`$W;~eOot=zar<9Op;bzg zrQX!umIv4t1w2Q(!EJktYJM0lIrw>JANSJCGo67*E4jDJ>fEE#(Xlm+t{yx?ime`f zLTygf<{*IW`V)}oGcbOB)zW3TDQm02@3cXagXo@5t6#7$eZ`KHg@5d-3aKS?%RfQw zXZc>r2I03&wriIeX~!5i1jbnroS|M%0@c*MQW=M{6EP27d|=BlTUm)c zL-t>z+I+=4Dv0jp>C_#UNjp_pVV8Pw>UKLv^Rq|R$?Swpzxv-R5DKHO|L!!s{d@zo z$_8n!H3x}Miy-+$trPADeBSyb1CPnr9;P@BmG*xgOeahyW({@G8j#sB0$v(7Os9do zK85fM5=b>nxN7Venam)?XHCIYTvizNl&3>eyczZ)Kz9FfxAdEo^a~K4V_VPj7i{U4NEO4mZFvPC02B zTDfl!!fs)vVwDss9ki1sx9F#+*(KUsl_7eUO`GAg8%0o|8#-T5&=f(EyAn zf_nEk5aw%~U1iUEv_N~N^)uQXyj1TsbT4g`zREquG0l@#MHa472L}%01$|gj7POOS;mz^nMj~7yFvT-tKvVo(=Rq=ACD~C^n+f9`s*xps&RNDDo zMvxjn(GORI?L&|HF$qm3@@?bz%h-gBO()o-D@Bieflapq^#iAVA@)zvgoJUNSDv{? z$7mpuR8-z9$9+0k4KC*z?OoW;tBqE!Gk~O|t_!tox2CZx$1#jsJAaAqDR z+PjxIHC;^4kfmiy*#^SdJE0bb`^TPJ%2ZG+)q~H&K~HMN)5#$tacqiE9rYr znnSvFpskZ)=(ZNoBl_5Z^jXh@Hp4Iaj`r00j%Ha?%17=spWa_r%~RC;y6R$X%^@p$ zm4VxINcl&$pUK2w{wahKz0B*~qLWU;sje;-C~@b&p-(hE8KDnzA3eL(d4xPq7GYW% z*~ZzBsIpxm6R8*#v^eeI<)LR?4nU}3knM9pKS9^*T(>nkytgFXa*EPQRph_LUV74& z9|C0~z2?n~fxbi1;v^7HeWlQm4PNto;1)*FEV1>RS$Y0^KdKIJf3*vn(48yN1<$^= z1i*&z5;Ml8{ypG}w`*M33N|QSdr94T`A+tg4#5_WZt|FlZ?_5i=`nQWr7n7efcvAB zN>&ZGx~6w~g?0DZaMh18!?aw#0*Ev-ztuX1N12uCaRimB5%7ik>4ddZbCp+ltWd*xeYoPxq;kFQ7U+fQ`}#qf;SH?mLsF?*39955Zhx?qA8u{6)o0}IQ5{939+AOykN zJibUJ{pI%FU`^c9xQM{I*98G2`(2>akww$OB84*{U&^5jE44c)7Im-t92T+d;!ls= zzwtEA9Y=7k>e4~(see25n!@#QV=dq0Z^;C%f^EdWe(b}cvEH}qmWPgfz`2ti+g4{% z8?_lWw5h_Cbd+}$?zKCS8puHWcvZoRbu{a>1`&*}~h3xYa0;kL4fTE?ZPt88AQU zB6ucU;Sdm6f$jc+yNk&Uk)^`Q!N3>RBrjzZL^&3VmY6#_Q*ub@-SBivP^FMdVcZ%1ka@e0h>tpDf{)))fA^LdB4b9YK%7g|7$?_B>^`TN!`fV7O zm(21KNbl=JNzqXR)Rj~(*EBbs1vMnIsKn-EYfbpoffF(OR7An;--3v{J0!(;VC<9b zRq8Wxfa)}}>0glS(INN}2RROqkv|YgFiaG{1upyqy@IdZ36S|qMV^tWc~L;fRe@tK zA13sa-KH#h4f65xwaW&qHjD<>47xcmIRN}i{ZB8NHE-SS+LA~`iRXJ&qxz}(Rtu&6 z-2l4lcuE3Vv(5+w0i+V>=lJh?8iFf*PWJNx%C3H%i`Bh}ahOjPI zdE$=Ue3F(=X3rA#`E!nTu13zJAD2cap+^Q)lcE>rkp5e%vfmLmtIy+I*ACQZdz3KL zN8XWd@@8ylC)6C7duq3q$I@NO7fbpT{7e*J%#X)=zj+!u&w#nBwkom*76z`b>EqdI zYZKZMBT}=SUJiCJt6Iy0XdW30f&&f_CK&xzDKL#EvL#iZy592+Ix9w*TIKVX9EC}F zO3!w0dumlG(Ve-&uS!?dcy6C_zn z#d7;c&jW3H3an+hYDP#;bsJ+nFO>@k4^DM17qZDdei&KZ=cj96*pcI!r0L2xJMRE0 zFn>wZNDgf&5HCm=3VkZ+=<2%w*&56G?g?w9Wd&nI#zTs*atyc1$INx^dEKKlv51Hq z*G@AW8N-82VcvRSZcdA;fPzR>m?L_-qM6y$;YW@2=b{!ZD8ENGCh83pZl1u|}B7mktky3(DVR zl7xn}r5!rdJ|_`Wm(MBaKGobvs%pjBUWuPA;f zhP%C>xxnLfaAs7M+MXqFQ5`axj|cr&^42#}kP9V|uqScW4z!zCh8c}?@%-c7!l`yA zjol@wtHV5Y*SzE>Xmdm=()}OeG5$F|;~zhhN8)eb+tNrH*|7tekz9th6Jp++j+}ix=%Qd-j^6bLg#Kr-GAo z`Y5eP%_qyy(~N;{D}98O-u!76 zMMSnmkSVodx>LBzcmtvpPd_3pwICzb9KTRpzJ2c-i_E2t37eZiH?QyCO@CS%m9z}n z?+`Bz4PA@4qNr|TJ8-MfKBQ2Q-aC#d(8$K!QO{Qh1;%n5H><&(#%hlgADYk-r@0tT z4p7O}Y=cv%BavZuSppC~Xyn#0x~v6q?NA_yQSXD1;<&j*qm6Mzd(YjDk=)Y}G zQty4%uNZnd(liw298R0-FA%!VjgF8UTNM(dLgw4OfnzjEnHx zYi{i1>$RaW7r$l}!cvlYw+B0s@5_E3FUx{s_H%M&>QmCLz|bJR@A6eJ+=yqmwOao2 zp-YhEQuJ$2M7DLdhCt@!WV2$Ma1?HUf>^uARGojqGzol7;V0-K&^5rURib$lj9=no z9JwqU%=gUslAqTj?!N8fW{A@G__eEeu?cdaJnBbcr|wuI^}07Q98pnO8S0}NHpTgg zEx7mALodo1alY4ADV^_%iyWFzrzZ@BtpwVg#l1t}I?7pi74*fWO!?}hU`1c>t1ivR z1xp+dOOzp#_Y*Wfr}7iD6xxe@ixy~}D_0731^Bs;TAGPqw>nohjXNu}b(LD3$M(Gb zcK5iNp56UEK!3Y%?HiANke0fTZ%_Z+l9P77rHWJG+t=A5H zsamvE5wG(jbP74*fXh^f6ANxVnV+tAH;FCt$ z3KZixmRs0;1R+9ZyRuYDQzs@!Y^Kw19^o5HugJmSEV%euV!#PS{{3vBGo+CfYqe0B zUAPJPkxJ#0P#%4!l8)>Ma6n*Va?av9tA28SLk$?LReJK+hhL8l=Q6yA{b0%aFe$8d z&mE=_3-{WGha)X_L7s~XRY8q(wiBnxlKOAm&*Puoe(L}>qwh@YyLxl}Cx}Eq1O+a) z3M_7<^d&>j1>gi0s4;Va!V`&7bK95Vjq1#d`hr~Jdt1z#ZD^AD@9L@(NHqf05?W2K zENjA~S8a*Y4awF@DwtkikZ`UXFFy7#%q{fTflJSFAkiG*2Q1{kRvr&Fed_tHZw1;_ z+T+K&XU|5m*mxm=E2Qi0iwePW1OU+3PbpgK26FB*mkveL`q(Lr!<+AsUb z2$;vB1>Teo1mmv{`_g2p3Xe-lUv<1XeXsmW*kFx<0>@hBx``#VzOh+MsjPp6flgAs znET9JA+SLC^zm2h_qX?YIbndZOdLKBJth89yWvVEdmkVyKiJc^ST*_#66q^YKOy+- zWso?4d&6-`ettzSQcVr-7tp@_KSw^G!C%uF}}p*@wShVrD5`CL}*fxN&r+r089)hQYVa?D(bc_2y13 z!!DIa`c?Ud=QOA^5{NbAEs`Pp2v0J0b#99Pgm>q9t25QB`kMaOTtm zLw~W=6aSX21|gWRxh{(`qN*(V&EulSF|F0zM?IZYl}{utX4&p6xh;?r=53mG>lSb0 z$Lw!cyD&tn1k-<8a$_h6`ss{$8_Ue* zY^IM(@hk4tu&|`e>-L!U8$Yz)7tn)^f}5SO_qZJK;-0&PnAIfqac|kQ9DyGPHE+0L zCdJG9_&Me8JpF7+1tar!%r(WD0Y7^XWb0nPpKo8 zIU)Ld9(OP4Lj+sl#UhaM?DS~ArRAg5k~(Z z9~+-WXt3h(9>1XeaX2&x7zE$g<5{rIyKPS0mLh$H1Cj=Y8n+uFGN!xjnI|rC?NNln zDdvN=uE|^mPckihnOyD<9GQJMUPb2~w4%y2KD1-^zDJl#b|w-f!VBWK;WR+ABAQnE zBITKIRhVH_W9sC{mVQ*;`V-TuAMqo6U7kbVc?CYDD4&dm`_^12z*@}{g^DCKnBa83 z$fjf|AYhDdBa`EYsA_k_szS}heLoQ2e9k)P;UNjpgZsYpyoJiM6G%kh%O)PiY5kxkL^@*}sj(iMy zijgQIrof8ic7{*m488uw;cS<_W~~x2+!!aDYpye@Q{9v==*l>L5G=>>jmWkIGGXq) z{uAVp+u#*nb0!IG_i{pUilpcDS@W+}MSR)!VjHj>N72^UyxSXb*VGf~1jUXw>Z}YN zlV9}JMLV`Jq)xSt81rsA(oD8{z(lfQ4EylKp5v}^m@2haHt_*X({M#kk$LD9JdG`$ zDeW;PA>2(qANGDtulAvJCF+NL(Wv4cTfm;<`&xeJGFX7*9&FC~vX;GQbL8R$i!*I_ z=>fpE%_HNW8LzV;vS=SV&@^(O|0EL4DY8tElM-1M_R{uP;3SeEkJ>p zxK+&;(7~l|Y6Ild+_~-P+`npr=F1){D7;J5f_t6YG6rg*$yZ0 z#2Ab`imnX__RLhn>@>I)8&2AU@Cr^h9x9W5%MLhfZukERw*(lX{bo2f&g|dliq`j( zYo3q9Hm)u-az4)=?&p^Kprf0ap=abp4f!));2+*_92)u!F=SeDvMzrnpz#xwdi6x} zJRuk0XfNRk&Z!Ch*Z->DKUa>=&GS@Ucw>uaOex=N_HhI!5l>DTxhwiz<5>^=M}gCQ zaB3R58qW#HYI*<_794Uqwgx8g=fug4```97R~ZvID@>AVkelT)^Y~UP6rdCCdaKd( zUnEcg5Gw%g{iA;WE{FU7u5kXp_@loq&IbEt(S!&Ugv_!&ZEw#`Deo$2XL_zfKlq+# zbYi{FUj+vTMBl9_$J1RfK2!zQ(=KgdD9-4dEk-vmR55fU`zF|?LpLi6k-HI2jx_>P zLe`!GtFp$;ov0shz0rD;c|X-B7{1mGF+p1a%5K5w=8J-NHMe6l7NLo8ry^&pKsdM5 z7;=k;1OG0lk*d{qfJ$FDoO|p;Txvw655x8qrEAk>@p-3F|EAs0oL~2q_}_0jQm8W{ z9|2;RM`iT8+^UkA7%@|l+K26rjxXw)8&^dlmy|I?=WmLExl8p4(IOJZ4+(`F+?$2Z z4d5%l|I~_BK0G1X5qoX_8Hs-J%Fp{XEG$KKT$!cjg-3|0;4%A3Eqtp1g7*|y2KIQZ zb0^n*MSg;w^+3)k<0b|#36Fd+x9_=dL8f5&kNN*USp$Gm!BxSbZW?4bqL`7#aq0Nk zQTv0FAH+mm7V%cbk+14M7i|y|y@7K0_k*wbli9#Q(yEv`RPpOsb|b0Wsy+P`>(5Xw zi2K_`ldV0Al4th`FS?`+K_!neM&A^YN9(}BrKx>W2HdrgEH>UqgE$K;_O|=O|n#g=-vWDp+OD2dFwz5xO zjnY-_z*NL1ltEzglNdxy4^dEFx~`5^%*v8;WJ1}&$nuKYT-k02#Bzpik@l_2d>E8Y zso0h-XL4ZM{srGHI)iYwcT4v2<1j{Tvvg4{-hM&pmk!qXzK&#G zpv+Qmv<1CTkg>UI)GG9&_Awi_-B#yO5kL!IWs5G+_RZDcCYlFRqenCW6?oN6Y9{8Rb$##w-zi-=*YR%}J2l{Ci>%)%mJc;(A96_qRRp zt0!3P)^QKP>GMkbuDv4=dTs$|SJm#*4S-EzbxB{1ygk$lXaIv$-)!0rdL-jxbM!xDsRTsW5 znOvMzKctR!Y$0dV9Igl&^7VmyI>|pqdAm(<{Cw8IreYEWg6^VIG>dww)u5~qr}R_OjBy=^7h4{wT+1op>^mFC`!K*%w)VF zI!Cc1906B;OB|*(g5b4GlyG^gY*y}kL2{|sT<@au6^Ou^08kr?i?;{bz*~IsEvZzmrOL0{GQ}8VCR31tB^8Iaq@H$v<<~9|NBn@30n+y`$Xx)H zH67R0a?VKJ-G>M+;_k3UnsY8p+YP&imTHtKSNI=|bgkuOgdRkN{D$m8{!8=E#!Kgg zKS3~Z3Y;XyAq)+kk58kmz=*Yd%c1#*h_zz=L{WFSrL0D~Lb-{MBb@Lg(`ONk<<=bM z7+qq$rBwB?W2p1ut+|)tO%aOY(3e-*4d1rAoN{I$C6SiMNkr#qXJqbqD$<5UR)!75 zl3nj{UFGeCna*3glReIg@O}Qb&r|9Riamqdyo+-3uN9hA=Ec9h|E-6+QR8EQ;H$~T z)1RQgm?^v$WZl?}29OQP{U#gSHyC$;g5P;2tJbH~8vTa&{c#VV42+-K2Lu!>L_N%n$G0tZ{vC=jiEoK|=1!>QWOwbe<5I z|CO7lKav*L3FsZ8{>nY%&wT5%D1h7{e`E$&Oa4`s)C7Rg^3PfZbcTQA+iCRw{nHU) zvbTMSCUB06DMsyjk`Wd4jDew>%&(5~baYoikzcYV*O>0+hA+09g!55Yi!?g;pl#mh3-uIDbPohHjs}`~-E~gMS9L9&bTjhkxGk z>($+q=_e@406vF*T|K!~FZL6}3OJ7=&o6;ob^hR_;6MLU8@M2!B%i0@6Ix#cBfo6X zDEjq*{3$#Ea8)@NPf~+0_SJNv%AU^8m0q=jiT$A3@=cY1*5QW^5wkZQ5WMP=*_?+@ z#vW+_ZW2+bOW2xu7RdqKiLA1-Yx&tTHKB8Qr3`}GDYBmYH_aHi-Y-2P?BE%4B`3mm z!!1H^95z`{>r{>;<=O~d3uMg34%6#?3jgsfgAmYlkC)fP3u7AsqxuCVoq^OO;7J~! zk2He!h()q|E{-PB&YbnNJug`&hXP*3h;IVl&5sx`bgg8rIBV=YYPExkOSH1+W=fGk zGdXW5xPgZ-a$bL9o63*i(k}uigc3r06uyXGJU_y_5pw-A^!8tU)}OyHgGF?tF&_$C z9$18>ksHo#9Ao^7Q9HV?XEc|d*WJ58xI8JrqTv4%G_hY<>3?ZdR%XK;PPv;i;w!{o zl6Q3~>}4OXHT#GBC;42v?-b1v36jR`*L#P@=(X5Bb-k!5u9O4 z2rN9WcjeFnE1&IE=ux3cjyq(-e480pIMxz>&(6)QQuU6_|rJ#dc#Hj;6BuHV|-EMDVGbf^vt7x@O~eWr0?>L&bz@ z8bBi)ZDE;EGtN_Tv1h6eeX5>jCOxT&cs9Fg8{}!3;Glfgdm%FG6;#y!JFL#OU+9!+WK%F`>)i30YpJ?h%KRf`i_BXulU#{zw$KysQIO;UrYH|15ax=YvkkMn z9&gWZ%Sh@O%h6P!Ty$m}b8HoxJGsaXv??_s$7WUvU77vdlB|5PI6QVnmD)DK3G%V2 zn~n3*9Q~yv4*FtgMRP+}+dD_F9{8sNFC`+&k9MtBweHsDGn6N-D0lRqwu@!D*KQ4+ z!qM`mxwm*e&r7~)3**(QCW83Zm&dkjj*?f*y_j}I^{>gA`N1%bsH%22D{xXpFbW7i z@bu9hy)`udu`7dkIg*n%{$XX6SwRz*UCv917aXG#Ymm0xP(WVp%W}qPO9#C|7EwJB zYC}J=VB~gY-$s0tAZti1y8eo+;mR<1T&tGnsL;N zE>1_My{QO!g5*x;H66dwdDi%18NfwFwvc7HxI|$2EpU1Sc%UmNt3=r76m3Iw1)3RG z80<+|jlWV4`}eyR0CRW?c#qksOfX{r)3gVjbuj-hE8$B zC^zomc|@ZG_Ue4fPf%#Fv>RWWa$&pmSHDy$(Z_sTcJr9y4xU5sg1|NvdTvoK9iEM4 zg?+LbF*C@aYBD2WsSKy|T4_j5pdmM>m++ZfpK#fSP?a)k^%kPi70v`aW-HT3j80S6 z6{z*A{q_DN6#m_nrYIelP1Oakboke>I~C=S6XN!tpbNm){@Zn+l0XKUjt|TpB z56QQ>Dk2OV9{X#4EG=H3U*rh42!Dap;_1Zm;s~%ZnEvtM5mZ$W-ytS9UUXPWnH0Tq z)*>EglCi8H8*Lk6 z_6?du4$JqvEu4%NwK5~ZU|-bO!_VN*BU!nb%v?># z6apZ^+18LU@+JY&$)fn+`J}5xPFWhCKQ_7RjqqCtsW~)%+%aG`>oww4UK(vAIZtdP z!bv4wjUvM8F%cJiu^cgf-{&M$l)PQDFe4o4PBkU%N>6=lb$NAb^UMsp+LTsyRF%Ub zIii)+bjp{SPFm$C)Z@gT?#Js8Q;CUtaO^&h>2rl%Mp`4oSTA5A4$qe(lL|Z`9kQZH z>ao5PWcfw|l0mF0@q6{z2hAeK_QzXlXS}v*&nD8yd5vwpCVA>8zsz5z6Q~%nyn2T| zCcBkpOTl3sSqk0S%<>$cLfuK34|@b0_r#UT6V1NF+bg(2A0BjX{v~}rTS@k_TG>!w z=}?UXRMox{nG;+^>(1pldov!F&*t4OdgLhgXez0b{S|EaXVB$;de!e^OxW@{lh`v4frn3(0|FBhB`AiCj*sHv}U6%(V_kY)?c1H z-q$_jEj0rc2d25lSfcq9Gcq3~bc?E=ZSz9RhF9@JyKC~?DqEk3-m5IJKIn4;Qv%K! zyMc3bj`oKdEY>g|KfBlL)sY6z5_&Ga4^F+DHZjpl?(8^?FKeyrB<1F-M9C#Hv`Mdj)HP5mOvKfG}7CJn0*S2P{b^!&&IhPwIS^Uv6E|e7{_JpCc7Ek(d751|Z5O zx^B18AB&H=txP+Ntaw9xVA-d~vW~!R=Mfe(%UXdhpJniJ?U4#8UVJw<`|2oUSbXVy zT(U)62$3}D%ggG1xy_Aa=m~(!C;Nd_YN3_a7JT8m1J>Qx=O(oC4_s(5(g)`)~u?V!nUra34`Ha=5 z_B37GY5x@H?~(9Y`9yTPxkIoWiq_b|pgk5wCsR7#)JyY%4Jv)4>Sv7mZ@-q0m%9_! zL^KNW+nlt{`dS`a8+sPOZB@PA-r=?~q736G{oz=;{v87lRQ-UZh%|8yY*Os4uQYFw zw1%zS;l(rE(Hxk&zFbmv+$Vx-KR9*vlb1*#t!ZU*E#$Y^i$_BF9Sz~F3YY)kP)yK2(GYBtn^AY}RdH9wHZ<_E1H z$`4TCXR!y0A5(Ak@;n$WdY7DWtgdB)O9F78T5{&!q;&t$i^oVFj1dZ3n*+%6Y&|m? zMdh_i?vi&t-L7;fzC7{#t?9ha*&va^e@&wQg0la4vq{3=AXl+yoxtC?)qNJ4KQ?K< z7#kFM`B>!|_V~dijf`5dvtkslyvwW;Y$DuLyJ1(RV7BJZ1_U676she7yYcv`&luVG z*y!n!N>OIbkB?D?srRZV7kPXmr7@iUi^x;9nU4W7Y5S@1YU9rxAADMvaMl8e?z)G-XTF8+d*Qp0DLM(>3 z?-4UTu1aDKmT(zdWGQSxF3doP0Ul@qvbzkl0eVDC=dyTcT(-C!ZeY!U3UigS#d7o| zHs}OZaqKvj>I6t)`o~0MG*C)m8Ka0hbq|N16!ft@A~=(CCZy`~?>*6kJHffJY4hY; zQw!uj7EMQS4;Ew;e}bN*=~U8|^6fwD%43$*{}w5f9Jw?x1|Tk`@Bwka_zN$xv+U_L zoRKaw@U41RymhgR0re6|sG41=1YK4*Z^z~BW#CbG-7WxI0%$(zMO+ki=r?$06}KO? z2U#?Ih3Win-FTk`9!Gafx0m@X>@4g=|K=~x08p`nwEcca*H2Ic$PNE{#YAxn>;M!` z@GoBhnAe|)7ABbZzd4r9Lslc>oPYi5mxK-y{g0A{_y~c0vM9qUju=Y3)~K2y>rzR+ ze%`?|4Zu}@whY(+;DqTsf=UR|cw14!I{v+n`D_~vcJ*pHX(e@8zYmUvP8oLMeu6Xr zP85oR4L6c))Mm}m)ZZqZhol&S+KtKcPgN8?K%BqNO!JJmLU2he@QjhazrsVp`6 z`?_+N8sasnM682s7v?FBm+QIgZJu3w-iZzG6H)#Y#zzG($0o*-61_1cgaOA<~G~t+9AX!1Cbfs9M3}b6U z_EHmhmzNW~6ZE_c(b|O1G{bLfLphp_Sw7B}Y&72HHxg+$mf@WePS*>2D|1fn_IvNs z@%p`cFa6REfk`|tW*_g>c>=~DerUu?{sjHrW0ZdHWX1A-XBvQD1t6=*@ZW|w&?fHp z4#WD_;P=;8zdoA~@!$E`&)1N@_hrrB$B9B9?E9}2{RY_nQRV@Erpy=_F+|nueU|ao za%AV-jc2cKIVb?a!oNlmgVV-r(UNS_bvlxKngh!FTQ$?Py4;Vt*~F!t?t{Z1zjiBY z{Ny-f^%Q;v!0(Gt4|wbC-?lH43Fn8v){+qbCx7i&Aiuczi^|f(3pMNnpUS81DKoHt z)MroJ^!>dkymrF!RMXdv82L&ITXUOfYK6{GB{%M?-@SK#^+Nei(BEC(ny^GiVOfX# zbFMyfBYO?eYRHwNE__a{6pP$dY)^Zuz^wM@lS>jMvq`EyeUZ{z8Sb{7v-E@XF3Db4-``ASAD87=_h$B|LmwevWEBnJ>bd># zM9=n1Ka*r#*Kvv+7(Lf8B{-9^J!)-=$CKAY8mU>y&+>0Ouvuq65RSSfI==CRoaiU0 z$n+=3a6w2ZB9ruCk$c?m+HjfS%-X?(_Ee{37?EiXt5~T+-=Y4{dQPExn-`+o(-_bD>J7|*Fh6-a__0VeBWB4j`tXAW&ua^u!UW7bUy~nrQ{hsJd zAuFs5Mp~x)>ec>>#`e0>%F(SmBZr(?p8T2CIT1liZcag3;}%Xl5V6kMG<=iJ{PQ!5(Lx=_#O4$rv%4&SWxO?Rz^r27SkjpgS6!CzYH$ zug4M6$Y&!FH5;WE@_WPd}i>wK3!+2MvqpEI-!5nSY2L}b(` zYgc8TKmC+A*KE%(R^9wk`Tewoho&;!G8+@`>ZNi#GZ)o5f{Tr=rbwQ(ILmW?onJZh zX6==HEkP8m@m(uI|8j9gYNKEKwymTs%zXkUxNaC6rWO@>0Kase)RE(lq;I^@ zsTFIqdOzVp$WrRRo3d7y#Zs$%noNyK9k25{gr~lft>7RQY1nF9KCvAzMGJ)8z#!k+ zNh_1y`BAL%Wl*q3UfNFU=|{{r$>@>Pigwsf&~;w}@~BlbN8kaEpNf%*ET5dR1OMc- zeY{dQ_bcj8643FQv>^GmRC4TF1Xik@%OMPP-K|c@YQ-;E*{?IwLSCRFkL(IZ72BzZ`<43?*Avaa(XT*;i zQs)q}KI8#7d%B47&F-u+Khd8c)!LYEN8^gu%u;U<6Lb)AkzRRr85U6nv}p3{&^cpI z`BsVzN&X}szQ9;z&zsdTkC-fqm=#F2_4>ucIT%oN$V;9AkI}LTqG`E3BBNC<-EM9! zFQ-K47`6e9)!ld|I60DBhZzr2a5^XecsXA6vCJ{cq z#aHH~IpTf|!o4ajgc1lztmykt+ZoJjS3VVYZA2kYc$m9%hhF}|Yi~G>7IwO<2kp|9 z;nr4^+lc-oZeNe8A%B~A-0JD*dM3lxkx*Ni?P6DQRjTkuZn)^6k)4C+>*~cpCvBD2 zuFNM6J7-5Gq4@>{-^5Bww`bB6>g*KZJFnr~`@}3+?$P}Qk;=y+>t*o#*z*xwVb5l- zRLlP$BIB<(sIo&csLC*#vK#EXU5tE%p%?Al&SCrW9G9HoadL8#H}ag6xX3n5q-+A9hM+ zeo?l9fd_6cdvc6#na7KAcTEUh)+4%j-RQ=fQT@fLEhvTvPoorp)3!vBPftQU{nb>T zi_ea~Jg*e!zx+O`$k(bMMO)KGS|i`GztH7nhc?dTLa7Q|f&d3=&rh37evw(&FaZPS zEJ(8*ef(B_+jKBAEW8Nga_0!CDs&1(Vy?Z)R{6S-m{OD+SvU6L6PsCXct9Ja_@?F$ zY+9>#IBH5`tcd@GLkKmd4*Xf~4w4lJLih~b(~;);2{Kzo;6E7azwy;a3$#KnS~pUR zHG)0cV3Rrdc4c!@ie200cOOlY-{Ys=eZi#BD>{Y}%9nEq4T|2EaE>CiMtvRS?zui% zkZalPS~N4KkrK7W@no#L=$1&5E^w}~n3QgAwE4xuCSFA~H7h^Mys6tOX-+JolvZ}p z;;weg%=cohU1|4!fFJa~i6II_T4)4L?uN2^9rA?b(<)m?c+uWY6rYLGG8NHd-*buW z(>xDu1atu{WGF|hZX;LC)MxDL=SLFExXP-&fXf;Wlitd_*_O79uq*p`W<3&9Y6IKw z8b*(o_1KzoX(Yb<5F2WgSDB=-?DO>8rvyV6d?*!FYEzq1G(AtX+$#A9I0j^leO~j6 zXH@GfOT-Jz<$PEU+bYaN{r#KBYJNo+Ch3UuCn)w!EWWu4c}nfJEGsi{V*+AL=Dd0o zU~jOMj;swr@z82iJfIXhp=jb@x~Ll0w8+!7v{Hhf^6%DJ9;nmxS@=iB{$elT3oKxa}V=FM{6mPfd0w`3`xC#P=}W6mOr$E2zWWx6(g| z^-NZ6Up-^$LAN#otFd-HjP+=|R2IC{FSwgy+k-%G#cTK2V|8agatv{lqOUsHk+SWx zQOgY35WPTu__`>}$$5FX{#{UieG`|E<)2knwU+F-J(y+w%nH%2|W5GxhT>u)FVC$pn2f zVhT#MM%2X zJLG)%TbyPR8yq(LdPUjeb&zO4Z%?z9M*Azm{m<`d3NyY9*$Q4-JJCL1!@;=Ag%KxL zn(>Dq@7sS8)BhVB_8;~y#Y8B&*N_F#5xd2TdP(=(?CDM~OXus4*b=1|os%83Qx*Nl z?ezT=o`D=U(bJUVG;|#ZV7b}CfbLmf$qFf5)EaiE;Hsl^@Bc@Zd7m%$D zE*c{TDUL0Zdg5=`js19PYN;wb@i6l+cf~JKA z@uh2EQalq@9kANhZ<(bAf=g$DAhO>&u6ntP>CQ3oJe#+$qTZzjBIo=Ty=dX|o-pPmm@4+PVa+`wpKZ6>@dt^ z7t4l5HcPUky@OkC-2#oVV*Jb!dX#Q zpZy}KZZ~&x6n73_BLJG&^$Im`M%)R6$0_)S>q{&Q5Mh;?$M+3Al^&K1&R0L%Q!=-w zDV2H^&|AX&+Nnd$)otc=YpqVET0>ME%6C>A=VxrpX30@@@Cbl?H>9s;gmV6AiS;kn zA|NbQ?k>E+;4nLj%U%&A#f+B=kRkbVwO1yRc5+$c0DOAANb>JJdw}%mpEvw^{T0nN zw*N(C6d=j{$7UY#NBH``q~o8{Sgfrxblb)d)$2gktv-LIude{|LLRwce}WP`fbak{ z@Q-64u4I?vd=EAZn6IVaOfcXkS%QXOz!l@&7h$HlcepiFLvC zfwdNRg*<>*r(wasKt%&hgP^qsPIww=0Uuh%pP+S}v6FnLP{e?h%9s4SBJycZSWB{~ z6oD$88X_={!fJ4dHdvn_9YzB_~J*i|ajtdo9|rG0IX%5tlx| z`)C)ii<{LrTN*k~1HvX`_uzAP8g7N|$UfbNZ=C^QKF6{66X9Q;|0p9sdhSdXaJcmY zgpdDHDq{EnB#RV2zLfx@xF-%p`3*O@vnjYo4;kgnHUijWCt(DDZEUy z&zVoPZ@m)h;>wgn$U(D3vp28}FyQQd$gP|9xYPg<$b#)}u?XpzYCl0uc|SoNMc;iD z(6ogd^uRAt&mfM^ZSXzYYN}6<^I4jFs@>kH$^`!$ipNa+YGZI5!kI;M{{AKR1 zYPbG7Z>G_|H;%tE2>GiZC$co}vpW7=no)lhqsTfS;Y^u zY-9h=f2^2C8-sjP4qJEaGcqhIs|$F=uGRZ)?NL8TY;<#<&-OpZ&0u$gQHGyP8ENv{ zm1~Tk0Cyoj`t2)4o6gJFinxI)0Ex5w%}Y2v3P9GIJ_5yCn?kNVQmvy_OvHM4!t>9b$17OXHpY`k!RH0q%EB{arz|J&swC76Sr$LGq5nZa z_!syt{I3?%e^w{9OkrNze9LvU5g9==Rvypa>T1R)%Yc{@4>tb!0J;EaBRp+xEA*66 zcn(Jrg#+;6xB2J^d{BfKpytQ~P*GeQAO?roKTABCPq{(P@*xq!qTCIBvtbVLs3d!j1O{ZcU?w!O2B5!e}So7&pW6yJ0Q_?m}-{$}}cETvi}k zPfq2^B08Ws&(DDmOhb+_@Qx3*l3sdFZWKBl>W57OgwhiWqCg#BGc}T)1i)ZI-(?E| zZ*{4ra1ZlTO^U(kKX9K?0Fg#P_6|6j3>)v`uN@a$Il z;gOpP5!Q;=oOD?-{Y(&+V^jI(7aUCL_CyZ{>@;f>ot0=#M$lGmrtFyAmMBJi&*@PC zRr@SUDa?mVAo`eYBR%kQ03#- zcKcn)lg;QUHsOp%-8b&uRwtJs^G)JtN~4*X+c3T1Q|H5Hq*FWSVByLBp+MwAi_!UK zOvt+~`qlJe+QlOmO#as}mD-8Qv5?PXQ8*2 z+}U!3RYB_`)ORdHy6=7sec7&P_+#xrzXEqKp{9`$|7hAl?;=(Bo7n{C(}E%Fb?|$HDgrm z867NoM@M_88CGT5S>X*OT z8Zc`%kG`fLVWHSRPQ>!kTff~qstL+GZR}~d`M7kX{JX2o5-jNvg2Qu#tejX(GP#PO zgC`T~f)?szB_GEr1)FD^k23`mmy+#`+MK+spBqy9ImYQ5l0)bH+RG)w(}fS zr4(ht>@~hrrLVQ_=Xjyv0}2Nlk`rz5@Uq-?DK)v-QwVj`&76`mll&NY=4iu?Zw5>S zvWo|72$AfCs2?M3m6P_VX($Q%7pg1{Oly@rLS6QB9v@?rqZ>X(hllc?G3s=ErBFL} zlBo4kt+KE#rut z*T=Qn;K4F{i2id~Ajr}pqFd)#n;U4A#_;t2koVqEO|@IUD2R$u1qGxADS}k#0)dE1 z7f_I1qM{%~Kzb(>DN+Rlq$^cwq=p`mCLp~@4ZW9y8X$>xxxfAH{l4yf_WAC(=Zg%iB^^9NCQ%(RLLt~&@@{Tjz1MN%xMFj6=aTbF-V1Z929@09OA+{y zzIZ?iGalzK-qL!~7nX~q$NAfi!eC1!1y#F;-*~2Lx<$M!uYycY0h;_@uS&2qgyTwf z=ecJ-M7y-7Vk0x$3?er5uxHi#<#H&TdMF+kFc*H35NsiH*Fk$gY!&m9>5-u466_hnQWMyH`W}etrH1e!j{5qydY(F{a>b4%ld8 zW$@x>0RgF$D3KIIR4|7G!mVT*uFY?O+JxtM>sa)M4HX|$-dOg$&uYITxo~SE2x<&y zPF(zW!>W1wKOK-m=FF)sw>e%-VVo+NY4}>a1?_mnT z_TMyNNbo=s=QQyEV4xnm?<0k`@$&nGoglCfV&IGE>*zy?{Z!g1k*xP z0SFaTDDH`Q+9T`rm|_6!BPJ+b_?^!pn1~(2zft4_;&@jy@r~^|?6(ahcp)IgAUl%z zt!eDWTbwu0t&=tcwaIJ^WL&y+Cx77u0iBiqgia0>_gE8^;tAx$*ZgFCe;|*4z8JxO zI#DpRkNtBJ=O@ehdx}E_XwLQl#zYK|UQRhILHqhbh@yS7TjclqH-+$PF4OkgM7UT$ z;QHwLS!Ck)5OYgmTBe^Y1A*Lib}Z7uuNO@wy1m>~k5NqEIieXoO;aCGKMHl=I8mcV&9M?T$)+;fwo1K?nmTco^;?z-PUl05qA|Fx>jZ z&I?RTWI8cN2JU~`l9Dtk%`&3Ir-G-{z z@!xDvpQ8nAC^E#WYKAHa*7xHz`%9jX^_BMv4HsUax-G7W;BcGw)YdsJXuvbLQHr5@r^9&B3-p{?T#ch2=$=k6~K>H)H9v0!G( z0aX&WeCKw>+lgaygP$JZ0*XH*Z3!9MZ5t1pkwqE^ps-Sme+Lyvi-%y^DjTFC0qfO4uLvb=hq|>3qqp^Gy$Hb!(un)#CL*XLmZg@E4 zJWfSarfWb*ua7rp((dYvX`t!Sio%}qmtESBnKPKJww|PDNp`Pg{N((ZC8|66uhojn zuQhiw%Sfv@k-6|&eT;E9h{jr3;AN^&-*p>{p*~5Iys~|RW@c4>4jEANky4HvVpdj8a zHlX=Zc!JLz%pr0fJ(1L!!Hk*i8edPze6zi^mFNCqRQ6fz<6?6%aer@rEsxq>E|+08 z5VU~+X}OwVrkNjqp#-=beK5dfyy@SYe=EllHBKn^lm%LJB_xpnD{(xu|( zj&Wi~(J;N+gq+mdgrv&MDD)+LkpuZTAsYvhOO&aZm6~i1^Jge`RcoVZ7>s835#N7x zqdBW6gy*Upu=nHLz`!2bI>?z`u-_K(sSdm5bPt<16~Zo&=4?@hy)*V8>5vVl?@VG< z5u{hQ_gS1w68Tiz7ZT>H<+&qPvSr(uSHfQZ($~d9M#O`Sn!ih8rN~;cc(FtVwlmm1 zlD}nnYJxja0KnFB1D94$EG4vsDo1O>dCA}JIt&kXwW|k*y=|DOdn=pt7 z;5K1J(rG6cN_Ia_n+DRo7i1Jz{VqfGR_R;&g)6A1q6|2djzibTZn%T(iE!IyO04@M zF{`^=o!31{S|6PUvpshCvaLu;?1!H7<6URsxPo)Y)%=LQdwEI<@k4i-h39deR=<5D z)#uYTZEdlXjb`V3ZKo2y=M@B6vNuG;t*4k_r)_=pacw!%UK88&rj@4e_+2ESu}QAw z)4j1co83uOfn++nGl`Kh-#={6#<1LJM5zrT_fUhQaPix<#Lt?vr6-@bxsN9`wrR9m3!N%`wB?1%xxk0YY`uP!c6j3N8?q>j6P zFDvW;(>G+%4ut96RVW4KXE(o3CtX03+%>(~z&{rcf34R#u*1K_&(ofg0|De}VrkxQ z8$Qr}?E(sk5NAICNc|Qxhd4bC%+9OtN}FnFe@n{G{Q21b>#LamQ62e@YAb2nO1E$0 zD@O|$;H1@EZDamLwndB^66Iy*Xp$ErDPDQ_&EmT3m&H=wMt-t0;cgvl43Gp?&}p7O ztFnGgQ+dVXBd1On-sBtGBJ!xP@nUvopcOr(wPC-gdoh=B!W0sk&cp zCZ<2pgdr2p1Ni~^5oe}eznN*f=Yt8lx|cN>m2uo>yXqr|p>0Wlewl;@WC*_Z2+|5+ z&WeKzZf>@#&$zmn@4oaH4;iZ2mDsX4Dg&O+7r@v%Ed_a$-@9&Vn7uFglf~L>8tm(}%w?OzOaAuD?!DTR8Xn#l>E6b#UCP559E&JZBVDd9bYWSGkNtSO;^S zbm&N#RBEXHGsMQTQXeHu(4lw*4oEvLzBCC9ha-g>jC1;O)j>b}dX{)rlF0j#9LYX> zIp~p@li7S?jcHNAHl-175J&2;elgOq>>WSAG3BbSqDv>i$KdaAp{()S3*bfHmVcaG zav`zbpwg`oxvu3W-6P{R*{9eIj%_$Ez=Ht?ASlo@BqT!)=MG$l;b9E^ zdi64G6#yZhNnJk#(hx2 z5!Q-6^%WWK84jBMxX~kbNmWFIRp%z1*>sq!q&}LYYasPaoCf74M%VJXVbodazpm6) z_L{TA;_U|1e=g-C;_n%9d>?f7; zKQt(QKbv7N$@a4KglfztdoAi&ln{CY8tFx=K{EOGSomLHfPa%d{GZmt?f(y;`#-3~ z{^gs_+M8u#X4<>rn?-xPihBQnwiSiDv4T%PQ^J2x!}kkq@xzE=5blObQ0WGo0Wap5 zwKgV$Rm~EpnEbl?$)WQ5D~&Ux&1=v!V2%yKjS+(hcYl(Q0&~YaY;SXv-s8KA(s6p=Zl9cQldppRCjr^vQF=T_6Fc$suRGB zk`Zwne$dye{^C>906Bgi`u*Wy7-S`j_|*U3e2^qDJYwq-P!qzpfnEd=y+oJ!&zK1O zakhVaDHs3E!4Qe?m!M;AAp3bj>9BZkK>NqZk7Ew20_{}i1WnhlRo_t#)$&~DCP@^v znXdaoZU_!FQ34tW6HF)}SQx(lxKxx#hoXb`i);|_5S(ESp1r@S+abK^a!t)pDOb3H z_DJ#!ll}u9W}aAoezHTWaOLMu5;$XQP5zRW{w3wyH3X_0_(afU_?QO}J?I*4=>MLW z^a1O=Fov^^w{dyCXoE{>=*!Pb8+Sg7YlyrUuSe6`vdJt$KakH zbBtYr*FzrpJ_kaL{Q`{AA7T0*%iqkb4E287@PK^oIZ#0W)uMiDa%dL%yI0lU+$sM! z?mvs=zq?fae;3&NW3DDCWI9Qx&L~=Wo)a(6tyGKV2s+tkUnh7B1g%RoU;yD^T4?u#3QNl&RJN%!F0kC{Vg z#}r4rrRL$Vk!_H%1MLPABeKj~1#>)FA|$b0Rs8@-xfF8SXsyKWk%krF zZuR!v!>1AopZFNCGHqH+9jJ?b=RG!C7Fg4DXD-@-G!s=I_LZs`H?a+~_~Sk{D%z4) zKS^k-dQ^>ZNpl3UIpiB3)soeegoHs@->2e0!3X{GvYc`E%*)9kA`-n~GmR9+AcY$S z!T077CFzywcx3r@FGVtnS6So1$YkOA#PJsV?*6?&`+WwCK@jHjQ9X`;@R3YypSdPy z5R)@uOD8iKlQP&fd(&+)ux2Yf`}8jU0roYVPL%0O-Iwx8oVB&XC#dOhvmzS2$1T+~ z6?OXfY-~`ps;Lzqof%FsCwE}z?Xr`LDH2c~ycTw* zU?GzZFNvWIa`kkH66|=}2Y2>;d1uNu@xtps{`V^|=~o>LYiJrp4v(ZcVq?K%Cd1T5 z23t+EgoBNr&qk5W-rmhrZvK{Ax{cmr=gd&!LwW^*>P5MwV@R}1ZVQgzTuW0BsU>LXZ1p$IF?AI=cu_#I0?LzvJEiwJbDA%(l#4J2I&*kef6f zzqh9)n8xGSo}2#ukmQUOb+nk>IMWM6cON6X`L3&cy1kvuTAWuNPD^GJ4NlC$+svd^G0UXcz8~IReEb6( zR{s`yu+SWj`pO!=w9+4{1P@ z4m4_hEDaT#46m7WI;W`68V6XTtG)xa?C8kEAcq zOI17MHZxbto2m!xO)ji>E>d$vUTP(ccAlsK;ebIb61A%J83^g#z`y2sj&caMbvs;l z2*q^VD$05J=V$3Zy zW@(P`YfvzrnNTkU3d^K-fu8k9YB{Xa&#SnB)C|jWd!GL8STp46HT1;;E@XzKiinuQ z{N%FdEkDZdwnGSmba?<`vqeU)!Acrp2G#|8ngsEB0G9-PehN3%7X6dNDmanmv^^g&j`eCS7K$O z1Vj@Z9zOG7eZMR@Z6++=CU0Jua4NX%SN;$RCicNARYQo77c%Z{j3v3YC&tPRW$t^@ z7bVKo(3Fj=Hq2i*BkB4xKNjUh84ZW0u@8a4Eutl_ON11;z!lM}zzoqpFJx-2W5XGD zUcfuLV_mSncsp@-T!bmAC3aQSWY1*l7i7#qPT0c-lh_Xcw!yz=hQEIQzb`vv1#~H5 zzdVrto3l&K-)zVJEZ_V$U2+lNQ5Q9?+P%CuQyz7T`H4gHxviWef^E&UfatrOQ@Ku_ z%@nZyjTKs;+R6;poCPuWwSCjt_3QZgDXRy zQ{+*&d-ixGj%>QIr5GJlEw#L{q|$aaV}EPc?z!ti<bJ{kJ ziz7>z&@ixq{mT;jk}P#g>1UST;+T$&$uYZP7B=~QLngt)L}w2#R+wQ_xI^tk;JxIJ z?kScW^jvyJcAvL-$bt+HpcD2B+MlDB@HfEp7IK6XSzg5_ZX)P-T#FS_!HkCVlTJ+ z8O@#*_(U0Ljrz>6-<0{BJvfc=6Zy8K(Gh8&TcmYNuFp@BLLZA!m!f)Dl&-h1+=a?| z!NZEgix~?KU}3p&jxWEpehBR*S(a&6cgnUY7M4FutREIi#N&)6O&jutb);t180Vf{ zFi{5=^VX2Nr#N|0H!LIQqKouRvg?2`@hpm`X`cVdjUo5IT|9cd&tOQAxg!s6HtHuR zde;c99*`B_1HLEb;jDE!GQm9ou8qo}8+! zW7kZ~XDa5L5Wa_x#B?6d!(W zP`PMiU+3!7UwR-P@<<@Fv7Qsbu!_Dwl$gP*4Oy={cOqJXszS6GGwUY)=%+t9mZq$6k-{ zo!hb{bR{T8tuA3Mj}#;O4&*KBlv9FoQ9su2tb9P^Rz{%5uY)4%qN38g?n5ro<1bQS zKfgswLx#cGU3>0qPq|qAJf_DMx1fg%xXxJwz1e!^`GzO#jXCvkved(eOhuOg(MA6a z1F~8wGD~??r44jN=%#f6{uVY8PVaYp{jIInNVfdMZ6Y#^gxLAjIT9AkP=~<0f zQ%z?fnBBR?%4ccCFPGIXOsTQOX^WHVd;~uS8eD2(nYJ$dBw^gFQn)7RHfkqDE1+I_ zt}nqJTOl%FujlyVmCQn(8e)(lQc-tZBfqN7u(3X!xg$&x^X?|j|F9YfY$ZLlhBvdR?uk(j*p%jSJCc0EG<;x6$!*C28bcr za0{kkumc9&Izu~{6D~Ln)2^)yUJ)u2idT84nPBkvL&mF|Q=q9l;Kb3lfbu_C36p{_ zq1TYHwxgJqOJ#{R%qB8Inx3CqNtzeVj=AyC%7o`jR;qR_Cbx4ipO>N5&C^7$Cz)||0qZ7F$iK2ol5nhlR_ z5x-%{9~2*=RNpc@doh-#NLD5vW3th7gV+po^pb*J(6Pg$v@0;RJ~c{VMu>`JoC!dA z#Kem+>#AM5_>Ih89U;gZ&}xvb5w4ho*6x_W>|9x5c4NBuI>BJ3)U4XE0lCst2hFzx zj%KIBA=3(f4ZrB~JfB3!HK)EN-7uDYFo%Bt2(Ums(63FEgoKx12HH(Tj?^ZQ3yvEa zAO~&pZc`}oCRj^&%`vgKHxsNlA)9dRQ*GA96VKvH= z^gNz|S2&|4m7W?$Q?jv9kwSIGkU_eS#=yG1vBwVdy|2rvI9Q4c@8;wH9ftaW*a@J` zmZDow*je;W=AvNOKiB!m{)f$JP`rKsouKmxR)*jXU_Z*depUY_dg^L0{YmmFmk6*S zbH1G@vJfR3A&)$^{G$9iP`la(4yP0VNi*vjqSxeKAo9##l}K)Yy%qwE-Et&9tvFB} zee_Tnu9126&j8!6b%t(_4dT7bOYk3ZI{>_1JhGXEs>t7Q{4&0LU9h8{@J%A*Av4@ zR7eB#`mq+)&JMiAJ7MD!By)4a*NTgUjfwDMuu^q*ehcL6wE+-pgC1M zw_E1k2;j1S`9LEcj>|r5BIJReoPu!+DwvL7mr3e7Xx*XUg~s)+-cqYLuxJt&)f3W1 zYlV$P6wU+H7IVVnqH{XG0#FpjlAyOfYTMI$A-H$MQ8W_wtvIfx(3zEwcz+{AWHsF+ z0FSwiD3jj+hsc-@WWG_lLpw;b%=FVl=W|1A@xmt!ootrmpBYZh{Uo_CosU0&58(xo z)Ni7UoLelHor@EjpkW>_H7XOT-KQ4#OZ$j)^*YDvKS}a&5C61-bLXutLEuq*Z9hcx zLah<6!2j!ig#y-s6eRz{{rJfuv+5x@l`Y6h5i#@kZ)Fpp%(4Os_6)=cJQ#$Dnt=Bi z5+Gmw|NEyhjKaHM+0kFoXELv>mgSCos|}$}V!lzWH4eF^m!SX%;F{8&WGb*M- z1SYfmZyjPr+Wm~*#k^AH!*jbs_eLO4OldptQpSMRV|^6+f&7OD_WoW0-*cZ~WK4WCrj`W)=8){s-(ff>RNsEI`Ny#!#o40xwG21)QA z100?65Iq|Eh&N~^A{YMo$d>EQ8#&Zr+rc}KRfrB3rEl4J>&fa13wnEEvYZ)SV<}^; z3q^%h&voS`fVZ=}@I6~oG<}iwLj$)-_i52@gj>MTAHzHEV?zmnmw}_xqhNx^Hn=C) zn0eLabnQJOoLw>8at8X9Go9FXt{vBMp7PDYTbkRlBrHerkjbFKs$u)tAz=8p+Ue}- zv;jO$xog|I@@WEv5oU=zv!tC;TT9730+I=`eDIC$_?9TVbcdDkYwSDgbBu{w`B}RW z&^H9S0jL78cY?1&6LdkO47=0XQ?ya{)|j!`u7oqXS?;wJGF*H&4S&pQm=zS*v8r)W zsJ9%RP_phv8uPV~Ay-{Xd)m?)qM3W_1z`3jYyrQQ8=ykOACO(uN#a*Vbmzvp?e85% z5~SA9z__|t;&GSwH4$}k)A0S+zbYoGhX3wT`0Jhd>km}Q$1Qb1G{g?thN5-NmopPg zErL{-c45x3bp>ZxJ=^{gXNZ{YMaxTlH=uuARHLD8pKY~;Hi*IuE94Ac)*$rd!hVMy z3}Wz-neB*^t3OG0b%%f_!7$Dv2s(n-D>mCW0mfWgRKw%J&MG}e68_@{=h#U54d=|9 z+i~~%s3|15d4>^%<|(Ua=S}g*ygZKVw28@lyjaY?FbWbIS%I*Yv56B$uAQWgNh~^~ zG+vUZ^Sq>)Oi>u0{4hqDjAXtE8dT9`>?idUc6~nH#N_0p(u+BdUVlyQ)f6El3w6^+ z7Tap|>~hiKA7!2NhsqYM zMjR#Qw)l-FU7yCZJ46zxv136r!5<0vTL2>!?tMvlBDqf<5Y;CsGaMS33BBluV+EyK zmJPM)Ogx%e2h$ZzyxnA`9kU*W6}^A}JFDw4OKbvpvnz{X%97;=9}NN5U+4a*&e1k4x{l^D+; z%}PJ*oQ1zvTKv>l+q}7=`(`ynwYjh%Vp6JS5qMi3yZ((&^9!{4rMCEUEc&0;5xuBM zzC-D1T!Ec4R&*}6+!WV-7VTv|iijty zp6zy%V3a5;a{JhAL3V)|5zz6N?~YITWHzMqmSM!r@lw`FUAH(~_6TGbcxg>1DCOlF zRko=iIsx1ErRGn=`QO!l+kRD8D6UEWiexc`Fi41oTc+x~c1r|^PEFjVxqVS0dM=lw z*(F;Y`(4jF(Xe+=DC#R{g39_fooz7DgXnpgR+vjIHn+<@@O(?&`)E0u54}n)HFK(6 z`2`OBDJS4ezQrn&B8vzl{xTLp*P!AN{qp=7X#IpP6xIoMuisd!1yIO=%<$mfImuTH z{0fTJOn6gmSw=P)89&{&DdjQBJ{L_Qv`891ltR+~8;-k$##9hl0BOy54t&-Z(91DF zrHCULQW*P2OhK`vf>+DK+EdqhPlK_CTG#to`E12*u>*eR*8eitT3A{{V8VBYbbt;l zrW?nD6BE=Lc2n9lr3kdUbzZSUhcYx?pB zTc@WrF#0~6>b?Zp?W^ZMZB*?(@)Ji)m6M*OdkdQdO;8^C%E{JZ#{%ps9y{|crCAbG zorP}0yA?OHw+}#~(|Gw956bvd_JHWrF2Vei-R(O2%E^uLm&=FQ#wQXB0+X1PP$@uJ zBt3CH;N_S*(yodQZeZEZ&lcx#CWgkt+4#Q(RmL87Z@0;ZOb1p9X97C;`~?r>XMwU4 zfpyLzs!V!%L&jEd%ssjhU$gfu64VyM_Zf8gE88_g$)bsrX<|g*F1qvNIK!F^?A^H; z^q+U+=ul=L$ohZLZPAUQpsO_ah9_3pJc>`7o&-|Ry6=Jih>vfSuF*@Df4+BHQ|uNA zO->4ltJ4g?xr^m%1s&4V1Ie!NBS1re2Qu@I6>30n z1EWU_kD;7F&FAY-zdsBgXy(J8IjKs*B!xI+NE6;IUh+IkH_Yazw+{Y5zJ?jvE z7{lTrfvpN zU0vVyCOwY-vW(IMlg?7p&Mk+esJu;G@{ww5p;DI&s@*5U8Ghi%=gAcNl}_QA;k;!)9S@}r|j*4dq#bL5}L$tr<2j#LZ1Sl8v)orf}IMOKRxZg zxbpw)QTNw=2riufC?z*84?t1$?!5LWnA?qNS2Uld`U*6lCR2e!=>4mojH( zBTc+$O5f%IDs~?jcuX^l{#>8_V_lzJ=l;+^y5fSyh~40J?-rF)8|PGXRP$MuMr9Je z`#yd+vQIw3!>nfgBinc}H(d1HL~ld;SPfrD4dH~t3qJyFoXAMd-;ncdPbi$solc*) zx)iQd%g!2jLF!l&dpb+=5rceS=X}?&9@92CFH8IVuymU1-3i?BbRT>`a$FiNKupSA zmz&9U$gyGEarbnazm*kf@9wrr@_|fq@POUnA#zYM!o9ws-jVI0ii~`{3yIg zm;2X7S=aREx;w2$HgBGT#7((f!?}UiLB=mAI{$z60hC(*Uw9jTi)f`%pC)pqQO#1N z>}7_cFYiOcb_$hqjb?smW`B#-Vc*xJ+>Up@yY5+Jc> z$7cP5L_UST_$JQQ#j;aFK(KtsX+>ApJ-(iTztq_TYY{xRbys~z3KnyH#WZblqIA@5 zmo$x@l?qne zY;r*xr}KhU{kDS;4||pHcm%o&$9fn`NNqq@`P{*I!%q8BOiwQ)?YP@~e2A|9urciX z_BI6aD_|4c*%_}tvd#e`0b)@D0;I?#trGXHqydItyg`5586W~fc0 z`_TOUhW>+~)N#R#AY~uEh4hPfso5w{TZ&F}6=kEU;fvSZhwXwg@9W>UUkM?lC3jTB zf%Va0EJ@*)I~?&cAu9$=Ly{3juWjsH%FL%FxXR+xjn$kJ1*7uwNt|Fq(S|+t#_nr& zF)W^F;p2~!B}bDEcehRi7k18~aia?@7UCFmm`D|+rlzJ$ZAFIZTL;b?aopn3uYQny zSm3mj>Y}7}2E6!k@P?snChtxv%v8VyB9zTb$rQ)Wjp96*Wp8ogyoZY`4ASZ*cUXIU zM|jC$()i*{V4g!nHVJuT0ur*;V;^=>l&?tdg&BEY={dXH8gZ^#r_HN3&y_`Tq|xNn z=>#iY!xRHVmWe)Cn5^^tBdUXkZuT8X^&uv&kJR5Pwe^_P8fuz ziy4=9J>&SV*o#Y?yG`q)bG5k41M=L?!TII+r$u|-)m6wnp@(Ln(XNvvEhP*Q5a401aNMfK1-a8yxu5Cd*@Ip!?r)-OZS#9JaZ#`D ztZ)CVf{($vW`hX{n-+pBb0TUg+ha2mAm~FVKi)X0b)qSMZu+v)2uRo8NEqnR7`$sT zWft@$**u8cpreb#a(IDU%5*L-)pMRe*5=2+acxvciqi9=SO<8ew`!vJl4qfxi)Bmj zqd8T!AXDGFM}7m{CymkWDa5036%fXy_Mnjg!<&(d*r-zp!W{OQj6A_wA2trld@M~X ze#rk|(=ky0&XUSPAkP8Akw|bZHLY6Jpz`oh)`+y{nCS9-{EEmAX2@Vg+bki@(2JPf z^I0|&X+KbIaC+)fmoofN*^%STf9^)}UmPw(2O<*a+83^P19#Nwc7h0NP@YRazpm-6 z?!%3^Yg>1BvXn(Wfe~K7yY3JZs`ty>>AMBa6il%ohIn1 z_BL_jN`RTCh1*B5yb|jW4pu_oN*%2&9do-66`r0fGp9cfu`%m?_$Ze3Qm-k6%F^{3 z=y;zQE~Zigr} z=%0e|?ARp#%AF7|bjYkC$KVAR|26C2lK0laY_a7v!twPy+kC?Dzu^3q%yMGN;hyR& zS{eqg=Se#HuD+581>XQ4F?52d{X9CQa_dl;s>hjkL*~;;p1=muc+#fOEljZbHiVa; zmPoDpc<#sJ+Bq%04&t@J2C{-_ydGAgX92=6?P0qZrE5TEbg%PBMoiK2S)BUhw_}gx zzVL>-So)4R;gA~C74Y4Btq&e2J6~b1P9mF3*19sBrpzuJHk7L3z9h9HYq?-b6{| zm6X013a_p+??O`|&69k^?Hr!sc(KlN>G@v~5kR4eZWf!D%@AFZYq2i2{;_1`3+xBJ z^xDO^FB#g3d;E?Tlc(D2jFedTtX%5*03=o@M5)m!s9UG84;1BvY=#78()cjt8+-I= z;asg}GcTi?Q{OW_^p?t2yn8Q+`AMMMv9}T%of#2%%0T?y#5L+rMX+oR^d@L{irDk8 z1mmA9B}dfTX$I?e)4%#at7N`GX*gcRYCBXllZZ?>I0kX+LB9ApNeRlH#=bLq_joFG z*gC(e%E(c5)6)(owP&w60Fw!lHl#4v5bPZfQn zu?&a^Kw+3(*BEh}xYq|*DL%1p(^aQ<=EkeeQK{cNn($ngP`8E7Lj@SoTqoR21k^{ZTi1!o;rUj5|;FJbpxUEIBdkR1- ziJO;SVS5XU#p-P8pWgClX=Tdb8wHD?9fs|B>*`)0?B|V_lDq50h3Zv|;$KrjRXnT# zZ&!?c!1Fl=N+adGH8~%@M~s+AE)jLbMWDI+t~yVgHtaqJeU3nvlNUt(U>{o0*6MRN zsCCxn$tUFk74&muV-<9dVD-UJg1c6Vn@Mm;?q!|)sSa0`ifb>@&F>bp+z?Rv2Bw=p z$$%;6Ky-d19Nf5od7Z01nqxi^GNG>BjiNdOm8Jt$)t4qN(c3JvFj?~iqHpk;F0V3e z!$Uw98^|&4cWN={mg!q-b-vTXN#!b5iBGK(^wp;Y#mH<0{Aq3~IO!z&+#|&LkpkRH zwi#ipVaSo~*ge)aTcy{l_r6{I9&x!avBRK!VQRD{MIt3?aL>@~bnAqTS;RW{>oCxi zlV_`2QLR=`!FNm$wj|nIvHX+d3aU-#f?t>F*FzA)OIH-L84QsZr7LVIuKg?_b5qRX zyHfbdaUJD>Sv}ee$yN-1j?I zqWa0W;wjU+6ra4Mokqfeo*_l(&`}hnH6{mwi87w{t(Je5;xV~pN@Zo0%tK%Q?rBa% zS|m*igC7$hfgmH&!a`eT$T1k?NVTMmD|pYWljT;+1^n3KWb(70&PHEsb80vTwYlhG zuzuo$g6g3|86O)k(P{Lh*xPx>nsnPeDvsOgnm82(Wmw!CtpY&t4JfV=1GKpTd`}yU zy&b)??m}K~v+5^g%xcNmO&Ez858kF5mtN*gC3&t!xIjquV+B;(D=jbx&WM9&q(Nz( z-Rf594iHj!=T;;nDc)1GGQJZ?wiInffAd!9Q3r@zk;O-COcF%zF?l!U(Qt!=Xl8!b zu11F5w&8K2jDD;;S9wS<9?FEx*x9JDhr@RAr1c>ewT=eOAxChU9dyLxis zma01^cI==)QYtv0DD*4H6o}5xvpMO_bj-D_UURp03z2>L)?QU*Hjvr^P*dF?N)mgT zu3=Qeo+LF_SJ+NmFS!{${(zY`&=4XdZizfH!>FEJi9dw=&*T4r+ke!{{=5Wnt>2vX z(Z!X`$57!S+GH{~hJ2(y=jNuT&5tjO)TdYpU3gs6cjxw#NawW702VW*j(LYrd$20F zc{@AwRG0bCOzv8O&r)oJ(UGbmXO<(Ub$AbE#xcuywk1HoH4Pwe#3bM8q7gHM!aSOHMd1ys**R_6tzZ{g|Jpj zc*ZUql^QLDi1{mER5kX!HCcQ37Mcp?y!$TO>Kd(QfD)aCrr$nEG(N)^nsrTC_uCzO z!y!U#fJlnx?Uyn&hpG49ld0Af>IbgPw=`71t)V!de3)eti~0&D#ow!`ZonF(9;T-1 z|A@#li_Cn|rBA(c@_Ijj)S4Wpjih@C=I>RsLwh)nK@3+>_-M=tbTFD_m__C1``Qklq$UxwLD$lt_u>AuTJPdu44SMV-Pnp#!7Y3xzG z(avHWEGevgYCKdKB~9mOX;Z+P_n}uDd~BlZAeHPEcPBGzg>L|2HLZ_mfRv0+*&>gQ z3=B78&Sz=%*w)`E_CC7#WH;mX!!&$0%5#A>5KRMiFHo$QR}kv)TMrxJ8EkKR@I;BC z*~`5hR)`4=^bwuay1B-|P-e<%Ww%XgZS5pho8I~Km3)T0;qc>I-V8bti6UA~u)|ch zs<^6zlF{9`&Da%#4!uNnJxy~tUjqD|i#gH^wS2GTcrdlFFohlHFxn($Xy+F% zY>9hDH)H!K)b%?TXZ0E^XB{X#j_#ZDwHXL{+ebAjTB)kG%Lrbhx}{j7(B?HhYHY|F zl)&8PY_VZz$Ls12TSpE|5VT)j=aMWexW47kzjyZY5I}<$ZIhORMCCP&(2uIO)}_x+ zHD=rWh^kUqG+%TEZdaq=k}wzaiig7^%yP+mkEYqsxuyN{fYHqrRC(Q<$-~Xa0*W7t z$vg{?8*9)PFVJK}rd2sRVnY6E*tHR^T@lT0!A>4eYNY4WE*XBv4K{yo1HULBHn`qj zSR%S~wT8b<#Bw&}? z31$o5eo;Cx9;{xu1M?yl@4Y(KXR*~7YdX^0Rp;(5_M`HV8mg?H=9*N6R;*J*D6Tyh znY$_%wRFT!MS85Zrty>HydR5tw(8vBK)~k^w;Ch-@h-0`MGxxx^tT6MX^w-9cfz|j z^xc=?o&yIgj7YB2*cB6i+5#uRC3dy9=np2uYXv_>K66*+esi8drr_K=H|k7_$~va6 zF(e*NUBniR!Ngltw@fJ02i3NC?%ym4@ZgwT93odqjtmhxa**uG+TQ6<}ef)+{!Gc0vG8tCKSkBkdW`(QU4Z0BIHG=L|y%vsY5VVh#HuKb|zmq=B zV;PjT(&%aGLxR&i3c;+lJ_p_f&)1$CM|bxR*DSh~uV5Lt{fwm?N4^fGznf35&+ci^ z#Kg=2xB$mR*C-)o;m4XUQf}}>JQG{7J*Pq$5FZ&njY$f?i_Ut>3N=VPt$rg$eQm0D zTUG0OYkVY7X>%(r59i>@j^U2~tV*e_ldcSHtdi9PbPopItw)ODRYRi+Pq(Bs6<1`> zlDvAoc{Z5&nv!Be+JVbM<1TyC3N^h*KL#Lp5YUAD{C}e>{0}CRdG$Fj2GyGNRn+-@ zp&+h4p{GjSc{BJsKyxTX&Kb=ovzk>YnjtDL=2NyL%C5Vf7Ajgex6gZ=0*#K0N=vMf zOt0?8-B!65{^cV_edyJ~lA<+!9#QWz$ENPf%B=2$sl9e@udx;T3LDIVIu;TRmcZ;h zU{btL*Uy*v=#9OF<}J~uomJ1?mvtwf@#Q*uQ@FO44iDz;#hOHAwRg|zFI}NE%MjcP zZRTLc0VcU5Xc***&%J7*OoMm4yTaB`o3q1Bw@2fo&*@1%YD*(!EyMyUu+k6;DE?QPGq`|Zr43mK#B2X+@!_PU6>oFxhOPcq-X8YVpNJ@-7mnyrD-5H zwTuyf-;n4gHDo@cF?amO~^~l16Y#K9dP&)z_Ms zL0dQcF~X!NDlc#tx$`W_{kcEjErT2*XQw7{p;u>98|-SPQ_%!kT}`C~j-GTKpRG2e zo4VH5!y3xwx_Eg5%I`Pew04vsjgbijJ9~>{&U&xZdatOwScvl&z8Yr;t*h;jot5Aa zi`Ds(aTP~92aj}PiD}8ae0Rm%XzHHiq_y|A@dTfaw^R17-YfH2a;SaV|3F*HJG{Rt zaxQJ`p{hJp*!Zw4N4pI!g zMND_(Pc>zH+)m^Z6Lb+jC$DtK$AH7;PnzK}I*d_RzC*LR{ff@z8QZ$F#3W4DO+~f) zVNsQb{4;5mBxHwj#BEw;5V-+58GnGKPr0#&vUP!Q?)bTh*(j3T2L{d2-+_Tpv?2D+%%+^la z^2TDn(et@FHZIAJ_=Br&pQXw9e=57qs3x~88VE&&5Cx?RJb?#J03n1XO;m~q1_40~ z#eztTp-3^HLO=+H5{ilf3Q<5%=_H7Nk$^;`7h`A(3ZWZ2OwFjLe3~yde2YXhHnX z#hGat&8b4SP63lE6A-|J9C7{VqjI`T7*^vC_jq-U^gA7y%e;C^ZRmU*d$nl1VO?lO zZ=);O_?hWg)WoG!b}I@Ym*4ZmB52HEG~Ii(EyhuRV2;D+ngZ{Ux8$_w6}MYn-JNP( zQU#aDRjr+43ejgD4fi^^yk1hNjsQ5!d|5fN9$D;h6sS?q)89H9^?b=bgl}_n?$bz^2?#Rp0SDeVYW7-1-wqQg&h=As!=`mqj3S8c| z6pzedUw%UX`S~b%&srj>loNVP@$hnR=lkCzi=ds;kkHiJW+0siYLGD`1dl7nz3n*B z8XJXAr!RY}8engwH=dH)#pde$gW= zg_(+G31z*z`L1Rr3&A<@Hy0*0e|+S$n8pT-Z|4edu6>mY_uI}C(_|+!yH?(e=U%|6B6OySMc7`e1Q+_lJ|t2gd9pJc6lOzgGy$i@9Y)iFi)GOw~ofFrG`X zDM~H_H*EKGb33&eP4zWwst`rQK<;z_G~v6y2*kLOt6J!{ZEde6Ls}5*QY&)?+xNMD zYT=3`S^0RpPZc%pP`q1?(+PaBB=nY6XN6DCYc2!FFx;H6hS#hZOx(%x zIu*aU=d8g?5XSpc7JJ^ItA}^tWY*gWi1{p){-*j38p)b9Pn>%&W;#`=mMeg=G6a?} z5P~)H3_LaKy2*#94vULt^G62wZ5rwOPKfzajIa>#%w~(5GcN$CcP;DVauulUsILY_ z>zNjsG|cw{sExGS$S9Iswr#);@y$M=cb!=Z!F#UEBI3Vt9sK#%U(0YQ5GKM2|2Rz!Iz+>REv_l_O4-tVm zYy8$8f!EV51Q5ZAKP3qlk2F{O@Pue)t|}x@cOKB{(?LmW zLyeY2t#{&8?->tf&gzX>!8dA8+5#)hva`cfpeIM6R-@UYLuf|UOjEx=5AA)vQBfOu zJC@`Jo35jDpm$((gCz`$0$9Sgdx>qH0Ydmfjfm!6$2U&|s!U&{2HZC(K`eS;(aTW* zk3S#Rk?)voE3N=d{-RBlg1ZZRfGNxeKTr0SVTrG=!!?VVQM;Zw_Ip)>4YP6|49JVd zDJx%Hz#XY(&}pt2_C`%XRnMCD>ATPKtric$9Y6D_QemwOI8d2zE(E|$>z>{ zU)ja>&-JCE)!#g{fbpb7kZ3`A>~r1nmye+|7cR~5Qks(4sjDVJE2>?axgdlXNq;0^ zyRw^cSo=bQKTBZp1L0Swl_HeiwNj8LHe}q`y%Rsz(RZDB4Ww$JgWVW?sjOP-V6*j(Jd9&Q}eXjVp?6ammc4HNK)dk=c&W87Sd}RYwAmsa+?I9lXf^(!q0Hk6h88Y=)5CLqCVRYY+ zQ1yuqNrA${hZyeVFZCXv?@`$A zdoNi5yk$WqSN)PyAi#8*aU!qVisk8HmxTyqcj&k7$G>7K?|SIAz)-niT}x}IqJc+9 zln$J#C+kp8&u+V>op~72tYQ~-t2+|qB4$^>`zd~GP%5PuTlX>gx|rCAysN20Y?I_= z;VrIUwu%<}_cCkW*(hr%?7B&ghBJ(Y-FJtB6YWSp7w1z9M&E|t4lDU_-`GGOf!p!y ziR$yS13I-bS(uqt=@VDOe0qn=8QtsF`>lFwJD1nf@(j`%qc135cnUrYK-G`*p{!xp zuf>Gu7MO9j!h<8himW)0Q&JoH`>UTga5KkujX!ep1!fX|PF)Be#IOd84+fn_j#F?i zL5Jjh6BSsy4XX7U?UiE9q3P|UPsamCv}+80&=83e>%w`wUJ-(Iixn1Nq+p9_t Date: Wed, 19 Jun 2024 13:57:45 -0700 Subject: [PATCH 20/45] update with revert back --- build/build_all.py | 4 ++-- 1 file changed, 2 insertions(+), 2 deletions(-) diff --git a/build/build_all.py b/build/build_all.py index eedbb0cd..1fa33efc 100644 --- a/build/build_all.py +++ b/build/build_all.py @@ -239,9 +239,9 @@ def compress_file(file_path): gene_thread = executor.submit(process_genes,executor) # Wait for both processes to complete before proceeding to omics and experiments - if args.drugs or args.all or args.exp: + if args.drugs or args.all: drug_thread.result() - if args.samples or args.all or args.omics or args.exp:##need to wait for samples for all of these + if args.samples or args.all:##need to wait for samples for all of these sample_thread.result() if args.samples or args.omics or args.exp or args.all: gene_thread.result() From b18ff083382d49dda510dfbba0bd007b1ee80df4 Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Wed, 19 Jun 2024 17:05:02 -0700 Subject: [PATCH 21/45] Update 01_mpnst_get_omics.R --- build/mpnst/01_mpnst_get_omics.R | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/build/mpnst/01_mpnst_get_omics.R b/build/mpnst/01_mpnst_get_omics.R index ae5f1730..975321bd 100755 --- a/build/mpnst/01_mpnst_get_omics.R +++ b/build/mpnst/01_mpnst_get_omics.R @@ -37,7 +37,7 @@ tumor_samps<-subset(samples_df,model_type=='tumor') ##now get the manifest from synapse manifest<-synapser::synTableQuery("select * from syn53503360")$asDataFrame()|> - as.data.frame() + as.data.frame()|> dplyr::rename(common_name='Sample') From 67db7894e48d2a0d43e27fde8750b6d071c8ca1b Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Wed, 19 Jun 2024 17:30:49 -0700 Subject: [PATCH 22/45] Update 01_mpnst_get_omics.R --- build/mpnst/01_mpnst_get_omics.R | 10 ++++------ 1 file changed, 4 insertions(+), 6 deletions(-) diff --git a/build/mpnst/01_mpnst_get_omics.R b/build/mpnst/01_mpnst_get_omics.R index 975321bd..31bf29b0 100755 --- a/build/mpnst/01_mpnst_get_omics.R +++ b/build/mpnst/01_mpnst_get_omics.R @@ -60,10 +60,8 @@ combined<-rbind(pdx_data,tumor_data)|>distinct() genes_df <- fread(genefile) - - ##added proteomics first -proteomics<-do.call('rbind',lapply(setdiff(combined$Proteomics,c('',NA)),function(x){ +proteomics<-do.call('rbind',lapply(setdiff(combined$Proteomics,c('',NA,"NA")),function(x){ # if(x!=""){ #print(x) sample<-subset(combined,Proteomics==x) @@ -90,7 +88,7 @@ fwrite(proteomics,'/tmp/mpnst_proteomics.csv.gz') #### FIRST WE GET RNASeq Data -rnaseq<-do.call('rbind',lapply(setdiff(combined$RNASeq,NA),function(x){ +rnaseq<-do.call('rbind',lapply(setdiff(combined$RNASeq,NA,"NA"),function(x){ # if(x!=""){ #print(x) sample<-subset(combined,RNASeq==x) @@ -116,7 +114,7 @@ fwrite(rnaseq,'/tmp/mpnst_transcriptomics.csv.gz') #####NEXT WE DO WES DATA print("Getting WES") -wes<-do.call(rbind,lapply(setdiff(combined$`Mutations`,NA),function(x){ +wes<-do.call(rbind,lapply(setdiff(combined$`Mutations`,NA,"NA"),function(x){ x2=x#gsub('"','',gsub("[",'',gsub("]",'',x,fixed=T),fixed=T),fixed=T) print(x) @@ -143,7 +141,7 @@ fwrite(wes,'/tmp/mpnst_mutations.csv.gz') print(paste("getting CNV")) ##next let's do CNVs! -cnv<-do.call(rbind,lapply(setdiff(combined$CopyNumber,NA),function(x){ +cnv<-do.call(rbind,lapply(setdiff(combined$CopyNumber,NA,"NA"),function(x){ x2=x#gsub('"','',gsub("[",'',gsub("]",'',x,fixed=T),fixed=T),fixed=T) print(x) From 0a5244b6169714cca99e9e13e89efc824ebc51bd Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Wed, 19 Jun 2024 17:54:37 -0700 Subject: [PATCH 23/45] Update 01_mpnst_get_omics.R --- build/mpnst/01_mpnst_get_omics.R | 6 +++--- 1 file changed, 3 insertions(+), 3 deletions(-) diff --git a/build/mpnst/01_mpnst_get_omics.R b/build/mpnst/01_mpnst_get_omics.R index 31bf29b0..77a5466d 100755 --- a/build/mpnst/01_mpnst_get_omics.R +++ b/build/mpnst/01_mpnst_get_omics.R @@ -88,7 +88,7 @@ fwrite(proteomics,'/tmp/mpnst_proteomics.csv.gz') #### FIRST WE GET RNASeq Data -rnaseq<-do.call('rbind',lapply(setdiff(combined$RNASeq,NA,"NA"),function(x){ +rnaseq<-do.call('rbind',lapply(setdiff(combined$RNASeq,c(NA,"NA")),function(x){ # if(x!=""){ #print(x) sample<-subset(combined,RNASeq==x) @@ -114,7 +114,7 @@ fwrite(rnaseq,'/tmp/mpnst_transcriptomics.csv.gz') #####NEXT WE DO WES DATA print("Getting WES") -wes<-do.call(rbind,lapply(setdiff(combined$`Mutations`,NA,"NA"),function(x){ +wes<-do.call(rbind,lapply(setdiff(combined$`Mutations`,c(NA,"NA")),function(x){ x2=x#gsub('"','',gsub("[",'',gsub("]",'',x,fixed=T),fixed=T),fixed=T) print(x) @@ -141,7 +141,7 @@ fwrite(wes,'/tmp/mpnst_mutations.csv.gz') print(paste("getting CNV")) ##next let's do CNVs! -cnv<-do.call(rbind,lapply(setdiff(combined$CopyNumber,NA,"NA"),function(x){ +cnv<-do.call(rbind,lapply(setdiff(combined$CopyNumber,c(NA,"NA")),function(x){ x2=x#gsub('"','',gsub("[",'',gsub("]",'',x,fixed=T),fixed=T),fixed=T) print(x) From 0a47adae711ef1e4abbf5323218aa090cf5ce240 Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Thu, 20 Jun 2024 06:43:41 -0700 Subject: [PATCH 24/45] updated numpy --- build/broad_sanger/requirements.txt | 2 +- build/mpnst/requirements.txt | 2 +- 2 files changed, 2 insertions(+), 2 deletions(-) diff --git a/build/broad_sanger/requirements.txt b/build/broad_sanger/requirements.txt index f4df6ef1..bf1dfe43 100755 --- a/build/broad_sanger/requirements.txt +++ b/build/broad_sanger/requirements.txt @@ -1,6 +1,6 @@ pandas matplotlib -numpy +numpy==1.26.0 argparse tqdm scikit-learn diff --git a/build/mpnst/requirements.txt b/build/mpnst/requirements.txt index fe381e8c..c9a8e6cb 100755 --- a/build/mpnst/requirements.txt +++ b/build/mpnst/requirements.txt @@ -1,7 +1,7 @@ pyarrow pandas matplotlib -numpy +numpy==1.26.0 argparse tqdm scikit-learn From fe3c6af14aef466fb2e6ff8af61579f5fbcdcd82 Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Thu, 20 Jun 2024 07:47:08 -0700 Subject: [PATCH 25/45] fixing up drug descriptor dependencies --- build/beatAML/build_drugs.sh | 2 +- build/broad_sanger/build_drugs.sh | 2 +- build/utils/build_drug_desc.py | 8 ++++++-- 3 files changed, 8 insertions(+), 4 deletions(-) diff --git a/build/beatAML/build_drugs.sh b/build/beatAML/build_drugs.sh index e1d1e033..bbeade15 100644 --- a/build/beatAML/build_drugs.sh +++ b/build/beatAML/build_drugs.sh @@ -1,2 +1,2 @@ python GetBeatAML.py --token $SYNAPSE_AUTH_TOKEN --drugs --drugFile $1 -python build_drug_desc.py --drugtable /tmp/beataml_drugs.tsv --desctable /tmp/beataml_drug_desciptors.tsv +python build_drug_desc.py --drugtable /tmp/beataml_drugs.tsv --desctable /tmp/beataml_drug_descriptors.tsv.gz diff --git a/build/broad_sanger/build_drugs.sh b/build/broad_sanger/build_drugs.sh index 429c7b57..fa4f4c12 100644 --- a/build/broad_sanger/build_drugs.sh +++ b/build/broad_sanger/build_drugs.sh @@ -1,3 +1,3 @@ /opt/venv/bin/python 03a-nci60Drugs.py Rscript 03-createDrugFile.R CTRPv2,GDSC,gCSI,PRISM,CCLE,FIMM -/opt/venv/bin/python build_drug_desc.py --drugtable /tmp/broad_sanger_drugs.tsv --desctable /tmp/broad_sanger_drug_desciptors.tsv +/opt/venv/bin/python build_drug_desc.py --drugtable /tmp/broad_sanger_drugs.tsv --desctable /tmp/broad_sanger_drug_desciptors.tsv.gz diff --git a/build/utils/build_drug_desc.py b/build/utils/build_drug_desc.py index 205e8236..ac3d4289 100644 --- a/build/utils/build_drug_desc.py +++ b/build/utils/build_drug_desc.py @@ -20,9 +20,13 @@ def smiles_to_fingerprint(smiles): ##get morgan fingerprint print('Computing morgan fingerprints for '+str(len(smiles))+' SMILES') for s in smiles: - print(s) + # print(s) mol = Chem.MolFromSmiles(s) - fingerprint = AllChem.GetMorganFingerprintAsBitVect(mol, radius=2, nBits=1024) # update these parameters + try: + fingerprint = AllChem.GetMorganFingerprintAsBitVect(mol, radius=2, nBits=1024) # update these parameters + except Error: + print('Cannot compute fingerprint for '+s) + continue fingerprint_array = np.array(fingerprint) fstr = ''.join([str(a) for a in fingerprint_array]) fdict.append({'smile':s,'descriptor_value':fstr,'structural_descriptor':'morgan fingerprint'}) From 268870ca6e5c49f9729e33d6e405fb442f6f917f Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Thu, 20 Jun 2024 08:08:35 -0700 Subject: [PATCH 26/45] updated for numpy update --- build/beatAML/requirements.txt | 2 +- build/broad_sanger/requirements.txt | 2 +- build/docker/Dockerfile.mpnst | 3 +-- build/mpnst/build_drugs.sh | 2 +- build/mpnst/requirements.txt | 2 +- 5 files changed, 5 insertions(+), 6 deletions(-) diff --git a/build/beatAML/requirements.txt b/build/beatAML/requirements.txt index 9851b4ad..3ff20f03 100755 --- a/build/beatAML/requirements.txt +++ b/build/beatAML/requirements.txt @@ -3,7 +3,7 @@ wget==3.2 requests synapseclient argparse -numpy==1.26.0 +numpy==1.26.4 openpyxl matplotlib scikit-learn diff --git a/build/broad_sanger/requirements.txt b/build/broad_sanger/requirements.txt index bf1dfe43..d28b9866 100755 --- a/build/broad_sanger/requirements.txt +++ b/build/broad_sanger/requirements.txt @@ -1,6 +1,6 @@ pandas matplotlib -numpy==1.26.0 +numpy==1.26.4 argparse tqdm scikit-learn diff --git a/build/docker/Dockerfile.mpnst b/build/docker/Dockerfile.mpnst index 89f128e5..2461abe8 100755 --- a/build/docker/Dockerfile.mpnst +++ b/build/docker/Dockerfile.mpnst @@ -12,9 +12,8 @@ WORKDIR /app ADD build/mpnst/requirements.txt . ADD build/mpnst/requirements.r . -ADD build/mpnst/*.R ./ +ADD build/mpnst/* ./ ADD build/utils/* ./ -ADD build/mpnst/*sh ./ # installing python libraries RUN /opt/venv/bin/pip3 install -r requirements.txt diff --git a/build/mpnst/build_drugs.sh b/build/mpnst/build_drugs.sh index 8e6ac887..8512222f 100644 --- a/build/mpnst/build_drugs.sh +++ b/build/mpnst/build_drugs.sh @@ -1,2 +1,2 @@ Rscript 02_get_drug_data.R $SYNAPSE_AUTH_TOKEN $1 /tmp/mpnst_drugs.tsv -/opt/venv/bin/python build_drug_desc.py --drugtable /tmp/mpnst_drugs.tsv --desctable /tmp/mpnst_drug_descriptors.tsv.gz +/opt/venv/bin/python3 build_drug_desc.py --drugtable /tmp/mpnst_drugs.tsv --desctable /tmp/mpnst_drug_descriptors.tsv.gz diff --git a/build/mpnst/requirements.txt b/build/mpnst/requirements.txt index c9a8e6cb..99f3c960 100755 --- a/build/mpnst/requirements.txt +++ b/build/mpnst/requirements.txt @@ -1,7 +1,7 @@ pyarrow pandas matplotlib -numpy==1.26.0 +numpy==1.26.4 argparse tqdm scikit-learn From 6bb03fc92f4c69ce3fc269933f2162f7097af6cc Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Thu, 20 Jun 2024 09:16:44 -0700 Subject: [PATCH 27/45] moving drug proceesing --- build/build_all.py | 17 +++++++++-------- 1 file changed, 9 insertions(+), 8 deletions(-) diff --git a/build/build_all.py b/build/build_all.py index 1fa33efc..3d4f029a 100644 --- a/build/build_all.py +++ b/build/build_all.py @@ -91,22 +91,23 @@ def process_drugs(executor, datasets): dflist = [] # WE NEED A METHOD TO CONFIRM THAT DRUG FILES ARE NOT INCOMPLETE - + ##THIS IS BUILT IN- always rerun drug code to check # Check for existing files and update dflist with processed files for da in datasets: if da not in ['cptac', 'hcmi']: file_path = f'local/{da}_drugs.tsv' - if os.path.exists(file_path): - dflist.append(f'/tmp/{da}_drugs.tsv') # Add to dflist if already processed + desc_path = f'local/{da}_drug_descriptor.tsv.gz' + #if os.path.exists(file_path): ##always rerun drug process + # dflist.append(f'/tmp/{da}_drugs.tsv') # Add to dflist if already processed for da in datasets: if da not in ['cptac', 'hcmi']: di = 'broad_sanger_exp' if da == 'broad_sanger' else da - if not os.path.exists(f'local/{da}_drugs.tsv'): - if last_drug_future: - last_drug_future.result() # Ensure the last drug process is completed before starting the next - last_drug_future = executor.submit(run_docker_cmd, [di, 'sh', 'build_drugs.sh', ','.join(dflist)], f'{da} drugs') - dflist.append(f'/tmp/{da}_drugs.tsv') + #if not os.path.exists(f'local/{da}_drugs.tsv'): + if last_drug_future: + last_drug_future.result() # Ensure the last drug process is completed before starting the next + last_drug_future = executor.submit(run_docker_cmd, [di, 'sh', 'build_drugs.sh', ','.join(dflist)], f'{da} drugs') + dflist.append(f'/tmp/{da}_drugs.tsv') def process_samples(executor, datasets): ''' From f1c4a43745f9de35d18c9366e785c1292f5501be Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Thu, 20 Jun 2024 10:20:56 -0700 Subject: [PATCH 28/45] fixed MPNST dependencies --- build/docker/Dockerfile.mpnst | 1 + build/mpnst/02_get_drug_data.R | 2 +- build/mpnst/requirements.r | 1 + 3 files changed, 3 insertions(+), 1 deletion(-) diff --git a/build/docker/Dockerfile.mpnst b/build/docker/Dockerfile.mpnst index 2461abe8..c35978cc 100755 --- a/build/docker/Dockerfile.mpnst +++ b/build/docker/Dockerfile.mpnst @@ -7,6 +7,7 @@ RUN apt-get install -y --allow-unauthenticated build-essential --fix-missing pyt RUN python3 -m venv /opt/venv RUN /opt/venv/bin/pip3 install --upgrade pip + ENV PYTHONPATH "${PYTHONPATH}:/app" WORKDIR /app diff --git a/build/mpnst/02_get_drug_data.R b/build/mpnst/02_get_drug_data.R index 27b238c6..fffd103b 100644 --- a/build/mpnst/02_get_drug_data.R +++ b/build/mpnst/02_get_drug_data.R @@ -1,7 +1,6 @@ # Load required libraries library(data.table) # library(biomaRt)# biomart issues still exist -library(synapser) library(dplyr) library(stringr) library(reticulate) @@ -22,6 +21,7 @@ PAT <- args[1] olddrugfiles <- args[2] newdrugfile <- args[3] # Log in to Synapse +library(synapser) synLogin(authToken = PAT) diff --git a/build/mpnst/requirements.r b/build/mpnst/requirements.r index bcb8d20b..160a55bc 100755 --- a/build/mpnst/requirements.r +++ b/build/mpnst/requirements.r @@ -3,6 +3,7 @@ install.packages("data.table") install.packages("synapser", repos = c("http://ran.synapse.org", "http://cran.fhcrc.org")) install.packages('R.utils') install.packages("stringr") +install.packages('reticulate') install.packages("tidyr") From 4cabd1ce2edb0be55823f2992d3f972539d5b59d Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Thu, 20 Jun 2024 10:56:20 -0700 Subject: [PATCH 29/45] fixed error --- build/utils/build_drug_desc.py | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/build/utils/build_drug_desc.py b/build/utils/build_drug_desc.py index ac3d4289..b5fdfaf1 100644 --- a/build/utils/build_drug_desc.py +++ b/build/utils/build_drug_desc.py @@ -24,7 +24,7 @@ def smiles_to_fingerprint(smiles): mol = Chem.MolFromSmiles(s) try: fingerprint = AllChem.GetMorganFingerprintAsBitVect(mol, radius=2, nBits=1024) # update these parameters - except Error: + except OSError: print('Cannot compute fingerprint for '+s) continue fingerprint_array = np.array(fingerprint) From 70d31f0497cc327ac92b8c952e94817ba2c524c1 Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Thu, 20 Jun 2024 11:34:56 -0700 Subject: [PATCH 30/45] fixed exception handling --- build/utils/build_drug_desc.py | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/build/utils/build_drug_desc.py b/build/utils/build_drug_desc.py index b5fdfaf1..e53570de 100644 --- a/build/utils/build_drug_desc.py +++ b/build/utils/build_drug_desc.py @@ -24,7 +24,7 @@ def smiles_to_fingerprint(smiles): mol = Chem.MolFromSmiles(s) try: fingerprint = AllChem.GetMorganFingerprintAsBitVect(mol, radius=2, nBits=1024) # update these parameters - except OSError: + except: print('Cannot compute fingerprint for '+s) continue fingerprint_array = np.array(fingerprint) From 878e6babbfc4ef7da8cc38e4f5cf532c657bcccd Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Fri, 21 Jun 2024 08:50:09 -0700 Subject: [PATCH 31/45] updaetd drug descriptor --- build/broad_sanger/build_drugs.sh | 3 ++- build/utils/build_drug_desc.py | 12 ++++++++++-- 2 files changed, 12 insertions(+), 3 deletions(-) diff --git a/build/broad_sanger/build_drugs.sh b/build/broad_sanger/build_drugs.sh index fa4f4c12..a58ba4d9 100644 --- a/build/broad_sanger/build_drugs.sh +++ b/build/broad_sanger/build_drugs.sh @@ -1,3 +1,4 @@ /opt/venv/bin/python 03a-nci60Drugs.py Rscript 03-createDrugFile.R CTRPv2,GDSC,gCSI,PRISM,CCLE,FIMM -/opt/venv/bin/python build_drug_desc.py --drugtable /tmp/broad_sanger_drugs.tsv --desctable /tmp/broad_sanger_drug_desciptors.tsv.gz +yes +/opt/venv/bin/python build_drug_desc.py --drugtable /tmp/broad_sanger_drugs.tsv --desctable /tmp/broad_sanger_drug_descriptors.tsv.gz diff --git a/build/utils/build_drug_desc.py b/build/utils/build_drug_desc.py index e53570de..9b6e91b4 100644 --- a/build/utils/build_drug_desc.py +++ b/build/utils/build_drug_desc.py @@ -40,12 +40,20 @@ def smiles_to_mordred(smiles): ''' print('Computing mordred descriptors for '+str(len(smiles))+' SMILES') + mols = [Chem.MolFromSmiles(s) for s in smiles] + smols = [] + ssmil = [] + for i in range(len(mols)): + m = moles[i] + if m is not None: + smols.append(m) + ssmil.append(smiles[i]) calc = Calculator(descriptors, ignore_3D=True) - dd = calc.pandas( mols, nmols=None, quiet=False, ipynb=False ) + dd = calc.pandas( smols, nmols=None, quiet=False, ipynb=False ) values = dd.columns - dd['smile'] = smiles + dd['smile'] = ssmil ##reformat here longtab = pd.melt(dd,id_vars='smile',value_vars=values) longtab = longtab.rename({'variable':'structural_descriptor','value':'descriptor_value'},axis=1) From 72d40ddf24344526d06d8b13aad1999ead0a78b7 Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Sun, 23 Jun 2024 14:16:12 -0700 Subject: [PATCH 32/45] Update build_drug_desc.py --- build/utils/build_drug_desc.py | 13 +++++++++---- 1 file changed, 9 insertions(+), 4 deletions(-) diff --git a/build/utils/build_drug_desc.py b/build/utils/build_drug_desc.py index 9b6e91b4..eff5101d 100644 --- a/build/utils/build_drug_desc.py +++ b/build/utils/build_drug_desc.py @@ -11,6 +11,8 @@ import pandas as pd import numpy as np from mordred import Calculator, descriptors +import multiprocessing + def smiles_to_fingerprint(smiles): ''' @@ -34,7 +36,7 @@ def smiles_to_fingerprint(smiles): return pd.DataFrame(fdict)#fingerprint_array -def smiles_to_mordred(smiles): +def smiles_to_mordred(smiles,nproc=2): ''' get descriptors - which ones? ''' @@ -45,13 +47,13 @@ def smiles_to_mordred(smiles): smols = [] ssmil = [] for i in range(len(mols)): - m = moles[i] + m = mols[i] if m is not None: smols.append(m) ssmil.append(smiles[i]) calc = Calculator(descriptors, ignore_3D=True) - dd = calc.pandas( smols, nmols=None, quiet=False, ipynb=False ) + dd = calc.pandas( smols, nproc=nproc, mols=None, quiet=False, ipynb=False ) values = dd.columns dd['smile'] = ssmil ##reformat here @@ -66,6 +68,9 @@ def main(): args = parser.parse_args() + cores = multiprocessing.cpu_count() + ncors = cores-1 + print("Running with "+str(ncors)+' out of '+str(cores)) print('Adding drug table for '+args.drugtable) tab = pd.read_csv(args.drugtable,sep='\t') @@ -76,7 +81,7 @@ def main(): ids = pd.DataFrame(tab[['improve_drug_id','canSMILES']]).drop_duplicates() id_morg = ids.rename({"canSMILES":'smile'},axis=1).merge(morgs)[['improve_drug_id','structural_descriptor','descriptor_value']] - mords = smiles_to_mordred(cansmiles) + mords = smiles_to_mordred(cansmiles,nproc=ncors) id_mord = ids.rename({'canSMILES':'smile'},axis=1).merge(mords)[['improve_drug_id','structural_descriptor','descriptor_value']] From fbe326d8a5ae57f4f94e6e972a58cc2d7d5dbb7c Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Fri, 28 Jun 2024 12:39:39 -0700 Subject: [PATCH 33/45] updated code with bug fix --- build/utils/build_drug_desc.py | 9 +++++++-- 1 file changed, 7 insertions(+), 2 deletions(-) diff --git a/build/utils/build_drug_desc.py b/build/utils/build_drug_desc.py index eff5101d..7e25212e 100644 --- a/build/utils/build_drug_desc.py +++ b/build/utils/build_drug_desc.py @@ -8,6 +8,7 @@ import argparse from rdkit import Chem from rdkit.Chem import AllChem +#from rdkit.Chem import rdFingerprintGenerator import pandas as pd import numpy as np from mordred import Calculator, descriptors @@ -21,11 +22,15 @@ def smiles_to_fingerprint(smiles): fdict = [] ##get morgan fingerprint print('Computing morgan fingerprints for '+str(len(smiles))+' SMILES') + # morgan_fp_gen = rdFingerprintGenerator.GetMorganGenerator(radius=2, fpSize=1024, useCountSimulation=False) for s in smiles: # print(s) mol = Chem.MolFromSmiles(s) try: + #this has been depracated despite being in Alex's original script fingerprint = AllChem.GetMorganFingerprintAsBitVect(mol, radius=2, nBits=1024) # update these parameters + # fingerprint = morgan_fp_gen.GetFingerprint(mol) + # vec2 = np.array(fp2) except: print('Cannot compute fingerprint for '+s) continue @@ -53,7 +58,7 @@ def smiles_to_mordred(smiles,nproc=2): ssmil.append(smiles[i]) calc = Calculator(descriptors, ignore_3D=True) - dd = calc.pandas( smols, nproc=nproc, mols=None, quiet=False, ipynb=False ) + dd = calc.pandas(mols=smols, nproc=nproc, quiet=False, ipynb=False ) values = dd.columns dd['smile'] = ssmil ##reformat here @@ -70,7 +75,7 @@ def main(): cores = multiprocessing.cpu_count() ncors = cores-1 - print("Running with "+str(ncors)+' out of '+str(cores)) + print("Running with "+str(ncors)+' out of '+str(cores)+' processors') print('Adding drug table for '+args.drugtable) tab = pd.read_csv(args.drugtable,sep='\t') From 72d7ce2f0f0efc2ab54bd187e8900c85fab5db1d Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Mon, 1 Jul 2024 07:12:38 -0700 Subject: [PATCH 34/45] found a bug in build drugs --- build/broad_sanger/build_drugs.sh | 1 - 1 file changed, 1 deletion(-) diff --git a/build/broad_sanger/build_drugs.sh b/build/broad_sanger/build_drugs.sh index a58ba4d9..2ee3f78a 100644 --- a/build/broad_sanger/build_drugs.sh +++ b/build/broad_sanger/build_drugs.sh @@ -1,4 +1,3 @@ /opt/venv/bin/python 03a-nci60Drugs.py Rscript 03-createDrugFile.R CTRPv2,GDSC,gCSI,PRISM,CCLE,FIMM -yes /opt/venv/bin/python build_drug_desc.py --drugtable /tmp/broad_sanger_drugs.tsv --desctable /tmp/broad_sanger_drug_descriptors.tsv.gz From acc67d39f6a784b7ff55793919119cab3d9d2820 Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Mon, 1 Jul 2024 12:58:03 -0700 Subject: [PATCH 35/45] Update build.yml --- .github/workflows/build.yml | 30 +++++++++++++++--------------- 1 file changed, 15 insertions(+), 15 deletions(-) diff --git a/.github/workflows/build.yml b/.github/workflows/build.yml index 51b9b3a2..a786e1f0 100755 --- a/.github/workflows/build.yml +++ b/.github/workflows/build.yml @@ -66,21 +66,21 @@ jobs: # docker build -t jjacobson95/hcmi -f build/docker/Dockerfile.hcmi . # docker push jjacobson95/hcmi -# beataml-docker-build: -# runs-on: ubuntu-latest -# environment: build -# steps: -# - name: Checkout Repo -# uses: actions/checkout@v2 -# - name: Log in to DockerHub -# uses: docker/login-action@v3 -# with: -# username: ${{ secrets.DOCKER_USERNAME }} -# password: ${{ secrets.DOCKER_TOKEN_SECRET }} -# - name: Build and push beataml image -# run: | -# docker build -t jjacobson95/beataml -f build/docker/Dockerfile.beataml . -# docker push jjacobson95/beataml + beataml-docker-build: + runs-on: ubuntu-latest + environment: build + steps: + - name: Checkout Repo + uses: actions/checkout@v2 + - name: Log in to DockerHub + uses: docker/login-action@v3 + with: + username: ${{ secrets.DOCKER_USERNAME }} + password: ${{ secrets.DOCKER_TOKEN_SECRET }} + - name: Build and push beataml image + run: | + docker build -t jjacobson95/beataml -f build/docker/Dockerfile.beataml . + docker push jjacobson95/beataml # #placeholder # mpnst-docker-build: From cec1acd6681906c8ed627632c00386ad866879dc Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Tue, 2 Jul 2024 16:58:14 -0700 Subject: [PATCH 36/45] updated mpnst debug --- build/build_all.py | 10 ++++------ build/docker/Dockerfile.mpnst | 2 +- build/mpnst/00_sample_gen.R | 2 +- build/mpnst/02_get_drug_data.R | 12 +++++++++--- build/mpnst/03_get_drug_response_data.R | 14 +++++++++++--- 5 files changed, 26 insertions(+), 14 deletions(-) diff --git a/build/build_all.py b/build/build_all.py index 3d4f029a..0c6fd43d 100644 --- a/build/build_all.py +++ b/build/build_all.py @@ -225,8 +225,7 @@ def compress_file(file_path): # Ouput is logged at local/docker.log if args.docker or args.all: process_docker() - - print("Docker image generation completed") + print("Docker image generation completed") ### Build Drugs files, Samples files, and Genes file. These two steps are run in Parallel. @@ -247,7 +246,7 @@ def compress_file(file_path): if args.samples or args.omics or args.exp or args.all: gene_thread.result() - print("All samples, drugs files, and genes file completed") + print("All samples, drugs files, and genes file completed or skipped") ### At this point in the pipeline, all samples and drugs files have been created. There are no blockers to proceed. @@ -262,11 +261,10 @@ def compress_file(file_path): if args.omics or args.all: omics_thread.result() + print("All omics files completed") if args.exp or args.all: exp_thread.result() - - - print("All omics and experiments files completed") + print("All experiments files completed") ###### ### Begin Upload diff --git a/build/docker/Dockerfile.mpnst b/build/docker/Dockerfile.mpnst index c35978cc..0204144b 100755 --- a/build/docker/Dockerfile.mpnst +++ b/build/docker/Dockerfile.mpnst @@ -1,4 +1,4 @@ -FROM r-base:4.3.1 +FROM r-base:4.3.2 ENV DEBIAN_FRONTEND=noninteractive RUN apt-get update --allow-insecure-repositories #RUN apt-get install -y --allow-unauthenticated build-essential --fix-missing libpq-dev python3-pip python3-setuptools python3-dev python3-venv libcurl4-openssl-dev libxml2-dev diff --git a/build/mpnst/00_sample_gen.R b/build/mpnst/00_sample_gen.R index ec68b873..299aa10f 100755 --- a/build/mpnst/00_sample_gen.R +++ b/build/mpnst/00_sample_gen.R @@ -45,7 +45,7 @@ sampTable<-manifest|> ##third, generate a sample for the MTs if they were generated pdxmt<-subset(sampTable,!is.na(MicroTissueDrugFolder)) pdxmt$model_type=rep('organoid',nrow(pdxmt)) -#print(pdxmt) +print(pdxmt) main<-rbind(sampTable,pdxmt)|> dplyr::select(-MicroTissueDrugFolder)|> diff --git a/build/mpnst/02_get_drug_data.R b/build/mpnst/02_get_drug_data.R index fffd103b..3b31683f 100644 --- a/build/mpnst/02_get_drug_data.R +++ b/build/mpnst/02_get_drug_data.R @@ -3,10 +3,8 @@ library(data.table) # library(biomaRt)# biomart issues still exist library(dplyr) library(stringr) -library(reticulate) +library(synapser) -use_python("/opt/venv/bin/python3", required = TRUE) -source_python("pubchem_retrieval.py") # Retrieve command line arguments args <- commandArgs(trailingOnly = TRUE) @@ -82,6 +80,14 @@ write.table(olddrugs,file=newdrugfile,sep='\t',row.names=F,quote=FALSE,col.names output_file_path <- newdrugfile ignore_file_path <- '/tmp/mpnst_ignore_chems.txt' + +##now load reticulate down here + +library(reticulate) + +use_python("/opt/venv/bin/python3", required = TRUE) +source_python("pubchem_retrieval.py") + update_dataframe_and_write_tsv(unique_names=alldrugs,output_filename=output_file_path,ignore_chems=ignore_file_path) diff --git a/build/mpnst/03_get_drug_response_data.R b/build/mpnst/03_get_drug_response_data.R index 4b44720e..357eb0aa 100644 --- a/build/mpnst/03_get_drug_response_data.R +++ b/build/mpnst/03_get_drug_response_data.R @@ -24,7 +24,8 @@ synLogin(authToken = PAT) # Read the sample mapping CSV and genes.csv samples_df <- fread(patients)|> dplyr::select(improve_sample_id,common_name,model_type)|> - distinct()#"mpnst/synapse_NF-MPNST_samples.csv") + distinct()#"mpnst/synapse_NF-MPNST_samples.csv") +print(head(samples_df)) pdx_samps<-subset(samples_df,model_type=='patient derived xenograft') org_samps<-subset(samples_df,model_type=='organoid') @@ -70,14 +71,16 @@ extract_date_hour <- function(experiment_id) { getDrugDataByParent<-function(parid,sampleId){ qtab<-synTableQuery(paste('select id,name,experimentalCondition,parentId from syn21993642 where parentId=\'',parid,'\''))$asDataFrame()|> as.data.frame()|> - subset(!is.na(experimentalCondition))|>dplyr::select(id,name,experimentalCondition) + subset(!is.na(experimentalCondition))|> + dplyr::select(id,name,experimentalCondition)|> + subset(name!='synapse_storage_manifest.csv') ##now we need to parse the metadatda table get the info res<-do.call(rbind,lapply(qtab$id,function(x){ sname <- subset(qtab,id==x) #print(sname) sname <-extract_date_hour(sname$name) - + #print(x) #print(sname) data <- fread(synGet(x)$path)|> filter(response_type=='percent viability')|> @@ -99,8 +102,13 @@ getDrugDataByParent<-function(parid,sampleId){ ##now loop through manifest to get all the files mts_fold <- data.table(mts)[,strsplit(as.character(MicroTissueDrugFolder),","), by = .(improve_sample_id,common_name)] +mts_fold <- mts_fold[which(!mts_fold$V1%in%c("NA",NA)),] + +print(mts_fold) + alldrugs<-do.call(rbind,lapply(mts_fold$V1,function(x){ samp<-subset(mts_fold,V1==x) + print(samp$common_name) res<-getDrugDataByParent(x,samp$improve_sample_id) return(res) })) From 314f2b308669e3e39b3ad833f7e3ce66f8a7ebdf Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Tue, 2 Jul 2024 17:07:07 -0700 Subject: [PATCH 37/45] new ci? --- .github/workflows/build.yml | 78 ++++++++++++++++++++++++++++++++++--- 1 file changed, 73 insertions(+), 5 deletions(-) diff --git a/.github/workflows/build.yml b/.github/workflows/build.yml index a786e1f0..c729634d 100755 --- a/.github/workflows/build.yml +++ b/.github/workflows/build.yml @@ -3,9 +3,7 @@ name: CI on: push: branches: - - builder_branch_JJ - - docs_update_4_5_24 - - doc_update_4_23_24 + - '**' # Allows you to run this workflow manually from the Actions tab workflow_dispatch: @@ -17,7 +15,6 @@ permissions: jobs: # Placeholder - # depmap-docker-build: # runs-on: ubuntu-latest # environment: build @@ -1448,4 +1445,75 @@ jobs: # run: | # python setup.py sdist bdist_wheel # twine upload dist/* --verbose - + build-docker: + runs-on: ubuntu-latest + steps: + - name: Checkout + uses: actions/checkout@v3 + - name: Set up QEMU + uses: docker/setup-qemu-action@v3 + - name: Set up Docker Buildx + uses: docker/setup-buildx-action@v3 + - name: Login to DockerHub + uses: docker/login-action@v2 + with: + username: ${{ secrets.DOCKERHUB_USERNAME }} + password: ${{ secrets.DOCKERHUB_PASSWORD }} + - name: Build and push broad sanger omics + uses: docker/build-push-action@v3 + with: + file: ./build/docker/Dockerfile.broad_sanger_omics + tags: jjacobson95/broad-sanger-omics:latest + push: true + platforms: linux/amd64,linux/arm64 + - name: Build and push broad sanger experiment + uses: docker/build-push-action@v3 + with: + file: ./build/docker/Dockerfile.broad_sanger_exp + tags: jjacobson95/broad-sanger-exp:latest + push: true + platforms: linux/amd64,linux/arm64 + - name: Build and push genes + uses: docker/build-push-action@v3 + with: + file: ./build/docker/Dockerfile.genes + tags: jjacobson95/genes:latest + push: true + platforms: linux/amd64,linux/arm64 + - name: Build and push hcmi + uses: docker/build-push-action@v3 + with: + file: ./build/docker/Dockerfile.hcmi + tags: jjacobson95/hcmi:latest + push: true + platforms: linux/amd64,linux/arm64 + - name: Build and push cptac + uses: docker/build-push-action@v3 + with: + file: ./build/docker/Dockerfile.c[tac + tags: jjacobson95/cptac:latest + push: true + platforms: linux/amd64,linux/arm64 + - name: Build and push mpnst + uses: docker/build-push-action@v3 + with: + file: ./build/docker/Dockerfile.mpnst + tags: jjacobson95/mpnst:latest + push: true + platforms: linux/amd64,linux/arm64 + - name: Build and push beataml + uses: docker/build-push-action@v3 + with: + file: ./build/docker/Dockerfile.beataml + tags: jjacobson95/beataml:latest + push: true + platforms: linux/amd64,linux/arm64 + - name: Build and push upload + uses: docker/build-push-action@v3 + with: + file: ./build/docker/Dockerfile.upload + tags: jjacobson95/upload:latest + push: true + platforms: linux/amd64,linux/arm64 + +>>>>>>> 158fe9a (new ci?) From fb2cddd1aa53cc2424a7069d651b254f09a9e6ca Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Tue, 2 Jul 2024 17:12:20 -0700 Subject: [PATCH 38/45] Update build.yml --- .github/workflows/build.yml | 68 +++++++++++-------------------------- 1 file changed, 19 insertions(+), 49 deletions(-) diff --git a/.github/workflows/build.yml b/.github/workflows/build.yml index c729634d..d5aa1c3a 100755 --- a/.github/workflows/build.yml +++ b/.github/workflows/build.yml @@ -14,6 +14,7 @@ permissions: id-token: write jobs: + # Placeholder # depmap-docker-build: # runs-on: ubuntu-latest @@ -62,24 +63,23 @@ jobs: # run: | # docker build -t jjacobson95/hcmi -f build/docker/Dockerfile.hcmi . # docker push jjacobson95/hcmi +# beataml-docker-build: +# runs-on: ubuntu-latest +# environment: build +# steps: +# - name: Checkout Repo +# uses: actions/checkout@v2 +# - name: Log in to DockerHub +# uses: docker/login-action@v3 +# with: +# username: ${{ secrets.DOCKER_USERNAME }} +# password: ${{ secrets.DOCKER_TOKEN_SECRET }} +# - name: Build and push beataml image +# run: | +# docker build -t jjacobson95/beataml -f build/docker/Dockerfile.beataml . +# docker push jjacobson95/beataml - beataml-docker-build: - runs-on: ubuntu-latest - environment: build - steps: - - name: Checkout Repo - uses: actions/checkout@v2 - - name: Log in to DockerHub - uses: docker/login-action@v3 - with: - username: ${{ secrets.DOCKER_USERNAME }} - password: ${{ secrets.DOCKER_TOKEN_SECRET }} - - name: Build and push beataml image - run: | - docker build -t jjacobson95/beataml -f build/docker/Dockerfile.beataml . - docker push jjacobson95/beataml - -# #placeholder +# # #placeholder # mpnst-docker-build: # runs-on: ubuntu-latest # environment: build @@ -840,34 +840,6 @@ jobs: # - name: Run linkml schema checker # run: bash schema/check_beataml_linkml.sh -# # build-depmap: -# # if: github.actor != 'github-actions[bot]' -# # needs: [build-depmap-samples] -# # runs-on: ubuntu-20.04 -# # environment: build -# # steps: -# # - name: Checkout code DepMap -# # uses: actions/checkout@v2 -# # - name: List files cwd before -# # run: ls -lah -# # - name: Install coderdata -# # run: pip install coderdata -# # - name: Download depmap data from coder data -# # run: coderdata download --prefix depmap -# # - name: List files cwd after -# # run: ls -lah -# # - name: Copy files from DepMap Container -# # run: | -# # mkdir depmap-files -# # for file in *depmap*sv*; do -# # cp $file depmap-files/$file -# # done -# # - name: Upload artifact for DepMap -# # uses: actions/upload-artifact@v2 -# # with: -# # name: depmap-files -# # path: depmap-files - # build-depmap: # if: github.actor != 'github-actions[bot]' # needs: [build-depmap-samples,build-drugs-depmap-capture-stragglers] @@ -1308,8 +1280,6 @@ jobs: # git status # git commit -m "Add figshare_latest.yml to docs/_data" # git push - - # update-package-download-function: # if: github.actor != 'github-actions[bot]' # needs: [upload-to-figshare] @@ -1458,7 +1428,7 @@ jobs: uses: docker/login-action@v2 with: username: ${{ secrets.DOCKERHUB_USERNAME }} - password: ${{ secrets.DOCKERHUB_PASSWORD }} + password: ${{ secrets.DOCKER_TOKEN_SECRET }} - name: Build and push broad sanger omics uses: docker/build-push-action@v3 with: @@ -1516,4 +1486,4 @@ jobs: push: true platforms: linux/amd64,linux/arm64 ->>>>>>> 158fe9a (new ci?) + From 1dc3d83730ddbf860a7a5a164dcf0caf37b54203 Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Tue, 2 Jul 2024 17:13:51 -0700 Subject: [PATCH 39/45] Update build.yml --- .github/workflows/build.yml | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/.github/workflows/build.yml b/.github/workflows/build.yml index d5aa1c3a..58443020 100755 --- a/.github/workflows/build.yml +++ b/.github/workflows/build.yml @@ -1427,7 +1427,7 @@ jobs: - name: Login to DockerHub uses: docker/login-action@v2 with: - username: ${{ secrets.DOCKERHUB_USERNAME }} + username: ${{ secrets.DOCKER_USERNAME }} password: ${{ secrets.DOCKER_TOKEN_SECRET }} - name: Build and push broad sanger omics uses: docker/build-push-action@v3 From d1b194e6cd8504094c1d466ebd62d06d094b3c4f Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Tue, 2 Jul 2024 17:18:41 -0700 Subject: [PATCH 40/45] Update build.yml --- .github/workflows/build.yml | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/.github/workflows/build.yml b/.github/workflows/build.yml index 58443020..359a5d72 100755 --- a/.github/workflows/build.yml +++ b/.github/workflows/build.yml @@ -1425,7 +1425,7 @@ jobs: - name: Set up Docker Buildx uses: docker/setup-buildx-action@v3 - name: Login to DockerHub - uses: docker/login-action@v2 + uses: docker/login-action@v3 with: username: ${{ secrets.DOCKER_USERNAME }} password: ${{ secrets.DOCKER_TOKEN_SECRET }} From 8d4cca80a18f4555112d67fa5624224db199fc25 Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Tue, 2 Jul 2024 17:24:51 -0700 Subject: [PATCH 41/45] Update build.yml --- .github/workflows/build.yml | 20 ++++++++++---------- 1 file changed, 10 insertions(+), 10 deletions(-) diff --git a/.github/workflows/build.yml b/.github/workflows/build.yml index 359a5d72..5dcae349 100755 --- a/.github/workflows/build.yml +++ b/.github/workflows/build.yml @@ -1427,62 +1427,62 @@ jobs: - name: Login to DockerHub uses: docker/login-action@v3 with: - username: ${{ secrets.DOCKER_USERNAME }} - password: ${{ secrets.DOCKER_TOKEN_SECRET }} + username: ${{ secrets.DOCKERHUB_USERNAME }} + password: ${{ secrets.DOCKERHUB_PASSWORD }} - name: Build and push broad sanger omics uses: docker/build-push-action@v3 with: file: ./build/docker/Dockerfile.broad_sanger_omics - tags: jjacobson95/broad-sanger-omics:latest + tags: sgosline/broad-sanger-omics:latest push: true platforms: linux/amd64,linux/arm64 - name: Build and push broad sanger experiment uses: docker/build-push-action@v3 with: file: ./build/docker/Dockerfile.broad_sanger_exp - tags: jjacobson95/broad-sanger-exp:latest + tags: sgosline/broad-sanger-exp:latest push: true platforms: linux/amd64,linux/arm64 - name: Build and push genes uses: docker/build-push-action@v3 with: file: ./build/docker/Dockerfile.genes - tags: jjacobson95/genes:latest + tags: sgosline/genes:latest push: true platforms: linux/amd64,linux/arm64 - name: Build and push hcmi uses: docker/build-push-action@v3 with: file: ./build/docker/Dockerfile.hcmi - tags: jjacobson95/hcmi:latest + tags: sgosline/hcmi:latest push: true platforms: linux/amd64,linux/arm64 - name: Build and push cptac uses: docker/build-push-action@v3 with: file: ./build/docker/Dockerfile.c[tac - tags: jjacobson95/cptac:latest + tags: sgosline/cptac:latest push: true platforms: linux/amd64,linux/arm64 - name: Build and push mpnst uses: docker/build-push-action@v3 with: file: ./build/docker/Dockerfile.mpnst - tags: jjacobson95/mpnst:latest + tags: sgosline/mpnst:latest push: true platforms: linux/amd64,linux/arm64 - name: Build and push beataml uses: docker/build-push-action@v3 with: file: ./build/docker/Dockerfile.beataml - tags: jjacobson95/beataml:latest + tags: sgosline/beataml:latest push: true platforms: linux/amd64,linux/arm64 - name: Build and push upload uses: docker/build-push-action@v3 with: file: ./build/docker/Dockerfile.upload - tags: jjacobson95/upload:latest + tags: sgosline/upload:latest push: true platforms: linux/amd64,linux/arm64 From 6b91bb3bfea65bc18440fc8ff6755dcb24e35189 Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Wed, 3 Jul 2024 07:37:27 -0700 Subject: [PATCH 42/45] tried to parralelize build --- .github/workflows/build.yml | 106 ++++++++++++++++++++++++++++++++++-- 1 file changed, 102 insertions(+), 4 deletions(-) diff --git a/.github/workflows/build.yml b/.github/workflows/build.yml index 5dcae349..e423027e 100755 --- a/.github/workflows/build.yml +++ b/.github/workflows/build.yml @@ -1415,7 +1415,7 @@ jobs: # run: | # python setup.py sdist bdist_wheel # twine upload dist/* --verbose - build-docker: + build-cellline-omics: runs-on: ubuntu-latest steps: - name: Checkout @@ -1436,6 +1436,20 @@ jobs: tags: sgosline/broad-sanger-omics:latest push: true platforms: linux/amd64,linux/arm64 + build-cellline-exp: + runs-on: ubuntu-latest + steps: + - name: Checkout + uses: actions/checkout@v3 + - name: Set up QEMU + uses: docker/setup-qemu-action@v3 + - name: Set up Docker Buildx + uses: docker/setup-buildx-action@v3 + - name: Login to DockerHub + uses: docker/login-action@v3 + with: + username: ${{ secrets.DOCKERHUB_USERNAME }} + password: ${{ secrets.DOCKERHUB_PASSWORD }} - name: Build and push broad sanger experiment uses: docker/build-push-action@v3 with: @@ -1443,6 +1457,20 @@ jobs: tags: sgosline/broad-sanger-exp:latest push: true platforms: linux/amd64,linux/arm64 + build-genes: + runs-on: ubuntu-latest + steps: + - name: Checkout + uses: actions/checkout@v3 + - name: Set up QEMU + uses: docker/setup-qemu-action@v3 + - name: Set up Docker Buildx + uses: docker/setup-buildx-action@v3 + - name: Login to DockerHub + uses: docker/login-action@v3 + with: + username: ${{ secrets.DOCKERHUB_USERNAME }} + password: ${{ secrets.DOCKERHUB_PASSWORD }} - name: Build and push genes uses: docker/build-push-action@v3 with: @@ -1450,13 +1478,41 @@ jobs: tags: sgosline/genes:latest push: true platforms: linux/amd64,linux/arm64 + build-hcmi: + runs-on: ubuntu-latest + steps: + - name: Checkout + uses: actions/checkout@v3 + - name: Set up QEMU + uses: docker/setup-qemu-action@v3 + - name: Set up Docker Buildx + uses: docker/setup-buildx-action@v3 + - name: Login to DockerHub + uses: docker/login-action@v3 + with: + username: ${{ secrets.DOCKERHUB_USERNAME }} + password: ${{ secrets.DOCKERHUB_PASSWORD }} - name: Build and push hcmi uses: docker/build-push-action@v3 with: file: ./build/docker/Dockerfile.hcmi tags: sgosline/hcmi:latest push: true - platforms: linux/amd64,linux/arm64 + platforms: linux/amd64,linux/arm64 + build-cptac: + runs-on: ubuntu-latest + steps: + - name: Checkout + uses: actions/checkout@v3 + - name: Set up QEMU + uses: docker/setup-qemu-action@v3 + - name: Set up Docker Buildx + uses: docker/setup-buildx-action@v3 + - name: Login to DockerHub + uses: docker/login-action@v3 + with: + username: ${{ secrets.DOCKERHUB_USERNAME }} + password: ${{ secrets.DOCKERHUB_PASSWORD }} - name: Build and push cptac uses: docker/build-push-action@v3 with: @@ -1464,13 +1520,41 @@ jobs: tags: sgosline/cptac:latest push: true platforms: linux/amd64,linux/arm64 + build-mpnst: + runs-on: ubuntu-latest + steps: + - name: Checkout + uses: actions/checkout@v3 + - name: Set up QEMU + uses: docker/setup-qemu-action@v3 + - name: Set up Docker Buildx + uses: docker/setup-buildx-action@v3 + - name: Login to DockerHub + uses: docker/login-action@v3 + with: + username: ${{ secrets.DOCKERHUB_USERNAME }} + password: ${{ secrets.DOCKERHUB_PASSWORD }} - name: Build and push mpnst uses: docker/build-push-action@v3 with: file: ./build/docker/Dockerfile.mpnst tags: sgosline/mpnst:latest push: true - platforms: linux/amd64,linux/arm64 + platforms: linux/amd64,linux/arm64 + build-beataml: + runs-on: ubuntu-latest + steps: + - name: Checkout + uses: actions/checkout@v3 + - name: Set up QEMU + uses: docker/setup-qemu-action@v3 + - name: Set up Docker Buildx + uses: docker/setup-buildx-action@v3 + - name: Login to DockerHub + uses: docker/login-action@v3 + with: + username: ${{ secrets.DOCKERHUB_USERNAME }} + password: ${{ secrets.DOCKERHUB_PASSWORD }} - name: Build and push beataml uses: docker/build-push-action@v3 with: @@ -1478,12 +1562,26 @@ jobs: tags: sgosline/beataml:latest push: true platforms: linux/amd64,linux/arm64 + build-upload: + runs-on: ubuntu-latest + steps: + - name: Checkout + uses: actions/checkout@v3 + - name: Set up QEMU + uses: docker/setup-qemu-action@v3 + - name: Set up Docker Buildx + uses: docker/setup-buildx-action@v3 + - name: Login to DockerHub + uses: docker/login-action@v3 + with: + username: ${{ secrets.DOCKERHUB_USERNAME }} + password: ${{ secrets.DOCKERHUB_PASSWORD }} - name: Build and push upload uses: docker/build-push-action@v3 with: file: ./build/docker/Dockerfile.upload tags: sgosline/upload:latest push: true - platforms: linux/amd64,linux/arm64 + platforms: linux/amd64,linux/arm64 From 6c5292177dd6ecb712f478ad53dbb3d156537d9c Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Wed, 3 Jul 2024 07:39:05 -0700 Subject: [PATCH 43/45] Update build.yml --- .github/workflows/build.yml | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/.github/workflows/build.yml b/.github/workflows/build.yml index e423027e..8d2e6e3a 100755 --- a/.github/workflows/build.yml +++ b/.github/workflows/build.yml @@ -1457,7 +1457,7 @@ jobs: tags: sgosline/broad-sanger-exp:latest push: true platforms: linux/amd64,linux/arm64 - build-genes: + build-genes: runs-on: ubuntu-latest steps: - name: Checkout From e7fed23da1ee2302415830625e02fbfe8046da42 Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Wed, 3 Jul 2024 07:48:24 -0700 Subject: [PATCH 44/45] focused on building docker images first --- .github/workflows/build.yml | 1405 +------------------------------ .github/workflows/old_ci | 1587 +++++++++++++++++++++++++++++++++++ 2 files changed, 1589 insertions(+), 1403 deletions(-) create mode 100755 .github/workflows/old_ci diff --git a/.github/workflows/build.yml b/.github/workflows/build.yml index 8d2e6e3a..1b4b96f4 100755 --- a/.github/workflows/build.yml +++ b/.github/workflows/build.yml @@ -1,4 +1,4 @@ -name: CI +name: Build docker images on: push: @@ -14,1407 +14,6 @@ permissions: id-token: write jobs: - -# Placeholder -# depmap-docker-build: -# runs-on: ubuntu-latest -# environment: build -# steps: -# - name: Checkout Repo -# uses: actions/checkout@v2 -# - name: Log in to DockerHub -# uses: docker/login-action@v3 -# with: -# username: ${{ secrets.DOCKER_USERNAME }} -# password: ${{ secrets.DOCKER_TOKEN_SECRET }} -# - name: Build and push depmap images -# run: | -# docker build -t jjacobson95/depmap -f build/docker/Dockerfile.depmap . -# docker push jjacobson95/depmap - -# cptac-docker-build: -# runs-on: ubuntu-latest -# environment: build -# steps: -# - name: Checkout Repo -# uses: actions/checkout@v2 -# - name: Log in to DockerHub -# uses: docker/login-action@v3 -# with: -# username: ${{ secrets.DOCKER_USERNAME }} -# password: ${{ secrets.DOCKER_TOKEN_SECRET }} -# - name: Build and push cptac images -# run: | -# docker build -t jjacobson95/cptac -f build/docker/Dockerfile.cptac . -# docker push jjacobson95/cptac - -# hcmi-docker-build: -# runs-on: ubuntu-latest -# environment: build -# steps: -# - name: Checkout Repo -# uses: actions/checkout@v2 -# - name: Log in to DockerHub -# uses: docker/login-action@v3 -# with: -# username: ${{ secrets.DOCKER_USERNAME }} -# password: ${{ secrets.DOCKER_TOKEN_SECRET }} -# - name: Build and push hcmi images -# run: | -# docker build -t jjacobson95/hcmi -f build/docker/Dockerfile.hcmi . -# docker push jjacobson95/hcmi -# beataml-docker-build: -# runs-on: ubuntu-latest -# environment: build -# steps: -# - name: Checkout Repo -# uses: actions/checkout@v2 -# - name: Log in to DockerHub -# uses: docker/login-action@v3 -# with: -# username: ${{ secrets.DOCKER_USERNAME }} -# password: ${{ secrets.DOCKER_TOKEN_SECRET }} -# - name: Build and push beataml image -# run: | -# docker build -t jjacobson95/beataml -f build/docker/Dockerfile.beataml . -# docker push jjacobson95/beataml - -# # #placeholder -# mpnst-docker-build: -# runs-on: ubuntu-latest -# environment: build -# steps: -# - uses: actions/checkout@v2 -# - name: Log in to DockerHub -# uses: docker/login-action@v3 -# with: -# username: ${{ secrets.DOCKER_USERNAME }} -# password: ${{ secrets.DOCKER_TOKEN_SECRET }} - -# build-depmap-samples: -# if: github.actor != 'github-actions[bot]' -# needs: [depmap-docker-build] -# runs-on: ubuntu-20.04 -# environment: build -# steps: -# #Add upload artifact from depmap Samples -# - name: Checkout DepMap -# uses: actions/checkout@v2 -# # - name: Copy DepMap sample from build location. -# # run: | -# # cp build/depmap/requirements.txt . -# # cp build/depmap/requirements.r . -# # cp build/depmap/*.R . -# # cp build/depmap/*.py . -# # cp build/utils/* . -# - name: List files cwd -# run: ls -lah -# - name: cat reqs -# run: cat requirements.txt -# - name: Pull depmap image -# run: docker pull jjacobson95/depmap -# - name: Run depmap samples Container -# run: | -# docker run -v $PWD:/tmp/ jjacobson95/depmap Rscript /app/00-buildGeneFile.R -# docker run -v $PWD:/tmp/ jjacobson95/depmap Rscript /app/01-depmapSamples.R -# - name: Copy file from depmap Samples Container -# run: | -# mkdir depmap-samples genes-file -# mv depmap_samples.csv depmap-samples -# mv genes.csv genes-file -# - name: Upload artifacts for depmap -# uses: actions/upload-artifact@v2 -# with: -# name: depmap-samples -# path: depmap-samples -# - name: Upload artifacts for genes -# uses: actions/upload-artifact@v2 -# with: -# name: genes-file -# path: genes-file - -# build-drugs-beataml: -# if: github.actor != 'github-actions[bot]' -# runs-on: ubuntu-20.04 -# environment: build -# steps: -# - name: Checkout Repo -# uses: actions/checkout@v2 -# - name: Copy pubchem util and drug script to base dir -# run: | -# cp build/utils/pubchem_retrieval.py . -# cp build/beatAML/beataml_drug_retrieval.py . -# - name: install reqs -# run: | -# pip install -r requirements.txt -# - name: Append PYTHONPATH -# run: echo "PYTHONPATH=$PWD" >> $GITHUB_ENV -# - name: Run beataml Drug retrieval -# run: python beataml_drug_retrieval.py -# - name: Run beataml Drug retrieval second time to catch stragglers -# run: | -# mkdir additive-drugs-file-1 -# mv ignore_chems.txt additive-drugs-file-1 -# python beataml_drug_retrieval.py -# - name: Copy drugs file to artifact -# run: | -# mv drugs.tsv additive-drugs-file-1 -# - name: Upload artifacts for genes -# uses: actions/upload-artifact@v2 -# with: -# name: additive-drugs-file-1 -# path: additive-drugs-file-1 - -# #placeholder -# # build-drugs-mpnst: -# # if: github.actor != 'github-actions[bot]' -# # runs-on: ubuntu-20.04 -# # environment: build -# # steps: -# # - name: Checkout Repo -# # uses: actions/checkout@v2 -# # - name: Download artifacts from previous drug gen -# # uses: actions/download-artifact@v2 -# # with: -# # name: additive-drugs-file -# # - name: List files cwd -# # run: ls -lah -# # - name: Run mpnst Drug retrieval -# # run: python /build/mpnst/retrieve_drugs_mpnst.py -# # - name: Copy drugs file to artifact -# # run: | -# # mkdir additive-drugs-file -# # mv drugs.tsv ignore_chems.txt additive-drugs-file -# # - name: Upload artifacts for genes -# # uses: actions/upload-artifact@v2 -# # with: -# # name: additive-drugs-file -# # path: additive-drugs-file - -# build-drugs-depmap-CTRPv2-GDSC-gCSI-PRISM-CCLE-FIMM: -# if: github.actor != 'github-actions[bot]' -# runs-on: ubuntu-20.04 -# environment: build -# needs: [build-drugs-beataml,depmap-docker-build] -# steps: -# - name: Checkout Repo -# uses: actions/checkout@v2 -# - name: Download artifacts from previous drug gen -# uses: actions/download-artifact@v2 -# with: -# name: additive-drugs-file-1 -# - name: List files cwd -# run: ls -lah -# # - name: Install R -# # uses: r-lib/actions/setup-r@v2 -# # - name: Install R and Python Packages -# # run: | -# # Rscript build/depmap/requirements.r -# # pip install -r build/depmap/requirements.txt -# - name: Pull depmap image -# run: docker pull jjacobson95/depmap -# - name: Run depmap CTRPv2 Drug retrieval -# run: | -# docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R CTRPv2 -# - name: List files cwd -# run: ls -lah -# - name: Run depmap GDSC Drug retrieval -# run: | -# docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R GDSC -# - name: Run depmap gCSI Drug retrieval -# run: | -# docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R gCSI -# - name: Run depmap PRISM Drug retrieval -# run: | -# docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R PRISM -# - name: Run depmap CCLE Drug retrieval -# run: | -# docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R CCLE -# - name: Run depmap FIMM Drug retrieval -# run: | -# docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R FIMM -# - name: List files cwd -# run: ls -lah -# - name: Copy drugs file to artifact -# run: | -# mkdir additive-drugs-file-2 -# mv drugs.tsv ignore_chems.txt additive-drugs-file-2 -# - name: Upload artifacts for genes -# uses: actions/upload-artifact@v2 -# with: -# name: additive-drugs-file-2 -# path: additive-drugs-file-2 - -# build-drugs-depmap-NCI60-pt1: -# if: github.actor != 'github-actions[bot]' -# runs-on: ubuntu-20.04 -# environment: build -# needs: [build-drugs-depmap-CTRPv2-GDSC-gCSI-PRISM-CCLE-FIMM] -# steps: -# - name: Checkout Repo -# uses: actions/checkout@v2 -# - name: Download artifacts from previous drug gen -# uses: actions/download-artifact@v2 -# with: -# name: additive-drugs-file-2 -# - name: List files cwd -# run: ls -lah -# # - name: Install R -# # uses: r-lib/actions/setup-r@v2 -# # - name: Install R and Python Packages -# # run: | -# # Rscript build/depmap/requirements.r -# # pip install -r build/depmap/requirements.txt -# - name: Pull depmap image -# run: docker pull jjacobson95/depmap -# - name: Run depmap NCI60 Drug retrieval -# run: | -# docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R NCI60 -# # - name: Run depmap NCI60 Drug retrieval -# # run: Rscript build/depmap/CreateDrugFileCL.R NCI60 -# - name: Copy drugs file to artifact -# run: | -# mkdir additive-drugs-file-3 -# mv drugs.tsv ignore_chems.txt additive-drugs-file-3 -# - name: Upload artifacts for genes -# uses: actions/upload-artifact@v2 -# with: -# name: additive-drugs-file-3 -# path: additive-drugs-file-3 - - -# build-drugs-depmap-NCI60-pt2: -# if: github.actor != 'github-actions[bot]' -# runs-on: ubuntu-20.04 -# environment: build -# needs: [build-drugs-depmap-NCI60-pt1] -# steps: -# - name: Checkout Repo -# uses: actions/checkout@v2 -# - name: Download artifacts from previous drug gen -# uses: actions/download-artifact@v2 -# with: -# name: additive-drugs-file-3 -# - name: List files cwd -# run: ls -lah -# - name: Pull depmap image -# run: docker pull jjacobson95/depmap -# - name: Run depmap NCI60 Drug retrieval -# run: | -# docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R NCI60 -# - name: Copy drugs file to artifact -# run: | -# mkdir additive-drugs-file-4 -# mv drugs.tsv ignore_chems.txt additive-drugs-file-4 -# - name: Upload artifacts for genes -# uses: actions/upload-artifact@v2 -# with: -# name: additive-drugs-file-4 -# path: additive-drugs-file-4 - - -# build-drugs-depmap-NCI60-pt3: -# if: github.actor != 'github-actions[bot]' -# runs-on: ubuntu-20.04 -# environment: build -# needs: [build-drugs-depmap-NCI60-pt2] -# steps: -# - name: Checkout Repo -# uses: actions/checkout@v2 -# - name: Download artifacts from previous drug gen -# uses: actions/download-artifact@v2 -# with: -# name: additive-drugs-file-4 -# - name: List files cwd -# run: ls -lah -# - name: Pull depmap image -# run: docker pull jjacobson95/depmap -# - name: Run depmap NCI60 Drug retrieval -# run: | -# docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R NCI60 -# - name: Copy drugs file to artifact -# run: | -# mkdir additive-drugs-file-5 -# mv drugs.tsv ignore_chems.txt additive-drugs-file-5 -# - name: Upload artifacts for genes -# uses: actions/upload-artifact@v2 -# with: -# name: additive-drugs-file-5 -# path: additive-drugs-file-5 - - -# build-drugs-depmap-NCI60-pt4: -# if: github.actor != 'github-actions[bot]' -# runs-on: ubuntu-20.04 -# environment: build -# needs: [build-drugs-depmap-NCI60-pt3] -# steps: -# - name: Checkout Repo -# uses: actions/checkout@v2 -# - name: Download artifacts from previous drug gen -# uses: actions/download-artifact@v2 -# with: -# name: additive-drugs-file-5 -# - name: List files cwd -# run: ls -lah -# - name: Pull depmap image -# run: docker pull jjacobson95/depmap -# - name: Run depmap NCI60 Drug retrieval -# run: | -# docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R NCI60 -# - name: Copy drugs file to artifact -# run: | -# mkdir additive-drugs-file-6 -# mv drugs.tsv ignore_chems.txt additive-drugs-file-6 -# - name: Upload artifacts for genes -# uses: actions/upload-artifact@v2 -# with: -# name: additive-drugs-file-6 -# path: additive-drugs-file-6 - -# # build-drugs-depmap-NCI60-pt5: -# # if: github.actor != 'github-actions[bot]' -# # runs-on: ubuntu-20.04 -# # environment: build -# # needs: [build-drugs-depmap-NCI60-pt4] -# # steps: -# # - name: Checkout Repo -# # uses: actions/checkout@v2 -# # - name: Download artifacts from previous drug gen -# # uses: actions/download-artifact@v2 -# # with: -# # name: additive-drugs-file-6 -# # - name: List files cwd -# # run: ls -lah -# # - name: Pull depmap image -# # run: docker pull jjacobson95/depmap -# # - name: Run depmap NCI60 Drug retrieval -# # run: | -# # docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R NCI60 -# # - name: Copy drugs file to artifact -# # run: | -# # mkdir additive-drugs-file-7 -# # mv drugs.tsv ignore_chems.txt additive-drugs-file-7 -# # - name: Upload artifacts for genes -# # uses: actions/upload-artifact@v2 -# # with: -# # name: additive-drugs-file-7 -# # path: additive-drugs-file-7 - -# # build-drugs-depmap-NCI60-pt6: -# # if: github.actor != 'github-actions[bot]' -# # runs-on: ubuntu-20.04 -# # environment: build -# # needs: [build-drugs-depmap-NCI60-pt5] -# # steps: -# # - name: Checkout Repo -# # uses: actions/checkout@v2 -# # - name: Download artifacts from previous drug gen -# # uses: actions/download-artifact@v2 -# # with: -# # name: additive-drugs-file-7 -# # - name: List files cwd -# # run: ls -lah -# # - name: Pull depmap image -# # run: docker pull jjacobson95/depmap -# # - name: Run depmap NCI60 Drug retrieval -# # run: | -# # docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R NCI60 -# # - name: Copy drugs file to artifact -# # run: | -# # mkdir additive-drugs-file-8 -# # mv drugs.tsv ignore_chems.txt additive-drugs-file-8 -# # - name: Upload artifacts for genes -# # uses: actions/upload-artifact@v2 -# # with: -# # name: additive-drugs-file-8 -# # path: additive-drugs-file-8 - -# # build-drugs-depmap-NCI60-pt7: -# # if: github.actor != 'github-actions[bot]' -# # runs-on: ubuntu-20.04 -# # environment: build -# # needs: [build-drugs-depmap-NCI60-pt6] -# # steps: -# # - name: Checkout Repo -# # uses: actions/checkout@v2 -# # - name: Download artifacts from previous drug gen -# # uses: actions/download-artifact@v2 -# # with: -# # name: additive-drugs-file-8 -# # - name: List files cwd -# # run: ls -lah -# # - name: Pull depmap image -# # run: docker pull jjacobson95/depmap -# # - name: Run depmap NCI60 Drug retrieval -# # run: | -# # docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R NCI60 -# # - name: Copy drugs file to artifact -# # run: | -# # mkdir additive-drugs-file-9 -# # mv drugs.tsv ignore_chems.txt additive-drugs-file-9 -# # - name: Upload artifacts for genes -# # uses: actions/upload-artifact@v2 -# # with: -# # name: additive-drugs-file-9 -# # path: additive-drugs-file-9 - -# # build-drugs-depmap-NCI60-pt8: -# # if: github.actor != 'github-actions[bot]' -# # runs-on: ubuntu-20.04 -# # environment: build -# # needs: [build-drugs-depmap-NCI60-pt7] -# # steps: -# # - name: Checkout Repo -# # uses: actions/checkout@v2 -# # - name: Download artifacts from previous drug gen -# # uses: actions/download-artifact@v2 -# # with: -# # name: additive-drugs-file-9 -# # - name: List files cwd -# # run: ls -lah -# # - name: Pull depmap image -# # run: docker pull jjacobson95/depmap -# # - name: Run depmap NCI60 Drug retrieval -# # run: | -# # docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R NCI60 -# # - name: Copy drugs file to artifact -# # run: | -# # mkdir additive-drugs-file-10 -# # mv drugs.tsv ignore_chems.txt additive-drugs-file-10 -# # - name: Upload artifacts for genes -# # uses: actions/upload-artifact@v2 -# # with: -# # name: additive-drugs-file-10 -# # path: additive-drugs-file-10 - -# # build-drugs-depmap-NCI60-pt9: -# # if: github.actor != 'github-actions[bot]' -# # runs-on: ubuntu-20.04 -# # environment: build -# # needs: [build-drugs-depmap-NCI60-pt8] -# # steps: -# # - name: Checkout Repo -# # uses: actions/checkout@v2 -# # - name: Download artifacts from previous drug gen -# # uses: actions/download-artifact@v2 -# # with: -# # name: additive-drugs-file-10 -# # - name: List files cwd -# # run: ls -lah -# # - name: Pull depmap image -# # run: docker pull jjacobson95/depmap -# # - name: Run depmap NCI60 Drug retrieval -# # run: | -# # docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R NCI60 -# # - name: Copy drugs file to artifact -# # run: | -# # mkdir additive-drugs-file-11 -# # mv drugs.tsv ignore_chems.txt additive-drugs-file-11 -# # - name: Upload artifacts for genes -# # uses: actions/upload-artifact@v2 -# # with: -# # name: additive-drugs-file-11 -# # path: additive-drugs-file-11 - -# # build-drugs-depmap-NCI60-pt10: -# # if: github.actor != 'github-actions[bot]' -# # runs-on: ubuntu-20.04 -# # environment: build -# # needs: [build-drugs-depmap-NCI60-pt9] -# # steps: -# # - name: Checkout Repo -# # uses: actions/checkout@v2 -# # - name: Download artifacts from previous drug gen -# # uses: actions/download-artifact@v2 -# # with: -# # name: additive-drugs-file-11 -# # - name: List files cwd -# # run: ls -lah -# # - name: Pull depmap image -# # run: docker pull jjacobson95/depmap -# # - name: Run depmap NCI60 Drug retrieval -# # run: | -# # docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R NCI60 -# # - name: Copy drugs file to artifact -# # run: | -# # mkdir additive-drugs-file-12 -# # mv drugs.tsv ignore_chems.txt additive-drugs-file-12 -# # - name: Upload artifacts for genes -# # uses: actions/upload-artifact@v2 -# # with: -# # name: additive-drugs-file-12 -# # path: additive-drugs-file-12 - -# # build-drugs-depmap-NCI60-pt11: -# # if: github.actor != 'github-actions[bot]' -# # runs-on: ubuntu-20.04 -# # environment: build -# # needs: [build-drugs-depmap-NCI60-pt10] -# # steps: -# # - name: Checkout Repo -# # uses: actions/checkout@v2 -# # - name: Download artifacts from previous drug gen -# # uses: actions/download-artifact@v2 -# # with: -# # name: additive-drugs-file-12 -# # - name: List files cwd -# # run: ls -lah -# # - name: Pull depmap image -# # run: docker pull jjacobson95/depmap -# # - name: Run depmap NCI60 Drug retrieval -# # run: | -# # docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R NCI60 -# # - name: Copy drugs file to artifact -# # run: | -# # mkdir additive-drugs-file-13 -# # mv drugs.tsv ignore_chems.txt additive-drugs-file-13 -# # - name: Upload artifacts for genes -# # uses: actions/upload-artifact@v2 -# # with: -# # name: additive-drugs-file-13 -# # path: additive-drugs-file-13 - -# build-drugs-depmap-capture-stragglers: -# if: github.actor != 'github-actions[bot]' -# runs-on: ubuntu-20.04 -# environment: build -# needs: [build-drugs-depmap-NCI60-pt4] -# steps: -# - name: Checkout Repo -# uses: actions/checkout@v2 -# - name: Download artifacts from previous drug gen -# uses: actions/download-artifact@v2 -# with: -# name: additive-drugs-file-6 -# - name: List files cwd -# run: ls -lah -# - name: List files cwd -# run: rm ignore_chems.txt -# - name: Pull depmap image -# run: docker pull jjacobson95/depmap -# - name: Run depmap straggler Drug retrieval -# run: | -# docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R CTRPv2,GDSC,gCSI,PRISM,CCLE,FIMM,NCI60 -# - name: Copy drugs file to artifact -# run: | -# mkdir additive-drugs-file-7 -# mv drugs.tsv ignore_chems.txt additive-drugs-file-7 -# - name: Upload artifacts for genes -# uses: actions/upload-artifact@v2 -# with: -# name: additive-drugs-file-7 -# path: additive-drugs-file-7 - -# build-cptac-samples: -# if: github.actor != 'github-actions[bot]' -# runs-on: ubuntu-20.04 -# environment: build -# needs: [build-depmap-samples,cptac-docker-build] -# steps: -# #Add upload artifact from CPTAC Samples -# - name: Checkout CPTAC -# uses: actions/checkout@v2 -# - name: Download artifacts from depmap -# uses: actions/download-artifact@v2 -# with: -# name: depmap-samples -# - name: Download artifacts from DepMap (genes) -# uses: actions/download-artifact@v2 -# with: -# name: genes-file -# # - name: Copy DepMap sample from build location. -# # run: | -# # cp build/cptac/requirements.txt . -# # cp build/cptac/*.py . -# # # copy build/genes.csv . -# - name: Pull cptac image -# run: docker pull jjacobson95/cptac -# - name: Run CPTAC samples Container -# run: docker run -v $PWD:/tmp jjacobson95/cptac --geneFile=/tmp/genes.csv --prevSampleFile=/tmp/depmap_samples.csv -# - name: Copy file from CPTAC Samples Container -# run: | -# mkdir cptac-samples -# mv cptac_samples.csv cptac-samples -# - name: Upload artifacts for CPTAC -# uses: actions/upload-artifact@v2 -# with: -# name: cptac-samples -# path: cptac-samples - -# build-hcmi-samples: -# if: github.actor != 'github-actions[bot]' -# runs-on: ubuntu-20.04 -# environment: build -# needs: [build-cptac-samples,hcmi-docker-build] -# steps: -# - name: Checkout HCMI -# uses: actions/checkout@v2 -# - name: Download artifacts from CPTAC -# uses: actions/download-artifact@v2 -# with: -# name: cptac-samples -# # - name: Build HCMI Image -# # run: docker build -t hcmi-samples-builder -f build/docker/Dockerfile.hcmi . -# - name: Pull hcmi image -# run: docker pull jjacobson95/hcmi -# - name: Run HCMI samples Container -# run: docker run -v $PWD:/tmp --name hcmi-samples-container jjacobson95/hcmi python 01-createHCMISamplesFile.py -# - name: Copy file from HCMI Samples Container -# run: | -# mkdir hcmi-samples -# for file in hcmi_samples.csv; do -# docker cp hcmi-samples-container:/usr/src/app/$file hcmi-samples/$file -# done -# - name: Get HCMI container logs -# run: docker logs hcmi-samples-container -# - name: Upload artifacts for HCMI -# uses: actions/upload-artifact@v2 -# with: -# name: hcmi-samples -# path: hcmi-samples - -# build-beataml-samples: -# if: github.actor != 'github-actions[bot]' -# runs-on: ubuntu-20.04 -# environment: build -# needs: [build-hcmi-samples,beataml-docker-build] -# steps: -# #Add upload artifact from CPTAC Samples -# - name: Checkout BeatAML -# uses: actions/checkout@v2 -# - name: Download artifacts from HCMI -# uses: actions/download-artifact@v2 -# with: -# name: hcmi-samples -# - name: Pull beataml image -# run: docker pull jjacobson95/beataml -# - name: Run BeatAML Container with samples option -# run: docker run -v $PWD:/tmp --name beataml-samples-container jjacobson95/beataml python GetBeatAML.py --token ${{ secrets.SYNAPSE_TOKEN_SECRET }} --samples -# - name: Copy file from BeatAML Samples Container -# run: | -# mkdir beataml-samples -# for file in beataml_samples.csv; do -# docker cp beataml-samples-container:/usr/src/app/$file beataml-samples/$file -# done -# - name: Get BeatAML container logs -# run: docker logs beataml-samples-container -# - name: Upload artifacts for BeatAML -# uses: actions/upload-artifact@v2 -# with: -# name: beataml-samples -# path: beataml-samples - -# # Placeholder -# build-mpnst-samples: -# if: github.actor != 'github-actions[bot]' -# runs-on: ubuntu-20.04 -# environment: build -# needs: [build-beataml-samples,mpnst-docker-build] -# steps: -# #Add upload artifact from CPTAC Samples -# - name: Checkout MPNST -# uses: actions/checkout@v2 - -# build-hcmi: -# if: github.actor != 'github-actions[bot]' -# needs: [build-hcmi-samples] -# runs-on: ubuntu-20.04 -# environment: build -# steps: -# - name: Checkout HCMI -# uses: actions/checkout@v2 -# - name: Download artifacts from HCMI -# uses: actions/download-artifact@v2 -# with: -# name: hcmi-samples -# - name: List files cwd -# run: ls -lah -# # - name: Build HCMI Image -# # run: docker build -t hcmi-builder -f build/docker/Dockerfile.hcmi . -# - name: Pull hcmi image -# run: docker pull jjacobson95/hcmi -# - name: Run HCMI Container -# run: | -# docker run -v $PWD:/tmp --name hcmi-container jjacobson95/hcmi /bin/bash -c "python 02-getHCMIData.py -m full_manifest.txt -t transcriptomics -o hcmi_transcriptomics.csv && python 02-getHCMIData.py -m full_manifest.txt -M full_manifest_files -t copy_number -o hcmi_copy_number.csv && python 02-getHCMIData.py -m full_manifest.txt -M full_manifest_files -t mutations -o hcmi_mutations.csv" -# - name: Copy files from HCMI Container -# run: | -# mkdir hcmi-files -# for file in hcmi_transcriptomics.csv hcmi_copy_number.csv hcmi_mutations.csv; do -# docker cp hcmi-container:/usr/src/app/$file hcmi-files/$file -# done -# cp hcmi_samples.csv hcmi-files -# - name: Get HCMI container logs -# run: docker logs hcmi-container -# - name: Upload artifacts for HCMI -# uses: actions/upload-artifact@v2 -# with: -# name: hcmi-files -# path: hcmi-files - -# check-hcmi-schema: -# if: github.actor != 'github-actions[bot]' -# needs: [build-hcmi] -# runs-on: ubuntu-20.04 -# environment: build -# steps: -# - name: Checkout code HCMI -# uses: actions/checkout@v2 -# - name: Download artifacts from HCMI Samples -# uses: actions/download-artifact@v2 -# with: -# name: hcmi-samples -# - name: Download artifacts from HCMI -# uses: actions/download-artifact@v2 -# with: -# name: hcmi-files -# - name: Download linkml -# run: | -# pip install linkml -# pip install linkml-validator -# - name: check dir -# run: ls -# - name: Run linkml schema checker -# run: bash schema/check_hcmi_linkml.sh - -# build-beataml: -# if: github.actor != 'github-actions[bot]' -# needs: [build-beataml-samples,build-drugs-depmap-capture-stragglers] -# runs-on: ubuntu-20.04 -# environment: build -# steps: -# - name: Checkout code BeatAML -# uses: actions/checkout@v2 -# - name: Download artifacts from Beataml Samples -# uses: actions/download-artifact@v2 -# with: -# name: beataml-samples -# - name: Download artifacts from Drugs -# uses: actions/download-artifact@v2 -# with: -# name: additive-drugs-file-7 -# - name: List files cwd -# run: ls -lah -# - name: Pull beataml image -# run: docker pull jjacobson95/beataml -# - name: Run BeatAML Container -# run: docker run -v $PWD:/tmp --name beataml-container jjacobson95/beataml python GetBeatAML.py --token ${{ secrets.SYNAPSE_TOKEN_SECRET }} -# - name: Copy files from BeatAML Container -# run: | -# mkdir beataml-files -# for file in beataml_transcriptomics.csv beataml_proteomics.csv beataml_mutations.csv beataml_drugs.tsv beataml_experiments.csv; do -# docker cp beataml-container:/usr/src/app/$file beataml-files/$file -# done -# cp beataml_samples.csv beataml-files -# - name: Get BeatAML container logs -# run: docker logs beataml-container -# - name: Upload artifact for BeatAML -# uses: actions/upload-artifact@v2 -# with: -# name: beataml-files -# path: beataml-files - - -# check-beataml-schema: -# if: github.actor != 'github-actions[bot]' -# needs: [build-beataml] -# runs-on: ubuntu-20.04 -# environment: build -# steps: -# - name: Checkout code BeatAML -# uses: actions/checkout@v2 -# - name: Download artifacts from Beataml Samples -# uses: actions/download-artifact@v2 -# with: -# name: beataml-samples -# - name: Download artifacts from Beataml -# uses: actions/download-artifact@v2 -# with: -# name: beataml-files -# - name: Download linkml -# run: | -# pip install linkml -# pip install linkml-validator -# - name: check dir -# run: ls -# - name: Run linkml schema checker -# run: bash schema/check_beataml_linkml.sh - -# build-depmap: -# if: github.actor != 'github-actions[bot]' -# needs: [build-depmap-samples,build-drugs-depmap-capture-stragglers] -# runs-on: ubuntu-20.04 -# environment: build -# steps: -# - name: Checkout DepMap -# uses: actions/checkout@v2 -# # - name: Copy DepMap sample from build location. -# # run: | -# # cp build/depmap/requirements.txt . -# # cp build/depmap/requirements.r . -# # cp build/depmap/*.R . -# # cp build/depmap/*.py . -# # cp build/utils/* . -# - name: Download artifacts from DepMap (samples) -# uses: actions/download-artifact@v2 -# with: -# name: depmap-samples -# - name: Download artifacts from DepMap (genes) -# uses: actions/download-artifact@v2 -# with: -# name: genes-file -# - name: Download artifacts from Drugs -# uses: actions/download-artifact@v2 -# with: -# name: additive-drugs-file-7 -# - name: gzip drugs file -# run: gzip drugs.tsv -# - name: List files cwd -# run: ls -lah -# - name: cat reqs -# run: cat requirements.txt -# - name: Pull depmap image -# run: docker pull jjacobson95/depmap -# # - name: docker save space and stats -# # run: | -# # docker image prune -f -# # docker container prune -f -# # docker volume prune -f -# # docker network prune -f -# # docker system df -# - name: Run depmap 02-pullDepMap.R Container -# run: | -# docker run -v $PWD:/tmp/ jjacobson95/depmap Rscript /app/02-pullDepMap.R /tmp/genes.csv /tmp/depmap_samples.csv -# - name: Run depmap 02b-pullSanger.R Container -# run: | -# docker run -v $PWD:/tmp/ jjacobson95/depmap Rscript /app/02b-pullSanger.R /tmp/genes.csv /tmp/depmap_samples.csv -# # - name: Run depmap 03-createDrugFile.RContainer -# # run: | -# # docker run -v $PWD:/tmp depmap Rscript 03-createDrugFile.R CTRPv2,GDSC,gCSI,PRISM,CCLE,FIMM,NCI60 -# - name: Run depmap 04-drug_dosage_and_curves.py Container -# run: | -# docker run -v $PWD:/tmp/ jjacobson95/depmap /opt/venv/bin/python /app/04-drug_dosage_and_curves.py --drugfile=/tmp/drugs.tsv.gz --curSampleFile=/tmp/depmap_samples.csv -# - name: Run depmap 01b-pullDrugs_LINCS.py Container -# run: | -# docker run -v $PWD:/tmp jjacobson95/depmap /opt/venv/bin/python /app/01b-pullDrugs_LINCS.py --drugFile /tmp/drugs.tsv.gz -# - name: Run depmap 04-pullDrugs_LINCS.py Container -# run: | -# docker run -v $PWD:/tmp jjacobson95/depmap /opt/venv/bin/python /app/04-pullDrugs_LINCS.py --drugFile /tmp/drugs.tsv.gz -# - name: Run depmap 05-LINCS_perturbations.py Container -# run: | -# docker run -v $PWD:/tmp/ jjacobson95/depmap Rscript /app/05-LINCS_perturbations.R /tmp/genes.csv /tmp/drugs.tsv.gz /tmp/depmap_samples.csv -# - name: List files cwd -# run: ls -lah -# - name: Copy files from DepMap Container -# run: | -# mkdir depmap-files -# cp depmap_* depmap-files -# - name: Upload artifacts for DepMap -# uses: actions/upload-artifact@v2 -# with: -# name: depmap-files -# path: depmap-files - -# check-depmap-schema: -# if: github.actor != 'github-actions[bot]' -# needs: [build-depmap] -# runs-on: ubuntu-20.04 -# environment: build -# steps: -# - name: Checkout code DepMap -# uses: actions/checkout@v2 -# - name: Download artifacts from DepMap Samples -# uses: actions/download-artifact@v2 -# with: -# name: depmap-samples -# - name: Download artifacts from DepMap -# uses: actions/download-artifact@v2 -# with: -# name: depmap-files -# - name: Download linkml -# run: | -# pip install linkml -# pip install linkml-validator -# - name: check dir -# run: ls -# - name: Run linkml schema checker -# run: bash schema/check_depmap_linkml.sh - - -# build-cptac: -# if: github.actor != 'github-actions[bot]' -# needs: [build-cptac-samples] -# runs-on: ubuntu-20.04 -# environment: build -# steps: -# - name: Checkout CPTAC -# uses: actions/checkout@v2 -# - name: Download artifacts from CPTAC -# uses: actions/download-artifact@v2 -# with: -# name: cptac-samples -# - name: Download artifacts from DepMap (genes) -# uses: actions/download-artifact@v2 -# with: -# name: genes-file -# - name: Copy files from build location. -# run: | -# cp build/cptac/*.py . -# cp build/cptac/requirements.txt . -# # copy build/genes.csv . -# - name: List files cwd -# run: ls -lah -# - name: Pull cptac image -# run: docker pull jjacobson95/cptac -# - name: Run CPTAC Container -# run: | -# docker run -v $PWD:/tmp jjacobson95/cptac --geneFile=/tmp/genes.csv --curSampleFile=/tmp/cptac_samples.csv -# - name: Copy files from CPTAC Container -# run: | -# mkdir cptac-files -# cp cptac_* cptac-files -# - name: Upload artifacts for CPTAC -# uses: actions/upload-artifact@v2 -# with: -# name: cptac-files -# path: cptac-files - -# check-cptac-schema: -# if: github.actor != 'github-actions[bot]' -# needs: [build-cptac] -# runs-on: ubuntu-20.04 -# environment: build -# steps: -# - name: Checkout code CPTAC -# uses: actions/checkout@v2 -# - name: Download artifacts from CPTAC Samples -# uses: actions/download-artifact@v2 -# with: -# name: cptac-samples -# - name: Download artifacts from CPTAC -# uses: actions/download-artifact@v2 -# with: -# name: cptac-files -# - name: Download linkml and gunzip files -# run: | -# pip install linkml -# pip install linkml-validator -# find . -type f -name '*.gz' -exec gunzip {} + -# - name: check dir -# run: ls -# - name: Run linkml schema checker -# run: bash schema/check_cptac_linkml.sh - -# #placeholder -# build-mpnst: -# if: github.actor != 'github-actions[bot]' -# needs: [build-mpnst-samples] -# runs-on: ubuntu-20.04 -# environment: build -# steps: -# - name: Checkout code MPNST -# uses: actions/checkout@v2 - -# # Placeholder -# check-mpnst-schema: -# if: github.actor != 'github-actions[bot]' -# needs: [build-mpnst] -# runs-on: ubuntu-20.04 -# environment: build -# steps: -# - name: Checkout code MPNST -# uses: actions/checkout@v2 -# # - name: Download artifacts from MPNST Samples -# # uses: actions/download-artifact@v2 -# # with: -# # name: mpnst-samples -# # - name: Download artifacts from MPNST -# # uses: actions/download-artifact@v2 -# # with: -# # name: mpnst-files -# # - name: Download linkml -# # run: | -# # pip install linkml -# # pip install linkml-validator -# # - name: check dir -# # run: ls -# # - name: Run linkml schema checker -# # run: bash schema/check_mpnst_linkml.sh - -# data-visualization: -# if: github.actor != 'github-actions[bot]' -# needs: [check-hcmi-schema, check-beataml-schema, check-depmap-schema, check-cptac-schema, check-mpnst-schema] -# environment: build -# runs-on: ubuntu-20.04 -# steps: -# - name: Set up R -# uses: r-lib/actions/setup-r@v2 -# - name: Install R packages -# run: | -# R -e "install.packages('RColorBrewer', dependencies=TRUE, repos='http://cran.rstudio.com/')" -# R -e "install.packages('circlize', dependencies=TRUE, repos='http://cran.rstudio.com/')" -# R -e "install.packages('dplyr', dependencies=TRUE, repos='http://cran.rstudio.com/')" -# R -e "install.packages('readr', dependencies=TRUE, repos='http://cran.rstudio.com/')" -# R -e "install.packages('tools', dependencies=TRUE, repos='http://cran.rstudio.com/')" -# R -e "install.packages('ggplot2', dependencies=TRUE, repos='http://cran.rstudio.com/')" -# R -e "install.packages('reshape2', dependencies=TRUE, repos='http://cran.rstudio.com/')" -# R -e "install.packages('ComplexUpset', dependencies=TRUE, repos='http://cran.rstudio.com/')" -# - name: checkout repo content -# uses: actions/checkout@v2 -# - name: Download artifacts from HCMI -# uses: actions/download-artifact@v2 -# with: -# name: hcmi-files -# - name: Download artifacts from BeatAML -# uses: actions/download-artifact@v2 -# with: -# name: beataml-files -# - name: Download artifacts from DepMap -# uses: actions/download-artifact@v2 -# with: -# name: depmap-files -# # - name: Download artifacts from MPNST -# # uses: actions/download-artifact@v2 -# # with: -# # name: mpnst-files -# - name: Download artifacts from cptac -# uses: actions/download-artifact@v2 -# with: -# name: cptac-files -# # - name: Install coderdata and skip build steps -# # run: pip install coderdata -# # - name: Download cptac data from coder data -# # run: coderdata download --prefix cptac -# # - name: Download depmap data from coder data -# # run: coderdata download --prefix depmap -# # - name: Download all data from coder data -# # run: coderdata download -# - name: Create all-files directory -# run: mkdir all-files -# - name: List files cwd -# run: ls -lah -# - name: List files dataSummary dir -# run: ls -lah dataSummary -# - name: Gzip all non-samples csv files in current dir. -# run: | -# find . -type f -name '*.csv' ! -name '*samples*' -exec gzip -k "{}" + -# - name: Run Visualization01 -# if: success() || failure() -# run: Rscript dataSummary/visualization01.R -# - name: Run Visualization02 -# if: success() || failure() -# run: Rscript dataSummary/visualization02.R -# - name: setup data-vis dir -# if: success() || failure() -# run: | -# mkdir -p data-vis -# rsync -av --remove-source-files --include='*.png' --include='*.pdf' --include='*table.csv' --exclude='*' . data-vis/ -# - name: Upload artifacts -# if: success() || failure() -# uses: actions/upload-artifact@v2 -# with: -# name: data-vis -# path: data-vis - -# data-visualization-save-to-docs: -# if: github.actor != 'github-actions[bot]' -# needs: [data-visualization] -# environment: build -# runs-on: ubuntu-20.04 -# steps: -# - name: Checkout repo content -# uses: actions/checkout@v2 -# - name: Setup Git config and pull -# run: | -# git config user.name "jjacobson95" -# git config user.email "jeremy.jacobson3402@gmail.com" -# git pull -# - name: Download artifacts from data-vis -# uses: actions/download-artifact@v2 -# with: -# name: data-vis -# - name: List files cwd -# run: ls -lah -# - name: List files .. -# run: ls -lah .. -# - name: List files all -# run: ls -lah * -# - name: Move files to docs directory -# run: | -# rsync -av --remove-source-files --include='*.png' --include='*.pdf' --exclude='*' . docs/assets/stats -# rsync -av --remove-source-files --include='*table.csv' --exclude='*' . docs/_data -# # rsync -av --remove-source-files --include='*.png' --include='*.pdf' --include='*table.csv' --exclude='*' . docs/ -# - name: List files in docs after moving -# run: ls -lah docs -# - name: List files in local after moving -# run: ls -lah -# - name: Git add and push new changes. -# run: | -# git add -f docs/* -# git status -# if git diff --staged --quiet; then -# echo "No changes to commit" -# else -# git commit -m "Add data visualization artifacts to docs" -# git push -# fi -# gen-stats-and-push: -# if: github.actor != 'github-actions[bot]' -# needs: [build-hcmi, build-beataml, build-depmap, build-cptac, build-mpnst] -# environment: build -# runs-on: ubuntu-20.04 -# steps: -# - name: Checkout repo content -# uses: actions/checkout@v2 -# - name: Setup Git config and pull -# run: | -# git config user.name "jjacobson95" -# git config user.email "jeremy.jacobson3402@gmail.com" -# git pull -# - name: Download artifacts from HCMI -# uses: actions/download-artifact@v2 -# with: -# name: hcmi-files -# - name: Download artifacts from BeatAML -# uses: actions/download-artifact@v2 -# with: -# name: beataml-files -# - name: Download artifacts from DepMap -# uses: actions/download-artifact@v2 -# with: -# name: depmap-files -# # If this pipeline is supported in the future, Gen stats has been updated to include mpnst too. -# # - name: Download artifacts from MPNST -# # uses: actions/download-artifact@v2 -# # with: -# # name: mpnst-files -# - name: Download artifacts from cptac -# uses: actions/download-artifact@v2 -# with: -# name: cptac-files -# - name: Install coderdata -# run: | -# pip install coderdata -# pip install pyyaml -# - name: Run stats generation script -# run: | -# python scripts/gen_stats.py -# - name: Git add and push new changes if they exist. -# run: | -# git pull -# mv stats.yml docs/_data/stats.yml -# git add -f docs/_data/stats.yml -# git status -# if git diff --staged --quiet; then -# echo "No changes to commit" -# else -# git commit -m "Add stats.yml to docs/_data" -# git push -# fi - -# upload-to-figshare: -# if: github.actor != 'github-actions[bot]' -# needs: [check-hcmi-schema, check-beataml-schema, check-depmap-schema, check-cptac-schema, check-mpnst-schema] -# # needs: [build-hcmi, build-beataml, build-depmap, build-cptac, build-mpnst] -# environment: build -# runs-on: ubuntu-20.04 -# steps: -# - name: checkout repo content -# uses: actions/checkout@v2 -# - name: Download artifacts from HCMI -# uses: actions/download-artifact@v2 -# with: -# name: hcmi-files -# - name: Download artifacts from BeatAML -# uses: actions/download-artifact@v2 -# with: -# name: beataml-files -# - name: Download artifacts from CPTAC -# uses: actions/download-artifact@v2 -# with: -# name: cptac-files -# - name: Download artifacts from DepMap -# uses: actions/download-artifact@v2 -# with: -# name: depmap-files -# # - name: Download artifacts from MPNST -# # uses: actions/download-artifact@v2 -# # with: -# # name: mpnst-files -# - name: Create all-files directory -# run: mkdir all-files -# - name: List files cwd -# run: ls -lah -# - name: Move files to all-files -# run: | -# rsync -av --remove-source-files --include='*.csv' --include='*.tsv' --include='*.gz' --exclude='*' . all-files/ -# - name: gzip all files in all-files -# run: gzip all-files/* -# - name: gunzip all samples files in all-files -# run: gunzip all-files/*samples* -# - name: List files in all-files -# run: ls -lah all-files/ -# # - name: Upload to Figshare -# # # This can be updated to trigger with tag releases. -# # # run: python scripts/push_to_figshare.py --directory all-files --title "CODERData${{ github.event.release.tag_name }}" --token ${{ secrets.FIGSHARE_TOKEN_SECRET }} -p False -# # #This is a short term alternative. Links to branch. Not as pretty but okay for now. - -# # #To do: Extract version number from setup.py and run there. This can occur after merge with package dev branch. -# # run: python scripts/push_to_figshare.py --directory all-files --title "CODERData${{ github.ref }}" --token ${{ secrets.FIGSHARE_TOKEN_SECRET }} --project_id 189342 --publish -# - name: Extract version from setup.py -# id: version -# run: echo "PACKAGE_VERSION=$(grep 'version=' setup.py | sed -n "s/.*version='\(.*\)'.*/\1/p")" >> $GITHUB_ENV -# - name: Upload to Figshare -# run: python scripts/push_to_figshare.py --directory all-files --title "CODERData${{ env.PACKAGE_VERSION }}" --token ${{ secrets.FIGSHARE_TOKEN_SECRET }} --project_id 189342 --publish -# - name: List files in all-files -# run: ls -lah all-files/ -# - name: Setup Git config -# run: | -# git config user.name "jjacobson95" -# git config user.email "jeremy.jacobson3402@gmail.com" -# - name: Commit and push changes -# run: | -# git pull -# mv figshare_latest.yml docs/_data -# git add -f docs/* -# git status -# git commit -m "Add figshare_latest.yml to docs/_data" -# git push - # update-package-download-function: - # if: github.actor != 'github-actions[bot]' - # needs: [upload-to-figshare] - # environment: build - # runs-on: ubuntu-20.04 - # steps: - # - name: checkout repo content - # uses: actions/checkout@v2 - # - name: Update figshare path in downloader.py - # run: | - # python scripts/update_download_function.py -y docs/_data/figshare_latest.yml -d coderdata/download/downloader.py - # cat coderdata/download/downloader.py - # - name: Setup Git config - # run: | - # git config user.name "jjacobson95" - # git config user.email "jeremy.jacobson3402@gmail.com" - # - name: Commit and push changes - # run: | - # git pull - # git add coderdata/download/downloader.py - # git commit -m "update downloader.py" - # git push - - # run-tests: - # if: github.actor != 'github-actions[bot]' - # needs: [update-package-download-function] - # runs-on: ubuntu-latest - # strategy: - # fail-fast: false - # matrix: - # test-file: [ - # 'test_download_and_load_beataml.py', - # 'test_download_and_load_depmap.py', - # 'test_download_beataml_cli.py', - # 'test_download_depmap_cli.py', - # 'test_download_and_load_cptac.py', - # 'test_download_and_load_hcmi.py', - # 'test_download_cptac_cli.py', - # 'test_download_hcmi_cli.py', - # 'test_reformat_datasets.py', - # 'test_reload_one.py', - # 'test_reload_all.py', - # 'test_join_datasets.py', - # 'test_info.py' - # ] - # outputs: - # result: ${{ steps.test-outcome.outcome }} - # steps: - # - uses: actions/checkout@v2 - # with: - # fetch-depth: 0 - # - name: Set up Python - # uses: actions/setup-python@v2 - # with: - # python-version: '3.10' - # - name: Install dependencies - # run: | - # python -m pip install --upgrade pip - # pip install -r requirements.txt - # pip install pytest-xdist - # - name: Install as package - # run: | - # pip install . - # - name: Run test - # id: test-outcome - # run: | - # pytest -n 4 tests/${{ matrix.test-file }} - - # build-and-publish: - # if: github.actor != 'github-actions[bot]' - # needs: [run-tests] - # runs-on: ubuntu-latest - # environment: build - # steps: - # - uses: actions/checkout@v2 - # with: - # fetch-depth: 0 - - # - name: Fetch tags from main branch - # run: | - # git fetch origin 'refs/tags/*:refs/tags/*' - - # - name: Set up Python - # uses: actions/setup-python@v2 - # with: - # python-version: '3.10' - - # - name: Install dependencies - # run: | - # python -m pip install --upgrade pip - # pip install setuptools wheel twine packaging - - # - name: Update version - # run: | - # # Extract the current version from setup.py - # CURRENT_VERSION=$(grep -oP "version='\K[0-9]+\.[0-9]+\.[0-9]+" setup.py) - # echo "Current version: $CURRENT_VERSION" - - # # Fetch tags and get the latest tag, removing the 'v' prefix - # git fetch --tags - # LATEST_TAG=$(git describe --tags `git rev-list --tags --max-count=1` | sed 's/^v//') - # echo "Latest tag: $LATEST_TAG" - - # # Use Python to compare versions - # HIGHER_VERSION=$(python -c "from packaging.version import parse as parse_version; \ - # current = parse_version('$CURRENT_VERSION'); \ - # latest = parse_version('$LATEST_TAG'); \ - # print(current if current > latest else latest)") - # echo "Higher version: $HIGHER_VERSION" - - # # If current version is higher, increment patch version in setup.py - # if [ "$CURRENT_VERSION" == "$HIGHER_VERSION" ]; then - # IFS='.' read -r -a VERSION_PARTS <<< "$CURRENT_VERSION" - # PATCH=$((VERSION_PARTS[2] + 1)) - # NEW_VERSION="${VERSION_PARTS[0]}.${VERSION_PARTS[1]}.$PATCH" - # echo "Incremented version: $NEW_VERSION" - # sed -i "s/version='\([0-9]\+\.[0-9]\+\.\)[0-9]\+'/version='\1$PATCH'/" setup.py - - # # Commit and push the updated setup.py - # git config --local user.email "action@github.com" - # git config --local user.name "GitHub Action" - # git pull - # git add setup.py - # git commit -m "Increment version number to $NEW_VERSION [skip ci]" - # git push - # else - # echo "No version increment needed" - # fi - # - name: Build local and publish to PyPI - # env: - # TWINE_USERNAME: __token__ - # TWINE_PASSWORD: ${{ secrets.PYPI_TOKEN_SECRET }} - # run: | - # python setup.py sdist bdist_wheel - # twine upload dist/* --verbose build-cellline-omics: runs-on: ubuntu-latest steps: @@ -1516,7 +115,7 @@ jobs: - name: Build and push cptac uses: docker/build-push-action@v3 with: - file: ./build/docker/Dockerfile.c[tac + file: ./build/docker/Dockerfile.cptac tags: sgosline/cptac:latest push: true platforms: linux/amd64,linux/arm64 diff --git a/.github/workflows/old_ci b/.github/workflows/old_ci new file mode 100755 index 00000000..db48886b --- /dev/null +++ b/.github/workflows/old_ci @@ -0,0 +1,1587 @@ +name: Build docker images + +on: + push: + branches: + - '**' + # Allows you to run this workflow manually from the Actions tab + workflow_dispatch: + +# Sets permissions of the GITHUB_TOKEN to allow deployment to GitHub Pages +permissions: + contents: write + pages: write + id-token: write + +jobs: + +# Placeholder +# depmap-docker-build: +# runs-on: ubuntu-latest +# environment: build +# steps: +# - name: Checkout Repo +# uses: actions/checkout@v2 +# - name: Log in to DockerHub +# uses: docker/login-action@v3 +# with: +# username: ${{ secrets.DOCKER_USERNAME }} +# password: ${{ secrets.DOCKER_TOKEN_SECRET }} +# - name: Build and push depmap images +# run: | +# docker build -t jjacobson95/depmap -f build/docker/Dockerfile.depmap . +# docker push jjacobson95/depmap + +# cptac-docker-build: +# runs-on: ubuntu-latest +# environment: build +# steps: +# - name: Checkout Repo +# uses: actions/checkout@v2 +# - name: Log in to DockerHub +# uses: docker/login-action@v3 +# with: +# username: ${{ secrets.DOCKER_USERNAME }} +# password: ${{ secrets.DOCKER_TOKEN_SECRET }} +# - name: Build and push cptac images +# run: | +# docker build -t jjacobson95/cptac -f build/docker/Dockerfile.cptac . +# docker push jjacobson95/cptac + +# hcmi-docker-build: +# runs-on: ubuntu-latest +# environment: build +# steps: +# - name: Checkout Repo +# uses: actions/checkout@v2 +# - name: Log in to DockerHub +# uses: docker/login-action@v3 +# with: +# username: ${{ secrets.DOCKER_USERNAME }} +# password: ${{ secrets.DOCKER_TOKEN_SECRET }} +# - name: Build and push hcmi images +# run: | +# docker build -t jjacobson95/hcmi -f build/docker/Dockerfile.hcmi . +# docker push jjacobson95/hcmi +# beataml-docker-build: +# runs-on: ubuntu-latest +# environment: build +# steps: +# - name: Checkout Repo +# uses: actions/checkout@v2 +# - name: Log in to DockerHub +# uses: docker/login-action@v3 +# with: +# username: ${{ secrets.DOCKER_USERNAME }} +# password: ${{ secrets.DOCKER_TOKEN_SECRET }} +# - name: Build and push beataml image +# run: | +# docker build -t jjacobson95/beataml -f build/docker/Dockerfile.beataml . +# docker push jjacobson95/beataml + +# # #placeholder +# mpnst-docker-build: +# runs-on: ubuntu-latest +# environment: build +# steps: +# - uses: actions/checkout@v2 +# - name: Log in to DockerHub +# uses: docker/login-action@v3 +# with: +# username: ${{ secrets.DOCKER_USERNAME }} +# password: ${{ secrets.DOCKER_TOKEN_SECRET }} + +# build-depmap-samples: +# if: github.actor != 'github-actions[bot]' +# needs: [depmap-docker-build] +# runs-on: ubuntu-20.04 +# environment: build +# steps: +# #Add upload artifact from depmap Samples +# - name: Checkout DepMap +# uses: actions/checkout@v2 +# # - name: Copy DepMap sample from build location. +# # run: | +# # cp build/depmap/requirements.txt . +# # cp build/depmap/requirements.r . +# # cp build/depmap/*.R . +# # cp build/depmap/*.py . +# # cp build/utils/* . +# - name: List files cwd +# run: ls -lah +# - name: cat reqs +# run: cat requirements.txt +# - name: Pull depmap image +# run: docker pull jjacobson95/depmap +# - name: Run depmap samples Container +# run: | +# docker run -v $PWD:/tmp/ jjacobson95/depmap Rscript /app/00-buildGeneFile.R +# docker run -v $PWD:/tmp/ jjacobson95/depmap Rscript /app/01-depmapSamples.R +# - name: Copy file from depmap Samples Container +# run: | +# mkdir depmap-samples genes-file +# mv depmap_samples.csv depmap-samples +# mv genes.csv genes-file +# - name: Upload artifacts for depmap +# uses: actions/upload-artifact@v2 +# with: +# name: depmap-samples +# path: depmap-samples +# - name: Upload artifacts for genes +# uses: actions/upload-artifact@v2 +# with: +# name: genes-file +# path: genes-file + +# build-drugs-beataml: +# if: github.actor != 'github-actions[bot]' +# runs-on: ubuntu-20.04 +# environment: build +# steps: +# - name: Checkout Repo +# uses: actions/checkout@v2 +# - name: Copy pubchem util and drug script to base dir +# run: | +# cp build/utils/pubchem_retrieval.py . +# cp build/beatAML/beataml_drug_retrieval.py . +# - name: install reqs +# run: | +# pip install -r requirements.txt +# - name: Append PYTHONPATH +# run: echo "PYTHONPATH=$PWD" >> $GITHUB_ENV +# - name: Run beataml Drug retrieval +# run: python beataml_drug_retrieval.py +# - name: Run beataml Drug retrieval second time to catch stragglers +# run: | +# mkdir additive-drugs-file-1 +# mv ignore_chems.txt additive-drugs-file-1 +# python beataml_drug_retrieval.py +# - name: Copy drugs file to artifact +# run: | +# mv drugs.tsv additive-drugs-file-1 +# - name: Upload artifacts for genes +# uses: actions/upload-artifact@v2 +# with: +# name: additive-drugs-file-1 +# path: additive-drugs-file-1 + +# #placeholder +# # build-drugs-mpnst: +# # if: github.actor != 'github-actions[bot]' +# # runs-on: ubuntu-20.04 +# # environment: build +# # steps: +# # - name: Checkout Repo +# # uses: actions/checkout@v2 +# # - name: Download artifacts from previous drug gen +# # uses: actions/download-artifact@v2 +# # with: +# # name: additive-drugs-file +# # - name: List files cwd +# # run: ls -lah +# # - name: Run mpnst Drug retrieval +# # run: python /build/mpnst/retrieve_drugs_mpnst.py +# # - name: Copy drugs file to artifact +# # run: | +# # mkdir additive-drugs-file +# # mv drugs.tsv ignore_chems.txt additive-drugs-file +# # - name: Upload artifacts for genes +# # uses: actions/upload-artifact@v2 +# # with: +# # name: additive-drugs-file +# # path: additive-drugs-file + +# build-drugs-depmap-CTRPv2-GDSC-gCSI-PRISM-CCLE-FIMM: +# if: github.actor != 'github-actions[bot]' +# runs-on: ubuntu-20.04 +# environment: build +# needs: [build-drugs-beataml,depmap-docker-build] +# steps: +# - name: Checkout Repo +# uses: actions/checkout@v2 +# - name: Download artifacts from previous drug gen +# uses: actions/download-artifact@v2 +# with: +# name: additive-drugs-file-1 +# - name: List files cwd +# run: ls -lah +# # - name: Install R +# # uses: r-lib/actions/setup-r@v2 +# # - name: Install R and Python Packages +# # run: | +# # Rscript build/depmap/requirements.r +# # pip install -r build/depmap/requirements.txt +# - name: Pull depmap image +# run: docker pull jjacobson95/depmap +# - name: Run depmap CTRPv2 Drug retrieval +# run: | +# docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R CTRPv2 +# - name: List files cwd +# run: ls -lah +# - name: Run depmap GDSC Drug retrieval +# run: | +# docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R GDSC +# - name: Run depmap gCSI Drug retrieval +# run: | +# docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R gCSI +# - name: Run depmap PRISM Drug retrieval +# run: | +# docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R PRISM +# - name: Run depmap CCLE Drug retrieval +# run: | +# docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R CCLE +# - name: Run depmap FIMM Drug retrieval +# run: | +# docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R FIMM +# - name: List files cwd +# run: ls -lah +# - name: Copy drugs file to artifact +# run: | +# mkdir additive-drugs-file-2 +# mv drugs.tsv ignore_chems.txt additive-drugs-file-2 +# - name: Upload artifacts for genes +# uses: actions/upload-artifact@v2 +# with: +# name: additive-drugs-file-2 +# path: additive-drugs-file-2 + +# build-drugs-depmap-NCI60-pt1: +# if: github.actor != 'github-actions[bot]' +# runs-on: ubuntu-20.04 +# environment: build +# needs: [build-drugs-depmap-CTRPv2-GDSC-gCSI-PRISM-CCLE-FIMM] +# steps: +# - name: Checkout Repo +# uses: actions/checkout@v2 +# - name: Download artifacts from previous drug gen +# uses: actions/download-artifact@v2 +# with: +# name: additive-drugs-file-2 +# - name: List files cwd +# run: ls -lah +# # - name: Install R +# # uses: r-lib/actions/setup-r@v2 +# # - name: Install R and Python Packages +# # run: | +# # Rscript build/depmap/requirements.r +# # pip install -r build/depmap/requirements.txt +# - name: Pull depmap image +# run: docker pull jjacobson95/depmap +# - name: Run depmap NCI60 Drug retrieval +# run: | +# docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R NCI60 +# # - name: Run depmap NCI60 Drug retrieval +# # run: Rscript build/depmap/CreateDrugFileCL.R NCI60 +# - name: Copy drugs file to artifact +# run: | +# mkdir additive-drugs-file-3 +# mv drugs.tsv ignore_chems.txt additive-drugs-file-3 +# - name: Upload artifacts for genes +# uses: actions/upload-artifact@v2 +# with: +# name: additive-drugs-file-3 +# path: additive-drugs-file-3 + + +# build-drugs-depmap-NCI60-pt2: +# if: github.actor != 'github-actions[bot]' +# runs-on: ubuntu-20.04 +# environment: build +# needs: [build-drugs-depmap-NCI60-pt1] +# steps: +# - name: Checkout Repo +# uses: actions/checkout@v2 +# - name: Download artifacts from previous drug gen +# uses: actions/download-artifact@v2 +# with: +# name: additive-drugs-file-3 +# - name: List files cwd +# run: ls -lah +# - name: Pull depmap image +# run: docker pull jjacobson95/depmap +# - name: Run depmap NCI60 Drug retrieval +# run: | +# docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R NCI60 +# - name: Copy drugs file to artifact +# run: | +# mkdir additive-drugs-file-4 +# mv drugs.tsv ignore_chems.txt additive-drugs-file-4 +# - name: Upload artifacts for genes +# uses: actions/upload-artifact@v2 +# with: +# name: additive-drugs-file-4 +# path: additive-drugs-file-4 + + +# build-drugs-depmap-NCI60-pt3: +# if: github.actor != 'github-actions[bot]' +# runs-on: ubuntu-20.04 +# environment: build +# needs: [build-drugs-depmap-NCI60-pt2] +# steps: +# - name: Checkout Repo +# uses: actions/checkout@v2 +# - name: Download artifacts from previous drug gen +# uses: actions/download-artifact@v2 +# with: +# name: additive-drugs-file-4 +# - name: List files cwd +# run: ls -lah +# - name: Pull depmap image +# run: docker pull jjacobson95/depmap +# - name: Run depmap NCI60 Drug retrieval +# run: | +# docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R NCI60 +# - name: Copy drugs file to artifact +# run: | +# mkdir additive-drugs-file-5 +# mv drugs.tsv ignore_chems.txt additive-drugs-file-5 +# - name: Upload artifacts for genes +# uses: actions/upload-artifact@v2 +# with: +# name: additive-drugs-file-5 +# path: additive-drugs-file-5 + + +# build-drugs-depmap-NCI60-pt4: +# if: github.actor != 'github-actions[bot]' +# runs-on: ubuntu-20.04 +# environment: build +# needs: [build-drugs-depmap-NCI60-pt3] +# steps: +# - name: Checkout Repo +# uses: actions/checkout@v2 +# - name: Download artifacts from previous drug gen +# uses: actions/download-artifact@v2 +# with: +# name: additive-drugs-file-5 +# - name: List files cwd +# run: ls -lah +# - name: Pull depmap image +# run: docker pull jjacobson95/depmap +# - name: Run depmap NCI60 Drug retrieval +# run: | +# docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R NCI60 +# - name: Copy drugs file to artifact +# run: | +# mkdir additive-drugs-file-6 +# mv drugs.tsv ignore_chems.txt additive-drugs-file-6 +# - name: Upload artifacts for genes +# uses: actions/upload-artifact@v2 +# with: +# name: additive-drugs-file-6 +# path: additive-drugs-file-6 + +# # build-drugs-depmap-NCI60-pt5: +# # if: github.actor != 'github-actions[bot]' +# # runs-on: ubuntu-20.04 +# # environment: build +# # needs: [build-drugs-depmap-NCI60-pt4] +# # steps: +# # - name: Checkout Repo +# # uses: actions/checkout@v2 +# # - name: Download artifacts from previous drug gen +# # uses: actions/download-artifact@v2 +# # with: +# # name: additive-drugs-file-6 +# # - name: List files cwd +# # run: ls -lah +# # - name: Pull depmap image +# # run: docker pull jjacobson95/depmap +# # - name: Run depmap NCI60 Drug retrieval +# # run: | +# # docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R NCI60 +# # - name: Copy drugs file to artifact +# # run: | +# # mkdir additive-drugs-file-7 +# # mv drugs.tsv ignore_chems.txt additive-drugs-file-7 +# # - name: Upload artifacts for genes +# # uses: actions/upload-artifact@v2 +# # with: +# # name: additive-drugs-file-7 +# # path: additive-drugs-file-7 + +# # build-drugs-depmap-NCI60-pt6: +# # if: github.actor != 'github-actions[bot]' +# # runs-on: ubuntu-20.04 +# # environment: build +# # needs: [build-drugs-depmap-NCI60-pt5] +# # steps: +# # - name: Checkout Repo +# # uses: actions/checkout@v2 +# # - name: Download artifacts from previous drug gen +# # uses: actions/download-artifact@v2 +# # with: +# # name: additive-drugs-file-7 +# # - name: List files cwd +# # run: ls -lah +# # - name: Pull depmap image +# # run: docker pull jjacobson95/depmap +# # - name: Run depmap NCI60 Drug retrieval +# # run: | +# # docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R NCI60 +# # - name: Copy drugs file to artifact +# # run: | +# # mkdir additive-drugs-file-8 +# # mv drugs.tsv ignore_chems.txt additive-drugs-file-8 +# # - name: Upload artifacts for genes +# # uses: actions/upload-artifact@v2 +# # with: +# # name: additive-drugs-file-8 +# # path: additive-drugs-file-8 + +# # build-drugs-depmap-NCI60-pt7: +# # if: github.actor != 'github-actions[bot]' +# # runs-on: ubuntu-20.04 +# # environment: build +# # needs: [build-drugs-depmap-NCI60-pt6] +# # steps: +# # - name: Checkout Repo +# # uses: actions/checkout@v2 +# # - name: Download artifacts from previous drug gen +# # uses: actions/download-artifact@v2 +# # with: +# # name: additive-drugs-file-8 +# # - name: List files cwd +# # run: ls -lah +# # - name: Pull depmap image +# # run: docker pull jjacobson95/depmap +# # - name: Run depmap NCI60 Drug retrieval +# # run: | +# # docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R NCI60 +# # - name: Copy drugs file to artifact +# # run: | +# # mkdir additive-drugs-file-9 +# # mv drugs.tsv ignore_chems.txt additive-drugs-file-9 +# # - name: Upload artifacts for genes +# # uses: actions/upload-artifact@v2 +# # with: +# # name: additive-drugs-file-9 +# # path: additive-drugs-file-9 + +# # build-drugs-depmap-NCI60-pt8: +# # if: github.actor != 'github-actions[bot]' +# # runs-on: ubuntu-20.04 +# # environment: build +# # needs: [build-drugs-depmap-NCI60-pt7] +# # steps: +# # - name: Checkout Repo +# # uses: actions/checkout@v2 +# # - name: Download artifacts from previous drug gen +# # uses: actions/download-artifact@v2 +# # with: +# # name: additive-drugs-file-9 +# # - name: List files cwd +# # run: ls -lah +# # - name: Pull depmap image +# # run: docker pull jjacobson95/depmap +# # - name: Run depmap NCI60 Drug retrieval +# # run: | +# # docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R NCI60 +# # - name: Copy drugs file to artifact +# # run: | +# # mkdir additive-drugs-file-10 +# # mv drugs.tsv ignore_chems.txt additive-drugs-file-10 +# # - name: Upload artifacts for genes +# # uses: actions/upload-artifact@v2 +# # with: +# # name: additive-drugs-file-10 +# # path: additive-drugs-file-10 + +# # build-drugs-depmap-NCI60-pt9: +# # if: github.actor != 'github-actions[bot]' +# # runs-on: ubuntu-20.04 +# # environment: build +# # needs: [build-drugs-depmap-NCI60-pt8] +# # steps: +# # - name: Checkout Repo +# # uses: actions/checkout@v2 +# # - name: Download artifacts from previous drug gen +# # uses: actions/download-artifact@v2 +# # with: +# # name: additive-drugs-file-10 +# # - name: List files cwd +# # run: ls -lah +# # - name: Pull depmap image +# # run: docker pull jjacobson95/depmap +# # - name: Run depmap NCI60 Drug retrieval +# # run: | +# # docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R NCI60 +# # - name: Copy drugs file to artifact +# # run: | +# # mkdir additive-drugs-file-11 +# # mv drugs.tsv ignore_chems.txt additive-drugs-file-11 +# # - name: Upload artifacts for genes +# # uses: actions/upload-artifact@v2 +# # with: +# # name: additive-drugs-file-11 +# # path: additive-drugs-file-11 + +# # build-drugs-depmap-NCI60-pt10: +# # if: github.actor != 'github-actions[bot]' +# # runs-on: ubuntu-20.04 +# # environment: build +# # needs: [build-drugs-depmap-NCI60-pt9] +# # steps: +# # - name: Checkout Repo +# # uses: actions/checkout@v2 +# # - name: Download artifacts from previous drug gen +# # uses: actions/download-artifact@v2 +# # with: +# # name: additive-drugs-file-11 +# # - name: List files cwd +# # run: ls -lah +# # - name: Pull depmap image +# # run: docker pull jjacobson95/depmap +# # - name: Run depmap NCI60 Drug retrieval +# # run: | +# # docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R NCI60 +# # - name: Copy drugs file to artifact +# # run: | +# # mkdir additive-drugs-file-12 +# # mv drugs.tsv ignore_chems.txt additive-drugs-file-12 +# # - name: Upload artifacts for genes +# # uses: actions/upload-artifact@v2 +# # with: +# # name: additive-drugs-file-12 +# # path: additive-drugs-file-12 + +# # build-drugs-depmap-NCI60-pt11: +# # if: github.actor != 'github-actions[bot]' +# # runs-on: ubuntu-20.04 +# # environment: build +# # needs: [build-drugs-depmap-NCI60-pt10] +# # steps: +# # - name: Checkout Repo +# # uses: actions/checkout@v2 +# # - name: Download artifacts from previous drug gen +# # uses: actions/download-artifact@v2 +# # with: +# # name: additive-drugs-file-12 +# # - name: List files cwd +# # run: ls -lah +# # - name: Pull depmap image +# # run: docker pull jjacobson95/depmap +# # - name: Run depmap NCI60 Drug retrieval +# # run: | +# # docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R NCI60 +# # - name: Copy drugs file to artifact +# # run: | +# # mkdir additive-drugs-file-13 +# # mv drugs.tsv ignore_chems.txt additive-drugs-file-13 +# # - name: Upload artifacts for genes +# # uses: actions/upload-artifact@v2 +# # with: +# # name: additive-drugs-file-13 +# # path: additive-drugs-file-13 + +# build-drugs-depmap-capture-stragglers: +# if: github.actor != 'github-actions[bot]' +# runs-on: ubuntu-20.04 +# environment: build +# needs: [build-drugs-depmap-NCI60-pt4] +# steps: +# - name: Checkout Repo +# uses: actions/checkout@v2 +# - name: Download artifacts from previous drug gen +# uses: actions/download-artifact@v2 +# with: +# name: additive-drugs-file-6 +# - name: List files cwd +# run: ls -lah +# - name: List files cwd +# run: rm ignore_chems.txt +# - name: Pull depmap image +# run: docker pull jjacobson95/depmap +# - name: Run depmap straggler Drug retrieval +# run: | +# docker run -v $PWD:/tmp jjacobson95/depmap Rscript /app/CreateDrugFileCL.R CTRPv2,GDSC,gCSI,PRISM,CCLE,FIMM,NCI60 +# - name: Copy drugs file to artifact +# run: | +# mkdir additive-drugs-file-7 +# mv drugs.tsv ignore_chems.txt additive-drugs-file-7 +# - name: Upload artifacts for genes +# uses: actions/upload-artifact@v2 +# with: +# name: additive-drugs-file-7 +# path: additive-drugs-file-7 + +# build-cptac-samples: +# if: github.actor != 'github-actions[bot]' +# runs-on: ubuntu-20.04 +# environment: build +# needs: [build-depmap-samples,cptac-docker-build] +# steps: +# #Add upload artifact from CPTAC Samples +# - name: Checkout CPTAC +# uses: actions/checkout@v2 +# - name: Download artifacts from depmap +# uses: actions/download-artifact@v2 +# with: +# name: depmap-samples +# - name: Download artifacts from DepMap (genes) +# uses: actions/download-artifact@v2 +# with: +# name: genes-file +# # - name: Copy DepMap sample from build location. +# # run: | +# # cp build/cptac/requirements.txt . +# # cp build/cptac/*.py . +# # # copy build/genes.csv . +# - name: Pull cptac image +# run: docker pull jjacobson95/cptac +# - name: Run CPTAC samples Container +# run: docker run -v $PWD:/tmp jjacobson95/cptac --geneFile=/tmp/genes.csv --prevSampleFile=/tmp/depmap_samples.csv +# - name: Copy file from CPTAC Samples Container +# run: | +# mkdir cptac-samples +# mv cptac_samples.csv cptac-samples +# - name: Upload artifacts for CPTAC +# uses: actions/upload-artifact@v2 +# with: +# name: cptac-samples +# path: cptac-samples + +# build-hcmi-samples: +# if: github.actor != 'github-actions[bot]' +# runs-on: ubuntu-20.04 +# environment: build +# needs: [build-cptac-samples,hcmi-docker-build] +# steps: +# - name: Checkout HCMI +# uses: actions/checkout@v2 +# - name: Download artifacts from CPTAC +# uses: actions/download-artifact@v2 +# with: +# name: cptac-samples +# # - name: Build HCMI Image +# # run: docker build -t hcmi-samples-builder -f build/docker/Dockerfile.hcmi . +# - name: Pull hcmi image +# run: docker pull jjacobson95/hcmi +# - name: Run HCMI samples Container +# run: docker run -v $PWD:/tmp --name hcmi-samples-container jjacobson95/hcmi python 01-createHCMISamplesFile.py +# - name: Copy file from HCMI Samples Container +# run: | +# mkdir hcmi-samples +# for file in hcmi_samples.csv; do +# docker cp hcmi-samples-container:/usr/src/app/$file hcmi-samples/$file +# done +# - name: Get HCMI container logs +# run: docker logs hcmi-samples-container +# - name: Upload artifacts for HCMI +# uses: actions/upload-artifact@v2 +# with: +# name: hcmi-samples +# path: hcmi-samples + +# build-beataml-samples: +# if: github.actor != 'github-actions[bot]' +# runs-on: ubuntu-20.04 +# environment: build +# needs: [build-hcmi-samples,beataml-docker-build] +# steps: +# #Add upload artifact from CPTAC Samples +# - name: Checkout BeatAML +# uses: actions/checkout@v2 +# - name: Download artifacts from HCMI +# uses: actions/download-artifact@v2 +# with: +# name: hcmi-samples +# - name: Pull beataml image +# run: docker pull jjacobson95/beataml +# - name: Run BeatAML Container with samples option +# run: docker run -v $PWD:/tmp --name beataml-samples-container jjacobson95/beataml python GetBeatAML.py --token ${{ secrets.SYNAPSE_TOKEN_SECRET }} --samples +# - name: Copy file from BeatAML Samples Container +# run: | +# mkdir beataml-samples +# for file in beataml_samples.csv; do +# docker cp beataml-samples-container:/usr/src/app/$file beataml-samples/$file +# done +# - name: Get BeatAML container logs +# run: docker logs beataml-samples-container +# - name: Upload artifacts for BeatAML +# uses: actions/upload-artifact@v2 +# with: +# name: beataml-samples +# path: beataml-samples + +# # Placeholder +# build-mpnst-samples: +# if: github.actor != 'github-actions[bot]' +# runs-on: ubuntu-20.04 +# environment: build +# needs: [build-beataml-samples,mpnst-docker-build] +# steps: +# #Add upload artifact from CPTAC Samples +# - name: Checkout MPNST +# uses: actions/checkout@v2 + +# build-hcmi: +# if: github.actor != 'github-actions[bot]' +# needs: [build-hcmi-samples] +# runs-on: ubuntu-20.04 +# environment: build +# steps: +# - name: Checkout HCMI +# uses: actions/checkout@v2 +# - name: Download artifacts from HCMI +# uses: actions/download-artifact@v2 +# with: +# name: hcmi-samples +# - name: List files cwd +# run: ls -lah +# # - name: Build HCMI Image +# # run: docker build -t hcmi-builder -f build/docker/Dockerfile.hcmi . +# - name: Pull hcmi image +# run: docker pull jjacobson95/hcmi +# - name: Run HCMI Container +# run: | +# docker run -v $PWD:/tmp --name hcmi-container jjacobson95/hcmi /bin/bash -c "python 02-getHCMIData.py -m full_manifest.txt -t transcriptomics -o hcmi_transcriptomics.csv && python 02-getHCMIData.py -m full_manifest.txt -M full_manifest_files -t copy_number -o hcmi_copy_number.csv && python 02-getHCMIData.py -m full_manifest.txt -M full_manifest_files -t mutations -o hcmi_mutations.csv" +# - name: Copy files from HCMI Container +# run: | +# mkdir hcmi-files +# for file in hcmi_transcriptomics.csv hcmi_copy_number.csv hcmi_mutations.csv; do +# docker cp hcmi-container:/usr/src/app/$file hcmi-files/$file +# done +# cp hcmi_samples.csv hcmi-files +# - name: Get HCMI container logs +# run: docker logs hcmi-container +# - name: Upload artifacts for HCMI +# uses: actions/upload-artifact@v2 +# with: +# name: hcmi-files +# path: hcmi-files + +# check-hcmi-schema: +# if: github.actor != 'github-actions[bot]' +# needs: [build-hcmi] +# runs-on: ubuntu-20.04 +# environment: build +# steps: +# - name: Checkout code HCMI +# uses: actions/checkout@v2 +# - name: Download artifacts from HCMI Samples +# uses: actions/download-artifact@v2 +# with: +# name: hcmi-samples +# - name: Download artifacts from HCMI +# uses: actions/download-artifact@v2 +# with: +# name: hcmi-files +# - name: Download linkml +# run: | +# pip install linkml +# pip install linkml-validator +# - name: check dir +# run: ls +# - name: Run linkml schema checker +# run: bash schema/check_hcmi_linkml.sh + +# build-beataml: +# if: github.actor != 'github-actions[bot]' +# needs: [build-beataml-samples,build-drugs-depmap-capture-stragglers] +# runs-on: ubuntu-20.04 +# environment: build +# steps: +# - name: Checkout code BeatAML +# uses: actions/checkout@v2 +# - name: Download artifacts from Beataml Samples +# uses: actions/download-artifact@v2 +# with: +# name: beataml-samples +# - name: Download artifacts from Drugs +# uses: actions/download-artifact@v2 +# with: +# name: additive-drugs-file-7 +# - name: List files cwd +# run: ls -lah +# - name: Pull beataml image +# run: docker pull jjacobson95/beataml +# - name: Run BeatAML Container +# run: docker run -v $PWD:/tmp --name beataml-container jjacobson95/beataml python GetBeatAML.py --token ${{ secrets.SYNAPSE_TOKEN_SECRET }} +# - name: Copy files from BeatAML Container +# run: | +# mkdir beataml-files +# for file in beataml_transcriptomics.csv beataml_proteomics.csv beataml_mutations.csv beataml_drugs.tsv beataml_experiments.csv; do +# docker cp beataml-container:/usr/src/app/$file beataml-files/$file +# done +# cp beataml_samples.csv beataml-files +# - name: Get BeatAML container logs +# run: docker logs beataml-container +# - name: Upload artifact for BeatAML +# uses: actions/upload-artifact@v2 +# with: +# name: beataml-files +# path: beataml-files + + +# check-beataml-schema: +# if: github.actor != 'github-actions[bot]' +# needs: [build-beataml] +# runs-on: ubuntu-20.04 +# environment: build +# steps: +# - name: Checkout code BeatAML +# uses: actions/checkout@v2 +# - name: Download artifacts from Beataml Samples +# uses: actions/download-artifact@v2 +# with: +# name: beataml-samples +# - name: Download artifacts from Beataml +# uses: actions/download-artifact@v2 +# with: +# name: beataml-files +# - name: Download linkml +# run: | +# pip install linkml +# pip install linkml-validator +# - name: check dir +# run: ls +# - name: Run linkml schema checker +# run: bash schema/check_beataml_linkml.sh + +# build-depmap: +# if: github.actor != 'github-actions[bot]' +# needs: [build-depmap-samples,build-drugs-depmap-capture-stragglers] +# runs-on: ubuntu-20.04 +# environment: build +# steps: +# - name: Checkout DepMap +# uses: actions/checkout@v2 +# # - name: Copy DepMap sample from build location. +# # run: | +# # cp build/depmap/requirements.txt . +# # cp build/depmap/requirements.r . +# # cp build/depmap/*.R . +# # cp build/depmap/*.py . +# # cp build/utils/* . +# - name: Download artifacts from DepMap (samples) +# uses: actions/download-artifact@v2 +# with: +# name: depmap-samples +# - name: Download artifacts from DepMap (genes) +# uses: actions/download-artifact@v2 +# with: +# name: genes-file +# - name: Download artifacts from Drugs +# uses: actions/download-artifact@v2 +# with: +# name: additive-drugs-file-7 +# - name: gzip drugs file +# run: gzip drugs.tsv +# - name: List files cwd +# run: ls -lah +# - name: cat reqs +# run: cat requirements.txt +# - name: Pull depmap image +# run: docker pull jjacobson95/depmap +# # - name: docker save space and stats +# # run: | +# # docker image prune -f +# # docker container prune -f +# # docker volume prune -f +# # docker network prune -f +# # docker system df +# - name: Run depmap 02-pullDepMap.R Container +# run: | +# docker run -v $PWD:/tmp/ jjacobson95/depmap Rscript /app/02-pullDepMap.R /tmp/genes.csv /tmp/depmap_samples.csv +# - name: Run depmap 02b-pullSanger.R Container +# run: | +# docker run -v $PWD:/tmp/ jjacobson95/depmap Rscript /app/02b-pullSanger.R /tmp/genes.csv /tmp/depmap_samples.csv +# # - name: Run depmap 03-createDrugFile.RContainer +# # run: | +# # docker run -v $PWD:/tmp depmap Rscript 03-createDrugFile.R CTRPv2,GDSC,gCSI,PRISM,CCLE,FIMM,NCI60 +# - name: Run depmap 04-drug_dosage_and_curves.py Container +# run: | +# docker run -v $PWD:/tmp/ jjacobson95/depmap /opt/venv/bin/python /app/04-drug_dosage_and_curves.py --drugfile=/tmp/drugs.tsv.gz --curSampleFile=/tmp/depmap_samples.csv +# - name: Run depmap 01b-pullDrugs_LINCS.py Container +# run: | +# docker run -v $PWD:/tmp jjacobson95/depmap /opt/venv/bin/python /app/01b-pullDrugs_LINCS.py --drugFile /tmp/drugs.tsv.gz +# - name: Run depmap 04-pullDrugs_LINCS.py Container +# run: | +# docker run -v $PWD:/tmp jjacobson95/depmap /opt/venv/bin/python /app/04-pullDrugs_LINCS.py --drugFile /tmp/drugs.tsv.gz +# - name: Run depmap 05-LINCS_perturbations.py Container +# run: | +# docker run -v $PWD:/tmp/ jjacobson95/depmap Rscript /app/05-LINCS_perturbations.R /tmp/genes.csv /tmp/drugs.tsv.gz /tmp/depmap_samples.csv +# - name: List files cwd +# run: ls -lah +# - name: Copy files from DepMap Container +# run: | +# mkdir depmap-files +# cp depmap_* depmap-files +# - name: Upload artifacts for DepMap +# uses: actions/upload-artifact@v2 +# with: +# name: depmap-files +# path: depmap-files + +# check-depmap-schema: +# if: github.actor != 'github-actions[bot]' +# needs: [build-depmap] +# runs-on: ubuntu-20.04 +# environment: build +# steps: +# - name: Checkout code DepMap +# uses: actions/checkout@v2 +# - name: Download artifacts from DepMap Samples +# uses: actions/download-artifact@v2 +# with: +# name: depmap-samples +# - name: Download artifacts from DepMap +# uses: actions/download-artifact@v2 +# with: +# name: depmap-files +# - name: Download linkml +# run: | +# pip install linkml +# pip install linkml-validator +# - name: check dir +# run: ls +# - name: Run linkml schema checker +# run: bash schema/check_depmap_linkml.sh + + +# build-cptac: +# if: github.actor != 'github-actions[bot]' +# needs: [build-cptac-samples] +# runs-on: ubuntu-20.04 +# environment: build +# steps: +# - name: Checkout CPTAC +# uses: actions/checkout@v2 +# - name: Download artifacts from CPTAC +# uses: actions/download-artifact@v2 +# with: +# name: cptac-samples +# - name: Download artifacts from DepMap (genes) +# uses: actions/download-artifact@v2 +# with: +# name: genes-file +# - name: Copy files from build location. +# run: | +# cp build/cptac/*.py . +# cp build/cptac/requirements.txt . +# # copy build/genes.csv . +# - name: List files cwd +# run: ls -lah +# - name: Pull cptac image +# run: docker pull jjacobson95/cptac +# - name: Run CPTAC Container +# run: | +# docker run -v $PWD:/tmp jjacobson95/cptac --geneFile=/tmp/genes.csv --curSampleFile=/tmp/cptac_samples.csv +# - name: Copy files from CPTAC Container +# run: | +# mkdir cptac-files +# cp cptac_* cptac-files +# - name: Upload artifacts for CPTAC +# uses: actions/upload-artifact@v2 +# with: +# name: cptac-files +# path: cptac-files + +# check-cptac-schema: +# if: github.actor != 'github-actions[bot]' +# needs: [build-cptac] +# runs-on: ubuntu-20.04 +# environment: build +# steps: +# - name: Checkout code CPTAC +# uses: actions/checkout@v2 +# - name: Download artifacts from CPTAC Samples +# uses: actions/download-artifact@v2 +# with: +# name: cptac-samples +# - name: Download artifacts from CPTAC +# uses: actions/download-artifact@v2 +# with: +# name: cptac-files +# - name: Download linkml and gunzip files +# run: | +# pip install linkml +# pip install linkml-validator +# find . -type f -name '*.gz' -exec gunzip {} + +# - name: check dir +# run: ls +# - name: Run linkml schema checker +# run: bash schema/check_cptac_linkml.sh + +# #placeholder +# build-mpnst: +# if: github.actor != 'github-actions[bot]' +# needs: [build-mpnst-samples] +# runs-on: ubuntu-20.04 +# environment: build +# steps: +# - name: Checkout code MPNST +# uses: actions/checkout@v2 + +# # Placeholder +# check-mpnst-schema: +# if: github.actor != 'github-actions[bot]' +# needs: [build-mpnst] +# runs-on: ubuntu-20.04 +# environment: build +# steps: +# - name: Checkout code MPNST +# uses: actions/checkout@v2 +# # - name: Download artifacts from MPNST Samples +# # uses: actions/download-artifact@v2 +# # with: +# # name: mpnst-samples +# # - name: Download artifacts from MPNST +# # uses: actions/download-artifact@v2 +# # with: +# # name: mpnst-files +# # - name: Download linkml +# # run: | +# # pip install linkml +# # pip install linkml-validator +# # - name: check dir +# # run: ls +# # - name: Run linkml schema checker +# # run: bash schema/check_mpnst_linkml.sh + +# data-visualization: +# if: github.actor != 'github-actions[bot]' +# needs: [check-hcmi-schema, check-beataml-schema, check-depmap-schema, check-cptac-schema, check-mpnst-schema] +# environment: build +# runs-on: ubuntu-20.04 +# steps: +# - name: Set up R +# uses: r-lib/actions/setup-r@v2 +# - name: Install R packages +# run: | +# R -e "install.packages('RColorBrewer', dependencies=TRUE, repos='http://cran.rstudio.com/')" +# R -e "install.packages('circlize', dependencies=TRUE, repos='http://cran.rstudio.com/')" +# R -e "install.packages('dplyr', dependencies=TRUE, repos='http://cran.rstudio.com/')" +# R -e "install.packages('readr', dependencies=TRUE, repos='http://cran.rstudio.com/')" +# R -e "install.packages('tools', dependencies=TRUE, repos='http://cran.rstudio.com/')" +# R -e "install.packages('ggplot2', dependencies=TRUE, repos='http://cran.rstudio.com/')" +# R -e "install.packages('reshape2', dependencies=TRUE, repos='http://cran.rstudio.com/')" +# R -e "install.packages('ComplexUpset', dependencies=TRUE, repos='http://cran.rstudio.com/')" +# - name: checkout repo content +# uses: actions/checkout@v2 +# - name: Download artifacts from HCMI +# uses: actions/download-artifact@v2 +# with: +# name: hcmi-files +# - name: Download artifacts from BeatAML +# uses: actions/download-artifact@v2 +# with: +# name: beataml-files +# - name: Download artifacts from DepMap +# uses: actions/download-artifact@v2 +# with: +# name: depmap-files +# # - name: Download artifacts from MPNST +# # uses: actions/download-artifact@v2 +# # with: +# # name: mpnst-files +# - name: Download artifacts from cptac +# uses: actions/download-artifact@v2 +# with: +# name: cptac-files +# # - name: Install coderdata and skip build steps +# # run: pip install coderdata +# # - name: Download cptac data from coder data +# # run: coderdata download --prefix cptac +# # - name: Download depmap data from coder data +# # run: coderdata download --prefix depmap +# # - name: Download all data from coder data +# # run: coderdata download +# - name: Create all-files directory +# run: mkdir all-files +# - name: List files cwd +# run: ls -lah +# - name: List files dataSummary dir +# run: ls -lah dataSummary +# - name: Gzip all non-samples csv files in current dir. +# run: | +# find . -type f -name '*.csv' ! -name '*samples*' -exec gzip -k "{}" + +# - name: Run Visualization01 +# if: success() || failure() +# run: Rscript dataSummary/visualization01.R +# - name: Run Visualization02 +# if: success() || failure() +# run: Rscript dataSummary/visualization02.R +# - name: setup data-vis dir +# if: success() || failure() +# run: | +# mkdir -p data-vis +# rsync -av --remove-source-files --include='*.png' --include='*.pdf' --include='*table.csv' --exclude='*' . data-vis/ +# - name: Upload artifacts +# if: success() || failure() +# uses: actions/upload-artifact@v2 +# with: +# name: data-vis +# path: data-vis + +# data-visualization-save-to-docs: +# if: github.actor != 'github-actions[bot]' +# needs: [data-visualization] +# environment: build +# runs-on: ubuntu-20.04 +# steps: +# - name: Checkout repo content +# uses: actions/checkout@v2 +# - name: Setup Git config and pull +# run: | +# git config user.name "jjacobson95" +# git config user.email "jeremy.jacobson3402@gmail.com" +# git pull +# - name: Download artifacts from data-vis +# uses: actions/download-artifact@v2 +# with: +# name: data-vis +# - name: List files cwd +# run: ls -lah +# - name: List files .. +# run: ls -lah .. +# - name: List files all +# run: ls -lah * +# - name: Move files to docs directory +# run: | +# rsync -av --remove-source-files --include='*.png' --include='*.pdf' --exclude='*' . docs/assets/stats +# rsync -av --remove-source-files --include='*table.csv' --exclude='*' . docs/_data +# # rsync -av --remove-source-files --include='*.png' --include='*.pdf' --include='*table.csv' --exclude='*' . docs/ +# - name: List files in docs after moving +# run: ls -lah docs +# - name: List files in local after moving +# run: ls -lah +# - name: Git add and push new changes. +# run: | +# git add -f docs/* +# git status +# if git diff --staged --quiet; then +# echo "No changes to commit" +# else +# git commit -m "Add data visualization artifacts to docs" +# git push +# fi +# gen-stats-and-push: +# if: github.actor != 'github-actions[bot]' +# needs: [build-hcmi, build-beataml, build-depmap, build-cptac, build-mpnst] +# environment: build +# runs-on: ubuntu-20.04 +# steps: +# - name: Checkout repo content +# uses: actions/checkout@v2 +# - name: Setup Git config and pull +# run: | +# git config user.name "jjacobson95" +# git config user.email "jeremy.jacobson3402@gmail.com" +# git pull +# - name: Download artifacts from HCMI +# uses: actions/download-artifact@v2 +# with: +# name: hcmi-files +# - name: Download artifacts from BeatAML +# uses: actions/download-artifact@v2 +# with: +# name: beataml-files +# - name: Download artifacts from DepMap +# uses: actions/download-artifact@v2 +# with: +# name: depmap-files +# # If this pipeline is supported in the future, Gen stats has been updated to include mpnst too. +# # - name: Download artifacts from MPNST +# # uses: actions/download-artifact@v2 +# # with: +# # name: mpnst-files +# - name: Download artifacts from cptac +# uses: actions/download-artifact@v2 +# with: +# name: cptac-files +# - name: Install coderdata +# run: | +# pip install coderdata +# pip install pyyaml +# - name: Run stats generation script +# run: | +# python scripts/gen_stats.py +# - name: Git add and push new changes if they exist. +# run: | +# git pull +# mv stats.yml docs/_data/stats.yml +# git add -f docs/_data/stats.yml +# git status +# if git diff --staged --quiet; then +# echo "No changes to commit" +# else +# git commit -m "Add stats.yml to docs/_data" +# git push +# fi + +# upload-to-figshare: +# if: github.actor != 'github-actions[bot]' +# needs: [check-hcmi-schema, check-beataml-schema, check-depmap-schema, check-cptac-schema, check-mpnst-schema] +# # needs: [build-hcmi, build-beataml, build-depmap, build-cptac, build-mpnst] +# environment: build +# runs-on: ubuntu-20.04 +# steps: +# - name: checkout repo content +# uses: actions/checkout@v2 +# - name: Download artifacts from HCMI +# uses: actions/download-artifact@v2 +# with: +# name: hcmi-files +# - name: Download artifacts from BeatAML +# uses: actions/download-artifact@v2 +# with: +# name: beataml-files +# - name: Download artifacts from CPTAC +# uses: actions/download-artifact@v2 +# with: +# name: cptac-files +# - name: Download artifacts from DepMap +# uses: actions/download-artifact@v2 +# with: +# name: depmap-files +# # - name: Download artifacts from MPNST +# # uses: actions/download-artifact@v2 +# # with: +# # name: mpnst-files +# - name: Create all-files directory +# run: mkdir all-files +# - name: List files cwd +# run: ls -lah +# - name: Move files to all-files +# run: | +# rsync -av --remove-source-files --include='*.csv' --include='*.tsv' --include='*.gz' --exclude='*' . all-files/ +# - name: gzip all files in all-files +# run: gzip all-files/* +# - name: gunzip all samples files in all-files +# run: gunzip all-files/*samples* +# - name: List files in all-files +# run: ls -lah all-files/ +# # - name: Upload to Figshare +# # # This can be updated to trigger with tag releases. +# # # run: python scripts/push_to_figshare.py --directory all-files --title "CODERData${{ github.event.release.tag_name }}" --token ${{ secrets.FIGSHARE_TOKEN_SECRET }} -p False +# # #This is a short term alternative. Links to branch. Not as pretty but okay for now. + +# # #To do: Extract version number from setup.py and run there. This can occur after merge with package dev branch. +# # run: python scripts/push_to_figshare.py --directory all-files --title "CODERData${{ github.ref }}" --token ${{ secrets.FIGSHARE_TOKEN_SECRET }} --project_id 189342 --publish +# - name: Extract version from setup.py +# id: version +# run: echo "PACKAGE_VERSION=$(grep 'version=' setup.py | sed -n "s/.*version='\(.*\)'.*/\1/p")" >> $GITHUB_ENV +# - name: Upload to Figshare +# run: python scripts/push_to_figshare.py --directory all-files --title "CODERData${{ env.PACKAGE_VERSION }}" --token ${{ secrets.FIGSHARE_TOKEN_SECRET }} --project_id 189342 --publish +# - name: List files in all-files +# run: ls -lah all-files/ +# - name: Setup Git config +# run: | +# git config user.name "jjacobson95" +# git config user.email "jeremy.jacobson3402@gmail.com" +# - name: Commit and push changes +# run: | +# git pull +# mv figshare_latest.yml docs/_data +# git add -f docs/* +# git status +# git commit -m "Add figshare_latest.yml to docs/_data" +# git push + # update-package-download-function: + # if: github.actor != 'github-actions[bot]' + # needs: [upload-to-figshare] + # environment: build + # runs-on: ubuntu-20.04 + # steps: + # - name: checkout repo content + # uses: actions/checkout@v2 + # - name: Update figshare path in downloader.py + # run: | + # python scripts/update_download_function.py -y docs/_data/figshare_latest.yml -d coderdata/download/downloader.py + # cat coderdata/download/downloader.py + # - name: Setup Git config + # run: | + # git config user.name "jjacobson95" + # git config user.email "jeremy.jacobson3402@gmail.com" + # - name: Commit and push changes + # run: | + # git pull + # git add coderdata/download/downloader.py + # git commit -m "update downloader.py" + # git push + + # run-tests: + # if: github.actor != 'github-actions[bot]' + # needs: [update-package-download-function] + # runs-on: ubuntu-latest + # strategy: + # fail-fast: false + # matrix: + # test-file: [ + # 'test_download_and_load_beataml.py', + # 'test_download_and_load_depmap.py', + # 'test_download_beataml_cli.py', + # 'test_download_depmap_cli.py', + # 'test_download_and_load_cptac.py', + # 'test_download_and_load_hcmi.py', + # 'test_download_cptac_cli.py', + # 'test_download_hcmi_cli.py', + # 'test_reformat_datasets.py', + # 'test_reload_one.py', + # 'test_reload_all.py', + # 'test_join_datasets.py', + # 'test_info.py' + # ] + # outputs: + # result: ${{ steps.test-outcome.outcome }} + # steps: + # - uses: actions/checkout@v2 + # with: + # fetch-depth: 0 + # - name: Set up Python + # uses: actions/setup-python@v2 + # with: + # python-version: '3.10' + # - name: Install dependencies + # run: | + # python -m pip install --upgrade pip + # pip install -r requirements.txt + # pip install pytest-xdist + # - name: Install as package + # run: | + # pip install . + # - name: Run test + # id: test-outcome + # run: | + # pytest -n 4 tests/${{ matrix.test-file }} + + # build-and-publish: + # if: github.actor != 'github-actions[bot]' + # needs: [run-tests] + # runs-on: ubuntu-latest + # environment: build + # steps: + # - uses: actions/checkout@v2 + # with: + # fetch-depth: 0 + + # - name: Fetch tags from main branch + # run: | + # git fetch origin 'refs/tags/*:refs/tags/*' + + # - name: Set up Python + # uses: actions/setup-python@v2 + # with: + # python-version: '3.10' + + # - name: Install dependencies + # run: | + # python -m pip install --upgrade pip + # pip install setuptools wheel twine packaging + + # - name: Update version + # run: | + # # Extract the current version from setup.py + # CURRENT_VERSION=$(grep -oP "version='\K[0-9]+\.[0-9]+\.[0-9]+" setup.py) + # echo "Current version: $CURRENT_VERSION" + + # # Fetch tags and get the latest tag, removing the 'v' prefix + # git fetch --tags + # LATEST_TAG=$(git describe --tags `git rev-list --tags --max-count=1` | sed 's/^v//') + # echo "Latest tag: $LATEST_TAG" + + # # Use Python to compare versions + # HIGHER_VERSION=$(python -c "from packaging.version import parse as parse_version; \ + # current = parse_version('$CURRENT_VERSION'); \ + # latest = parse_version('$LATEST_TAG'); \ + # print(current if current > latest else latest)") + # echo "Higher version: $HIGHER_VERSION" + + # # If current version is higher, increment patch version in setup.py + # if [ "$CURRENT_VERSION" == "$HIGHER_VERSION" ]; then + # IFS='.' read -r -a VERSION_PARTS <<< "$CURRENT_VERSION" + # PATCH=$((VERSION_PARTS[2] + 1)) + # NEW_VERSION="${VERSION_PARTS[0]}.${VERSION_PARTS[1]}.$PATCH" + # echo "Incremented version: $NEW_VERSION" + # sed -i "s/version='\([0-9]\+\.[0-9]\+\.\)[0-9]\+'/version='\1$PATCH'/" setup.py + + # # Commit and push the updated setup.py + # git config --local user.email "action@github.com" + # git config --local user.name "GitHub Action" + # git pull + # git add setup.py + # git commit -m "Increment version number to $NEW_VERSION [skip ci]" + # git push + # else + # echo "No version increment needed" + # fi + # - name: Build local and publish to PyPI + # env: + # TWINE_USERNAME: __token__ + # TWINE_PASSWORD: ${{ secrets.PYPI_TOKEN_SECRET }} + # run: | + # python setup.py sdist bdist_wheel + # twine upload dist/* --verbose + build-cellline-omics: + runs-on: ubuntu-latest + steps: + - name: Checkout + uses: actions/checkout@v3 + - name: Set up QEMU + uses: docker/setup-qemu-action@v3 + - name: Set up Docker Buildx + uses: docker/setup-buildx-action@v3 + - name: Login to DockerHub + uses: docker/login-action@v3 + with: + username: ${{ secrets.DOCKERHUB_USERNAME }} + password: ${{ secrets.DOCKERHUB_PASSWORD }} + - name: Build and push broad sanger omics + uses: docker/build-push-action@v3 + with: + file: ./build/docker/Dockerfile.broad_sanger_omics + tags: sgosline/broad-sanger-omics:latest + push: true + platforms: linux/amd64,linux/arm64 + build-cellline-exp: + runs-on: ubuntu-latest + steps: + - name: Checkout + uses: actions/checkout@v3 + - name: Set up QEMU + uses: docker/setup-qemu-action@v3 + - name: Set up Docker Buildx + uses: docker/setup-buildx-action@v3 + - name: Login to DockerHub + uses: docker/login-action@v3 + with: + username: ${{ secrets.DOCKERHUB_USERNAME }} + password: ${{ secrets.DOCKERHUB_PASSWORD }} + - name: Build and push broad sanger experiment + uses: docker/build-push-action@v3 + with: + file: ./build/docker/Dockerfile.broad_sanger_exp + tags: sgosline/broad-sanger-exp:latest + push: true + platforms: linux/amd64,linux/arm64 + build-genes: + runs-on: ubuntu-latest + steps: + - name: Checkout + uses: actions/checkout@v3 + - name: Set up QEMU + uses: docker/setup-qemu-action@v3 + - name: Set up Docker Buildx + uses: docker/setup-buildx-action@v3 + - name: Login to DockerHub + uses: docker/login-action@v3 + with: + username: ${{ secrets.DOCKERHUB_USERNAME }} + password: ${{ secrets.DOCKERHUB_PASSWORD }} + - name: Build and push genes + uses: docker/build-push-action@v3 + with: + file: ./build/docker/Dockerfile.genes + tags: sgosline/genes:latest + push: true + platforms: linux/amd64,linux/arm64 + build-hcmi: + runs-on: ubuntu-latest + steps: + - name: Checkout + uses: actions/checkout@v3 + - name: Set up QEMU + uses: docker/setup-qemu-action@v3 + - name: Set up Docker Buildx + uses: docker/setup-buildx-action@v3 + - name: Login to DockerHub + uses: docker/login-action@v3 + with: + username: ${{ secrets.DOCKERHUB_USERNAME }} + password: ${{ secrets.DOCKERHUB_PASSWORD }} + - name: Build and push hcmi + uses: docker/build-push-action@v3 + with: + file: ./build/docker/Dockerfile.hcmi + tags: sgosline/hcmi:latest + push: true + platforms: linux/amd64,linux/arm64 + build-cptac: + runs-on: ubuntu-latest + steps: + - name: Checkout + uses: actions/checkout@v3 + - name: Set up QEMU + uses: docker/setup-qemu-action@v3 + - name: Set up Docker Buildx + uses: docker/setup-buildx-action@v3 + - name: Login to DockerHub + uses: docker/login-action@v3 + with: + username: ${{ secrets.DOCKERHUB_USERNAME }} + password: ${{ secrets.DOCKERHUB_PASSWORD }} + - name: Build and push cptac + uses: docker/build-push-action@v3 + with: + file: ./build/docker/Dockerfile.cptac + tags: sgosline/cptac:latest + push: true + platforms: linux/amd64,linux/arm64 + build-mpnst: + runs-on: ubuntu-latest + steps: + - name: Checkout + uses: actions/checkout@v3 + - name: Set up QEMU + uses: docker/setup-qemu-action@v3 + - name: Set up Docker Buildx + uses: docker/setup-buildx-action@v3 + - name: Login to DockerHub + uses: docker/login-action@v3 + with: + username: ${{ secrets.DOCKERHUB_USERNAME }} + password: ${{ secrets.DOCKERHUB_PASSWORD }} + - name: Build and push mpnst + uses: docker/build-push-action@v3 + with: + file: ./build/docker/Dockerfile.mpnst + tags: sgosline/mpnst:latest + push: true + platforms: linux/amd64,linux/arm64 + build-beataml: + runs-on: ubuntu-latest + steps: + - name: Checkout + uses: actions/checkout@v3 + - name: Set up QEMU + uses: docker/setup-qemu-action@v3 + - name: Set up Docker Buildx + uses: docker/setup-buildx-action@v3 + - name: Login to DockerHub + uses: docker/login-action@v3 + with: + username: ${{ secrets.DOCKERHUB_USERNAME }} + password: ${{ secrets.DOCKERHUB_PASSWORD }} + - name: Build and push beataml + uses: docker/build-push-action@v3 + with: + file: ./build/docker/Dockerfile.beataml + tags: sgosline/beataml:latest + push: true + platforms: linux/amd64,linux/arm64 + build-upload: + runs-on: ubuntu-latest + steps: + - name: Checkout + uses: actions/checkout@v3 + - name: Set up QEMU + uses: docker/setup-qemu-action@v3 + - name: Set up Docker Buildx + uses: docker/setup-buildx-action@v3 + - name: Login to DockerHub + uses: docker/login-action@v3 + with: + username: ${{ secrets.DOCKERHUB_USERNAME }} + password: ${{ secrets.DOCKERHUB_PASSWORD }} + - name: Build and push upload + uses: docker/build-push-action@v3 + with: + file: ./build/docker/Dockerfile.upload + tags: sgosline/upload:latest + push: true + platforms: linux/amd64,linux/arm64 + + From 786689ffbeba4f4917f5c55f4b4aaafb579f634e Mon Sep 17 00:00:00 2001 From: Sara JC Gosline Date: Wed, 3 Jul 2024 07:49:06 -0700 Subject: [PATCH 45/45] Update build.yml --- .github/workflows/build.yml | 5 ----- 1 file changed, 5 deletions(-) diff --git a/.github/workflows/build.yml b/.github/workflows/build.yml index 1b4b96f4..682ddfe6 100755 --- a/.github/workflows/build.yml +++ b/.github/workflows/build.yml @@ -7,11 +7,6 @@ on: # Allows you to run this workflow manually from the Actions tab workflow_dispatch: -# Sets permissions of the GITHUB_TOKEN to allow deployment to GitHub Pages -permissions: - contents: write - pages: write - id-token: write jobs: build-cellline-omics: